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ABSTRACT OF DISSERTATION 
 
 
Redox Proteomics Identification of Oxidatively Modified Proteins and Their 
Pharmacological Modulation: Insights into Oxidative Stress in Brain Aging, Mild 
Cognitive Impairment 
 
 The studies presented in this work were completed with the goal of 
gaining greater insight into the roles of protein oxidation in brain aging and age-related 
cognitive impairment.  Aging is associated with the impairment of physiological systems 
such as the central nervous system (CNS), homeostatic system, immune system, etc.  
Functional impairments of the CNS is associated with increased susceptibility to develop 
many neurodegenerative diseases such as Alzheimer’s diseases (AD), Parkinson’s disease 
(PD), and amyotrophic lateral sclerosis (ALS). One of the most noticeable functional 
impairments of the CNS is manifested by cognitive decline. In the past three decades, the 
free radical theory of aging has gained relatively strong support in this area. Excessive 
production reactive oxygen species (ROS) was demonstrated as a contributing factor in 
age-related memory and synaptic plasticity dysfunction. This dissertation use proteomics 
to identify the proteins that are oxidatively modified and post-translationally altered in 
aged brain with cognitive impairment and normal aging brain. 
Ongoing research is being pursued for development of regime to prevent 
oxidative damage by age-related oxidative stress. Among which are those that scavenge 
free radicals by antioxidants, i.e. α-lipoic acid (LA), and protecting the brains by 
reducing production of neurotoxic substance, i.e. reducing production of amyloid β(Aβ). 
Therefore, proteomics were also used to identify the alteration of specific proteins in aged 
brain treated with LA and antisense oligonucleotides again amyloid protein precursor. 
This dissertation provides evidences that certain proteins are less oxidatively modified 
and post-translationally altered in cognitively impaired aged brain treated with LA and 
antisense oligonucleotides against the Aβ region of amyloid precursor protein (APP) 
(AO). 
Together, the studies in this dissertation demonstrated that increased oxidative 
stress in brain play a significant role in age-related cognitive impairment. Moreover, such 
increased oxidative stress leads to specific protein oxidation in the brain of cognitive 
impaired subject, thereby leading to cognitive function impairment. Moreover, the 
functional alterations of the proteins identified by proteomics in this dissertation may 
leads to impaired metabolism, decline antioxidant system, and damaged synaptic 
communication. Ultimately, impairment of these processes lead to neuronal damages and 
cognitive decline. This dissertation also show that several of the up-regulated and 
oxidized proteins in the brains of normal aging mice identified are known to be oxidized 
in neurodegenerative diseases as well, suggesting that the expression levels of certain 
proteins may increase as a compensatory response to oxidative stress. This compensation 
would allow for the maintenance of proper molecular functions in normal aging brains 
and protection against neurodegeneration.   
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CHAPTER ONE 
Introduction and Research Aims 
 The studies presented in this work were completed with the goal of gaining 
greater insights into the roles of protein oxidation in brain aging and age-related cognitive 
impairment. Aging, defined as the gradual alteration in structure and function that occurs 
over time, eventually leads to increased probability of non-disease or non-trauma related 
death (Ashok and Ali, 1999). Aging is associated with the impairment of physiological 
systems such as the central nervous system (CNS), homeostatic system, immune system, 
etc.  Functional impairments of the CNS are associated with increased susceptibility to 
develop many neurodegenerative diseases such as Alzheimer’s diseases (AD), 
Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). One of the most 
noticeable functional impairments of the CNS is manifested by cognitive decline. As 
most, but not all, people over age of 60 will attest, a decline in learning and memory is a 
part of the aging process (Barnes, 1988). Using various learning paradigms, these 
memory dysfunctions are recapitulated in aging rodents (Barnes, 1988).  Several theories 
have been offered to understand the phenomenon of aging. In the past three decades, the 
free radical theory by Harman (Harman, 1956) has gained relatively strong support in this 
area. Excessive production of reactive oxygen species (ROS) was demonstrated as a 
contributing factor in age-related memory and synaptic plasticity dysfunction (Lynch, 
1998). 
Increased ROS causes oxidative stress in the CNS of aged subjects (Poon et al., 
2004a, b). Oxidative stress is manifested by protein oxidation in the CNS. Protein 
oxidation is an exothermic event where peptides react with ROS. This reaction is mainly, 
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though exclusively, mediated by the OH· free radicals, which is mostly produced by the 
Fenton reaction through the decomposition of H2O2 in the presence of redox metals (Cu+ 
and Fe+) (Butterfield and Stadtman, 1997). Free radicals can attack peptides at two 
locations: back bone and side-chain. Both of these oxidative modifications of proteins 
generally cause the loss of catalytic or structural function in the affected protein and 
contribute serious deleterious effects on cellular and organ functions (Levine and 
Stadtman, 2001). It should be noted that the oxidative modification of proteins during 
aging and age-related neurodegenerative disorders is specific (Stadtman, 1992; Agarwal 
and Sohal, 1994; Agrawal et al., 1996; Butterfield and Stadtman, 1997; Stadtman, 2001; 
Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003; Keller et al., 2004; 
Poon et al., 2004d).  
Although protein oxidation in aged brain is well established, little is known about 
the specific proteins that are oxidatively modified in age brain. Therefore, it is the 
intention of this dissertation to identify the proteins that are oxidatively modified and 
post-translationally altered in aged brain. Moreover, this dissertation will also identified 
the proteins that are oxidatively modified and post-translationally altered in aged brain 
with cognitive decline.  
Ongoing research is being pursued for development of regime to prevent 
oxidative damage by age-related oxidative stress. Among which are those that scavenge 
free radicals by antioxidants, i.e. α-lipoic acid (LA) (Butterfield et al., 2002e; Butterfield 
et al., 2002b); protecting the brains by reducing production of neurotoxic substance, i.e. 
reducing production of amyloid β(Aβ) (Poon et al., 2004c). Interestingly, administration 
of LA and reducing production of Aβ can improve the cognitive impairment observed in 
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aged subjects (Ingram et al., 1987; Stoll et al., 1993; Castorina and Ferraris, 1994; Kumar 
et al., 2000b; Farr et al., 2003). However, little is known about the mechanism of the 
beneficial effects of these stratergies on brain aging. Therefore, we hypothesize that the 
beneficial effects of these stratergies are due to alteration of specific proteins in aged 
brain. This dissertation provides evidences that certain proteins are less oxidatively 
modified and post-translationally altered in cognitively impaired aged brain treated with 
LA and antisense oligonucleotides against the Aβ region of amyloid precursor protein 
(APP) (AO).  
In summary, this dissertation address the following questions: 
1. Does oxidative stress play a role in age-related cognitive impairment? 
2. Does oxidative stress leads to specific protein oxidation in the brain of cognitive 
impaired subject, thereby leading to cognitive function impairment? 
3.  Which proteins are oxidatively modified and post-translationally altered in the 
aged brain with cognitive impairment and how these proteins contribute to the 
functional impairment observed in aged brain? 
4. Which protein are less oxidatively modified and altered in the aged rodent brain 
treated with LA and AO and how these proteins contribute to the improvement of 
the functional impairment in aged brain? 
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CHAPTER TWO 
Background 
2.1 Biochemistry of Aging 
 One of the most fascinating topics that have interested philosopher and scientist 
for centuries is aging. Over the past two decades, the interest in the aging process has 
remarkably accelerated due to the increasing percentage of the elderly population and 
their used of a disproportionate prevent of heath care costs (Knight, 2000). 
What is aging? Although the term aging is generally understood in broad terms, 
the aging process itself is extremely complex.  Therefore it is useful to define the term 
aging early in this dissertation. It is note worthy that no single definition of aging is 
universally accepted. Aging was defined as a deleterious, progressive, intrinsic, and 
universal process (Harman, 1981), which is a progressive accumulation of alteration as a 
function of time associated with or responsible for the ever-increasing susceptibility to 
age-related disease and death (Harman, 1981). Therefore, aging process is manifested in: 
(a) progressive decreased in most, if not all, physiologic functions; (b) atrophy of most 
organs; (c) increased susceptibility to infection, trauma and various immune 
abnormalities; (d) increased susceptibility to malignancy; and (e) decreased capacity of 
gas exchange during respiration.   
2.1.1 Theories of Aging 
 Although the specific biologic basis of aging remains ambiguous, it is generally 
agreed that aging phenotype can be explained in molecular level. Moreover, these 
explanations should also consistently explain the life span differences between species 
and the fact the non-dividing cells (e.g., neurons and myocytes) undergo a relatively 
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uniform functional decline with age. Numerous theories have been proposed to 
understand the phenomenon of aging. A credent theory of aging should able to (a) 
explain how the loss of homeostasis occurs in aged individual organisms; (b) account for 
the life-span variation among cohort genetic strains and species; (c) identify the crucial 
factor(s) responsible for life-span extension by genetic mutation or experimental 
regimens such as caloric restriction (CR); (d) demonstrate that variation of senescent 
factors can manipulate the rate of aging (Sohal et al., 2002). It should be emphasized that 
there is not a single theory can entirely explain the aging phenomenon. Current theories 
of aging can be classified into stochastic, developmental, genome-based and free radicals 
(Knight, 2000). The current theories of aging and their brief description are sumaized in 
Table 2.1. However, in the past three decades, the free radical theory by Harman 
(Harman, 1956) has gained relatively strong support. It was suggested that aging is due to 
a combination of several theories, the free radical theory of aging presumably being the 
most important, while other theories may play a definite role.  
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 Table 2.1 Theories of Aging 
 A. Stochastic  
1. Somatic mutation   
Surrounding insult, such as background radiation and endogenous mutagens cause 
genetic loci alteration, thereby leading to critical functions failure and cell death. 
2. Error catastrophe   
Random errors during translation or transcription cause erroneous chromosomal proteins 
that sequentially lead to abnormal protein synthesis and cell death. 
3. Protein glycosylation   
Nonenzymatic reactions between glucose and biomolecules, such as protein and DNA, 
cause structural alterations and dysfunctions of these molecules, thereby cell death. 
 B. Developmental  
1. Immune   
A decline in ummunolgical function with increasing age cause older inducuduals more 
susceptible to infectious disease. 
2. Neuroendocrine   
A decline in hyohthalamic-pituitary system cause the functional decline in the endocrine 
target organs as founction of age. 
 C. Genome-based  
1. Intrisic mutagenesis   
Specific genetic constitutions regulate the fidelity of the genetic material and its 
replication, thereby regulates the rate of mutation or errors, and thus the life span 
2. Progammed   
Genes carry specific instructions that control growth, maturation, decline and death. 
 D. Free radical  
Producation of reactive free radical causes damages to biomacromolecules, thereby 
leading to cellullar dysfunction and cell death. 
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2.1.1.1 Free Radical Theory 
The free radical theory aging of postulates that the free radical reactions with 
biomolecules, such as proteins and lipid membranes, are responsible for the functional 
deterioration related to aging (Harman, 1969). The free radical theory of aging has gain 
significant support due to the following reasons: (a) it fulfill most of the requirement to 
define the aging process; (b) it provides an excellent model for molecular and 
mechanistic investigation; (c) it provides testable experimental approaches; and (d) it 
provides the best molecular explanation for the interaction between aging and age-related 
disease (Yu and Yang, 1996). This theory was later refined that mitochondria play a key 
role in aging as the major source of oxidants and a target for their damages (Miquel et al., 
1980).  It was proposed that there is a correlation between mitochondrial oxidant 
production and longevity in mammalian species (Miquel et al., 1980). Since O2 is used by 
aerobic organisms for energy, generation and leakage of free electrons from mitochondria 
is inevitable. When oxygen is partially reduced by these electrons, free radicals are 
formed to attack cell components. The free radicals can then form longer half-lives toxic 
species that travel distant from where the free radicals were produced. These toxic 
species and free radicals are collectively called reactive oxygen species (ROS) and 
reactive nitrogen species (RNS). ROS and RNS have the capacity to modify proteins, 
lipids and nucleic acids to develop or enhance age-related manifestations.  
Several antioxidant defense mechanisms have evolved to protect cell components 
from the attacks of ROS and RNS. The three main mechanisms in organisms include: (a) 
scavenging ROS/RNS and their precursors; (b) binding catalytic metal ions needed for 
ROS formation; and (c) generating and up-regulating endogenous antioxidant defenses. 
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Two major groups of endogenous antioxidant are low molecular weight antioxidants 
compounds, e.g., vitamin C and E, lipoic acid and ubiquinones, and antioxidant enzymes, 
e.g., superoxide dismutases (SOD), superoxide reductases (SOR), catalase , glutathione 
peroxidases (GPx), as well as many heat shocks proteins (Gilgun-Sherki et al., 2001). 
Oxidative stress is described as the inbalance state that the production of ROS and RNS 
exceed the capacity of these antioxidant defense systems.  
2.1.2 Brain Aging  
2.1.2.1 Neuronal Loss and Cell Growth 
 Declined brain volume and weight, enlarged ventricles, and narrowed gyri and 
sulci are the most noticeable changes in aged human brain. Moreover, large neurons (> 
90 μm) appear to atrophy. However, the total number of neurons, neuronal density, and 
percentage of cell area in the cerebral cortex are unchanged with normal aging (Terry et 
al., 1987) as number of small neurons (< 40μm) increased in aged brain.  Progressive 
increased in the number of atrophic neurons and glial cell are also demonstrated after 55 
years of age (Terry et al., 1987). In contrast to cerebral cortex, progressive loss of 
dopaminergic neurons in substantia nigra (CN) begin at 30 years of age, indicating that 
aging clearly does not affect all brain region equally (Rogers and Bloom, 1985). 
   In aged rodents, approximately 20% of cell loss is observed in their CN, and less 
than 20% of neuronal loss is observed their hippocampus (HP) (Morgan et al., 1987). The 
specific subfield (e.g., CA1 and CA3) of HP which lose neurons during aging are 
correlated to those that are selectively vulnerable to metabolic encephalopathies, 
suggesting that certain neurons are more susceptible to aging and pathology. 
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While certain brain regions show minor neuronal losses, others show major 
neuronal loss. Despite the loss of neurons, the functional capacity of central nervous 
system cricuts is well preserved. The neuronal loss triggers the surviving cells to sprount 
and replace lost connection in the aged CNS. Consistent with this notion, reactive 
synaptogenesis is observed in injured aged mice (Coleman and Flood, 1986). Moreover, 
dendritic arbors continue to grow between middle and old aged in brain regions that show 
neuronal loss (Cotman and Anderson, 1988).  Therefore, compensatory mechanisms of 
growth and remodeling may be part of the lifelong program to maintain and adapt brain 
function. 
2.1.2.2 Neurochemical Alteration 
 Although acetylcholine is a minor neurotransmitter in the CNS quantitatively, it 
plays a significant role in intellectual activity, including memory.  Despite no changes of 
either choline or acetylcholine content, the in vivo and in vitro synthesis, release and 
choline uptake are decreased in aged brain (Gibson et al., 1981). The number of 
muscarinic receptor and the sensitivity of hippocampal pyramidal cell to acetylcholine 
are also declined as a function of age (Gilgun-Sherki et al., 2001). Moreover, alteration in 
the glycolytic enzymes causes decline in glycolysis, thereby decreasing the level of acetyl 
coenzyme A, which is the key substrate for acetylcholine synthesis (Meier-Ruge et al., 
1984). These studies suggest that cholinergic transmission is diminished in aged brain, 
although no direct electrophysiological evidence has been reported. It is possible that 
various regulatory mechanisms compensate for loss of specific measures. 
 Pre- and postsynaptic dopamine metabolisms are selectively altered in aged brain. 
Synthesis of dopamine is decreased with age in the nigrostriatal stem and in the nucleus 
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accumbens (Giaquinto, 1988), and levels of dopamine and number of dopamine-
containing neurons are declined in advance age subjects (Morgan et al., 1987). Moreover, 
the activity of the dompamine-degrading enzyme, monoamine oxidase, decreases as a 
function of age in brain. The density of dompamine D2 receptors are also decreased both 
in aged human and rodent.  Another neurochemical, norepinephrine (NE), are synthesized 
by dompamine-beta-hydroxylase (DBH) from dopamine. Therefore, many of the age-
related changes in dompamine are also found in NE. However, no alteration of DBH 
activity is observed in striate nor in the substantia nigra (Morgan et al., 1987). However, 
the NE level is decreased in the brain stem, hypothalamus and hippocampus (Morgan et 
al., 1987).   
 Gamma-amminobytyric acid (GABA) is the most widely distributed 
neurotransmitter in the CNS. The synthesis of GABA is decreased in in cerebellum, 
substantia nigra and hippocampus (Giaquinto, 1988). GABA is synthesized from 
glutamate, the neurotransmitter in most of the excitatory synapses and appears to be 
involved in age-related functional alteration, such as motor behavior, cognition and 
emotion. Glutamate level is decreased in cerebral cortex and hippocampus in aged 
animals, although it may be mainly a consequence of alteration in metabolic activity 
rather than glutamatergic neurotransmission (Segovia et al., 2001). Although, there is no 
change in glutamate release during aging, reduced glutamate uptake and loss in glutamate 
transporters in glutamatergic terminals are demonstrated in aged rats. Therefore, the lack 
of changes in glutamate release may be due to compensatory alteration in glutamate 
uptake. Moreover, decrease in the density of glutamatergic NMDA receptors is 
 10
consistently reported in aged brain (Segovia et al., 2001), suggesting the glutamate 
neurotransmission alteration in aged brain. 
2.1.2.3 Calcium Ion Dysregulation 
 The regulation of Ca2+ and its compartmentalization is essential to synaptic  
events, such as transmitter release, excitablility and second-messanger responses) . Ca2+ 
homeostatsis response differently to aging in different brain compartment, suggesting 
age-related Ca2+ regulation is impaired in age brain (Gibson and Peterson, 1987). Only 
1/10,000th of total neuronal Ca2+ is in cytosolic. This cytosolic Ca2+ is the  physiological 
active pool of Ca2+, thus dysregulation of the homeostasis of the 
intracellular/extracellular in neuron  could cause deleterious changes in neuronal function 
by altering receptor mobility the coupling of receptors with enzymes involve in 
phosphoinositide hydrolysis, the function of GTP-binding proteins, Ca2+ transport 
systems, Ca2+ binding proteins, and Ca2+-activated protease (Gibson and Peterson, 1987). 
For example, the Ca2+ activated protease, calpain, is present in high concentration in 
selectively vulnerable neuron in aged brain (Baudry et al., 1986). Moreover, prolong Ca2+ 
dependent K+-mediated hyperpolarization after repetitive stimulation is demonstrated in 
hippocampal brains slices from aged rats (Gibson and Peterson, 1987). These studies 
suggest that free Ca2+ in hippocampal neurons is dysregulated in age brain. It was 
suggests that the changes of Ca2+ homeostatic and Ca2+ signaling pathways are underlie 
the development of these biological markers of aging (Foster and Kumar, 2002).  
2.1.2.4 Energy Metabolism Impairment 
 Synthesis of adenosine triphosphate (ATP) by neuron and glia is critical to the 
normal brain function. There are only slight declines in energy metabolism in the 
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sensory-related areas of aged rats with few age-related neuropathological changes 
(Cotman and Peterson, 1989). Moreover, positron emission tomography (PET) studies 
show that cerebral metabolic rate and cerebral blood flow were reduced in aged brain 
when elderly subjects with diseases were not excluded (Cotman and Peterson, 1989). 
However, the brain oxidative metabolism does not change significantly with age in the 
subjects that are cognitively intact and disease free (Duara et al., 1984). These studies 
demonstrate that metabolic impairment in age brain is not an universal pheromone, 
metabolism in aging can be preserved in healthy individuals.   
2.1.2.5 Protein Abnormality  
  Protein abnormality in age brain was manifested by structure called neuritic or 
senile plaques. These protein structures accumulate with age in the neuropil of frontal 
cortex and hippocampus (Cotman and Peterson, 1989). These plaques (20-50 μm in 
diameter) are involved in the enlarged axonal and dendritic processes that sprout and 
dengerate. More over the degenerating neurites was surrounded by extracellular protein 
aceous filaments called β-amyloid (Aβ). Senile plaques are present in brain of primates, 
dogs and polar bears, but not rats.  
 Another abnormal protein inclusion is neurofibrillary tangles (NFT), which is 
increased with advancing age. NFT are composed of primary microtubule-associated 
protein tau (tau) and other insoluble proteins (Kosik et al., 1986). NFT are found in 
normal aged brain, and the number of NFT increased during the ninth and tenth decades 
of life.  
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2.2 Supports for the Free Radical Theory in Brain Aging 
2.2.1 Free Radical Production 
 Mitochondria are the most significant source of oxidants in cells because 
approximately 1-2 % of electrons flow through the electron transport chain results in 
generation of free raidcals (Calabrese et al., 2000a). Moreover, various toxins in the 
environment can injure mitochondrial enzymes, leading to increased generation of free 
radicals that play important major roles in aging (Ventura et al., 2002). It was reported 
that the low abundant mitochondria in aged animals are enlarged with vacuolization, 
cristae rupture and accumulation of paracrystalline inclusions [6]. Lacking many 
endogenous antioxidant mechanisms, mitochondria depend on glutathione (GSH) to 
remove H2O2 (Fernandez-Checa et al., 1998; Coll et al., 2003). Therefore, the role of 
mitochondria in free radical formation is likely  a major contributor to aging (Calabrese et 
al., 2001).  As a source of these toxic oxidants, mitochondria are also potential victims of 
free radicals (Sastre et al., 2003), and mitochondrial decay is also a main contributor of 
acceleration of aging (Atamna et al., 2002; Ames, 2003). Accumulation of mtDNA 
mutations during life is a major cause of age-related disorders. The high mutagenic 
propensity of mtDNA derives from its lack of introns and protective histones, which 
limits nucleotide excision and recombination DNA repair mechanisms; and its location in 
the inner mitochondrial membrane, which exposes mtDNA to an enriched free radical 
milieu. mtDNA mutations increase as a function of age in brains and muscles. Age-
related increase in mtDNA deletion (common deletion) was found in elderly brain and in 
PD (Ozawa et al., 1990). Common deletion removes a 5-kb region of mtDNA that 
encodes for six essential polypeptides of the respiratory chain and five tRNAs. Relevant 
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to mitochondrial bioenergetics is the diminishment of state 3/state 4 ratio in aged brains 
(Barja, 1999). This ratio relates to the coupling efficiency between electron flux through 
the electron transport chain and ATP production.  An increase in state 4 would result in a 
more reductive state of mitochondrial complexes and, consequently, to an increase in free 
radical species production. Therefore, a decrease in the state 3/state 4 ratio during aging 
indicates increase free radical production, which is associated with a significant decrease 
in cardiolipin content in brain mitochondria (Ruggiero et al., 1992).  
2.2.1.1 Reactive oxygen species (ROS) 
 The terms “free radicals” and “ROS” are commonly used synonymously. 
However, it should be made clear that ROS refer to a number of chemically reactive 
molecules derived from ground-state oxygen (O2) (Halliwell, 1996; Fridovich, 1999; 
Halliwell, 1999a; Betteridge, 2000), while free radicals refer to the low molecular weight 
molecules with at least one unpaired electron (Nordberg and Arner, 2001). ROS include 
superoxide (O2·-), hydroxyl radical (HO·), hydrogen peroxide (H2O2), and hypochlorous 
acid (HOCl); H2O2 is not a free radical, yet is still considered as ROS.  ROS vary in their 
reactivities and toxicities, two terms that are not necessary equal (for example, H2O2 is 
less reactive, but more toxic than O2·- because of its ability to penetrate biological 
membranes). Figure 2.1 summarizes the formations and metabolisms of ROS at the 
intracellular level. We will individually discuss four major forms of ROS in terms of their 
pathways and cellular effects. 
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Figure 2.1 
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2.2.1.1.1 Superoxide (O2·-) 
 Significant amounts of O2·- are produced by the reaction of O2 with a escaped 
electron from the respiratory chain in mitochondria (Nordberg and Arner, 2001) 
(Reaction 1): 
   O2 + e- ? O2·-      (Reaction 1) 
 O2·- can also be produced endogenously by flavoenzymes such as xanthine 
oxidase (Kuppusamy and Zweier, 1989), lipoxygenase, and cyclooxygenase (Kontos et 
al., 1985; McIntyre et al., 1999). The NADPH-dependent oxidase complex in phagocytic 
cells liberates large amounts of O2·- (Babior, 1999; Nauseef, 1999) during bacterial 
infections to defend against intruding bacteria (Thomas et al., 1988). In non-phagocytic 
cells, a similar NADPH-dependent oxidase complex is believed to involved in cell 
signaling (Thannickal and Fanburg, 2000). 
 Since O2·- is an anion and a modestly reactive compound, it requires a specific 
transport system acts to penetrate lipid membranes to produce further damage. O2·-, as 
well as its damages, are usually enclosed in the compartments where this free radical 
anion is produced; therefore, superoxide radical anion is considered to be less toxic 
compared to HO· (Nordberg and Arner, 2001). 
2.2.1.1.2 Hydrogen peroxide (H2O2)  
 In among other reactions, H2O2 is produced when cells try to detoxify O2·- 
(Reaction 2) by Cu,Zn-superoxide dismutases (SOD) in cytosol, or Mn-SOD in 
mitochondria (McCord and Fridovich, 1969; Yost and Fridovich, 1973; Fridovich, 1997).  
2O2·- + 2H+ ? 2H2O2 +O2   (Reaction 2) 
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Besides serving as an intermediate of detoxifying pathway of O2·-, H2O2 is also proposed 
to be an intracellular signaling molecule (Sundaresan et al., 1995; Chae et al., 1999a).  
H2O2 can remodel the structure of (Choi et al., 2001) and activate a transcription factor, 
which is responsible for initiating the transcription of a number of antioxidant genes, in 
E. Coli (Aslund et al., 1999) and yeast (Carmel-Harel et al., 2001).  H2O2 is removed by 
antioxidant enzymes, such as catalase, gluthathione peroxidases, and peroxiredoxins, 
once it was produced (Chae et al., 1999b; Chen et al., 1999; Guerra et al., 2000) 
(Reaction 3): 
2H2O2 ? 2H2O + O2     (Reaction 3) 
However, when the rate of H2O2 production exceeds the rate of Reaction 3, H2O2 
accumulates and becomes toxic to cells because of its oxidative nature. Accumulation of 
H2O2 can also lead to formation of HO· (Halliwell, 1987, 1999b) and HOCl (Winterbourn 
et al., 2000) described below. 
2.2.1.1.3 Hypochlorous acid (HOCl) 
 HOCl is formed by the enzymatic reaction of H+, Cl- and H2O2 catalzed by 
myeloperoxidase (Rossi et al., 1985) (Reaction 4) 
   H+ + Cl- + H2O2 ? HOCl + H2O  (Reaction 4) 
 Myeloperoxidase is expressed in the phagosomes of neutrophils (Winterbourn et 
al., 2000) to produce HOCl as an antimicrobial agent for elimination of bacteria ingested 
by the phagocyte. It was found that HOCl terminates the bacterial DNA replication by 
destroying the DNA anchoring at the bacterial membrane (Rossi et al., 1985).  
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2.2.1.1.4 Hydroxyl radical (HO·) 
 HO· can be produced spontaneously by either reaction of HOCl with O2·- 
(Reaction 5), or metal ion-meidated catalytic reactions (Reaction 6 and 7) (Nordberg and 
Arner, 2001): 
   HOCl + O2·- ? O2 + HO· + Cl-   (Reaction 5)  
HOCl + Fe2+ ? HO· + Cl- + Fe3+   (Reaction 6) 
   HOCl  + Cu+ ? HO· + Cl- + Cu2+   (Reaction 7) 
However, the steady-state concentration of HOCl is generally low due to its high 
reactivity. Therefore, except in activated phagocytes, Reaction 5 seems unlikely to be a 
significant source of HO· radicals (Mikkelsen and Wardman, 2003). 
Formation of HO· from H2O2 through Fenton reactions (Reaction 8 and 9): is also 
catalyzed by the metal ions (Fe2+ or Cu+) bound to proteins or other molecules  
   H2O2 + Fe2+ ? HO· + OH- + Fe3+   (Reaction 8) 
   H2O2 + Cu+ ? HO· + OH- + Cu2+   (Reaction 9) 
 Only small amount of metal ions are needed for Reaction 8 and 9 because the 
metals ions are recycled by reacting with O2·- (Reaction 10 and 11): 
   O2·-  + Fe3+ ? O2 + Fe2+    (Reaction 10) 
   O2·-  + Cu2+ ? O2 + Cu+   (Reaction 11) 
 The net reaction that H2O2 reacts with O2·- to yield HO·, OH- and O2 is 
collectively called the Haber-Weiss reaction (Reaction 12) (Nordberg and Arner, 2001): 
   H2O2 + O2·- ? O2 + HO· + OH-   (Reaction 12) 
 It was proposed that the metal ions in the in vivo Haber-Weiss reaction are 
released from ferritin (Harris et al., 1994) and the co-factor of different dehydrolases by 
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reaction of O2·- (Fridovich, 1997).  HO· is considered one of the most toxic free radicals 
among other ROS because of its high reactivity, short half-life, and irreversible 
modification of lipid, protein and DNA (Halliwell, 1987; Betteridge, 2000).  
2.2.1.2 Reactive Nitrogen Species (RNS)  
RNS refer to nitric oxide (NO) and molecules derived from NO, such as 
peroxynitrite (-OONO), and nitrogen dioxide (NO2). Although RNS have different 
reactivities from each other, their half-lives of RNS are generally longer than HO· and 
O2·- (Balazy and Nigam, 2003).  The pathways for formation and metabolism of RNS in 
intracellular level are shown in Figure 2.2. 
2.2.1.2.1 Nitric oxide (NO)  
 NO is synthesized enzymatically by NO synthase (NOS). Presently, there are 
three distinct isoforms of NO synthases: neuronal (nNOS), inducible (iNOS), and 
endothelial (eNOS). iNOS is different from the other isoforms because of its permanent 
calmodulin binding and Ca2+-independent expression (Andrew and Mayer, 1999; Beck et 
al., 1999; Bredt, 1999; Kroncke et al., 2000; Drew and Leeuwenburgh, 2002). By using 
an electron from NADPH (C21H30N7O17P3), NOS catalytically oxidizes L-arginine 
(C6H14N4O2) to form L-citrulline (C6H13N3O3) with NO as a by-product (Reaction 13) 
(Andrew and Mayer, 1999; Beck et al., 1999; Bredt, 1999):  
 
C6H14N4O2 + O2 + C21H27N7O17P3? C6H13N3O3 + NO + C21H26N7O17 P3+ + e-  
         (Reaction 13) 
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 NO has a long half-life (1-10s) when compared to that of O2·- (10-8s) and HO· (10-
9s) (Balazy and Nigam, 2003). Therefore, the reaction between NO and other free 
radicals, such as O2·- and HO·, stabilizes these free radicals. As a result, it was proposed 
that NO can function as a free radical scavenger; evidences showed that low dose of NO 
can inhibit lipid peroxidation in cell membranes (Hogg and Kalyanaraman, 1998; Rubbo 
et al., 2000).   
 In normal physiological concentration, NO serves as an intracellular messenger 
for guanylate cyclase and protein kinase (Ignarro, 1990). However, the stability of NO 
enables it to travel across cell membranes and even transmit the signals intercellularly. 
When iNOS is induced by endotoxin, large amounts of NO are produced to control the 
cellular function by redox reaction (Ignarro, 1990). 
NO is removed by conjugation with glutathione. However, when glutathione 
levels are depleted, such as in aging (Liu and Mori, 1993; Hussain et al., 1995), excessive 
NO can nitrosylate protein, to cause dysfunction, or it can react with other reactive 
molecules to form other RNS causing further damages to cells. 
 20
Figure 2.2 
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2.2.1.2.2Peroxynitrite (-OONO) 
NO reacts with O2·-, it form –OONO which has a half-life of 0.9s (Reaction 14) 
(Balazy and Nigam, 2003): 
   NO + O2·- ? -OONO    (Reaction 14) 
When the NO concentration is sufficiently high, such as in stimulated leukocytes, 
the rate of reaction 14 is greater than 109 M-1s-1 (Balazy and Nigam, 2003). At this rate, 
Reaction 14 can be faster than the dismutation of O2·- by SOD. Therefore, Reaction 14 
competes with SOD for O2·- to form –OONO (Beckman and Koppenol, 1996). –OONO 
can then undergo homolysis to form HO· to damage cells. Studies have revealed that –
OONO also play a role in age-associated oxidative stress (van der Loo et al., 2000; Imam 
and Ali, 2001) by initiating fatty acids transformation through peroxidation, epoxidation 
and nitration (Radi et al., 1991; Balazy, 1994; O'Donnell et al., 1999).   
2.2.1.2.3 Nitrogen dioxide (NO2) 
Increased production of –OONO leads to auto-homolysis into HO· and NO2 in the 
acidic conditions provided by the cellular CO2 concentration (Meli et al., 2002) (Reaction 
15): 
   -OONO + H+ ? HO· + NO2   (Reaction 15)  
Although it was shown that decomposition of –OONO is the major source of NO2, 
NO2 can also be produced through the direct oxidation by O2 (Balazy and Nigam, 2003) 
(Reaction 16) 
2NO + O2 ? 2NO2     (Reaction 16) 
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NO2 oxidatively modifies lipids (Singh et al., 1998; Goss et al., 1999; Jiang et al., 
1999), suggesting NO2 may also contribute to the initiation of oxidative damage in 
tissues. 
It should be noted that not all of ROS and RNS have been discussed above. Nor 
have other reactions been described, such as rearrangement of –OONO forming NO3- and 
carboxylation of –OONO forming ONOOCO2-, which also are important in ROS and 
RNS formations. Recently, carbon monoxide (CO) has drawn attention because, like NO, 
this gas binds to guanylate cyclase to activate cGMP (Verma et al., 1993; Maines, 1997). 
Binding of CO to guanylate cyclase was abolished by a potent heme oxygenase inhibitor, 
but not by NOS inhibitors (White and Marletta, 1992; Glaum and Miller, 1993). Heme 
oxygenase (HO) is a CO synthetic enzyme with 60% homology to the carboxyl terminal 
of NOS at the amino acid level (Foresti and Motterlini, 1999), suggesting CO plays a 
similar role as NO in the signal transduction mechanism to regulate intercellular 
communication (Graser et al., 1990). HO inhibition increases NO production in mouse 
when macrophages are exposed to endotoxin (Wang and Wu, 2003), indicating that CO 
plays a significant role of in regulating NO generation. On-going research is aimed to 
understand the relation between CO and NO. Another important point to be noted is that 
ROS and RNS are not necessarily harmful to normal cellular functions, such as defense 
against infection and cellular signaling (Nordberg and Arner, 2001), but they are 
essential. It is the excessive amounts of ROS and RNS that exceed the capacity of the 
antioxidant defense system, creating an imbalanced oxidative system that causes damage 
to cells.  
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2.2.2 Antioxidant Defense 
 ROS and RNS have the capacity to modify proteins, lipids and nucleic acids to 
develop or enhance the age-related manifestations. Fortunately, living organisms 
developed several mechanisms to protect themselves from the attack of ROS and RNOS. 
These antioxidant defense mechanisms include: (a) scavenging ROS/RNOS and their 
precursors; (b) binding metal ions needed for catalyzed ROS; (c) generating and up-
regulating the endogenous antioxidant defenses. Two major groups of antioxidant 
defense systems are low molecular weight antioxidant compounds, e.g vitamin C and E, 
lipoic acid and ubiquinones, and anitoxidant enzymes, e.g. superoxide dismutases (SOD), 
superoxide reductases (SOR), catalases , glutathione peroxidases (GPx) (Gilgun-Sherki et 
al., 2001). When the production of ROS and RNOS exceed the capacity of the 
antioxidant defenses systems, the new state is named oxidative stress.  
Two of the major endogenous antioxidant defense systems are heat shock proteins 
and glutathione. Reduced glutathione (GSH) is the most prevalent non-protein thiol in 
animal cells. Its de novo and salvage synthesis maintain a reduced cellular environment. 
The tripeptide of glutathione is a co-factor for many cytoplasmic enzymes and also acts 
as an important post-translational modification in a number of cellular proteins.  The 
cysteine thiol acts as a nucleophile in both exogenous and endogenous reactions. 
Consequently, ROS are frequently removed by GSH in both spontaneous and catalytic 
reactions (Butterfield et al., 2002a; Butterfield et al., 2002e; Drake et al., 2002; Drake et 
al., 2003; Poon et al., 2004a). Since ROS have defined roles in cell signaling events as 
well as in human disease pathologies, an imbalance in expression of GSH and associated 
enzymes has been implicated in a variety of pathological conditions (Butterfield et al., 
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2002b; Calabrese et al., 2003a). GSH metabolism plays an important role in diseases such 
as cancer, neurodegenerative diseases and aging (Droge, 2002).  
Another antioxidant defense system is the heat shock response. In the CNS, heat 
shock protein (HSP) synthesis is induced by the alterations in the intracellular redox 
environment, exposure to heavy metals, amino acid analogs or cytotoxic drugs (Calabrese 
et al., 2003b; Calabrese et al., 2003a). While prolonged exposure to conditions of extreme 
stress is harmful, induction of HSP synthesis can result in increased stress tolerance and 
cytoprotection against stress-induced molecular damage (Calabrese et al., 2002b). Hence, 
the heat shock response contributes to establishing a cytoprotective state in a variety of 
metabolic disturbances, such as age-related neurodegenerative disease and aging 
(Motterlini et al., 2000; Calabrese et al., 2002a; Mayer, 2003). In aged animals, 
oxidatively modified proteins lead to protein aggregation, cell damage, and decreased 
function of organs. HSP, stress proteins or molecular chaperones play a role in protecting 
cells from damage through defense against denaturation or renaturing the denatured 
proteins. Therefore, alterations of the expression and activity of stress proteins are related 
to protein denaturation with aging. The details of HSP and glutathione are discussed 
below. 
2.2.2.1 Heat Shock Proteins  
 Heat shock proteins serve as chaperones that bind to other proteins and regulate 
their conformation, regulate the protein movement across membranes or through 
organelles, or regulate the availability of a receptor or activity of an enzyme. In 
mammalian cells the induction of the heat shock response requires the activation and 
translocation to the nucleus of one or more heat shock transcription factors which control 
 25
the expression of a specific set of genes encoding cytoprotective HSPs. In the nervous 
system, HSPs are induced in a variety of pathological conditions, including cerebral 
ischemia, neurodegenerative disorders, epilepsy and trauma. Expression of the gene 
encoding HSPs has been found in various cell populations within the nervous system, 
including neurons, glia and endothelial cells (Kelly and Yenari, 2002). HSPs consist of 
both stress-inducible and constitutive family members. Some of the known HSPs include 
ubiquitin, HSP10, HSP27, HSP32 (or HO-1), HSP47, HSP60, HSC70, HSP70 (or 
HSP72), HSP90 and HSP100/105. Most of the proteins are named according to their 
molecular weight.  
 The 70 kDa family of HSPs has been studied extensively. Included in this 
family are HSC70 (heat shock cognate, the constitutive form), HSP70 (the inducible 
form, also referred to as HSP72), GRP75 (a constitutively expressed glucose-regulated 
protein found in the endoplasmic reticulum). After a variety of CNS insults, HSP70 is 
synthesized at high levels and is present in the cytosol, nucleus and endoplasmic 
reticulum. Denaturated proteins are proposed to stimulate the HSP70 synthesis. 
Denaturated proteins activate heat shock factors (HSFs) by dissociating other HSPs that 
are normally bound to HSF (Calabrese et al., 2001). Free HSFs are then phosphorylated 
and form trimers to enter the nucleus. Once in the nucleus, they bind to heat shock 
elements (HSE) within the promoters of different heat shock genes leading to 
transcription and synthesis of HSPs. The synthesis of HSP70 is terminated when it 
becomes the most abundant single protein in a cell. HSP70 binds to denaturated proteins 
in an ATP-dependent manner. Recently, transgenic animals that overexpress the gene 
encoding HSP70 demonstrated that overproduction of HSP70 were reported to lead to 
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neuroprotection in several different models of CNS injury (Kelly et al., 2002).  Mild heat 
shock protects neurons against glutamate-mediated toxicity and protects astrocytes 
against injury produced by lethal acidosis (Narasimhan et al., 1996). Transfection of 
cultured astrocytes with HSP70 protects them from ischemia or glucose deprivation (Fink 
et al., 1997). Cytokine-induced nitrosative stress is associated with an increased synthesis 
of HSP70 stress proteins in astroglial cell cultures. Increased HSP70 protein expression 
was also found after treatment of cells with the NO generating compound sodium 
nitroprusside (SNP), suggesting HSP70 proteins possibly protect cells from RNS. The 
molecular mechanisms regulating the NO-induced activation of heat-shock signal seems 
to involve cellular oxidant/antioxidant balance, mainly represented by the glutathione 
status and the antioxidant enzymes (Calabrese et al., 2000c; Calabrese et al., 2000b).   
  HSP 32 or heme oxygenase (HO) is the rate-limiting enzyme in the production of 
bilirubin. There are three isoforms of heme oxygenase, HO-1 or inducible isoform, HO-2 
or constitutive isoform and the recently discovered HO-3 (Schipper, 2000; Goldbaum and 
Richter-Landsberg, 2001; Sahlas et al., 2002; Scapagnini et al., 2002). HO catalyzes the 
multistep degradation of heme by consuming energy. HO catalyzes the α-specific 
oxidative cleavage of the heme molecule to form biliverdin and carbon monoxide (CO). 
The iron released by HO-1 is bound by ferritin, perhaps via a HO-1 chaperone function 
(Nath et al., 2000). Similar to other antioxidant, increasing evidence suggests that the 
HO-1 gene is redox regulated and contains in its promoter region the antioxidant 
responsive element (ARE). Heme oxygenase-1 is rapidly upregulated by oxidative and 
nitrosative stresses, as well as by glutathione depletion. All these findings have 
introduced new perspectives in medicine and pharmacology, as molecules activating this 
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defense mechanism appear to be possible candidates for novel cytoprotective strategies 
(Butterfield et al., 2002a).  
Ubiquitin is one of the smallest HSPs. It is involved in targeting and chaperoning 
of proteins degraded by proteasomes. HSP27 is synthesized mainly in astrocytes in 
response to ischemic situations or to kainic acid administration. It chaperones 
cytoskeletal proteins, such as intermediate filaments, actin or glial fibrillary acidic protein 
following stress in astrocytes. HSP27 also protects cells against H2O2-induced necrosis 
(Bechtold and Brown, 2003). HSP47 is synthesized mainly in microglia following 
cerebral ischemia and subarachnoid hemorrhage (Valentim et al., 2003). HSP60, glucose-
regulated protein 75 (GRP75) and HSP10 chaperone proteins within mitochondria. 
GRP75 and GRP78, also called oxygen-regulated proteins, (ORPs) are produced by low 
levels of oxygen and glucose to protect brain cells against ischemia and seizures in vivo 
(Turner et al., 1999; Izaki et al., 2001). 
2.2.2.2 Glutathione 
Because mitochondria lack the enzymes needed to synthesize GSH, this tripeptide 
must be transported into the mitochondria. The tri-peptide glutathione (γ-glutamyl-
cyteinyl-glycine) is an endogenous antioxidant of great importance. Glutathione exists in 
either a reduced (GSH) or oxidized (GSSG) form and participates in redox reactions 
through the reversible oxidation of its active thiol. In addition, GSH acts as a coenzyme 
of numerous enzymes involved in cell defense. In unstressed cells the majority (99 %) of 
this redox regulator is in the reduced form, and its intracellular concentration is between 
0.5 and 10 mM depending on the cell type (Butterfield et al., 2002a; Butterfield et al., 
2002e). Depletion of glutathione has been shown to occur in conditions of moderate or 
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severe oxidative stress and has been associated with increased susceptibility to cell 
damage (Calabrese et al., 2000c; Calabrese et al., 2000b; Calabrese et al., 2002b; 
Calabrese et al., 2003b; Calabrese et al., 2003a; Poon et al., 2004a).  Glutathione (GSH) 
is required for the maintenance of the thiol redox status of the cell, protection against 
oxidative damage, detoxification of endogenous and exogenous reactive species, storage 
and transport of cysteine, protein and DNA synthesis, cell cycle regulation and cell 
differentiation (Butterfield et al., 2002a).  In addition, glutathione and glutathione-related 
enzymes play a key role in protecting the cell against the effects of reactive oxygen 
species.  The key functional element of glutathione is the cysteinyl moiety, which 
provides the reactive thiol group.  Glutathione is the predominant defense against ROS, 
which are reduced by GSH in the presence of GSH peroxidase.  As a result, GSH is 
oxidized to GSSG, which in turn is rapidly reduced back to GSH by GSSG reductase at 
the expense of NADPH.  The thiol-disulfide redox cycle also aids in maintaining reduced 
protein and enzyme thiols.  Without a process to reduce protein disulfides, vulnerable 
cysteinyl residues of essential enzymes might remain oxidized, leading to changes in 
catalytic activity.  Glutathione also aids in the storage and transfer of cysteine as well.  
Cysteine oxidizes rapidly into cystine which produce toxic oxygen radicals.  To avoid 
this toxicity, most of the nonprotein cysteine is stored in glutathione. In addition to 
protection against ROS, glutathione is an excellent scavenger of lipid peroxidation 
products such as HNE and acrolein, both of which have been found to bind proteins 
inhibiting their activities (Pocernich et al., 2000; Pocernich et al., 2001).  Glutathione also 
reacts with saturated reactive carbon atoms (epoxides), unsaturated carbon atoms 
(quinones, esters), and aromatic carbon atoms (aryl nitro compounds) to detoxify the 
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nucleophilic attack from the electrophilic carbon on these compounds (Hammond et al., 
2001; Butterfield et al., 2002a). Glutathione also forms metal complexes via 
nonenzymatic reactions to terminate Fenton reactions (Hammond et al., 2001; Butterfield 
et al., 2002a; Butterfield et al., 2002e).  
A complex GSH system in the brain has been connected with the oxidative stress 
occurring in neurological diseases (Butterfield et al., 2002b; Drake et al., 2003; Poon et 
al., 2004a). Recent data demonstrate that GSH has also important extracellular functions 
in brain. Astrocytes appear to play a key role in the GSH metabolism of the brain, since 
astroglial GSH export is essential for providing GSH precursors to neurons. Among the 
different brain cell cultures studied in vitro, only astrocytes release substantial amounts of 
GSH and GSSG during oxidative stress (Dringen and Hirrlinger, 2003).  
Evidence suggests that there exists a direct relation between decreased glutathione 
levels by oxidant stress and rapid up-regulation of HO-1 (mRNA and protein) in a variety 
of cells of rat brains, human fibroblasts, endothelial cells and rat cardiomyocytes 
(Calabrese et al., 2000a).  In addition, increased production of NO and RNS can lead to 
changes in intracellular glutathione. In astroglial cell cultures, stimulation of iNOS 
decreases total glutathione, while raising GSSG, and this effect was abolished by pre-
treatment of glial cells with NOS inhibitors (Calabrese et al., 2000c). Moreover, elevation 
of intracellular glutathione prior to exposure of endothelial cells to NO donors almost 
completely abolishes activation of the heme oxygenase pathway, which suggests that 
glutathione can antagonize the effect of RNS by inducing HO-1 (Calabrese et al., 2003b). 
All these reports support the notion that the decline of antioxidant defense systems is as 
important as the generation of ROS and RNS in damaged of the aged CNS.  
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2.2.3 Oxidative stress and Brain Aging 
As mention earlier, oxidative stress is the inbalance condition in which the 
production of ROS and RNS exceed the capacity of these antioxidant defense systems. 
The brain is more susceptible to oxidative stress for the following reasons: (a) high 
content of peroxidizable unsaturated fatty acid, (b) high oxygen consumption per unit 
weight, (c) high content of lipid peroxidation key ingredients: iron and ascorbate, and (d) 
the scarcity of antioxidant defenses systems (Floyd, 1999). It is widely held that free 
radicals induce oxidative stress increases in brain aging. The increased oxidative stress is 
manifested by protein oxidation and lipid peroxidation.  
2.2.3.1 Lipid Peroxidation 
The mechanism of lipid peroxidation can be divided into three stages: initiation, 
propagation, and termination. In initiation, since OH· is a very reactive ROS (Halliwell 
and Gutteridge, 1992), it attacks the hydrogens from nearly any C-H bond to form H2O. 
The electron-rich hydrogens at the CH2 group in the system -CH=CH-CH2-CH=CH- of 
polyunsaturated fatty acids (PUFA) are even more vulnerable to the OH· attack due to the 
electron donating double bonds (Frankel, 1984). The OH· irruptions, along with other 
radicals (Spiteller, 2001), generate racemic peroxyl radicals which attack the hydrogens 
from other PUFAs and begin a chain reaction (Frankel, 1984). These chain reactions are 
collectively called propagation. The peroxyl radicals will then undergo the Esterbauer 
dioxetane mechanism to from multiple aldehydes with varying lengths of carbons, such 
as 4- hydroxyl-2-nenonal (HNE) (Esterbauer et al., 1991), and terminate the chain 
reaction, thus the termination stage. The end products of lipid peroxidation are usually 
more stable than the free radicals, serving as excellent markers for free radical irruptions. 
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Although these aldehydes have lower activity than free radicals, their longer half-life 
allows the, to be more neurotoxic. 
2.2.3.1.1 Phospholipids Composition 
One way to assess the lipid peroxidation is to use the compositional alterations of 
brain phospholipids. PUFAs, such as arachidonic (AA, 20:4n-6), docosatetraenoic acid 
(DCS, 22:4n-6) and decosohexaenic acid (DCH, 22:6n-6), are abundant in brains and 
highly susceptible to free radical attack by the mechanism mentioned above. When 
PUFAs act as substrates of lipid peroxidation and become oxidized, their lipid 
peroxidation end-product fatty acids, e.g. palmitic acid (16:0), stearic acid (18:0), palmitc 
acid (16:1n-7), oleic acid (18:1n-9) and godonic acid (20:1n-9), will process reduced 
number of double bonds as well as different chemical and physical properties. Therefore, 
the quantity of lipid peroxidation can be estimated by measuring the depletion of PUFAs, 
or the ratio change between PUFAs and saturated/monounsaturated fatty acids. These 
measurements can be done by simple extraction (Delsal, 1944) and separation of the fatty 
acids by thin layer chromatography (TLC) (Vitiello and Zanetta, 1978; Hedegaard and 
Jensen, 1981), gas chromatography (GC) (Lanza et al., 1980) or high-performance liquid 
chromatography (HPLC) (Murphy et al., 1993) followed by Ultra Violet (UV) or mass 
spectrometry for identification of the fatty acids.  
It was ubiquitously reported that brain aging is accompanied by changes in the 
overall membrane lipid composition (Schroeder et al., 1984; Lopez et al., 1995). The 
most important changes involve a decreased level in PUFA (20:4n-6, 22:4n-6, 22:6n-3) 
and an increase in monounsaturated fatty acids (18:1n-9 and 20:1n-9) in cerebral cortex 
and cerebellum of aged rats (Giusto et al., 2002). Moreover, AA, along with n-6 and n-3 
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fatty acids, were also reported to decrease in brains of aged rats with cognitive deficit 
(Ulmann et al., 2001). This study suggested that low levels of AA might be related to the 
cognitive deficit in rats as membrane AA concentration were showed to be correlated 
with the log-term potentiation (LTP). LTP is a form of synaptic plasticity characterized 
by persistent synaptic efficacious increases, which follow tetanic stimulation from an 
afferent pathway to one of the hippocampal subfields (Lynch, 1998). The ability to 
sustain LTP is usually used as a parameter of cognitive function. The changes in 
phospholipid composition provide evidence that free-radical mediated lipid peroxidation 
occurs in brains and such changes might also be responsible for the cognitive deficit we 
observed in aged animals and humans. 
2.2.3.1.2 Reactive aldehyde 
HNE is an end product of linoeic acid (mainly, but not exclusively) peroxidation 
(Esterbauer et al., 1991). Because of its extensive half-life, HNE is able to diffuse to sites 
that are distant from that of its formation and cause further damage. HNE introduce 
neurotoxicity and cause apoptosis in many ways. This major product of lipid peroxidation 
can inhibit proliferation and cell cycle progression by the down regulation of D1, D2, and 
A cyclin expression (Pizzimenti et al., 1999). It can also react with the bases in DNA and 
lipid amino groups by Michael-addition (Uchida and Stadtman, 1992; Guichardant et al., 
1998) to alter the proper function of these biological molecules. The most damaging 
effect of HNE comes from its ability to form covalent adduct of histidine, lysine and 
cysteine residues in proteins to modify their activity. HNE deactivate aldose reductase 
and glutathione peroxidase, which detoxify HNE (Del Corso et al., 1998) and catalyze the 
reduction of H2O2 by glutathione (Boschi-Muller et al., 2000) respectively. HNE reduces 
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Na+/K+ -ATPase activity (Siems et al., 1996). Reduction of these critical ion pumps 
causes neurotoxicity in rat hippocampal neurons by disrupting the Ca2+ homeostasis 
(Butterfield et al., 2002d) and impairing glucose transport (Mark et al., 1997).  
 Acrolein is the most reactive of the α,β-unsaturated aldehydes formed by lipid 
peroxidation source that are not fully characterized as yet. (Uchida et al., 1998). Sharing 
the chemical properties of HNE, acrolein introduces toxicity to primary hippocampal 
culture (Lovell et al., 2001). This toxicity can due to the distortion of the transmembrane 
and cytoskeletal proteins structures (Pocernich et al., 2001) as well as the inhibition of the 
glucose and glutamate uptake (Lovell et al., 2000). 
Since acrolein and HNE adducts are more stable than most free radicals, acrolein- 
and HNE adducts, in particular acrolein- and HNE-modified proteins, provide a effective 
marker for free radical mediated lipid peroxidation. It was also suggested that the protein-
bound acrolein is a potential marker of oxidative stress in aging (Uchida et al., 1998). 
Study showed that the amount of HNE-modified protein staining increased 
logarithmically with age in human oculomotor neurons, but not melanized neurons 
(Yoritaka et al., 1996). Additonally, the HNE-modified proteins, along with 
neurofibrillary tangles, are also observed in the senile plaques in aged dogs (Papaioannou 
et al., 2001).  
Malondialdehyde (MDA) is the most abundant toxic aldehyde formed when 
arachidonic aicd (AA) acts as the PUFA source for the lipid peroxidation (Basu and 
Marnett, 1983; Michiels and Remacle, 1991; Esterbauer, 1993). MDA can catalytically 
hydrolyze to formic acid or acetaldehydes by lysine or arginine (Nair, 1988). Similar to 
HNE, MDA can react with amino acids in protein to from MDA adducts. Lysine, 
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tryptophan and histidine react with MDA to form N-β-lysyl-ammino-acrolein (β-LAA) 
(Nair et al., 1981; Slatter et al., 1998), whereas arginine reacts with MDA to form N-(2-
pyrimidyl)-l-ornithine (NPO) (King, 1966; Slatter et al., 1999). β-LAA can then further 
react with another MDA molecule to form N-lysyl-4-methyl-2,6-dihydropyridine-3,5-
dicarbaldehyde (NLMDD) (Nair, 1988; Xu et al., 1998) which contains an aldehyde side-
chain on the dihydropyridine ring responsible for reactions with lysine, to form a 
reversible crosslink (Slatter et al., 1998). Although there is no evidence that such a 
reaction occurs physiologically, it is possible that HNE, arolein etc can also react, in 
place of the second MDA, with NLMD to form a reversible crosslink reaction. (Slatter et 
al., 2000). MDA is also a highly reactive genotoxic compound that induces DNA damage 
by reacting with nucleic acids to form adducts, thus disrupting base-pairing (Agarwal and 
Draper, 1992). One of these adducts, deoxyguanosine-MDA (dG-MDA), is shown to 
induce cell cycle arrests in human cell cultures (Ji et al., 1998).  
MDA reacts with thiobarbituric acid (TBA) to produce fluorescent thiobarbituric 
acid reacting substances (TBARS), commonly used to measure MDA levels (Yagi, 1982; 
Yagi, 1994). However, TBA also reacts with other carbonyl-containing compounds. 
Therefore,TBARS are generally considered a non-specific measurement of MDA. Such a 
problem can be corrected through HPLC coupling with post column TBA derivatization. 
This column will be able to specifically identify TBA-MDA complexes, thereby 
providing a relevant assay in biological systems (Wong et al., 1987; Young and Trimble, 
1991; Fukunaga et al., 1998). The cellular distribution of MDA can also be assessed 
immunohistochemically (Slatter et al., 2000).  
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In aged human brain, it was shown that the MDA was increased in inferior 
temperal cortexes (Palinski et al., 1990), and in cytoplasm of neurons and astrocytes (Dei 
et al., 2002) compared to the young controls. Through electron microscopic 
immunohistochemistry, MDA was shown to form linear deposit. These deposits are cap-
like when associating with lipofuscin in neuron and vacuole-encircling when find in glia 
in the CA4 region of human hippocampus (Dei et al., 2002). In a human aging canine 
model, which naturally develops extensive diffused deposits of human-type Amyloid-β 
(Aβ), MDA were increased in the prefrontal cortex of aged brains (Head et al., 2002). 
Although there is no significant increase of MDA-modified protein observed in aged rat 
brains (Mooradian et al., 1994), it was shown that the basal MDA level was significantly 
raised (19%) in hippocampus of old rats (Cini and Moretti, 1995). Additionally, five dG-
MDA adducts were identified as the indigenous DNA (iDNA) adducts, which considered 
a biomarker of aging brain (Cai et al., 1996) due to the increase of iDNA with age 
(Randerath et al., 1989; Gupta et al., 1990; Randerath et al., 1990; Randerath et al., 
1993). The above studies suggest that the presence of free radical mediated MDA 
production could induce further damage of the proteins or DNAs in brain. In Mooradian 
study, the increased MDA-modified proteins were not observed. This could be due to the 
fact that MDA-modified protein react with lipid peroxidation products to crosslink with 
each other. Therefore, MDA-modified proteins could not be detected immunochemically.  
2.2.3.2 Protein Oxidation 
 Protein oxidation is an exothermic event where peptides react with free radicals. 
This reaction is mainly, though exclusively, mediated by the OH·, which is mostly 
produced by the Fenton reaction through the decomposition of H2O2 in the presence of 
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redox metals (Cu+ and Fe+) (Butterfield and Stadtman, 1997). Free radicals can attack 
peptides at two locations: back bone and side-chain. In backbone modification, a free 
radical attacks the hydrogen on the α-carbon to form a carbon-centered radical. In 
presence of oxygen, this radical then further converts into a peroxyl radical (Butterfield 
and Stadtman, 1997) which can attack other hydrogen of the same or differing peptides to 
propagate the free radical oxidation in a similar fashion as the initial and propagation 
stage of free radical mediated lipid peroxidation. Such oxidation can lead to protein 
cross-linking and/or peptide bond cleavage. Four types of cleavage are reported: (a) α-
amidation which yields RCOCOOH and NH3; (b) diamide which yields RCOOH, CO2 
and NH3; (c)glutamate oxidation which yields CH3COCOOH, HOOC-COOH and NH3; 
and (d) proline oxidation which yields H2NCH2(CH2)2COOH and CO2 (Levine and 
Stadtman, 2001). In side-chain modification, the free radicals attack the amino acid side 
chains of a peptide. Although most amino acids side-chains are vulnerable to oxidative 
modification, only some of these modifications are fully characterized: (a) histidine 
modified to aspartic, aspargine or oxo-histidine; (b) tyrosine modified to 3,4-
dihyroxyphenlalaine and Tyr-Tyr cross-links; (c) phenylalanine modified to 2-,3-,4- 
hydroyphenylalanine; (d) tryptophan modified to N-formylkynureine, kynurenine, 2-4-,5-
,and 6-hydroxyvaline; (e) valine modified to 3-hydroxyvaline; (f) leucine modified to 3- 
and 4-hydoryleucine (g)lysine modified to 2-aminoadipic semialdehyde; (h) arginine 
modified to gluamic semialdehyde; (i)proline modified to glutamic semialdehye , 
pyrogluamic acid, 2-pyroglutamic acid, 2-pyrrolidone, and 4-hydroxyproline; (j)glutamic 
acid modified to 4-hydroyglutamic acid, and pyruvate α-ketoglutaric acid; (k) threonine 
modified to 2-amino-3ketobutyric acid; (l) methioine modified to methionine sulfoxide, 
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and methionine sulfone; (m) cysteine modified to disulfides such as Cys-S-S-Cys and 
Cys-S-S-R (Stadtman, 1990, 1995). These oxidative modifications generally cause the 
loss of catalytic or structural function in the affected protein and contribute serious 
deleterious effects on cellular and organ functions (Levine and Stadtman, 2001). Free 
radical modification of proteins may be responsible for the gradual alteration of 
physiological function and accumulation of altered enzymes in aged brain. In a recent 
review (Levine and Stadtman, 2001), evidences supporting this view are classified into 
seven major areas: (a) in vitro free radical alteration of catalytic activities, thermal 
stability and sensitivity to photolytic degradation is similar to aging; (b) inducing free 
radicals to young animals in vivo can change the enzymes to aged-like forms; (c) 
increasing the life-span of animals by factors or physiological condition can lead to 
decreases of protein carbonyl levels , and vice-versa; (d) increased levels of oxidized 
protein in frontal pole and occipital pole concur with the age-related loss of cognitive 
function; (e) proteins from aged animals are more sensitive to oxidative damage, 
compared to the proteins from young animals; (f) protein oxidation levels are correlated 
to increased surface hydrophobicity of protein in aged animals; (g) protein carbonyl 
levels increase exponentially with age in different animal species and tissues. The review 
further proposed that free radical induced protein oxidation might be the cause of changes 
in aging. Concisely, free radicals and free-radical-mediated protein modification is 
essential to the brain aging process.  
2.2.3.2.1 Protein Carbonyl level 
 Carbonyl level is probably the most commonly used method of assessing the 
oxidative modification of proteins. Besides introducing carbonyl to proteins directly as 
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previously described, free radicals can introduce carbonyl to protein through lipid 
peroxidation end product such as HNE, arolein and MDA. Due to the resonance effect 
between the double bonds, the α-carbon of these reactive aldehydes are highly 
electrophobic and able to covalently bind to the electron-rich site of Cys, His and Lys by 
Michael addition. Therefore, the increased carbonyl number is introduced to the proteins 
as these aldehydes process at least one carbonyl group. Carbonyl contents of proteins are 
generally indices by its 2,4-dinitrophenylhydrazone (DNP-) adduct formed by reacting 
the proteins with 2,4-dinitrophenylhydrazine (DNPH) (Butterfield and Stadtman, 1997). 
The DNP-adduct can be detected by UV-Vis, fluorescence spectroscopy, or 
immunochemically. It should be noticed that the quantity of the protein carbonyl level 
depends not only on its formation, but also the degradation of the oxidized protein. 
Therefore, we can only conclude that increased carbonyl levels are due to increased free-
radicals attack if the protein degradation system is normal.  
It was found that protein carbonyl levels were increased in frontal and occipital 
cortex (Smith et al., 1991) of aged humans, in the cortex of Brown-Norway rats 
(Aksenova et al., 1998) and Mongolian gerbils (Dubey et al., 1995), in forebrain of 
Wistar rats (Cakatay et al., 2001), and in brain homogenates of aged canine models (Head 
et al., 2002). The carbonyl level increase of proteins at 65kDa was also reported to be in 
the hippocampus of aged spatial learning-impaired rodents (Nicolle et al., 2001), 
suggesting free radical induced protein carbonyl is involved in the dementia observed in 
some elderly. Since the alkaline protease activity in rat brains did not decline with age 
(Agarwal and Sohal, 1994), the carbonyl level increase reported by these studies are most 
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likely due to the increased free radical assault rather than the decrease the oxidative 
modified protein degradation. 
2.2.3.2.2 Protein 3-Nitrotyrosine (3-NT) level 
 3-NTs were derived from the nitration of the ortho position on the tyrosine 
nitration of proteins (Beckman and Koppenol, 1996). Such reaction is a form of protein 
oxidation by definition (Butterfield and Lauderback, 2002). 3-NT can make the aromatic 
moiety more hydrophilic, thereby altering the secondary and tertiary structures of a 
protein. It can also sterically or electronically hinder the phosphorylation or 
dephosphorylation on the para-OH group of Tyr, thus interfering with the cell signaling 
(Butterfield and Kanski, 2001). Protein 3-NT levels can be detected immunochemically 
or by HPLC, couple with MS/MS to avoid the electrochemical potential complications of 
3-NT (Althaus et al., 2000). 
 Although protein 3-NT levels of brain homogenate were found to decrease in 
aged Wistar rats (Cakatay et al., 2001), it was increased in the hippocampus and the 
cerebral cortex of aged rats (Shin et al., 2002), the CSF of aged human (Tohgi et al., 
1999), and the subcortical white matter of aged monkeys (Sloane et al., 1999). Moreover, 
the most prominent labeling of 3-NT was discovered in prukije cell layers and molecular 
layers of cerebellar cortex, as well as in the surroundings of neuropil in cerebellar nuclei 
of aged rats (Chung et al., 2002). These suggest that increases in protein 3-NT level is in 
regionally specific fashion. Such specificity could be attributed to the level of nitric oxide 
synthase, which produces NO to activate tyrosine nitration, in cells (Tohgi et al., 1999). 
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2.2.3.2.3 Electron Paramagnetic Resonance (EPR) 
 Free radical mediated protein oxidation can also be indirectly assessed by EPR 
spin-labels. 2,2,6,6-tetramethyl-4-maleimidopiperdin-oxyl (MAL-6) spin-labels can 
covalently bond to SH groups on Cys. The W/S ratio is a parameter derived from the 
relative spectral amplitude of the low-field weakly immobilized line to the strongly-
immobilized line. The amplitude of low field weakly immobilized line indicates the 
relatively fast MAL-6 motion as MAL 6 is binding to a weakly-immobilized SH group 
while the amplitude of low field strongly immobilized line indicates the relatively slow 
MAL-6 motion as MAL 6 is binding to a strongly-immobilized SH group. Therefore, the 
W/S ratio is lowered when protein crosslinkings increase, protein-protein interactions 
increase, and segmental motions of spin labeled protein decrease. Since all these protein 
alterations occur when free radicals induce oxidation to proteins, change in W/S ratio 
indices the protein conformation change due to free radical irruption (Butterfield et al., 
1982).  
 It was found that W/S ratio is extremely precise when assessing the oxidative 
conformational changes of proteins (Hall et al., 1995; Hall et al., 1997; Subramaniam et 
al., 1998; Koppal et al., 1999). It was also found that the W/S ratio decrease when OH• 
induce oxidation to rodents’ synaptosomes in vivo and in vitro (Hensley et al., 1994; 
Pocernich et al., 2000). Such W/S ratio decrease is also observed in cortical 
synaptosomes, erythrocyte membranes of rats (Hensley et al., 1995a), synaptosomes of 
senescence accelerated mice (SAM) (Farr et al., 2003). This suggests that free-radical 
induced protein oxidations and thus conformational alteration are significant events occur 
during brain aging. 
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2.2.3.2.4 Oxidative Stress Sensitive Enzyme Activity. 
 Oxidative deactivation of enzymes is another index of free radical oxidative 
damage to proteins. As described above, the free radical induced oxidative modification 
of protein usually results in structural and functional change in proteins. Decreased 
activities of glutamine synthetase (GS), creatine kinase (CK), and tyrosine hydroxylase 
(Floyd, 1990; Hensley et al., 1995b; Hensley et al., 1995c; Howard et al., 1996) by free 
radical induced modification were observed. Since the activities of these enzymes, 
particularly CK and GS, can be easily determined by their efficiency of end-products 
productions, their activities serve as efficient indexes for oxidative modification of 
proteins.  
Studies shows that the activities of CK and GS were decreased in aged brown 
Norway rats’ brains (Aksenova et al., 1998), and in aged human frontal and occipital 
lopes (Smith et al., 1991). Since CK and GS activity is very sensitive to free radical 
induced oxidative modification, the declined activity of CK and GS in aged animals 
demonstrates direct evidence that free radical induced oxidative modification of proteins 
are essential during the aging process. It should be noticed that the activities of many 
enzymes are also altered during aging. These proteins include: (a) lipid metabolic 
enzymes phospholipase D, phosphatease phosphohydrolase, diacylglycerol lipase, 
phosphatidylserine synthase, and phosphatidylserine decarboxylase (Giusto et al., 2002); 
(b) metabolic enzyme, α-ketoglutarated dehydrogenase complex, pyruvate kinase, NAD-
siocitrate dehydrogenase, NAD-malate dehydrogenase (Vitorica et al., 1981), enolase 
(Deloulme et al., 1996) ,and lactate dehydrogenase (Mizuno and Ohta, 1986; Ferrante and 
Amenta, 1987; Hrachovina and Mourek, 1990; Agrawal et al., 1996); (c) mitochondrial 
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enzymes, citrate synthetase, and electron transport complex I – IV (Sandhu and Kaur, 
2003); (d) ionic homeostatic and signaling proteins: Na+, K+-ATPase (Kocak et al., 
2002), and acetylcholine esterase (Gorini et al., 2002); (e) antioxidant enzymes, 
superoxide dismutase, catalase, glutathione peroxidase, γ'-glutamylcysteine synthetase, 
glutathione reductase; glutathione-s-transferase; and γ-glutamyl transpeptidase (Tsay et 
al., 2000; Vohra et al., 2001; Sandhu and Kaur, 2002). Although the alteration of these 
enzymes are most likely due to oxidative modification of the proteins, no direct 
correlation is established between the oxidative modification of the proteins and their 
activity decline.  
2.3 Learning and Memory 
The abnormal cellular components mentioned above manifest in CNS 
dysfunction.  Learning and memory deficit is one of the common symptoms of the CNS 
dysfunction.  The term “learning” is defined as the acquisition of an altered behavioral 
response due to an environmental stimulus, and “memory” is defined as the process by 
which the learned item is stored and retrieved (Sweatt, 2003a). Two types of memory are 
defined depending on how long it persists: short term (minutes to hours) and long term 
(days to years). It is generally accepted that memory results from changes in the 
particular synaptic structure and/or function. Long-term memory has the general attribute 
that it undergoes a period of consolidation that involves the formation or elimination of 
specific synapses in the brain and the synthesis of new mRNAs and proteins. Since short-
term memory is too rapid to be attributed to such alterations, it was suggested that 
changes in the release and function of neurotransmitters at particular synapses are the 
basis of short-term memory (Lodish et al., 2000).  
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2.3.1 Molecular Learning and Memory 
  The Hebbian theory is the current molecular basis of learning and memory. 
Hebb’s hypothesis  propose that the coincident activation of pre- and postsynaptic 
neurons lead to modifications of synaptic efficacy between the two cells, thereby creating 
associative links between them. Memories are stored as alterations of these synaptic 
alterations (Hebb, 1949). Current hypothesis concerning the neurochemical basis of 
learning and memory based on three basic assumptions (Agranoff et al., 1999). 
 The first assumption is that the basic behavioral paradigms in learning and 
memory studies are the conditioned response. For example, in Pavlov’s characterization 
of condition experiment, when a food stimulus is presented to a dog, a strong salivatory 
response is elicited. This salivation is referred as unconditioned response and the food 
stimulus is referred to as unconditioned stimulus (Sweatt, 2003a). The dog could then be 
trained to associate the food stimulus with the ringing of a bell where, over time, the bell 
ring alone would cause a salivatory response similar to the food does. This bell-elicited 
salivation was termed conditioned response, and the bell ring was termed the conditioned 
stimulus (CS) (Sweatt, 2003a). In order for learning to occur, the conditioned stimulus 
must precede the unconditioned stimulus. 
The second assumption is that protein synthesis is required to from long-term, but 
not short-term memory. The formation of long-term and short-term memory can be 
distinguished by their susceptibility to protein synthesis inhibitors (Agranoff, 1980). 
Since learning and short-term memory occur with in milliseconds and last for minutes to 
hours, they are proposed to be mediated by post-translational modifications at the 
synapse. However, since long-term memory require longer acquisition time and last life 
 44
time. It is predicted to be mediated by process that (1) require protein synthesis, (2) is 
neuronal genome dependent; and (3) require intraneuronal communication, such as 
axonal transport (Agranoff et al., 1999). 
The last assumption is that memory is stored in synaptic connections. The 
development and environment stimulation increase the synaptic complexity, and such 
synaptic alteration is depend on the genome regulates phenotypic expression generated in 
the nucleus to response to the environment (Agranoff et al., 1999). 
2.3.1.1. Long-Term Potentiation (LTP) 
LTP is the most frequently studied as the cellular basis of learning and memory in 
vertebrates. LTP is defined as a long-lasting (hours to weeks) increase of excitatory 
postsynaptic potentials amplitude in synaptic efficacy as a result high-frequency 
stimulation of afferent pathway (Villarreal et al., 2002). It is measured both as the 
amplitude of excitatory postsynaptic potentials and as the magnitude of the postsynaptic 
cell population spike (Villarreal et al., 2002).  
LTP was first discovered by application of high frequency electrical stimulation 
to enhance synaptic transmission in the rabbit (Bliss and Lomo, 1973). In this study, the a 
brief period of stimulation can increase the strength of synaptic connections of neurons 
and likelihood of the cells firing action potentials in response to a constant synaptic input 
for hours (Bliss and Lomo, 1973). These phenomena were termed LTP (Bliss and Lomo, 
1973). LTP is considered as an analog of memory since LTP is a long-lasting alteration in 
neuronal function which is resulted from a brief period of stimulus (Sweatt, 2003b).    
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Several other properties of LTP make it an good analog of mechanisms from 
learning and memory. There properties are state-dependent, input specificity, and 
associativity (Purves et al., 2001).  
LTP is state-dependent since LTP only occurs when the postsynaptic cell reach 
certain degree of depolarization with specific period of time (Sweatt, 2003b). For 
example, the increased firing action potential is only possible if the postsynaptic 
depolarization occurs within about 100 ms of presynaptic transmitter release. Since a 
requirement for coincident activation of presynaptic and postsynaptic elements is 
necessary to formation of memory according to Hebbian theory (Hebb, 1949), LTP forms 
a theoretical framework of the synaptic changes underlying learning and memory. 
LTP is also exhibits input specific. When LTP is induced by the stimulation of 
one particular synapse, other synapses of the same neurons remain inactive. Therefore, 
LTP is restricted to activated synapses rather than to all of the synapses on a given neuron 
This properties of LTP is consistent with the memory formation in which only the 
activated synapses are potentiated, leading to selectively enhance particular sets of inputs, 
as is required for learning and memory (Purves et al., 2001). 
Another important property of LTP is associativity, which is analog of the linkage 
of one set of information with another in neuronal network. Since weak stimulation of a 
synapse cannot trigger LTP by itself, a simultaneous input from a weak stimulation and a 
strong stimulation of a neighboring synapse of the same neuron can trigger both synaptic 
pathways to undergo LTP (Purves et al., 2001). This conjoint enhancement of synaptic 
inputs is often considered as a neuronal analog of associative conditioning observed in 
Pavlov’s conditioning experiment (Sweatt, 2003a).  
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It should be noted that LTP does not equal to memory. Rather, it is an important 
component of memory formation (Stevens, 1998). Moreover, LTP is a mechanism of 
activity-dependent synaptic plasticity that is capable of detecting multiple conincidence 
events. Such properties suggest that LTP contribute to memory consolidation, formation 
of complicated association, sequentially serving as a short-term memory buffer for 
assicative conditioning (Sweatt, 2003a). 
2.3.1.2 Synaptic Remodeling 
 As mentioned in the previous section, environmental stimulates leads to the 
shaping and tuning of neuronal connectivity during development, and this process, 
termed synaptic remodeling, continues throughout the life-span of the organisms. Since 
neuronal connectivity is a dynamic process, the remodeling of synaptic connectivity 
occur in response to general environmental manipulations, sensory stimulation or 
learning a specific new task and may even be associated with cyclic changes in the 
physiological status of the organism (Agranoff et al., 1999). 
The mechanisms that are known to be involved in the initiation and maintenance 
of synaptic plasticity is base on Hebbian theory (Lamprecht and LeDoux, 2004). It is 
generally believed that the calcium influx into postsynaptic neurons through excitatory 
amino-acid receptors, specifically NMDA (N-methyl-D-aspartate) receptors, and possibly 
L-type voltage-gated calcium channels (VGCCs), is the initial event of synaptic plasticity 
(Magee and Johnston, 1997; Bauer et al., 2002).  
Receptor mediated calcium influx is usually blocked by magnesium at resting 
membrane potentials. However, when glutamate is released presynaptically, it binds and 
activates NMDA receptors, thereby relieving the magnesium and allowing calcium enters 
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the neuron at the synapse. Since activation of NMDA receptors by glutamate will only 
occur when the postsynaptic cell membrane is depolarized, the NMDA receptor act as a 
coincidence detector that only allows calcium influx when presynaptic activity and 
postsynaptic activity coincide (Lamprecht and LeDoux, 2004).  Calcium also influx into 
postsynaptic membrane during depolarization through VGCCs (Magee and Johnston, 
1995, 1997). VGCCs are opened by back-propagating action potential, an action potential 
that initiated at the cell body and propagate back into the dendrites plasticity. The 
opening of VGCCs amplify the excitatory postsynaptic potentials at the synapse that were 
recently activated by glutamate receptors (Lamprecht and LeDoux, 2004), thereby 
shaping the integration of synaptic activity and influencing the induction of synaptic. The 
net result of calcium influx is the activation of signaling pathways. For example, calcium 
influx causes phosphorylation of calcium/calmodulin-dependent protein kinases 
(CaMKs) and protein kinase C (Tanaka and Nishizuka, 1994; Lisman et al., 2002), which 
results in an increase in synaptic efficacy, and subsequently activation of gene 
transcription and protein synthesis that can also lead to structural changes in synapses 
(Poo, 2001; West et al., 2002). Moreover, elevation of calcium leads to rearrangement of 
the cytoskeleton at the synapse by actin polymerization and cytoskeletal rearrangements. 
These processes result in new synaptic structures (Matus, 2000). Since these structural 
alterations occur too quickly to be accounted for by nuclear or even dendritic protein 
synthesis, they are not considered as the result from protein synthesis. Therefore, such 
changes might participate in both short-term and long-term memory (Lamprecht and 
LeDoux, 2004). 
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The rapid changes in the concentrations of calcium and other signaling molecules 
take place in dendritic spines. Spines are specialized compartments on dendrites that 
contain receptors, channels and signaling molecules that couple synaptic activity with 
postsynaptic biochemistry (Sheng and Kim, 2002). Since the induction of synaptic 
plasticity (LTP induction or memory formation) leads to changes in the number or shape 
of spines (Weiler et al., 1995), modulation of the number of dendritic spines and their 
morphology was proposed to associated with the excitatory synaptic transmission 
alterations during learning (Nimchinsky et al., 2002). Alteration of spine number and 
morphology depends on its specialized structure of cytoskeletal actin filament (Matus, 
2000). Actin is present ubiquitously in spine to interact with the receptors, channels and 
signaling molecules, and the reorganization and/or polymerization of actin alter spine 
stability and contribute to structural plasticity of spines after LTP induction and learning 
(Lamprecht and LeDoux, 2004). The orientation, kinetics of assembly and stability of 
actin filaments are regulated by extracellular stimulation, such as NMDA receptor 
activation (Matus, 2000), indicating that NMDA-dependent actin polymerization is 
important for the consolidation of memory. Another glutamate receptor, AMPA (α-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor, is found to stabilize 
spine morphology (Fischer et al., 2000). Therefore, NMDA receptors is important in the 
initial phase of spine motility, followed by a stabilization phase that is mediated by 
AMPA receptors. Since AMPA receptor is activated spontaneously with NMDA receptor 
during glutamate release in synapses, the alteration and stabilization of dendritic spine 
also occurs simultaneously (Lamprecht and LeDoux, 2004). Moreover, AMPA receptor 
levels increase after LTP induction or learning experiences, indicating that an increase in 
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AMPA receptors in spines could contribute to spine stability and thereby memory 
formation (Malinow, 2003).  
Cytoskeleton-mediated alteration of spine and dendritic morphology is regulated 
by Rho GTPases and their downstream effectors (Luo, 2002). The schematic diagram the 
Rho GTPases mediate extracellular stimulation-induced actin cytoskeleton 
rearrangements is summarized in Figure 2.3. Another roles of Rho GTPases played in 
synaptic plasticity is to mediate the activity of adhesion molecules and to regulate cellular 
interactions (Lamprecht and LeDoux, 2004). Adhesion molecules, such as integrins, 
cadherins, neurexin and the immunoglobulin superfamily, are membrane-bound 
molecules that interacts with proteins in the extracellular matrix and synaptic membranes 
to adhere the membranes between the pre- and postsynaptic components (Lamprecht and 
LeDoux, 2004). This adhesion is a dynamic process that involves morphological 
alterations and modulation of connection between the pre and postsynaptic neurons, and 
result in new contacts (Benson et al., 2000). Adhesion molecules can also mediate 
signaling pathways to regulate the extracellular connectivity with intracellular events that 
control spine morphology (Lamprecht and LeDoux, 2004). Therefore, adhesion 
molecules play a critical role in neuronal connectivity and spin morphogy, as well as 
stabilization of synaptic connectivity that leads to consolidation of memory (Lamprecht 
and LeDoux, 2004). 
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Figure 2.3 
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 The formation of memory involves learning and consolidation. During learning, 
stimulation on specific synapses initiate molecular changes, and cellular alterations are 
progressively stabilized during consolidation. The initiate molecular alterations caused by 
learning are complex and require coordination within and between signalling pathways 
that involved Rho ATPases (Luo, 2002), and the modulation and stabilization of neurons 
after LTP induction or learning is controlled in part by actin dynamics, a process that is 
initiated by NMDA receptor activation and stabilized by AMPA receptor activation. The 
process of actin dynamic in neuron causes morphological changes in dendritic spin, and 
leads to the formation and stabilization of new synaptic contact of the pre and 
postsynaptic elements (Lamprecht and LeDoux, 2004). The formation of new neuronal 
connections is regulated by adhesion molecules that are also affected by both the 
cytoskeleton and glutamate receptors. The remodeling of the synapses results in modified 
neuronal circuit which represent the memory stored in the brain, and synaptic plasticity 
are mediated by molecular activity at the synapse during specific time windows after 
learning (Lamprecht and LeDoux, 2004).  
2.3.2 Learning and Memory in Aging 
 Learning and memory decline is a part of the aging process (Barnes, 1988). The 
most noticeable cognitive decline in age human is the hippocampus-dependent forms of 
memory deficits, which is manifested by the difficulty of learning and remembering of 
new names, recent events and even spatial information (Sweatt, 2001). These types of 
cognitive impairment can be recapitulated in aging rodent by assessing their cognitive 
function by learning and retention paradigms. Therefore, the age-related cognitive 
impairment in behavioral and cellular manifestations of learning and memory is well 
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established in humans and other mammals (Sweatt, 2001).  Moreover, LTP is diminished 
in aged animals (Barnes et al., 2000). However, the mechanisms underlie the cognitive 
impairment in aged animals and human are still not clear. Although the bases of such 
decline remain unknown, oxidative stress is proposed to play a significant role in age-
related memory and synaptic plasticity dysfunction (Lynch, 1998). Moreover, the decline 
of cognitive function in aging subjects can be more server due to numerous reasons, such 
as stroke, vascular problems, psychiatric disorders, PD and AD. These conditions can 
cause the cognitive impairment to be more pronounced in normal aging (Sweatt, 2001).   
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CHAPTER THREE 
Principles Behind Applied Methods 
3.1 Bicinchoninic acid (BCA) Protein Assay 
The BCA Protein Assay is based on formation of colometric BCA-Cu+ complex. 
All proteins have the characteristic peptide bond and the commonly found amino acids 
(Cys, Trp, Tyr). When reacted with copper sulfate (CuSO4) in alkaline solutions, Cu2+ are 
reduced to Cu+  by the electron-rich peptide bond and amino acids (the biuret reaction). 
Cu+ can then be complex with two BCA to from a soluble purple BCA-Cu+ complex 
exhibits a strong absorbance at 562 nm (Figure 3.1). The absorbance of this complex is 
nearly linear with increasing protein concentrations over a broad working range (0.02-2 
μg/μl).  The final color of the BCA protein assay continues to develop, therefore it is not 
a true end-point measure. However, the rate of continued absorbance development is 
sufficiently slow to allow large numbers of samples to be assayed together. The total 
protein concentration generally are measured by using a common protein, such as bovine 
serum albumin (BSA), as reference standards. A series of dilutions of known 
concentration of BSA are prepared and assayed alongside the sample before the 
concentration of each sample is determined based on the standard curve obtain from the 
BSA standard. 
 54
Figure 3.1 
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3.2 Oxidative Parameters 
3.2.1 Protein Carbonyls 
 The assay of carbonyl groups in proteins is a common way for detecting and 
quantifying oxidative modification of proteins. As mentioned previously, protein 
carbonyl is induced by reaction between ROS and proteins, thereby increasing protein 
carbonyl level imply increased oxidative stress of the system under studies.  Carbonyl 
contents of proteins are generally indices by its 2,4-dinitrophenylhydrazone (DNP-) 
adduct formed by reacting the proteins with 2,4-dinitrophenylhydrazine (DNPH) (Figure 
3.2). The DNP-adduct can be detected by immunochemically. Generally, the protein 
DNP-adducts are immobilized on a nitrocellulose membrane. The membrane are the 
incubated with the primary antibody specific for DNP-adduct. The alkaline phosphatase 
(AP) conjugated secondary antibody are then bind to the primary antibody at room 
temperature.  The AP convert 5-Bromo-4-Chloro-3-Indolyl Phosphate/Nitroblue 
Tetrazolium solution (BCIP/NIT) to produce a purple reaction product with the color 
intensity correlated to the amount of DNP-adduct present. The intensity of the purple 
color were analysis digitally by densimetric software to quantify the amount of the DNP-
adduct. 
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Figure 3.2 
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3.2.2 4-Hydroxynonenal (HNE) 
HNE is an end product of linoeic acid (mainly, but not exclusively) peroxidation 
(Esterbauer et al., 1991). HNE is a major product of lipid peroxidation and covently 
modify amino groups of protein by Michael-addition (Uchida and Stadtman, 1992; 
Guichardant et al., 1998) (Figure3.3). Therefore, increased HNE level indicating increasd 
oxidative stress.Similar to the DNP-adduct, HNE adduct can then be detected 
immunochemically by using primary and secondary antibody mentioned in the previous 
section. However, increased protein HNE level not only indicating increased oxidative 
modification of protein, but also imply that lipid are significantly peroxidized in cells. 
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Figure. 3.3 
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3.2.3 3-Nitrotyrosine (3-NT) 
 3-NTs were the direct products of ONOO- and tyrosine (Beckman and Koppenol, 
1996), Nitration of the ortho position on the tyrosine nitration of proteins is a form of 
protein oxidation by definition (Butterfield and Lauderback, 2002) (Fig 3.4). Protein 3-
NT levels are also detected immunochemically similarly to the quantitative detection of 
protein HNE- and protein DNP-adducts previously described. It should be noted that NO, 
precursor of ONOO-, is produced by NOS. Therefore, although increased protein 3-NT 
level generally indicating increased oxidative stress, no change of 3-NT level could also 
be interpreted as the absent of NOS activity.  
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Figure 3.4    
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3.2.4 Electron Paramagnetic Resonance (EPR) Spin Labeling 
EPR is an accurate measure to provid information on molecular motion, orientation, 
environmental polarity and conformational changes of proteins and membranes.  EPR 
measure the energy absorbed by unpaired electrons in the presence of a microwave 
electromagnetic field. However, unpaired electrons are negligible in most biological 
systems, stable paramagnetic spin labels are used to study biological systems by EPR. 
2,2,6,6-tetramethyl-4-maleimidopiperidin-1oxyl (MAL-6, Fig 3.5) is a nitroxide free 
radical contain an in the p orbital of the nitrogen.    In the absence of magnetic filed, this 
unpaired electron that has electron spin quantum numbers of Ms = + ½ or – ½, 
corresponding to the two possible spinning motions of the electron. However, when a 
magnetic field is applied, the electron will align either parallel (Ms = + ½) or anti-parallel 
(Ms = - ½) to the magnetic field (Figure 3.6) causing the change of energy of the electron 
to MI = +1, MI = 0 and MI = -1. This change of the energy levels due to the applied 
magnetic field is known as the Zeeman effect. Since the alignment of the electron change 
the energy state, when a constant microwave frequency (about 9.5 GHz) are applied and 
absorption of energy corresponding to three different levels are observed (Figure 3.6). 
When MAL-6 covalently binds to cysteine sulfhydryl groups on synaptosomal proteins in 
synaptosomes, a three line EPR spectrum are observed (Figure 3.7) (Butterfield et al., 
1982).  Due to the folding of a protein, MAL-6 can bind to the surface or/and in the 
pockets of proteins.  When binding to the protein surface, MAL-6 is weakly immobilized.  
In contrast, binding of protein pockets cause MAL-6 strongly immobilized (Butterfield et 
al., 1982).  These weakly (W) and strongly (S) immobilized components are shown in the 
low field line (MI = +1) of the EPR spectrum of MAL-6 (Figure 3.7).  The ratio of the 
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weakly to strongly immobilized spectral amplitudes (the W/S ratio) is lowed by oxidative 
stress mediated protein alteration, such as to crosslinkings increase, protein-protein 
interactions increase, and segmental motions of spin labeled protein decrease. Since all 
these protein alterations occur when free radicals induce oxidation to proteins, change in 
W/S ratio indices the protein conformation change due to free radical irruption 
(Butterfield et al., 1982).  Therefore, decreased W/S ratio is an indirect assessment of 
protein oxidation. 
 63
Figure 3.5  
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Figure 3.6 
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Figure 3.7 
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3.2.5 Thiobarbituric Acid Reactive Substances (TBARS) 
Malondialdehyde (MDA) is the most abundant toxic aldehyde formed when 
arachidonic aicd (AA) acts as the PUFA source for the lipid peroxidation (Basu and 
Marnett, 1983; Michiels and Remacle, 1991; Esterbauer, 1993). Therefore, lipid 
peroxidation can be assessed by determining the amount of MDA in the system. MDA 
was first extracted by organic solvent, then reacts with thiobarbituric acid (TBA) to 
produce fluorescent thiobarbituric acid reacting substances (TBARS) at 95oC (Fig 3.8). 
However, TBA also reacts with other carbonyl-containing compounds. Therefore 
TBARS are generally considered a non-specific measurement of MDA, results usually 
required validation of HNE level to ensure lipid peroxidation.  
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Figure 3.8 
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3.3 Enzyme Assay 
 Oxidative modification of a protein alters its structure and function. Therefore, 
one way to validate the oxidation of specific protein is measuring their enzyme activity.  
Moreover, activities of some enzymes are particular sensitive to oxidative modification 
due the nature of its activity site. Therefore, activities of CK and GS can also serve as 
efficient indexes for oxidative modification of proteins.  
3.3.1 Glutamine Synthase (GS) 
 The biosynthesis of glutamine is catalyzed by GS with the requirement of ATP. 
Moreover, GS catalyze a γ-glutamyl transfer reaction in the presence of nucleotide (ATP 
or ADP) and arsenate:  
L-Glutamine + NH3OH ↔L-γ-glutamylhydroxamate + NH2
Therefore, the activity of GS can be determined by amount of γ-glutamylhydroxamate in 
certain amount of time. γ-Glutamylhdroxamate gives a characteristic brown color with 
absorbance at 535 nm on addition of ferric chloride, therefore measuring the change of 
absorbace at 535 nm in specific amount of time is proportion to the activity of GS. The γ-
glutamyl transfer activity of GS is about 10 times greater than synthase activity, 
therefore, measuring the γ-glutamyl transfer activity is more sensitive mway to determine 
the activity of GS. 
3.3.2 Lactate Dehydrogenase 
Lactate dehydrogenase (LDH) catalyzes the following reaction: 
Pyruvate + NADH ↔ Lactate + NAD+ 
NADH has absorbance at 340 nm. Therefore, the activity of LDH can be determined 
reaction velocity of a decrease in absorbance at 340 nm resulting from the oxidation of 
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NADH. One unit causes the oxidation of one micromole of NADH per minute at 25°C 
and pH 7.3 (Zewe and Fromm, 1965; Stambaugh and Post, 1966). 
3.3.3 Enolase 
 In the presence of enolase, KCl and Mg2+ , D-glyceric acid 2-phosphate is 
dehydrated to pyruvic acid phosphate. Pyruvic acid phosphate has a strong absorbance at 
240nm. Therefore, the activity of enolase can be measured by the increase of absorbance 
at 240nm in certain amount of time in the present of D-glyceric acid 2-phosphate, KCl 
and Mg2+ (Wagner et al., 2000).  
3.3.4 Creatine Kinase 
CK reversibly catalyzes the transfer of a phosphate group from creatine phosphate 
to ATP, which is then is used to produce glucose-6-phosphate and ADP from glucose by 
hexokinase (HK). The glucose-6 phosphate is then oxidized by glucose-6 phosphate 
dehydrogenase (G-6-PDH) with simultaneous reduction of the NADP to give NADPH 
and 6-phosphogluconate. The reactions are listed as the following: 
Creatine phosphate + ADP ? Creatine + ATP 
ATP + d-glucose ? glucose-6-phosphate + ADP 
Glucose-6-phosphate + NADP+ ? gluconate-6-phosphate + NADPH 
The rate of increase of absorbance at 340 nm due to the formation of NADPH is 
directly proportional to the activity of the CK in the sample.  
3.4 Redox Proteomics 
3.4.1 Overview  
As mentioned in the previous sections, most protein oxidative modifications are 
irreversible (lysine and arginine carbonylation, tyrosin nitration, tryptophan nitration, 
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dityrosine formation, protein-protein cross-linking), some oxidative modifications are 
reversible (glutathionylation, S-nitrosylation). These reduced forms of oxidized proteins 
together with those non-oxidized proteins are considered in their reduced states, in 
contrast to the oxidatively modified proteins in their oxidized states. This redox state of 
the proteins contributes to the redox regulation of the cellular responses to oxidative 
stress and antioxidant status in brains (recently reviewed in(Calabrese et al., 2003b; Poon 
et al., 2004a)). Initial attempts to address the redox states of these specific oxidized 
protein is by double immunopercipitation, in which oxidized proteins are first 
immunopercipitated using an antibody, followed by a similar immunopercipitation step 
with the antibody against the protein of interested (Lauderback et al., 2001). Although 
this one-at-a-time method is commonly used and accepted, it is impractical and 
unfeasible for the enormous brain proteome, a term was first defined in 1994 as the total 
set of proteins expressed in a given cell at a given time (Dove, 1999). 
The study of proteome, termed "proteomics", encompasses the separation, 
identification, and qualitative, quantitative and functional characterization of the entire 
protein profile of a given cell, tissue and/or organism. Not only the native proteins are 
analyzed in proteomics, the profiling of isoforms, splice variants, mutants, and post-
translationally modified species, and the definition of protein-protein interactions are also 
studied  (Schoneich, 2003). Recent advances in proteomics allow the identification of a 
large number of proteins as well as their redox states, hence referred to as redox 
proteomics (Ghezzi and Bonetto, 2003; Dalle-Donne et al., 2005).  
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3.4.2 Sample Preparation 
 The samples being analyzed are first derivatized by dinitrophenolhydrazine 
(DNPH) to from DNP-adduction for carbonyl detection. If 3-nitrotyrosine levels or 
protein levels are measured, no derivatization step is needed. The samples after 
derivatization usually contain high concentration of ions since an acidic buffer is used to 
optimize the reaction. The high level of ions in the buffer can cause variation of voltage 
and current during isoelectric focusing (IEF), thereby preventing successful isoelectric 
separation. This phenomenon usually manifested by horizontal smearing of the protein 
spot (Figure 3.9).  
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Figure 3.9 
 
 
 73
This horizontal smearing problem is usually avoided by using trichloroacetic acid (TCA) 
to precipitate the protein and using organic solvents to wash the pellet substantially. 
Commercial spin ion-removal columns (Sigma and Pierce) are also available to remove 
ion from samples prior to IEF.  
3.4.3 Two-dimensional (2D) gel electrophoresis 
 2D gel electrophoresis can separate a mixture of proteins into single detectable 
protein spots in most cases. The 2D separation of proteins is usually achieved by two 
separation steps. In the first step, proteins are separated according to their isoelectric 
point by IEF on an IEF gel, or strip. The resulting IEF strips are then treated with 
dithiothreitol and iodacetamide to avoid cysteine-cysteine interaction, which will 
decrease the resolution of the second step of separation. In the second step, proteins are 
separated according to their molecular migration rate (similar to molecular weight in 
most cases). Therefore, if cross-linking between the cysteine residues occurs, vertical 
smearing will appear in the 2D gel since the molecular migration rate is shape-dependent 
as well as molecular weight dependent (Fig 3.10).  
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The resulting 2D map allows comparison within and between groups of samples for 
statistical analysis (Tilleman et al., 2002). The ability to compare and match between 
different samples on 2D electrophoresis is especially important in redox proteomics. This 
is because in order to identify the oxidation state of a protein, the 2D gels are transferred 
and developed by Western blotting.  Therefore, the 2D map of the gels and the blots can 
be matched to determine the unit of oxidative modification per unit of proteins (specific 
carbonyl level or specific 3-NT level of a protein). The advantages of the 2D gel 
electrophoresis are its consistency and high resolution. However, some drawbacks of this 
technique are still present. The solubilization of membrane proteins is still the main 
obstacle for 2D-electrophorsis, because the ionic detergents used for solubilization of 
membrane proteins can interfere with the focusing process. Additionally, the mass range 
and the detection limits also represent technical limitations of the method. However, our 
laboratory and many others are trying to overcome these issues by using chaotropic 
agents, subcelluar 2D gel electrophoresis, etc. High throughput proteomic techniques, 
such as HPLC, are also available to separate proteins without 2D electrophoresis 
(Soreghan et al., 2003). However, the application of these techniques in redox proteomics 
is still at an embryonic stage, and more development in these techniques to obtain 
quantitative data regarding the redox state of a protein will be beneficial to overcome the 
limitation of 2D electrophoresis.      
3.4.3 Image Analysis and Statistical Analysis 
 The 2D gels traditionally were visualized by classical detection methods, 
including Coomassie blue and silver staining. However, these detection methods remain 
problematic due to low sensitivity (for Commassie) or poor reproducibility and dynamic 
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range (for silver). The recent development of fluorescent dyes, namely SYPRO™ Ruby, 
overcame these problems with its sensitive (1-2ng) detection limits and linear dynamic 
range over three orders of magnitude (Molloy and Witzmann, 2002). The result 2D map 
images are then analyzed by specially programmed software.  
 Image analysis allows gel-to-gel comparison and generated a large amount of data 
accumulated from multiple 2D gels. Therefore, special programmed softwares are 
commercially available to manage these data. Some of these softwares were evaluated in 
a recent survey (Righetti et al., 2004). These softwares enable investigator matching and 
analysis of visualized protein spots among differential gels and blots. The principles of 
measuring intensity values by 2-D analysis software were similar to those of 
densitometric measurement. After completion of spot matching, the normalized intensity 
of each protein spot from individual gels (or blots) is compared between groups using 
statistical analysis. Although the softwares use raw-image-based alignment coupled with 
neighbor matching spots to improve the spots matching steps by significantly reduced 
analysis time, hands-on processing is still necessary for accuracy of the matching.  
3.4.4 In-gel Digestion and Mass Spectrometry 
The protein of interest is excised and treated with ammonium bicarbonate and 
acetonitrile to provide optimal protease digestion in the gel. The excised spots are then 
in-gel-digested with a protease (trypsin is commonly used) in an optimal buffer for its 
activity. The digested peptides are then easily eluted from the gel to undergo mass 
spectrometry analysis. In-gel-digestion not only reduces the mass of a protein into small 
peptides ideal for mass spectrometry, it also forms a collection of proteolytically 
sequence-specific peptides that enable the identification of the protein.  
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 Mass spectrometry has made a great impact on proteomics by facilitating the 
rapid identification and characterization of thousands of protein. The traditional 
ionization fragmentation of peptides, thus fail to provide accurate peptide mass. 
However, development of two Nobel prize-winning ionization methods, MALDI (matrix 
assisted laser desorption/ionixation) and ESI (electrospray ionization), enabled the 
ionization of large biological macromolecules without fragmentation, thus enabling the 
identification of proteins. However, both of these ionization processes are very sensitive 
to charges, low concentration of salt is required for the peptide solution to be analyzed. 
The peaks detected by mass spectrometer results in a mass spectrum represent the peptide 
ions mass which can be used for protein identification. 
3.4.4.1 MALDI-TOF  
In MALDI, the peptide samples are mixed to an acidic matrix and condense on a 
plate that is subjected to laser radiation. The peptides are incorporated into the crystal 
lattice of the matrix during the condensation process.  Various compound are used as the 
matrices for laser absorption. One of the wildly used matrices for peptides is α-cyano-4-
hyroxy cinnamic acid because it provides high sensitivity and negligible matrix adduction 
during the laser absorption (Beavis and Chait, 1989). When the high energy of laser is 
applied to the matrix, the peptides along with the matrix particles were vaporized. In 
order to ensure the sublimation of the matrix-peptides solid, high vacuum are generally 
applied during this process. The positive ions of the peptides are formed in gas phrase 
due the acidic nature of the matrix. The ions are then accelerated into the mass analyzer 
(Fig 3.11). Since MALDI is a pulsed ionization technique, it is generally couple with 
TOF (time-of-flight) mass analyzer. 
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Fig 3.11 
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3.4.4.2 ESI  
In ESI, the peptide in the solution is sprayed at atmospheric pressure through an 
outlet with a high potential difference between the outlet and the mass spectrometer. This 
potential difference generates a repulsive coulombic force between the like charges on 
the droplets to extend the solution to form a cone (Taylor cone) from the outlet, causeing 
the solution to disperse into fine droplets (Taylor, 1964). The solvent continuously 
evaporates while the charges of the droplets remain constant. Droplet fission occurs when 
the coulombic repulsion exceed the surface tension of the droplets. This process 
continues until nanometer sized droplets are produced to forms a single peptide ion for 
the mass spectrometer (Fig 3.12) the charges on the sing;e peptide are sttistica;;y 
distributed over the peptide’s potential charge site., thereby, multiply charged ions are 
possible.  This unique feature of ESI yields an effectively rduced mass/charge ratio from 
peptides of interest. Therefore, ESI offer significant advantages for the analyis of 
peptides with large molecular weight.  
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3.4.5 Bioinformatics and Identification 
Since the peaks of the resulting mass spectrum represent the peptide ions mass of 
the sample of interest, the peaks should be correlated to the mass of the peptides 
produced by the protease from a larger protein (see Fig 3.13). 
 Databases are available for theoretical digests of all known proteins,; thus, 
matching the peptide mass data obtained from samples interested to this theoretical 
digested protein database can successfully identify the proteins. This process, known as 
peptide mass fingerprinting, must accounts for several factors, such as molecular weight, 
pI and the probability of a single peptide appears in the whole database, for the 
identification of a protein. Many search engines can perform this matching process with 
an output of a probability score for each theoretical digested protein indicating the 
certainty of the identification. The threshold score, which indicates if the experimental 
mass spectrum significantly matches the theorical digested protein spectrum, is calculated 
by mathematical algorithms specific to each search engine and each experimental mass 
spectrum. Although false identification is conceivable, it can be avoided by taking into 
account the molecular weight and pI range on the 2D map in the identification. Moreover, 
prior results suggest that the accuracy of protein identification by mass spectrometry is 
equivalent to immunochemical identification (Castegna et al., 2002b). 
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Figure 3.13 
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CHAPTER FOUR 
The Antioxidant α-Lipoic Acid Reverse Memory Impairment and Brain 
Oxidative Stress in Aged SAMP8 mice 
4.1 Introduction 
4.1.1 SAMP8 model 
 The senescence-accelerated mouse (SAM) is a model of accelerated senescence 
that was established through phenotypic selection from a common genetic pool of AKR/J 
strain of mice (Takeda et al., 1981). In 1975, certain littermates of AKR/J mice were 
noticed to become senile at an early age and had a shorter life span. Five of these litters 
with early senescence were selected as the progenitors of the senescence-accelerated-
prone mice (SAMP). Three litters with normal aging process were also selected as the 
progenitors of senescence-accelerated-resistant mice (SAMR) (Takeda et al., 1981; 
Miyamoto, 1997). Thereafter, selective inbreeding was applied based on the degree of 
senescence, the lifespan, and the age-associated pathologic phenotypes (Hosokawa et al., 
1997). In 1981, the SAM model was established, including nine major SAMP substrains 
and three major SAMR substrains, each of which exhibits characteristic disorders. The 
characteristics of the SAMP substrains are summarized in Table 4.1. It should be noted 
that other strains were also derived from these major substrains (Takeda, 1999). 
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 Table 4.1: Summary of the characteristics of different 
substrains of SAMP model 
Strain Characteristics 
SAMP1 Senile amyloidosis, impaired immune system, impaired audiatory 
system, retinal atrophy, hypertensive vascular disease, contracted 
kidney, pulmonary hyperinflation  
SAMP2 Senile amyloidosis, impaired immue system 
SAMP3 Degenerative arthrosis 
SAMP6 Senile osteoporosis 
SAMP7 Senile amyloidosis, thymoma 
SAMP8 Age-related learning and memory deficits, anxiety, impaired immune 
system, age-dependent deposition of amyloid β-peptide 
SAMP9 Age-related cataracts 
SAMP 10 Brain atrophy, age-related learning and memory deficits, age-related 
depression 
SAMP11 Age-relating thickening of tunic media of thoracic aorta, senile 
amyloidosis, contracted kidney. 
SAMR1 Normal aging with non-thymic lymphoma, histiocytic sarcoma and 
ovarian cysts. 
SAMR4. Normal aging with non-thymic lymphoma, histiocytic sarcoma, no 
ovarian cysts. 
SAMR5 Normal aging with colitis. 
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 Recently, SAMP8 mice have drawn attention in gerontological research of 
dementia due to its characteristic learning and memory deficits at old age (Flood and 
Morley, 1998). The life span of ARK/J mice is approximately 10 months. Depending on 
the microbiological condition of housing, the life span of SAMP8 mice ranges from 10 
months to 17 months. Such life span is shorter than that of SAMR1, which ranges from 
19 months to 21 months (Flood and Morley, 1998). The unique characteristic of SAMP8 
mice is that it has low incidence of other phenotypic aging alterations when its deficits in 
learning and memory are developed (Flood and Morley, 1998). Therefore, it is a good 
rodent model for cognitive impairment in age subjects. Moreover, in comparison with 
aged SAMR1 mice, the aged SAMP8 mice show impairments in learning tasks, altered 
emotion, abnormality of circadian rhythm (Miyamoto, 1997), and increased oxidative 
stress (Butterfield et al., 1997a). When compared to young SAMP8, aged SAMP8 mice 
also show clear age-related impairment in learning assessed by foot shock avoidance 
(Flood and Morley, 1993), which correlates with oxidative stress parameters (Farr et al., 
2003). These findings are consistent with the free radical theory of aging that posits the 
oxidative modification by reactive oxidative species (ROS) on biomolecules contribute to 
the cellular dysfunction in aging (Harman, 1956). 
Cross breeding of a CD-1 dame and a SAMP8 sire developed a series of paternal 
backcross strains. Siblings from each backcross were then bred to establish strains with 
different percentages of SAMP8 genes. It was demonstrated that the age-related learning 
and memory impairment is correlated to the percentage of SAMP8 genes (Morley et al., 
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2002). Initial examination of the genetic profiles revealed that at least one genotype in 
SAMP8 strain is different from that in the AKR/J strain (Takeda, 1999). Moreover, a 
series of Southern hybridization analyses of DNA isolated from SAMP8 mice showed 
that:  (1) the SAMP8 genome is genetically distinguishable from that of other SAM mice; 
(2) SAMP8 mice resemble other SAMP, but are clearly different from the parental 
AKR/J strain; and (3) the level of murine leukemia virus in SAMP8 mice is increased 
(Takeda, 1999).  
 One of the interesting genes that affects the learning and memory in SAMP8 mice 
is the amyloid precursor protein (APP) (Kumar et al., 2000b). The function of APP is not 
entirely understood; however, the internalization and endosomal processing of APP 
produces neurotoxic Aβ (Perez et al., 1999), and recent studies suggest that rodent Aβ is 
toxic (Boyd-Kimball et al., 2004).  APP cDNA cloned from the hippocampus of 8-
month-old SAMP8 mouse shows high similarity to that of other species (Kumar et al., 
2001). At the amino acid level, the homology was 99.2% with other rodent APP 
sequences. A single amino acid substitution of alanine instead of valine at position 300 of 
APP was unique to SAMP8. However, familial AD mutations were not observed in 
SAMP8 cDNA, suggesting that the learning and memory deficits of SAMP8 maybe 
different from that in familial AD (Kumar et al., 2001). Moreover, the age-related 
increase of APP mRNA affects the learning and memory in SAMP8 mice (Morley et al., 
2000). Such cognitive deficits are significantly improved when the expression of APP is 
down-regulated by using an antisense oligonucleotide specific to APP mRNA in aged 
SAMP8 mice (Kumar et al., 2000b; Kumar et al., 2001). Therefore, these studies indicate 
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that the abnormal processing of APP may contribute to the increased oxidative stress and 
cognitive deficits in aged SAMP8 mice.  
Further identification of genes that are specifically expressed in the hippocampus 
of SAMP8 was performed to understand the molecular basis of the pathological changes 
and cognitive deficits of SAMP8 (Wei et al., 1999b).  The mRNAs of eukaryotic 
translation initiation factor 2B subunit 1 (EIF-2B) like gene and phospholipase D like 
gene are only expressed in SAMP8 mice but not in SAMR1, suggesting these genes are 
relevant to the dysfunction of the central nervous system (CNS) of SAMP8 mice (Wei et 
al., 1999b). 
Other analyses of neurotrophic genes revealed that the expression of hippocampal 
glial cell line-derived neurotrophic factor (GDNF) mRNA in SAMP8 is less than that in 
SAMR1 (Miyazaki et al., 2003), and neurotrophin–3 (NT-3) and nerve growth factor 
(NGF) mRNA levels in the midbrain, hippocampus and forebrain of SAMP8 mice are 
also lower than those in SAMR1 at early stages (Kaisho et al., 1994). These studies 
suggest that low neurotrophic gene expression in young SAMP8 may contribute to their 
hippocampal dysfunction. 
Comparing the levels of Alzheimer’s disease (AD)-related genes in the 
hippocampus and cerebral cortex of SAMP8 mice to those of the SAMR1 by reverse 
transcription polymerase chain reaction (RT-PCR) showed that levels of apohyprotein E 
(apoE) and mineralocorticoid receptor (MR) mRNAs of SAMP8 were decreased, while 
bcl-2 alpha and presenilin-2 (PS-2) mRNA levels were significantly increased (Wei et al., 
1999a). These studies suggest that the abnormal expression of these AD-related genes 
contribute to the age-related deterioration of learning and memory in SAMP8.  A 
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microarray study of mRNA in SAMP8 hippocampus also showed that genes associated 
with the stress response and antioxidant systems are strongly affected during age-related 
cognitive impairment (Kumar et al., 2000a). The genes identified in this study were 
V(D)J recombination activating protein (RAG-1), ubiquitin-like protein, T-complex 
proteins a and b subunits, T-complex protein 1 delta, episilon, gamma, eta, theta, zeta 
subunit, heme oxygenase 1, endoplasmin precursor, calnexin precursor, phospholipase C-
alpha, JNK stress-activated protein kinase, mitogen-activated protein kinase (MAPK) p38 
, MAPK kinase 4, JNK activating kinase, RhoB, peroxisome proliferator activated 
receptor beta, cytochrome P450 IIB9, cytochrome P450 IIIA, quinone oxidoreductase, 
and  microsomal UDP-glucuronosyltransferase 1-1 precursor (Kumar et al., 2000a). Since 
the translational products of these affected genes are involved in signaling, chaperone 
function and antioxidant systems, this study suggests that abnormalities of the signal 
transduction, protein folding and antioxidant system may contribute to the cognitive 
decline in aged SAMP8 mice.  
 In addition to genes that are involved in neuroprotection, signal transduction, 
protein folding and degradation, other altered gene expression in SAMP8 mice are related 
to involved in energy metabolism, immune response, the cytoskeleton and transport. 
Decreased Δ 9-desaturase mRNA with age in SAMP8 mice could contribute to altered 
membrane fluidity and signaling pathways in synapses (Kumar et al., 1999) The mRNAs 
of bullous pemphigoid antigen like gene is only present in SAMR1, while the mRNAs of 
glycogen debranching enzyme isoform like gene is only expressed in SAMP8 mice, 
suggesting these genes are relevant to the dysfunction of the CNS of SAMP8 mice (Wei 
et al., 1999b). Comparing the levels of AD-related genes in the hippocampus and cerebral 
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cortex of SAMP8 mice to that of the SAMR1 by RT-PCR showed that levels of apoE and 
glucocorticoid receptor-alpha (GR alpha) mRNAs of SAMP8 were decreased, while tau 
mRNA levels were significantly increased (Wei et al., 1999a). Moreover, the ubiquitous 
kinesin heavy chain gene is altered in SAMP8 mice brain. Since all of these genes are 
involved in energy metabolism, immune response, cytoskeleton and transport, the 
alteration of these genes may affect these process and lead to neuronal damage in SAMP8 
mice brain. 
The alterations of gene expression described in the studies cited above can be 
functionally classified into neuroprotection, signal transduction, protein 
folding/degradation, the cytoskeleton, transport, and immune response (Table 4.2). These 
changes in gene levels are consistent with the pathological and neurochemical findings in 
SAMP8 mice (Nomura et al., 1996). All of these processes are reportedly involved in 
age-related cognitive decline (Lal and Forster, 1988; Butterfield and Stadtman, 1997; 
Wilson et al., 2002; Poon et al., 2004a, b). Moreover, the abnormal APP and Aβ 
metabolism in SAMP8 mice brain suggest that the learning and memory deficits in 
SAMP8 could have some similarities to those in AD. These findings support the view 
that SAMP8 mouse is useful for the investigation of the mechanism of age-related 
learning and memory deficits (Nomura et al., 1996).  
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 Table 2: Altered genes in SAMP8 mice brain 
 
Gene Expression changes * Function of gene products 
# Reference
Neuroprotection 
APP ↑ 
A cell surface protease inhibitor 
that reduces copper; proteolytic 
peptides (Aβ) are found in amyloid 
deposits. 
(Kumar et 
al., 
2000b) 
apoE ↓ 
An lipoprotein that binds low 
density lipoprotein receptor 
(LDLR), involved in clearance of 
circulating cholesterol, allele 4 
linked to Alzheimer disease. 
(Wei et 
al., 1999a)
heme oxygenase 1 ↓ 
An enzyme that cleaves the heme 
ring at the alpha methylene bridge 
to form biliverdin and carbon 
monoxide, involved in oxidative 
stress response; altered expression 
of human version is associated 
with AD and Parkinson disease 
(PD). 
(Kumar et 
al., 2000a)
cytochrome P450 IIB9 ↓ 
A cytochrome P450 enzyme that is 
induced by phenobarbital and 
regulated by sex hormones in a 
sex-dependent, organ-dependent 
fashion 
(Kumar et 
al., 2000a)
cytochrome P450 IIIA ↑ 
A major drug metabolizing enzyme 
that oxidizes the Ca2+ channel 
inhibior nifedipine, involved in 
benzopyrene, steroid, retinoid, and 
toxin metabolism. 
(Kumar et 
al., 2000a)
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 4.1.2 Lipoic Acid 
 α-Lipoic acid (LA), a coenzyme involved in production of ATP in mitochondria, 
is a potent antioxidant (Packer et al., 1997a; Packer et al., 1997b). The antioxidant 
properties are proposed due to its its ability to (a) act as a scavenger of reactive oxygen 
species (ROS); (b) chelate metals; and (c) to recycle endogenous antioxidants . LA can 
scavenge singlet oxygen, H2O2, OH•, NO and ONOO-, and the reduced form of LA, 
dihyrolipoic acid,  can further scavenge O2• and peroxyl radical (Kagan et al., 1992). LA 
can also chelate several divalent cations, e.g. Mn2+, Cu2+, Zn2+, Cd2+, Pb2+. Therefore, LA 
can inhibit ascorbate-induced production of H2O2 by Cu+ (44). LA can act to recycle 
endogenous antioxidants, e.g. GSH (Ou et al., 1995) and vitamin C (Sen et al., 1997), 
which regenerates vitamin E.  GSH, vitamin C and vitamin E all protect brain from 
oxidative stress (Drake et al., 2002; Butterfield and Pocernich, 2003). It was shown that 
LA can improve memory in aged female NMR1 mice (Kidd, 1999) and reverse partial 
brain mitochondrial decay, RNA/DNA oxidation and memory loss in old rats (Liu et al., 
2002). AD patients with LA treatment for approximately 1 year resulted in mild cognitive 
improvements (Hager et al., 2001).  
 Our lab demonstrated a higher oxidative stress insult present in SAMP8 mouse 
brain compared to SAMR1 mouse. If oxidative stress is involved in the learning and 
memory in aged SAMP8 mice, aged SAMP8 mice should have higher oxidative stress 
than young SAMP8 mice, correlating to their learning and memory decline as a function 
of aged. In addition, this study examined the ability of LA to protect SAMP8 mouse 
against the behavior deficits and oxidative stress of accelerated aging. 
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4.2 Experimental Procedures 
4.2.1 Subjects  
Experimentally naive, 4- and 12-month-old male SAMP8 mice were obtained 
from the breeding colony at St. Louis University. The colony is derived from siblings 
generously provided by Dr Takeda of (Kyoto University, Japan), and has been 
maintained as an inbred strain for 12 years under clean-room procedures (i.e. use of 
sterile gloves in handling mice, sterilized cages and bedding, restricted access to breeding 
area), and housed in microisolator HEPA filter units (Allentown Caging, PA, USA). The 
colony routinely undergoes serological testing for viral and bacterial contamination and 
has remained free of pathogens for over 5 years. Mice are housed in rooms with a 12 : 12 
light/dark cycle (lights on at 06.00 h) at 20-22°C with water and food (Richmond 
Laboratory Rodent Diet 5001) available ad libitum. All experiments were conducted after 
institutional approval of the animal use subcommittee, which subscribes to the NIH 
Guide for Care and Use of Laboratory Animals. 
4.2.2 LA Administration 
LA were obtained from Jarrow Formulas, Inc. (Los Angeles, CA, USA), and 
dissolved in saline at pH 7.0. LA (100 mg/kg), or saline were administered 
subcutaneously once daily for 4 weeks at 1 PM. At the end of week one, animals were 
tested in the T-maze footshock avoidance paradigm. The following day, activity was 
tested in an open field and a 1-week habituation to milk was begun. At the end of the 1-
week habituation, mice were trained in the lever press. Behavioral measures and training 
were conducted between 07.30 and 11.30 h. 
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4.2.3 T-maze Footshock Avoidance
The T-mase training was performed by Dr. Susan Farr at St. Louis University. 
Training procedures for the T-maze footshock avoidance apparatus have been described 
(Farr et al., 1999; Farr et al., 2000). The maze consisted of a black plastic start alley with 
a start box at one end and two goal boxes at the other. A stainless steel rod floor ran 
throughout the maze. The start box was separated from the start alley by a plastic 
guillotine door that prevented the mouse from moving down the alley until the training 
started. 
A training trial began when a mouse was placed into the start box. The guillotine 
door was raised and the buzzer was sounded simultaneously; 5 s later, footshock was 
applied. The goal box the mouse first entered on the first trial was designated as 
'incorrect'. Footshock was continued until the mouse entered the other goal box, which on 
all subsequent trials was designated 'correct' for the particular mouse. At the end of each 
trial, the mouse was removed from the goal box and returned to its home cage. A new 
trial began by placing the mouse back in the start box, sounding the buzzer, and raising 
the guillotine door. Footshock was applied 5 s later if the mouse did not leave the start 
box or failed to enter the correct goal box. 
Training used an intertrial interval of 45 s and a door-bell type buzzer at 65 dB as 
the conditioned stimulus warning of onset of foot shock at 0.40 mA (Coulbourn 
Instruments scrambled grid floor shocker model E13-08). Mice were trained until they 
made one avoidance. 
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4.2.4 Sample Preparation 
 SAMP8 brains samples were flash frozen in liquid nitrogen in St. Louis and sent 
to Lexington on ice overnight. The samples were homogenized in 0.32M sucrose 
isolation buffer (2mM EDTA, 2mM EGTA, 20mM HEPES, 20μ.g/mL Trysin inhibitor, 4 
μg/mL Leupeptin, 4 μg/mL pepstatin, 5 μg/mL aprotinin) by sonication and the protein 
concentration was determined by the BCA method.  
4.2.5 Carbonyl Level  
Protein carbonyl levels of proteins were determined immuchemically as adducts 
of 2,4-dinitrophenylhydrazine (32). 5μL of the samples were treated with equal volume of 
12% SDS. Samples were then derivatized with 10 μL of 20 mM 2,4-DNPH for 20 
minutes. The reaction was stopped by addition of neutralizing reagent (7.5 μL of  2M 
Tris/ 30% glycerol buffer, pH = 8.0). Levels of protein carbonyls were measured by using 
the slot-blot technique with 250 ng of protein loaded per slot. The 2,4-dinitrophenyl 
hydrazone (DNP) adduct of the carbonyls is detected on the nitrocellulose paper using a 
primary rabbit antibody (Intergen) specific for DNP-protein adducts (1:100) and then a 
secondary goat anti-rabbit IgG (Sigma) antibody. The resultant stain was developed by 
application of Sigma-Fast (BCIP/NBT) tablets, and the line densities were quantified by 
Scion-Image software package. 
4.2.6 TBARS 
The concentration of TBARS in brain tissue was determined according the 
method of Ohkawa et al. (33). 50 mL of 10% w/v of ice cold TCA was added into 0.25 
mL of 4mg/mL tissue homogenate. The samples were spun in an Eppendorf centrifuge 
tube for 5 min at 3,000 g. The supernatant was collected (0.5 ml) and treated with TBA 
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reagent (20 mM TBA in 50% v/v glacial acetic acid). The samples were then heated at 
100°C for 1 hr. After the cooling period, butanol was added, and the organic layer was 
removed and redistributed to a black microtiter plate (Corning Inc, Acton, MA). End 
point fluorescence was measured at λex = 515 nm and λem = 585 nm. 
4.2.7 W/S Ratio 
4.2.7.1 Synaptosome Isolation.  
Synaptosomes were purified as described (26, 34, 35). The crude homogenate was 
removed and respun at 20,000 × g at 4°C for 10 min. The resulting pellet was 
resuspended in the 0.32M sucrose isolation buffer and layered on a discontinuous sucrose 
gradient (10 ml of 1.18 M sucrose, pH 8.5/ 10 ml of 1.0 M sucrose, pH 7.4/ 10 ml of 0.85 
M sucrose, pH 7.4, each containing 2 mM EDTA/2 mM EGTA/10 mM Hepes). The 
samples were then spun at 82,500 × g at 4°C for 60 min in a Beckman swinging-bucket 
rotor. Synaptosomes were removed from the 1.18/1.0 M sucrose interface and 
resuspended in 20 ml of lysing buffer (10 mM Hepes/2 mM EDTA/2 mM EGTA, pH 
7.4). The samples were then centrifuged at 32,000 × g at 4°C for 10 min. The pellet was 
removed and resuspended in PBS buffer and spun down two more times. After the third 
wash, the protein concentration was determined by the BCA method 
4.2.7.2 Spin Labeling  
Spin labeling of synaptosomal membrane proteins was performed as described 
(26, 36). Isolated synaptosomes were suspended in lysing buffer for 30 minutes.  Lysed 
synaptosomal membranes were labeled with the protein-specific spin label MAL-6. After 
incubation for 18 hr at 4°C with 20 µg MAL-6/mg protein, samples were washed six 
times in lysing buffer to remove excess spin label. The pellet was then resuspended in 
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approximately 400 μl lysing buffer and allowed to come to room temperature. EPR 
spectra were acquired on a Bruker model EMX EPR spectrometer (Bruker, Billerica, MA) 
operating at an incident microwave power of 18 mW, a modulation amplitude of 0.4 G, a 
time constant of 1.28 msec, and a conversion time of 10 msec.  
4.2.8 Statistics 
The data of oxidative parameter measurements were analyzed by Student's t tests. 
Result of T-maze avoidance was analyzed with one-way analysis of variance (ANOVA) 
and a two-way analysis of variance. A value of p < 0.05 was considered statistically 
significant.   
4.3 Results 
4.3.1 T-maze Footshock Avoidance 
The acquisition decline as a function of age in SAMP8 mice. However, 
administration of LA improved acquisition as tested in the T-maze footshock avoidance 
paradigm. The ANOVA for the trials to first avoidance measure indicated a significant 
effect (F 2,27 = 34.31, p < 0.001). Statistical analysis revealed 12-month-old SAMP8 mice 
that had received LA took significantly fewer trials to reach criterion than the 12-month-
old SAMP8 mice which received saline. The group of mice administered LA did not 
significantly differ from the 4-month-old SAMP8 mice administered saline. The ANOVA 
for latencies to escape shock on the first trial did not indicate a significant difference. 
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Figure 4.1 
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4.3.2 Protein Carbonyl level 
To determine whether the protein carbonyl levels of cortical synaptosomal 
membranes were increased in the 12 month SAMP8 mouse relative to those from 4 
month SAMP8 mouse, the 2,4-dinitrophenylhydrazone adducts were measured 
immunochemically. The results suggest that the protein carbonyl levels of brain proteins 
in 12 month SAMP8 were significantly greater than those of 4 month SAMP8 by 29%  
(Fig. 4.2 ; P < 0.01). However, if 12-month-old and 4-month-old SAMP8 mice were 
treated with LA,  the protein carbonyl level of 12 month SAMP8 mice only increase 17% 
with no significant difference (Fig. 4.2). 
4.3.3 W/S Ratio 
Consistent with result of protein carbonyl levels, the W/S ratio is decreased 
significantly in synaptosomal membrane proteins of 12-month SAMP8 mice compared 
with that of 4-month SAMP8 mice (Fig 4.3; p < 0.001). There is no significant difference 
between this parameter in brain membranes from 4-month and 12-month old SAMP8 
mice with prior in-vivo LA treatment (Fig. 4.3) 
4.3.4 TBARS 
 Additional oxidative stress markers were decreased in 12-month old SAMP8 
mice. Increased TBARS levels were observed in brain from 12-month-old SAMP8 mice 
compared to 4-month-old SAMP8 mice (Fig. 4.4 p < 0.05). This result suggested that 
increased lipid peroxidation in 12-month-old SAMP8 mice compared with that of 4-
month-old SAMP8 mice. (Fig. 4.4 p < 0.05). Again, there is no significant difference in 
brain lipid peroxidation as indicated by TBARS between the 4-month and 12-month 
SAMP8 mice if they were treated previously in vivo with LA. 
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Figure 4.2 
 
 100
Figure 4.3 
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Figure 4.4 
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4.4 Discussion 
  By comparing oxidative stress indices: protein carbonyl level, W/S ratio 
and TBARS, it has been well established that brain from SAMP8 mice has more 
oxidative stress than normal aging mice model (ddY and SAMR1) . Consistent with the 
multiple evidence of other laboratories (Yagi et al., 1988; Miyamoto, 1997; Morley et al., 
2000), the results from the present study show that the brains of 12-month-old SAMP8 
mice suffer from higher oxidative insult than 4-month SAMP8 mice . This suggests that 
either antioxidant defense of SAMP8 mice is weakened or endogenous oxidative stress 
was strengthened by accelerated aging.  
Consistent with oxidative stress, impairment of learning was reported for SAMP8 
mice at 12 months of age. Previously, 4-month and 12-month old SAMP8 mice were 
trained to learn a specific sequence of left-right or black-white responses to obtain milk 
reinforcement. All of the 12-month-old SAMP8 mice failed to learn the task, whereas 
about 60% of the 4-month-old SAMP8 mice learned the task (Flood and Morley, 1998). 
Also, impairment of memory retention for passive avoidance training was detected in 8 
month SAMP8 (Yagi et al., 1988). Morely, Flood and coworkers reported that there is 
significant difference of accumulation of APP in the hippocampal area between 8-month-
old SAMP8 mice and 12-month-old SAMP8 mice, and plaque formation occurs only well 
after development of cognitive deficits in SAMPP8 mice (Kumar et al., 2000b).  
Increased APP leads to Aβ accumulation and oxidative damage to brain tissue 
(Butterfield, 1997, 2002; Butterfield et al., 2002d). The current study indicates that 
oxidative stress is closely related to learning ability and memory retention in SAMP8 
mice. Lesion studies in other animals have shown that spatial learning is dependent on 
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the integrity of the septohippocampal pathway (O'Keefe, 1978). It is possible that free 
radicals react with enzymes, receptors or/and neurotransmitters (Norepinephrine, 
dopamine etc.) in the pathway and therefore destroy their proper functions. As the result, 
the functioning of the whole septohippocampal pathway was decreased as Reddy et. al. 
hypothesized (Reddy et al., 1998). Further studies will be needed to prove this 
hypothesis.  
Ames and coworkers have shown that LA is able to partially reverse memory loss 
in normal aging rats by delaying mitochondrial dysfunction and RNA/DNA oxidation 
(Liu et al., 2002). Mitochondrial dysfunction is accompanied by a leakage of O2• and 
H2O2. That LA is readily taken up into mitochondria where it acts as a cofactor in 
oxidative decarboxylation of α-keto acids has led to the view that LA maybe a useful 
therapeutic agent in disease which are characterized by mitochondria dysfunction or 
oxidative stress (Packer et al., 1997a; Packer et al., 1997b). The present result showed 
that LA is also a good therapeutic for accelerated aging. The results of present study 
show that if 12-month-old SAMP8 mice are treated with LA, there is no significant 
between age groups in oxidative stress parameters and T-maze footshock avoidance test. 
  After 12-month-old SAMP8 mice were treated with LA, the learning is 
improved as shown by T-maze footshock avoidance test, perhaps because of the 
improved antioxidant defense by LA. LA possibly protects the septohippocampal 
pathway by reducing the oxidation of dopamine and norepinephrine (Biewenga et al., 
1997) which are activated by training of the animals (Flood and Morley, 1998).  LA acts 
not only by increasing the concentration of dopamine and norepinephrine, but also by the 
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scavenging action that stops the toxic end products of dopamine and norpinephphrine 
oxidation, H2O2 and O2• (Packer et al., 1997b).  LA should protect other enzymes and 
receptors in the septohippocampal pathway from oxidative damage as well because of its 
antioxidant ability.  
We conclude that increased oxidative stress observed in 12-month-old SAMP8 
mouse brain when compared to 4-month-old SAMP8 mice is contributed to the memory 
and learning deficits in aged SAMP8 mice. This is probably due to the oxidative damage 
to the septohippocampal pathway. LA was able to reverse these changes. Therefore, LA 
may be an efficient treatment or supplement for age related cognitive impairment. 
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CHAPTER FIVE 
Quantitative Proteomics Analysis of Specific Protein Expression and 
Oxidative Modification in Aged Senescence-Accelerated-Prone 8 Mice Brain 
5.1 Introduction 
 In the last chapter, we showed that 12-month-old SAMP8 mice have higher 
protein oxidation, and lipid peroxidation compared with 4-month-old SAMP8 (Farr et al., 
2003). In order to investigate the relations among age-related oxidative stress on proteins, 
physiological alterations and impairments in learning and memory, we used proteomics 
to identify brain proteins that are expressed differently and oxidatively modified with 
aging in SAMP8 mice brain.  
5.2 Experimental Procedures  
5.2.1 Rodent Subjects  
 Rodent subjects used are the same as described in section 4.2.1 
5.2.2 Sample Preparation 
 The whole brains of SAMP8 mice were flash frozen in liquid nitrogen in the 
laboratory of Geriatric Research Education and Clinical Center (GRECC), VA Medical 
Center, St. Louis and sent to the Chemistry Department, University of Kentucky, 
Lexington on dry ice overnight. The whole brain samples were homogenized in a lysis 
buffer (10 mM HEPES, 137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and 
0.5 mg/mL leupeptin, 0.7µg/mL pepstatin, 0.5 µg/mL trypsin inhibitor, and 40 µg/mL 
PMSF). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The 
supernatant was extracted to determine the concentration by the BCA method (Pierce, 
IL). 
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5.2.3 Two-dimensional electrophoresis  
Samples of brain proteins were prepared according to the procedure of Levine et 
al. (Levine et al., 1994). 200μg of protein were incubated with 4 volumes of 2N HCl at 
room temperature (25°C) for 20min. Proteins were then precipitated by addition of ice-
cold 100% trichloroacetic acid (TCA) to obtain a final concentration of 15% TCA final. 
Samples are placed on ice for 10 min to let protein precipitate. Precipitates were 
centrifuged at 15,800 g for 2 min. This process removed ions that affect the voltage 
during the isoelectric focusing. The pellets were washed with 1mL of 1:1 (v/v) 
ethanol/ethyl acetate solution. After centrifugation and washing with ethanol/ethyl acetate 
solution three times, the samples were dissolved in 25 μL of 8 M urea (Bio-Rad, CA). The 
samples then were mixed with 185μL of rehydration buffer (8 M urea, 20mM 
dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea and bromophenol blue).  
In first-dimension electrophoresis, 200 µL of sample solution were applied to a 
ReadyStrip™ IPG strip (Bio-Rad, CA). The strips were soaked in the sample solution for 
1 hour to ensure uptake of the proteins. The strip was then actively rehydrated in the 
protean IEF cell (Bio-Rad) for 16 hours at 50V. The isoelectric focusing was performed 
at 300V for 2 hours linearly; 500V for 2 hr linearly; 1000V for 2 hr linearly, 8000V for 8 
hr linearly and 8000V for 10 hr rapidly. All the processes above were carried out at 22oC. 
The strip was stored in –80oC until the second dimension electrophoresis was performed. 
For the second dimension, IPG® Strips pH 3-10 were equilibrated for 10 min in 
50 mM Tris-HCl (pH 6.8) containing 6M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 
30% (v/v) glycerol, and 0.5% dithiothreitol, and then re-equilibrated for 15min in the 
same buffer containing 4.5% iodacetamide in place of dithiothreitol. 8-16% Linear 
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gradient precast criterion Tris-HCl gels (Bio-Rad, CA) were used to perform second 
dimension electrophoresis. Precision ProteinTM Standards (Bio-Rad, CA) were run along 
with the sample at 200V for 65 min. 
The gel was incubated in fixing solution (7% acetic acid, 40% methanol) for 20 
min after the second dimension electrophoresis. Approximately, 60 mL of Bio-Safe 
Coomassie blue were used to stain the gel for 2 hours. The gels were destained in 
deionized water overnight. 
5.2.4 Western Blotting 
 200μg of protein were incubated with 4 volumes of 20 mM DNPH at room 
temperature (25°C) for 20min. The gels were prepared in the same manner as for 2D-
electrophoresis. After the second dimension, the proteins from gels were transferred to 
nitrocellulose papers (Bio-Rad) using the Transblot-Blot® SD semi-Dry Transfer Cell 
(Bio-Rad) at 15V for 4 hrs. The 2,4-dinitrophenyl hydrazone (DNP) adduct of the 
carbonyls of the proteins was detected on the nitrocellulose paper using a primary rabbit 
antibody (Chemicon, CA) specific for DNP-protein adducts (1:100), and then a 
secondary goat anti-rabbit IgG (Sigma, MO) antibody was applied. The resultant stain 
was developed by application of Sigma-Fast (BCIP/NBT) tablets. 
5.2.5 Image Analysis 
 The gels and nitrocellulose papers were scanned and saved in TIFF format using 
Scanjet 3300C (Hewlett Packard, CA). Investigator HT analyzer (Genomic Solutions 
Inc., MI) was used for matching and analysis of visualized protein spots among 
differential gels and oxyblots.  The principles of measuring intensity values by 2-D 
analysis software were similar to those of densitometric measurement.  Average mode of 
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background subtraction was used to normalize intensity value, which represents the 
amount of protein (total protein on gel and oxidized protein on oxyblot) per spot.  After 
completion of spot matching, the normalized intensity of each protein spot from 
individual gels (or oxyblots) was compared between groups using statistical analysis. 
5.2.6 Trypsin Digestion 
Samples were prepared using techniques described by Jensen (Jensen et al., 
1999), modified by (Thongboonkerd et al., 2002). The protein spots were excised with a 
clean blade and transferred into clean microcentrifuge tubes. The protein spots were then 
washed with 0.1M ammonium bicarbonate (NH4HCO3) at room temperature for 15 min. 
Acetonitrile was added to the gel pieces and incubated at room temperature for 15 min. 
The solvent was removed, and the gel pieces were dried in a flow hood. The protein spots 
were incubated with 20 µl of 20 mM DTT in 0.1M NH4HCO3 at 56°C for 45min. The 
DTT solution was then removed and replaced with 20µl of 55mM iodoacetamide in 0.1M 
NH4HCO3. The solution was incubated at room temperature in the dark for 30min. The 
iodoacetamide was removed and replaced with 0.2ml of 50mM NH4HCO3 and incubated 
at room temperature for 15 min. 200μL of acetonitrile was added. After 15min 
incubation, the solvent was removed, and the gel spots were dried in a flow hood for 30 
min. The gel pieces were rehydrated with 20 ng/µl modified trypsin (Promega, Madison, 
WI) in 50 mM NH4HCO3 with the minimal volume to cover the gel pieces. The gel pieces 
were chopped into smaller pieces and incubated at 37°C overnight in a shaking incubator. 
5.2.7 Mass Spectrometry 
All mass spectra reported in this study were acquired from the University of 
Kentucky Mass Spectrometry Facility (UKMSF). LC/MS/MS spectra were acquired on a 
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Finnigan LCQ 'Classic' quadrupole ion trap mass spectrometer (Finnigan). Separations 
were performed with an HP 1100 HPLC modified with a custom splitter to deliver 
4µL/min to a custom C18 capillary column (300µm id x15cm, packed in-house with 
Macrophere 300 5µm C18 (Alltech Associates). Gradient separations consisted of 2 min 
isocratic at 95% water: 5% acetonitrile (both phases contain 0.1% formic acid), the 
organic phase was increased to 20% acetonitrile over 8min, then increased to 90% 
acetonitrile over 25min, held at 90% acetonitrile for 8min, then increased to 95% in 
2min, and finally returned to initial conditions in 10min (total acquisition time 45 min 
with a 10-min recycle time). Tandem mass spectra were acquired in a data dependent 
manner. Three microscans were averaged to generate the data-dependent full scan 
spectrum. The most intense ion was subjected to tandem mass spectrometry and three 
microscans were averaged to produce the MS/MS spectrum. Masses subjected to the 
MS/MS scan were placed on an exclusion list for 2min. The tandem spectra obtained 
were searched against the NCBI protein databases using the MASCOT search engine ( 
http://www.matrixscience.com). For the MS/MS spectra, the peptides were also assumed 
to be monoisotopic, oxidized at methionine residues and carbamidomethylated at cysteine 
residues. A 0.8-Da MS/MS mass tolerance was used for searching. 
5.2.8 Statistics 
The data of protein levels and protein specific carbonyl levels of 6 animals per 
group  (young and old SAMP8 mice) were analyzed by Student's t tests. A value of p < 
0.05 was considered statistically significant. Only the proteins that are considered 
significantly different by Student’s t-test are reported. 
5.3 Results  
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5.3.1 Protein expression level 
Proteomics was used to study oxidized proteins in AD (Castegna et al., 2002b; 
Castegna et al., 2002a; Castegna et al., 2003). The specific carbonyl levels were obtained 
by dividing the carbonyl level of a protein spot on the nitrocellulose membrane by the 
protein level of its corresponding protein spot on the gel. Such numbers give the carbonyl 
level per unit of protein. We found that in comparison to 4-month-old SAMP8 mice, 12-
month-old SAMP8 mice brain have five proteins that are expressed significantly 
differently and five proteins that have significantly higher specific carbonyl levels. All 
the mass spectra of the peptides were matched to the mass spectra in NCBI protein 
databases. The identified proteins are listed in Table 5.1. The probability-based Mowse 
score is assigned for each spectrum to indicate the probability that the match between the 
database and the spectra is a random event. Scores greater than 66 were considered 
significant. Thus, if a match has a score higher than 66, the probability of the match being 
a random event is lower than 0.05. All protein identifications agree with the expected 
MrW and pI range based on their positions on the gel.  
Fig. 5.1 shows a gel for 2D-electrophoresis after Coomassie Blue staining. The 
proteins that were expressed differently in SAMP8 brains are summarized in Table 5.2. 
The expression of neurofilament triplet L protein (NF-L), lactate dehydrogenase 2 (LDH-
2) and heat shock protein 86 (HSP86), α-spectrin are significantly decreased, whereas the 
expression of triosephosphate isomerase (TPI) was significantly increased in brain 
from12-month-old SAMP8 mice. 
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Figure 5.1 
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5.3.2 Specific Protein Carbonyl Level. 
Fig. 5.2 shows an example of a Western blot for detection of the level of protein 
carbonyl. The summary of the specific protein carbonyl levels is given in Table 5.3. The 
specific protein carbonyl levels of LDH-2, dihydropyrimidinase-like protein 2 (DRP-2), 
α-spectrin and creatine kinase (CK) are significantly increased in the brain of 12-month-
old SAMP8. The specific carbonyl level of α-enolase was showed a trend toward being 
higher in 12-month-old SAMP8 with P-value lower than 0.07.  
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Figure 5.2 
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5.4 Discussion 
 Proteomics were used to identify oxidized and nitrated protein in Alziemer’s 
disease (AD) brain (Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003). 
α-enolase, CK, and DRP-2 were reported to be more oxidized, and α-enolase and TPI 
were significantly nitrated in AD brain  when compared to age-matched controls 
(Castegna et al., 2002b; Castegna et al., 2002a; Castegna et al., 2003). Our current study 
shows that the specific protein carbonyl levels of LDH-2, α-enolase, α-spectrin and 
DRP-2 were significantly decreased, and the protein expression level of TPI, LDH-2, NF-
L, α-spectrin and HSP86 are significantly changed, in 12-month-old SAMP8 brains. 
α-enolase is a subunit of enolase, the other subunits are β- and γ-enolase. α-
enolase is present in embryonic development and switches to γ or β, concurring with 
terminal differentiation of the muscle or neuron (Giallongo et al., 1990). A mutation by 
inserting splice-trap vectors into the first intron disrupts the α-enolase gene results in 
early embryonic lethality (Couldrey et al., 1998). Two of the subunits form active enolase 
isoforms (αα, ββ, γγ, αβ and αβ), which interconverts 2-phosphoglycerate and 
phoenolpyruvate. Since αγ abd γγ isoforms are predominate in the brain, they are called 
neuron-specific enolase (NSE) (Keller et al., 1994). NSE has been well used as a 
neuronal marker for structural damage (el-Mallakh et al., 1992) and neuronal metabolic 
properties (Trapp et al., 1981; Marangos and Schmechel, 1987; Hamre et al., 1989). 
Expression and high activity of NSE were detected in rat oligodendroglial cells at a 
certain stage of differentiation. However, when the culture was treated with basic 
fibroblast growth factor to stimulate the proliferation and block the differentiation of the 
oligodendrocyte precursor cell, the activity of NSE decreased (Deloulme et al., 1996). It 
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was also reported that the expression of NSE coincides with the onset of synaptic 
connections (Maxwell et al., 1982; Whitehead et al., 1982; Hedgecock et al., 1985). 
These studies show that enolase is not only involved in metabolism, but also in cell 
differentiation and normal growth in brains. In primary human fetal mixed brain cell 
cultures, the NSE level decreases correlated to the treatment of Aβ(1-40) (Hayes et al., 
2002). Although the level of NSE is not significantly alter in aged brain (Kato et al., 
1990) and in AD brain (Kato et al., 1991), α-enolase specific carbonyl level and protein 
level (Schonberger et al., 2001; Castegna et al., 2002a) are increased in AD brain when 
comparing to age-matched control, suggesting that the loss of activity by oxidative 
modification of α-enolase is compensated by the increased protein level. It was shown 
that the decline of enolase activity results in abnormal growth and reduced metabolism in 
brain (Tholey et al., 1982). Our current study show that the specific carbonyl level of α-
enolase is significantly increase while protein level of α-enolase is not, indicating the 
activity of α-enolase is reduced in SAMP8 brain.  
LDH-2 is a subunit of lactate dehydrogenase (LDH). The five isoenzymes of 
tetrameric LDH are found in various proportions of different somatic tissues in the 
combination of the A and B subunit in mammals (Sakai et al., 1987). LDH is also a 
glycolytic protein that catalyzes the reversible NAD-dependent interconversion of 
pyruvate to L-lactate. A single mutation in LDH-2 lower the activity of LDH (Maekawa 
et al., 1993; Sudo et al., 1994) suggesting LDH-2 subunit is critical to LDH activity. LDH 
release is a common indicator of damage to plasma membrane integrity. LDH activity is 
significantly increased in neuron and glial cell cultures from the brains of chick embryos 
(Tholey et al., 1982) and rat brains during postnatal development (Bilger and Nehlig, 
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1991) between 3 and 6 days, suggesting that LDH is important in the energy metabolism 
of the brain and differentiation process in the brain, and lactate appears to be the only 
oxidizible energy substrate available to support neuronal recovery (Schurr et al., 1997a, 
b). Although the activity of LDH shows no significant difference in AD compared to 
matched-age controls (Chandrasekaran et al., 1994), many studies show that LDH 
activity in rat brains declined with age increased (Mizuno and Ohta, 1986; Ferrante and 
Amenta, 1987; Hrachovina and Mourek, 1990; Agrawal et al., 1996). Total LDH activity 
in the brains of aged rats that rose under chronic hypoxia is also diminished (Lai et al., 
2003) Since aging and chronic hypoxia are highly associated with oxidative stress, the 
above studies suggest that the observed LDH activity loss may due to the oxidative 
modification of the enzyme, and our current study shows direct evidence that LDH-2 is 
significantly modified by oxidative insult in aged SAMP8 brains. 
 TPI catalyzes the reversible interconversion of glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate during glycolysis. A case study in 1982 reported that a 12-
year-old girl who had chronic nonspherocytic hemolytic aemia, due to TPI deficiency 
eventually developed cerebellar dysfunction and spasticity with hyperreflexia (Clay et al., 
1982). Also, inhibition of TPI by α-monochlorohydrin causes decreased neuronal ATP 
production followed by progressive neuronal death (Sheline and Choi, 1998). Therefore 
if TPI are oxidized or nitrated in AD (Castegna et al., 2003), lower activity of TPI should 
be observed. However, activity of TPI is not altered in neither AD patients (Meier-Ruge 
et al., 1984) nor demented patients (Iwangoff et al., 1980). Our current study provide a 
possible explanation: since the level of TPI in aged SAMP8 brain significantly increase, 
the “non-specific” carbonyl level must also increase to maintain a similar (94%) specific 
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carbonyl level between the 4-month old and 12-month-old SAMP8, indicating that 
although more TPI are inactivated by oxidative modification, there are also more TPI 
proteins available to catalysis the reaction. Therefore, no net decrease in activity is 
observed. Consistent with this explanation, the TPI level was reported to increase when 
inducing oxidative stress by hypoxia to tissue (Lushchak et al., 1998) suggesting cells 
upregulate TPI to compensate its loss of activity by oxidative modification. 
CK, which is highly sensitive to oxidation, is found in cytoplasm and 
mitochondria of cells to catalyze the reversible transfer of high energy phosphoryl 
between the ATP and creatine phosphate (Schlegel et al., 1990; Wallimann et al., 1992; 
Wyss et al., 1992; Kaldis et al., 1994). At least other three isoenzymes of CK have been 
described. It is proposed that three CK genes exist (Eppenberger et al., 1967; Sobel et al., 
1972; Roberts, 1980) to encode the three protein subunits, designated M(muscle), B 
(brain), and mitochondrial (Mi). These subunits form three dimeric cytosolic (MM, BB 
and MB) and distinct mitochondrial isoenzymes (Mi-CKs). In AD brains, the expression 
of CK-BB was decreased compared to the age-matched controls (David et al., 1998). It 
was also well established that oxidative modification of CK-BB decrease its activity in 
aging, AD and other neurodegenareative disease brain (Aksenova et al., 1998; Aksenova 
et al., 1999a; Yatin et al., 1999b; Aksenov et al., 2000; Castegna et al., 2002b). Our 
current study, consistent with many others, shows that CK in aged SAMP8 brain is 
oxidized significantly, and therefore affect its activity to produce ATP. 
It was reported that the reduced glucose metabolism in aged SAMP8 (Shimano, 
1998). Our current study indicated the reduced ATP production possibly due to loss of 
activity of specific glycolytic enzymes and CK by oxidative modification. Since 20% of 
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ATP in brain is produced from glycolysis, loss of activity of glycolytic enzymes by 
oxidative modification will significantly decrease the energy availability to neurons and 
synaptic elements for defending oxidative stress. Another abnormal observation in aged 
SAMP8 brain is the 14.6% acetylcholine concentration decrease in hippocampus 
(Ikegami et al., 1992). Choline is derived from serine, an endogenous product from 
glycolysis. The loss of activity of glycolytic enzymes and CK by oxidative modification 
could reduce the production of substrates, glycerate-3-phosphate, to generate serine 
endogenously, therefore lowered the concentration of choline for acetylcholine synthesis. 
Our current suggests that oxidative modification of CK and glycolytic enzyme may be 
responsible for the alteration of matabolism and neurochemicals reported in SAMP8. 
DRP-2 is one of the four members of the dihydropyrimidinase-related protein 
family (DRP-1, -2,-3 and –4), which are originally identified in human by their homology 
to dihydropyrimidinase (Hamajima et al., 1996; Wang and Strittmatter, 1996; Kato et al., 
1998). Other non-human counterparts of the human DRPs are chicken collapsing 
response mediator protein (CRMP-62) (Goshima et al., 1995), rat turned on after division 
(TOAD)-64 (Minturn et al., 1995) and mouse unc-33-like phosphoprotein (Ulip). Based 
on the comparison of the amino acid sequences, these genes were classified into 4 
groups; DRP-1/CRMP-1/Ulip3, DRP-2/CRMP2/TOAD-64/Ulip2, DRP-3/CRMP-4/Ulip1 
and DRP-4/CRMP-3 (Byk et al., 1996; Hamajima et al., 1996). The amino acid 
sequences of DRP proteins show 64-79% identical to each other. The DRP family is 
involved in axonal outgrowth and pathfinding through transmission and modulation of 
extracellular signals. (Goshima et al., 1995; Minturn et al., 1995; Byk et al., 1996). One 
of the identified extracellular signals is mediated by the proteins of the collapsing-
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semaphorin family in collaboration with their receptor, neuropilion (He and Tessier-
Lavigne, 1997; Kolodkin et al., 1997). Collapsin contribute to axonal pathfinding by 
inducing growth cone (the tip of a growing axon responding to guidance cues) collapse 
which repel the outgrowing axon (Luo et al., 1993). It was reported that CRMP-2 can 
induce growth cone collapse (Goshima et al., 1995; Wang and Strittmatter, 1996) by 
Rho-kinase phosphorylation (Arimura et al., 2000), and binding to tubulin heterodimers 
and bundled microtubule as carriers to promote microtubules assembly and dynamics (Gu 
and Ihara, 2000; Fukata et al., 2002). Also, neuropilion is expressed coordinately to 
CRMP-2/DRP-2 axonal injury (Pasterkamp et al., 1998). Many neurodegenerative 
diseases are associated with DRP-2 mutation in the unc-33 gene, a C. elegans homologue 
of DRP-2, results in uncoordinated movements and abnormal swelling of axonal endings 
with premature termination. (Pasterkamp et al., 1998). Yoshida et al suggested that 
incorporation of DRP2 in the neurofilbrilary tangles decrease cytosolic DRP-2 and leads 
to abnormal neuritic and axonal growth, thus accelerating the neurotic degeneration in 
AD (Yoshida et al., 1998). Decreased expression of DRP-2 protein were observed in AD, 
adult Down’s Syndrome (DS) (Lubec et al., 1999), fetal DS (Weitzdoerfer et al., 2001), 
schizophrenia, and affective disorders (Johnston-Wilson et al., 2000). The deranged 
DRP-2 mRNA level and the increased specific carbonyl level of DRP2 were indicated in 
DS (Lubec et al., 1999) and AD (Castegna et al., 2002a), repectively. These studies 
suggested that the DRP-2 activity loss, due to either reduced expression or oxidative 
modification, disturbs neural development and plasticity in the CNS, resulting in mental 
retardation and impairment in learning and memory. Consistent will others, our studys 
show that the oxidative modification of DRP2 is significantly increased in the 12-month-
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old SAMP8 brain suggesting that the oxidative modification of DRP2 play an important 
role in memory and learning deficit observed in aged SAMP8. 
Neurofilaments (NFs) are axonal proteins that give axons their structure and 
define axonal diameter (Hoffman et al., 1987; Brady, 1993). NFs are composed of three 
subunits of light (NF-L), medium (NF-M) and heavy (NF-H), which assemble to from 
long filmarcolmolecular filament in 6:2:1 ratio. NF-L is able to assemble homogously 
while the other subunits cannot assemble competently without NF-L (Cohlberg et al., 
1995). All three subunits contain an α-helic rod domain, an amino-terminal head domain 
and a carboxyl-terminal tail domain (Lee and Cleveland, 1996).  The rod domains wrap 
around each other to form a superhelix (Lupas, 1996). These structures combine to form 
protofilaments through head-to-tail domain binding. Two protofilaments wrap around 
each other to form protofibrils, and four protofibrils are combined to form the 
characteristic 10-nm diameter NFs. Since the natures of NFs are dynamic, the individual 
neurofilament proteins are turned over or exchanged within NFs in the axon (Okabe et 
al., 1993; Takeda et al., 1994). The mechanism regulating the filament assembly is 
believed to involve the phosphorylation of Ser-55 in the head domain (Gibb et al., 1996). 
The modification of the NFs structure will result in the destabilization of the interactions 
between the neurofilament proteins. Such destabilization is particularly dreadful to motor 
neurons because motor neurons, which possess elongated axonal length and high axonal 
constitution, contain more neurofilaments than other neurons (Crow et al., 1997). It was 
shown that both of the transgenic mice expressing point mutation in NF-L, and mice 
oversexpressing either NF-L or NF-H, display accumulations of disarrayed filaments in 
motorneuronal perikarya and proximal axons, thus developed motor neuron disease (Cote 
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et al., 1993; Lee et al., 1993; Xu et al., 1993). Oxidation and nitration of neurofilament 
proteins will transform the α-helix to β-sheet and random coil (Gelinas et al., 2000), and 
these oxidized proteins will then be degraded by protease (Grune et al., 1996; Davies, 
2001; Inai and Nishikimi, 2002; Grune et al., 2003). Consequently, the oxidative 
modification could be responsible for the NFs abnormalities observed in several 
oxidative-stress-related neurodegenerative disease. It was shown that there was a 
decrement in the transcription rate and mRNA level of NF-L in aged male Fischer 344 rat 
brains (Krekoski et al., 1996). Consistent with this result, the expression NF-L in SAMP8 
brains is significantly decreased in aged SAMP8 brain, suggesting the decreased level of 
NF-L in brain caused the increased axonal dystrophy in the gracile nucleus observed in 
aged SAMP8 mice (Kawamata et al., 1998).  
The spectrins is a family of widely distributed filamentous proteins.  α-spectrin,  a 
component of the membrane-associated cytoskeleton, form a supporting and organized 
scaffold for intracellular cohesion with the association of actins (Leto et al., 1988). 
mRNA level of α-spectrin increase gradually during the first postnatal days and reach 
plateau between second and third week of life following by decreased globally during the 
young adulthoods in rat (Gelot et al., 1994). This suggests that α-spectrin is important 
during central nervous system (CNS) development and normal function. The breakdown 
products of α-spectrin from calcium-activated proteolysis are commonly used as markers 
of apoptosis (Vanderklish and Bahr, 2000). It was reported that Aβ can also induced 
these α-spectrin breakdown products in cultured rat cortical neurons by activating 
capases (Harada and Sugimoto, 1999). Similar increases of α-spectrin breakdown 
products were also observed in some regions of aged Balb/c mice brain (Bahr et al., 
 125
1991), indicating the level of α-spectrin decrease as function of age in mice brain (Bahr 
et al., 1994). Consistent of these studies, our results show decreased level of α-spectrin in 
aged SAMP8, as well as increased specific carbonyl level, suggest that the proteolytic 
mechanism in apoptosis involve oxidative modification and degradation of α-spectrin. 
Loss of α-spectrin by oxidation or degradation disrupts the cytoskeleton and the structure 
of cells in brain affecting intercellular and intracellular communications, consequently 
causes the learning and memory deficits in SAMP8 
DRP-2, α-spectrin, NF-L are involved in signaling, intracellular trafficking  and 
maintaining structure of dendrites and axons in neurons. Increased oxidation or reduced 
expression of these proteins may account for the neuronal atropy and loss in posterior 
cholinergic column, reduction of dendritic spines of hippocampal pyramidal neurons, and 
increased axonal dystrophy in the gracile nucleus observed in aged SAMP8 (Kawamata 
et al., 1998). These physiological alterations may further disrupt the communications 
between neurons therefore causing learning and memory impairments in SAMP8. 
Heat shock protein referred to a group of proteins that their syntheses are induced 
when cells in culture respond to heat and chemical stress (Welch, 1992). The most 
hightly expressed heat shock protein in unstressed cells is the 90k-Da heat shock protein 
(HSP 90) (Perdew et al., 1993).  While most studies examine HSP90 as a single protein, 
there are two separate structural genes, HSP86 and HSP84 in mouse (Moore et al., 1989; 
Moore et al., 1990), or HSP89α and HSP89β in human cells (Rebbe et al., 1989). The 
sequences of HSP90-related proteins are highly conserved among vertebates (Perdew et 
al., 1993). Although HSP84 and HSP86 are highly conserved, examination of the level of 
expression of HSP86/HSP84 in murine tissues revealed that HSP86 is expressed in brain, 
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testis, and placenta while HSP84 is highly expressed in liver, thymus, kidney, etc. (Lee, 
1990). It was shown that HSP90 has the ability to bind to actin (Koyasu et al., 1986) in a 
Ca2+- calmodulin-dependent manner (Nishida et al., 1986; Koyasu et al., 1989) and 
interact with many receptors and kinases (Brugge, 1986; Ziemiecki et al., 1986). These 
studies suggest that HSP90 play a critical role in cell signaling for calcium homeostatic, 
apoptosis etc. cell cycle processes. HSP90 also involves in protecting protease activity 
from oxidative modification (Conconi et al., 1996; Conconi and Friguet, 1997), 
indicating HSP90 possess antioxidant activity. It was also shown that hepatic HSP90 
(HSP84) level was decreased in liver of aged rats (Nardai et al., 2002). Consistent with 
this study, we show that level of HSP86 was decreased in aged SAMP8 brain suggesting 
that the weakened antioxidant defense in aged SAMP8 may contribute to the increased 
oxidative modification of proteins, which consequently leads to the neurochemicals 
changes and learning and memory deficit observed in SAMP8 brains 
In previous chapter, we demonstrated that protein oxidation is increased in  
SAMP8 mice brain. In our current study, we have identified the proteins that are 
oxidatively modified, as well as differently expressed, in SAMP8 brain as result of 
increased oxidative stress. These proteins are critical to metabolism, structure, 
communications and antioxidant defense of the brain. The losses of the activities of these 
proteins by oxidative modification, or decreased levels, maybe contribute to the abnormal 
metabolism (Shimano, 1998) and neurochemicals changes (Nardai et al., 2002), thus 
learning and memory deficits observed in aged SAMP8.  Base on our result, individual 
purification or assay of these proteins will be needed to investigate their inactivation by 
oxidative modification. However, this study provides evidence that the oxidative-stress-
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induced  learning and memory impairment involved specific protein oxidation and 
changes of expression. Identifying these proteins can provide valuable information on 
potential therapeutic targets for future studies. 
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CHAPTER SIX 
Metabolic Enzymes Impairment in Aged SAMP8 Mice: Implications of Energy 
Metabolism in Cognitive Function 
6.1 Introduction 
 We deomstrated that increased oxidative stress in aged SAMP8 mice brain is 
manifested by increased protein oxidation (Howard et al., 1996; Butterfield et al., 2001a; 
Farr et al., 2003). However, protein oxidation is not a random event, but rather is 
associated with increased oxidative modification of particular proteins (Castegna et al., 
2002b; Castegna et al., 2002a; Poon et al., 2004d; Perluigi et al., 2005; Poon et al., 
2005b; Poon et al., 2005c). Using redox proteomics, we identified the brain proteins that 
are oxidatively modified in aged SAMP8 mice when compared to that in young SAMP8 
mice in the pervious chapter. These proteins are α-enolase, lactate dehydrogenase 2, 
dihydropyrimidinase-like protein 2, α-spectrin and creatine kinase (CK). Since oxidative 
modification of proteins alters their confirmation and activity (Hensley et al., 1994; 
Lauderback et al., 2001; Sultana and Butterfield, 2004; Poon et al., 2005c), we 
hypothesize that oxidative modification of α-enolase, lactate dehydrogenase, and CK 
alters their functions in aged SAMP8 mice brain. In order to investigate this hypothesis, 
we determine the activity of enolase (ENO), lactate dehydrogenase (LDH) and CK in 
aged SAMP8 mice brain relative to that in young SAMP8 mice brain. 
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6.2 Experimental Procedures 
 
6.2.1 Rodent subjects 
 The rodents subjects used is previously describled in Section 4.2.1 
6.2.2Sample preparation 
The sample preparation is the same is previously describled in Section 5.2.2 
6.2.3 Ex-vivo protein oxidation 
 4-month-old brain homogenates of SAMP8 mice were oxidized ex vivo by 
incubating with 30 mM FeSO4 and 10 mM H2O2  for 30 min at room temperature. The 
enzyme activities in ex-vivo oxidized young brain homogenates were determined with 
the young and old brain homogenates. 
6.2.4 Enzyme Activities Assay 
 LDH enzymatic activity was determined by the method previously described 
(Zewe and Fromm, 1965; Poon et al., 2005c). Briefly, the assay for the enzyme activity 
of LDH was performed in 100 μL Tris buffer (0.2M Tris.HCl, 30mM sodium pyruvate, 
6.6mM NADH, pH 7.3). The reaction was initiated by adding 5 µL of the samples 
(2mg/mL). LDH activity was measured as the reduction of NADH to NAD+. A decrease 
in absorbance at 340 nm was recorded as change in A340 min-1 by using a PowerWaveX® 
microtiter plated UV-VIS spectrophotometer (Bio-Tek Instruments, Winooki, VT). 
 Enolase activity assay was performed as described previously (Wagner et al., 
2000; Poon et al., 2005c) with modification. Enolase was added to 100 μL of assay 
mixture (20 mM Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-
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glycerate) in a UV-transparent microtiter plate (Corning, MA). The enzymatic activity 
was determined by the change of absorption at A240 for 5 min. 
 The activity of CK is determined by a Stanbio CK-NAC kit (Stanbio, Boern, TX). 
Briefly, 95 μL of CK reagent ( 2 mM ADP, 5 mM AMP, 10 mM 
diadenosinepentaphosphate, 2 mM NAD, 3000 U/mL hexokinase, 3000 U/mL glucose-6 
phosphate dehydrogenase, 20mM N-acetylcysteine, 20mM D-glucose, 10 mM Mg2+, 2 
mM EDTA) is mixed with 5 µL of the samples (2mg/mL). LDH activity was measured as 
the reduction of NAD+ to NADH.  The change in absorbance at 340 nm was recorded in 
A340 min-1 by using a PowerWaveX® microtiter plated UV-VIS spectrophotometer (Bio-
Tek Instruments, Winooki, VT). 
6.2.5 Statistics 
The data of oxidative parameter measurements were analyzed by Student's t tests. 
6.3 Results 
 The activity of ENO decreased approximately 50%  in aged SAMP8 mice brain 
when compared to that in young SAMP8 mice brain. Ex vivo oxidation of young SAMP8 
brain homogenate mimicked such activity decline (Figure 6.1), indicating oxidative 
modification contribute its function decline.  
 Similarly, LDH activity is significantly decreased 15% in aged SAMP8 mice 
brain, and the similar activity decline was detected in the young SAMP8 mice brain 
homogenate which is oxidized by Fe/H2O2 (Figure 6.2). 
 Although there was only 5% decrease in the activity of CK in aged SAMP8 mice 
brain, it is statistically significant when compare to that in young SAMP8 mice brain. 
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Moreover, such activity decline was mimicked by oxidation of young SAMP8 mice brain 
homogenate ex vivo (Figure 6.3). 
 
Figure 6.1 
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Figure 6.2 
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Figure 6.3 
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6.4 Discussion 
 Previous chapter indicates that α-enolase, lactate dehydrogenase 2 and CK are 
oxidatively modified in aged SAMP8 mice brain when compared to that in young 
SAMP8 mice brain (Poon et al., 2004d). Our current study should that the oxidative 
modification of these enzymes leads to their functional decline.  
ENO interconvert 2-phosphoglycerate to phosphoenolpyruvate in glycolysis, and 
a decline of enolase activity results in abnormal growth and reduced metabolism in brain 
(Tholey et al., 1982). LDH is a glycolytic protein that catalyzes the reversible NAD-
dependent interconversion of pyruvate to lactate, and production of lactate also serves as 
intercellular energy transfer from astrocytes to neurons for ATP production (Deitmer, 
2001). CK is a highly oxidative sensitive protein that is located in cytoplasm and 
mitochondria of cell. CK catalyzes the transfer of high energy phosphoryl between ATP 
and creatine phosphate. It was also well established that oxidative modification of CK 
decreased its activity with aging, AD and other neurodegenerative disease brain (Hensley 
et al., 1995c; Aksenova et al., 1998; Aksenova et al., 1999b; Yatin et al., 1999a; Aksenov 
et al., 2001; Castegna et al., 2002b).  
The striking feature of these proteins is that they are all involved in the ATP 
production in neuron. Therefore, oxidative inactivation of these proteins may contribute 
to the lowered glucose metabolism and ATP production in the brain of SAMP8 mice 
(Shimano, 1998), leading to impairment of ATP-dependent process in neuron, such as 
cell potential maintenance, signal transduction and protein synthesis. Since these 
processes are critical to learning and memory (Lamprecht and LeDoux, 2004), oxidative 
inactivation of ENO, LDH and CK may play a significant role in the cognitive decline in 
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aged SAMP8 mice. Consistent with this notion, glucose metabolism, an important 
process to maintain intact cognitive function (Messier and Gagnon, 1996), is impaired in 
SAMP8 mice (Rossignol et al., 2000). 
Our current study demonstrated that oxidative modification of ENO, LDH and 
CK contribute to their activities decline in aged SAMP8 mice brain indeed. These 
oxidative inhibitions may contribute to the decreased ATP production, thereby leading to 
learning and memory deficits in aged SAMP8 mice.   
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CHAPTER SEVEN 
Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with α-
Lipoic Acid: Implications for Aging and Age-related Neurodegenerative Disorders 
7.1 Introduction 
 Aging and age-related neurodegenerative disorders are becoming more important 
as the mean age of the United States' population increases. Ongoing research is being 
pursued for development of therapeutics for oxidative stress related neurodegenerative 
diseases, among which are those that scavenge free radicals by antioxidants. α-Lipoic 
acid (LA), a coenzyme involved in production of ATP in mitochondria, is a potent 
antioxidant (Packer et al., 1997a; Packer et al., 1997b; Liu et al., 2002). Increased protein 
oxidation and lipid peroxidation were demonstrated in 12-month-old SAMP8 mouse 
brains when compared to 4-month-old SAMP8 and the same age SAMR1 mice 
(Butterfield et al., 1997a; Farr et al., 2003), and oxidative inhibition of specific proteins 
in aged SAMP8 mice may lead to learning and memory deficits in aged SAMP8 mice. 
The increases in protein oxidation and lipid peroxidation seen in aged SAMP8 mouse 
brains were reversed by injecting the mice with LA as shown in Chapter three (Farr et al., 
2003). We rationalized that LA improves the learning and memory in SAMP8 mouse by 
reducing oxidation and changing the expression of specific proteins in SAMP8 mice 
brain. To test this hypothesis, we used proteomics to identify the proteins that are 
expressed differently and/or the proteins that are less oxidized in the 12-month-old 
SAMP8 mouse brain treated with LA.  
7.2 Experimental Procedures 
7.2.1 Rodent Subjects  
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 Rodent subjects used are the same as Section 4.2.1 
7.2.2. Drug Administration 
 LA administration is the same as Section 4.2.2 
7.2.3 Sample Preparation 
 Sample preparation is the same as Section 5.2.2 
7.2.4 Two-dimensional electrophoresis  
 2D electrophoresis is the same as Section 5.2.3 
7.2.5 Western Blotting 
 Western blotting is the same as Section 5.2.4 
7.2.6 Image Analysis 
 Image analysis is the same as Section 5.2.5 
7.2.7 Trypsin digestion 
 Trypsin digestion is the same as Section 5.2.6 
7.2.8 Mass Spectrometry 
 Mass spectrometry is the same as Section 5.2.7 
7.2.9 Statistics 
 Statistical analysis is the same as Section 5.2.8 
7.3 Results 
7.3.1 Protein expression levels 
 We used a proteomics parallel approach to investigate the effect of LA treatment 
in aged SAMP8 mice. Fifty-six proteins were screened. We found that expression of 
three proteins were significantly increased and that the specific carbonyl levels of three 
proteins were significantly decreased in aged 12-month-old SAMP8 mouse brains when 
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compared to that in 12-month-old SAMP8 mice not treated with LA (n=6 in each group). 
All the mass spectra of the identified proteins were matched to the mass spectra in NCBI 
protein databases. All identified proteins (Table 7.1) appeared in the expected MrW and 
pI range on the gels.  
Fig. 7.1 shows the 2D-electrophoresis gels after Coomassie blue staining. The 
levels of the proteins that are expressed differently are summarized in Table 7.2. We 
report here that the expressions of brain resident neurofilament triplet L protein (NF-L), 
α-enolase, and ubiquous mitochondrial creatine kinase (uMiCK) are significantly 
increased in aged SAMP8 mice injected with LA compared to aged, non-treated SAMP8 
mice. 
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 Table 7.1: Summary of proteins identified by mass spectrometry 
Identified Protein GI accession# 
 # Peptide matches 
Identified 
% Coverage 
matched 
peptides 
pI, MrW Mowse Score 
Probability 
of a 
random hit
Lactate dehydrogenase 2 
(LDH 2) 
gi|6678674 14 41 
5.87,  
36.6 
632 2x10-62
α-enolase gi|12963491 17 47 
6.69, 
47.1 
947 2x10-95
dihydropyrimidinase-like 2 
(DRP-2) 
gi|1351260 14 35 
6.16, 
62.16 
 
776 2.5x10-78
ubiquous mitochondrial 
creatine kinase 
(uMiCK) 
gi|6753428 8 14 
8.65, 
47.7 
245 3.2x10-25
Neurofilament L 
(NF-L) 
gi|417355 18 37 
4.40, 
61.5 
922 6.3x10-100
 
Mowse scores greater than 62 are considered significant (p<0.05). 
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 Table 7.2: Proteins expressed differently when 12-month old SAMP8 
mice are treated with LA compared to non-treated 12-month old SAMP8 
mice 
Identified Proteins 
Protein levels of 12-month-old 
SAMP8 injected with LAa (n =6) 
p-value 
Neurofilament triplet L protein 
(NF-L) 
625±58% p < 0.005 
α-enolase 143±47% p < 0.05 
ubiquous Mitochondrial 
creatine kinase 
(uMiCK) 
 
183±28% p < 0.05 
 
a Percent of the level found in brain from 12-month old, no-treated SAMP8 mice 
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Figure 7.1 
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7.3.2 Specific Protein carbonyl levels 
 Fig. 7.2 shows the resultant nitrocellulose membranes for protein carbonyl 
detection. The summary of the proteins that have significantly increased specific carbonyl 
levels is given in Table 7.3. We show that the specific protein carbonyl levels of lactate 
dehyrogenase 2 (LDH-2), dihydropyrimidinase-like protein 2(DRP-2), and α-enolase are 
significantly decreased in the brains of aged SAMP8 mice treated with LA. 
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 Table 7.3: Proteins that have specific carbonyl level decreased by LA 
Identified Proteins 
Specific protein carbonyl 
levels of 12-month-old 
SAMP8 injected with LA 
(n=6) 
p-value 
 
Lactate dehyrogenase 2 
(LDH-2) 
11.5±10.2% P < 0.01 
 
Dihydropyrimidinase-like 2 (DRP-2) 
16.4±16.4% p < 0.05 
α-enolase 0.17±0.17% P = 0.05 
 
a Percent of the level found in brain from 12-month old, no-treated SAMP8 mice 
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Figure 7.2 
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7.4 Discussion 
 LA is able to partially reverse memory loss in normal aging rats by delaying 
mitochondrial dysfunction and RNA/DNA oxidation (Liu et al., 2002). In SAMP8 mice, 
LA treatment markedly improved learning and memory of even older rodents (Farr et al., 
2003).   Mitochondrial dysfunction is accompanied by a leakage of O2· and H2O2. Since 
LA is readily taken up into mitochondria, it is suggested that LA may be a useful 
therapeutic agent in diseases that are characterized by mitochondria dysfunction or 
oxidative stress (Packer et al., 1997a; Packer et al., 1997b; Lynch, 2001). We report here 
that in brains from aged SAMP8 mice treated with LA, the specific carbonyl levels of 
LDH-2, DRP-2, and α-enolase are significantly decreased and the expression levels of 
the α-enolase, NF-L, and uMiCK, are increased in comparison to aged SAMP8 mice not 
treated with LA. 
α-Enolase and DRP-2 is known to be more oxidized in AD (Castegna et al., 
2002b; Castegna et al., 2002a; Castegna et al., 2003). Our previous study showed that the 
specific carbonyl levels of α-enolase, DRP-2, LDH-2, creatine kinase (CK), and α-
spectrin are increased in aged SAMP8 brains. We report here that injecting LA can 
decrease the specific carbonyl levels of α-enolase, DRP-2, and LDH-2 and can increase 
the protein levels of uMiCK, α-enolase, and LDH-2 in aged SAMP8 mice brains. These 
alterations of proteins may be responsible for the improvement of learning and memory 
in LA-injected SAMP8.  
DRP-2 is involved in axonal outgrowth and path finding through transmission and 
modulation of intracellular signals. (Goshima et al., 1995; Minturn et al., 1995; Byk et 
al., 1996). DRP-2 can induce growth cone collapse (Goshima et al., 1995; Wang and 
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Strittmatter, 1996). Decreased expression or increased oxidation of DRP-2 in AD 
(Castegna et al., 2002a), adult DS (Lubec et al., 1999), fetal DS (Weitzdoerfer et al., 
2001), schizophrenia and affective disorders suggest that the DRP-2 activity is decreased 
in these disorders. An increased specific carbonyl level of DRP-2 is also observed in aged 
SAMP8 brains (Poon et al., 2004d), suggesting the oxidative deactivation of DRP-2 may 
be responsible for the impairment of learning and memory in aged SAMP8. We show 
here that the oxidative modification of DRP2 is significantly reduced by treating the aged 
SAMP8 mice with LA, possibly resulting in restoration of DRP-2 activity, and  thus, the 
normal neurogenesis of axons. 
α-Enolase, a subunit of enolase, is also found oxidized in aged SAMP8 mouse 
brains (Poon et al., 2004d). Enolase is not only involved in metabolism, but also in cell 
differentiation and normal brain growth. Although the levels of neuronal specific enolase 
(NSE) are not significantly altered in aged brains (Kato et al., 1990) and in AD brains 
(Kato et al., 1991), the specific carbonyl level and protein level of α-enolase are 
increased in AD (Schonberger et al., 2001; Castegna et al., 2002a), suggesting the 
reduced enolase activity caused by oxidation is compensated for by its increased 
expression. The decline of enolase activity results in abnormal growth and reduced 
metabolism in brains (Tholey et al., 1982), therefore oxidation of α-enolase observed in 
aged SAMP8 brains (Poon et al., 2004d) may be responsible for the reduced ATP 
production (Shimano, 1998) and acetylcholine concentration (Ikegami et al., 1992) seen 
in the brains of aged SAMP8 mice. Our current study shows that injecting the SAMP8 
mice with LA is able to reduce the oxidative modification and increase the protein level 
of α-enolase, suggesting the possibility that the activity of α-enolase may be restored. 
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Therefore, the reduced glucose metabolism and neurochemical alterations in SAMP8 
mouse brains (Ikegami et al., 1992; Shimano) are possibly reversed by the LA injections 
as well. 
LDH-B is a subunit of lactate dehydrogenase (LDH), which catalyzes the 
reversible NAD-dependent interconversion of pyruvate to L-lactate. This may be an 
important step for neuroprotection as lactate is considered the only oxidizible energy 
substrate available to support neuronal recovery (Schurr et al., 1997a, b).  Although the 
activity of LDH shows no significant alteration in AD (Chandrasekaran et al., 1994), 
many studies showed that LDH activity in rat brains declined in advanced age (Mizuno 
and Ohta, 1986; Ferrante and Amenta, 1987; Hrachovina and Mourek, 1990), suggesting 
the LDH activity loss may be caused by the oxidative modification of the enzyme. 
Oxidation and depleted levels of LDH were observed in aged SAMP8 mouse brain, 
suggesting LDH activity is also impaired in aged SAMP8 brain (Poon et al., 2004d). Our 
current study shows that the carbonyl level of LDH decreases when SAMP8 mice are 
injected with LA, suggesting that treatment of LA can possibly restore the ability of LDH 
to produce lactate in aged SAMP8.  Therefore, recovered LDH activity can possibly 
facilitate neuronal recovery, and thus improvement in learning and memory, in aged 
SAMP8 mice. 
uMiCK, one of the isoenzymes of creatine kinase (CK), is considered as the 
counterpart of cytoplasmic brain-type creatine kinase (CK-BB) in brain (Kanemitsu et al., 
2000). uMi-CK is responsible for the transfer of a high energy phosphoryl group (Pi) 
from mitochondria to the cytosolic carrier and creatine (Payne and Strauss, 1994). In 
neurons, a coordinated pattern in expression of CKBB and uMiCK was demonstrated 
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(Friedman and Roberts, 1994), suggesting metabolic energy was transferred via a creatine 
phosphate energy shuttle between cytosol and mitochondria. Recently, it was proposed 
that uMiCK couples with CK to regulate ATP concentration in cerebral gray matter 
(Kekelidze et al., 2001). Moreover, the mitochondrial synthesis of creatine phosphate is 
restricted to uMiCK expressing neurons, suggesting uMiCK protects neurons from 
energy shortage during periods of increased energy demands (Boero et al., 2003). It was 
suggested that the increased oxidation of CKBB could be the cause of the decreased 
production of ATP observed in aged SAMP8 mice brains (Shimano, 1998). Increasing 
uMiCK expression by LA injection conceivably can compensate for the decreased ATP 
synthesis due to the loss of CKBB activity in aged SAMP8 brains. This would result in 
restoration of ATP production for antioxidant defensive systems in neurons and synaptic 
elements. 
 Neurofilament-L is an subunit of neurofilaments (NFs), which give axons their 
structure and diameter (Hoffman et al., 1987; Brady, 1993). Depletion of NF-L level in 
AD, DS, and ALS brains (Bergeron et al., 1994; Bajo et al., 2001) indicates that the 
normal NF-L expression is critical to central nervous system (CNS) functions. It was 
suggested that the decreased NF-L expression in SAMP8 brains causes the increased 
axonal dystrophy in the gracile nucleus. We report here that treating SAMP8 mice with 
LA can raise the level of NF-L in aged SAMP8 brains and possibly decrease the axonal 
dystrophy in the gracile nucleus, which consequently improves the learning and memory 
in aged SAMP8. 
Chapter four showed that LA reverses learning and memory impairment by 
decreasing protein oxidation and lipid peroxidation of SAMP8 mice brains (Farr et al., 
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2003). We now identify the specific proteins (DRP-2, α-enolase, LDH, CK, and NF-L) 
that are protected by LA injection. LA is a disulfide compound that is found naturally in 
mitochondria as a coenzyme for pyruvate dehydrogenase (PDH) and α-ketoglutarate 
dehydrogenase (KGD). Therefore, LA protection in aged SAMP8 mouse brains is 
possibly owed to its free radical scavenging ability and its accessibility to mitochondria. 
Since LDH and enolase are involved in the oxidoreduction-phoshphorylation stage of 
glycolytic pathways, they locate near the mitochondria for substrate accessibility and 
become the immediate targets for free radicals produced by mitochondria. Since LA has 
easy access to mitochondria, LA can scavenge the free radicals produced by 
mitochondria, or may even reduce the oxidation on the LDH and α-enolase. As a result, a 
significant decrease of specific carbonyl levels in α-enolase and LDH-2 are observed in 
SAMP8 brains. The increased level of α-enolase is possibly in response to the recovered 
activity of LDH, which, in turn, is caused by a reduction of oxidative damage following 
LA treatment. Demand for pyruvate is increased as the restored LDH activity speeds up 
the conversion of pyruvates to lactate. In order to meet this demand, enolase levels are 
increased to produce sufficient phosphophenol pyruvate (PEP) for pyruvate production. 
The standard free energy of conversation from 2-phospho-D-glycerate to PEP is -14.8 
kcal-mol-1.  This suggests that increasing the level of the catalytic enolase, which 
mediates this high-energy and rate limiting reaction, is the most efficient way to control 
the substrate concentration for its downstream reactions. Increased uMiCK is possibly 
controlled by similar mechanisms. Since a Pi is eliminated from PEP to form pyruvate, 
extra creatine kinase activity will be needed to transfer Pi to creatine. Therefore, the level 
of uMiCK is increased to reduce the Pi level in SAMP8 mice brain. This indicates that 
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LA can rescue the energy depletion and neurochemical changes observed in aged SAMP8 
mouse brains (Ikegami et al., 1992; Shimano, 1998) by improving the function of the 
glycolytic pathway and increasing NADPH production. 
 γ-Enolase, encoded by a single gene as α-enolase, is associated with DRP-2 in 
the complex of NADH-dichlorophenol-indophenol (DCIP) reductase (Bulliard et al., 
1997). DCIP reductase, one of the trans-plasma-membrane oxidoreductases (PMOs), is 
involved in redox control of receptor function through the receptor-mediated signal-
transduction pathway (Fuhrmann et al., 1989; Toole-Simms et al., 1991).  More 
importantly, it is involved in control of cell growth and development in response to 
external oxidative stress or anti-oxidants (Bulliard et al., 1997). Therefore, the restored 
enolase activity may trigger the decrease in the carbonyl level of DRP-2 in the DCIP 
reductase complex, which in turn signals within the cells that the oxidative stress is 
relieved by the LA treatment. The cells, consequently, increase NF-L production to 
restore the normal structure of the neuron for recovery. However, more experiments are 
needed to investigate the putative relationship between enolase and DRP-2, as well as 
their roles in the signaling of DCIP reductase complex and oxidative stress.  
Although no direct evidence is provided in the current study that injection of LA 
can reverse neurochemical changes, increased ATP production, and improve learning and 
memory in aged SAMP8 mice, we suggest here that the improvement of learning and 
memory in LA treated SAMP8 mice is associated with the reduced specific carbonyl 
levels and increased the protein levels of specific proteins. The latter are involved in 
metabolism (LDH-2, α-enolase, uMiCK), cell signaling (DRP-2), and axonal structure 
(NF-L) in cells. The possibly improved glycolytic pathway induced by reduction of 
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enzyme oxidation may provide sufficient energy for neuronal recovery from oxidative 
stress that may be consequently responsible for the improvement of learning and memory 
in aged SAMP8 mice treated with LA. Therefore, improvement in energy metabolism 
may lead to, at least partially, neuronal recovery, such as a restored cytoskeletal network 
and enhancement of interneuronal communication in aged SAMP8 mice. However, 
further studies will be needed to investigate the relation among enolase, DRP-2, and NF-
L in the recovery of neuronal function (Farr et al., 2003). Here, we used proteomics to 
gain insight of the mechanism of cognitive improvement by LA injection in SAMP8 
mice. 
Our current study suggests that the improved learning and memory observed in 
LA injected SAMP8 is associated with the restoration to the normal condition of oxidized 
DRP-2, α-enolase, LDH, uMiCK, and NF-L in aged SAMP8 mouse brains.   
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CHAPTER EIGHT 
Antisense Oligonucleotides Directed at the Aβ Region of APP Decreases 
Brain Oxidative Markers in Aged Senescence Accelerated Mice 
8.1 Introduction 
 In previous chapters, we showed oxidative stress in brain play significant 
role in the learning and memory deficits, and reducing oxidative stress by LA can reduce 
oxidative stress and improve cognitive functions in aged SAMP8 mice. Therefore, using 
an alternative strategy to reduce oxidative stress should also improve learning and 
memory. One way to reduce oxidative stress is by reducing the production of neurotoxic 
agent, such as amyloid β-peptide (Aβ)  
Aβ is the major constituent of the senile plaques, a pathological hallmark of 
Alzheimer’s disease (AD). It is generally accepted that Aβ(1-42) plays a central role in 
the pathophysiology of AD (Selkoe, 1996). Our laboratory, along with others, suggested 
that Aβ neurotoxicity is mediated through its ability to produce free-radical oxidative 
stress (Butterfield et al., 1994; Varadarajan et al., 2000; Butterfield et al., 2001b; 
Butterfield et al., 2002c; Butterfield and Kanski, 2002; Butterfield and Lauderback, 
2002). The methionine residue at position 35 (Met-35) is important in this process 
(Butterfield and Kanski, 2002). Other mechanisms by which Aβ can induce neurotoxicity 
include binding to the nicotinic acetylcholine receptor (Wang et al., 2000), forming 
calcium and potassium channels in cell membranes (Arispe et al., 1993; Etcheberrigaray 
et al., 1994; Engstrom et al., 1995), decreasing glucose transport across brain endothelial 
cells (Blanc et al., 1997), and actuating the release of chemokines (Fiala et al., 1998) and 
cytokines(Akama and Van Eldik, 2000).  
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When Aβ is given exogenously, it causes deficits in learning and memory in 
animals (Flood et al., 1991, 1994; Cleary et al., 1995; Sisodia and Gallagher, 1998; 
Tanaka et al., 1998; Yamada et al., 1998; Chen and Fernandez, 1999). Such learning and 
memory impairments are also present when Aβ is overly expressed in transgenic models 
(Hsiao et al., 1996) and the SAMP8 mouse (Flood and Morley, 1992, 1993; Flood et al., 
1993; Flood et al., 1995; Nomura et al., 1996; Flood and Morley, 1998; Farr et al., 2003). 
It has, therefore, been proposed that reducing the levels of Aβ could slow or even 
prevent cognitive impairment observed in AD or age-related dementia (McMahon et al., 
2002). Such reductions can be achieved by site-directed antisense oligonucleotide 
therapy. This type of oligonucleotide is designed to bind to a complementary sequence 
(referred to as the "target sequence") in a selected mRNA, inhibiting gene expression at 
the translational level. As a consequence, the protein product coded by that particular 
mRNA is not produced (Gewirtz et al., 1998). Since antisense oligonucleotides are 
intended to inactivate specific RNA nucleotide sequences rather than three-dimensional 
protein structures as antibodies do, they offer the advantage of discriminating among 
closely related gene products (Seidman et al., 1999). Therefore, site-directed antisense 
oligonucleotide therapy offers significant advantages for the specific reduction of Aβ 
production. 
As mentioned in previous chapters, SAMP8 mice produce increased amounts of 
APP and Aβ in brain similar to those moieties observed in AD. Unlike transgenic mice 
that have 5-14 times the normal amount of Aβ in their brains, the Aβ of SAMP8 mice had 
only a 100% increase from 4 month to 12 months (Kumar et al., 2001). Such an increase 
is much closer to the estimated 50% increase in Aβ seen in AD (Rosenberg, 2000) than is 
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observed in transgenic mouse models. The APP and APP mRNA of SAMP8 mice also 
increase significantly as the mice age from 4 months to 12 months (Morley et al., 2000; 
Kumar et al., 2001). Hence, SAMP8 mice serve as a useful model in the study of age-
related cognitive impairment.  
It is possible to decrease the Aβ production in the brain by giving an 
intracerebroventricular injection of a 42 mer phosphorothiolated antisense 
oligonucleotide (AO) directed at the Aβ region of the APP gene. Injection of AO twice or 
more has been shown to improve acquisition and retention in a footshock avoidance 
paradigm (Kumar et al., 2000b). Although many in vitro studies show the benefits of 
reducing APP level by antisense RNA (LeBlanc et al., 1992), antisense ribozoymes 
(Denman et al., 1993; Denman et al., 1994; Denman and Phillips, 1998), or AOs 
(Majocha et al., 1994; Allinquant et al., 1995; Coulson et al., 1997), little is known about 
the relation between the reduced Aβ level and oxidative stress. Therefore, in this current 
study, we hypothesized that the cognitive improvement resulting from AO treatment of 
SAMP8 mice is caused by a decrease in Aβ-induced free radical insults. To test this 
hypothesis, we compared the protein oxidation and lipid peroxidation markers in brain 
from 4-month-old SAMP8 mice treated with saline (4m), 12-month-old SAMP8 mice 
treated with random AO (12mR), and 12-month-old SAMP8 mice treated with the 42mer 
AO directed at the Aβ region of the APP gene (12mA). 
8.2 Experimental Procedures 
8.2.1 Rodent Subjects  
Rodent subjects used are the same as Section 4.2.1 
8.2.2 Antisense oligonucleotides (AO) and its permeability to cell membrane 
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We designed phosphorothiolated antisense oligonucleotides (AO) directed at 
positions 17 to 30 of the Aβ region of the APP gene (Midland Certified Reagent 
Company, Midland, TX). The sequences of the designated AO and of a random AO used 
as a control are given in Table 8.1. These AOs were previously used to reverse the 
learning and memory deficit observed in aged SAMP8 mouse (Kumar et al., 2000b).  
Hippocampal neuronal cultures were prepared from 18-day old Sprague-Dawley 
rat fetuses as described previously (Drake et al., 2003). Incorporation of AO into neurons 
was observed using fluorescien conjugated-AO. Briefly, neuronal cells were incubated 
with  5'-FITC-AO for 2 hr at 37oC followed by washing with PBS (3 times) to remove the 
excess of  5'-FITC-AO  and the cells were examined under a confocal fluorescence 
microscope equipped with an argon laser (λex 485 nm, λem 530 nm).  
 8.2.3 Antisense Administration 
Mice were anesthetized in a stereotactic instrument with methoxyflurane. Three 
injections of vehicle or AO were given to the mice by intracerebroventricular (ICV) 
injection at 2 weeks intervals. All substances (65ng) were injected in a 2 μL volume by 
drilling a hole through the skull over the third ventricle (-0.5 relative to Bregma; 0.5 mm 
right of central suture). The scalp wound was closed and the mice were returned to their 
cages. 
 
 
 157
 Table 8.1: the antisense and control random phosphorothiolated 
oligonucleotides used for inhibition of APP translation 
AO Sequence 
AO 
inhibiting 
APP 
translation 
GGCGCCTTTGTTCGAACCCACATCTTCAAAAGAACACCAG
Random 
AO 
GATCACGTACACATCGACACCAGTCGCCATGACTGAGCTT
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8.2.4 Sample Preparation  
Mice are scarified two weeks after the last injection. SAMP8 mouse brains were 
flash frozen in liquid nitrogen in St. Louis and flown to Lexington on ice overnight. The 
samples were homogenized in PBS with protease inhibitors (2mM EDTA, 2mM EGTA, 
20mM HEPES, 20μ.g/mL Trypsin inhibitor, 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5 
μg/mL aprotinin) by sonication. Protein concentration was determined by the BCA Assay 
method.  
8.2.5 Immunochemistry  
 12.5 μL of the samples was treated with an equal volume Laemmli buffer 
(0.125M Trizma base, 4%SDS, 20% glycerol) for 20 minutes. 12.5% linear Gradient 
Precast criterion Tris-HCl gels (Bio-Rad) were used to perform the separation of the 
proteins. Precision ProteinTM Standards (Bio-Rad) were run along with the sample at 
200V for 45 min. The proteins from gels were transferred to a nitrocellulose paper (Bio-
Rad) using the Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 8V for 45 
minutes. Aβ level was detected on the nitrocellulose paper using a primary mouse 
antibody (a generous gift from Dr. Ralph N. Martins) specific for Aβ (1:50) and then a 
secondary anti-mouse IgG (AnaSpec) antibody. The resultant stain was developed by 
application of Sigma-Fast (BCIP/NBT) tablets. 
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls 
were determined immunochemically. Protein carbonyl levels were determined as 
described in Section 4.2.5. HNE and 3-NT levels were determined in the same manner. 
5μL of the samples was treated with an equal volume of 12% SDS. Samples were then 
further denatured with 10 μL of Laemmli buffer (0.125M Trizma base, 4%SDS, 20% 
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glycerol) for 20 minutes. Levels of 3-NT and HNE were measured by using the slot-blot 
technique: 500 ng of protein per slot for protein 3-NT levels and 250 ng of protein per 
slot for HNE levels. The HNE levels were detected on the nitrocellulose paper using a 
primary rabbit antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000). 
The 3-NT levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT 
(1:100). The same secondary goat anti-rabbit IgG (Sigma) antibody was then used. The 
resultant stain was developed by application of Sigma-Fast (BCIP/NBT) tablets; and the 
line densities were quantified by Scion-Image software package 
8.2.6 TBARS 
TBARS is determined as Section 4.2.6 
8.2.7 Glutamine Synthetase (GS) assay 
 
Fresh, non-frozen-brains, shipped on ice overnight from St. Louis to Lexington, 
were homogenized in a 0.32M sucrose isolation buffer (2mM EDTA, 2mM EGTA, 
20mM HEPES, 20μg/mL Trysin inhibitor, 4 μg/mL Leupeptin, 4 μg/mL pepstatin, 5 
μg/mL aprotinin). The samples were then centrifuged at 20,000 × g at 4°C for 10 min. 
Supernatants that contain GS and other cytosolic proteins were extracted. The protein 
concentration was determined by the BCA method and normalized to 0.4mg/mL by 
addition of the 0.32M sucrose solution. GS activity was determined by the method of 
Rowe et al. (Rowe et al., 1970; Meister, 1985) as modified by Miller et al. (Miller et al., 
1978). The absorbance was recorded at 505nm in a microtiter plate reader ( 
PowerWaveX®, Bio-Tek Instruments). 
8.2.7 Statistics 
Statistical Analysis applied is the same as Section 4.2.8 
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8.3 Results 
8.3.1 Accessibility to cells and effects on Aβ levels of AO 
8.3.1.1 Accessibility of AO in Cell Cultures 
 The AO approach previously was used to reverse the learning and memory 
deficits of aged SAMP8 mice (Kumar et al., 2000b), consistent with the notion that the 
AO penetrated nucleuses in vivo. To model this result, we used neuronal cultures. Fig. 
8.1A shows bright-field microscopy of living neurons (arrows) and Fig. 8.1B shows the 
fluorescence intensity of AO inside the neurons, indicating that the AOs successfully 
cross the cell membrane and remain in the neurons after washes. Approximately 8% of 
the neurons successfully took up the AO.  
8.3.1.2 Effect of AO on Aβ levels in SAMP 8 mice brain 
 Fig. 8.2A shows the Western blot of Aβ levels in 12mR and 12mA brain 
homogenate. The Aβ level in the 12mA SAMP8 mice brain is decreased by 40% due to 
the effect of AO (p<0.05), while the Aβ level in brain from SAMP8 mice treated with 
12mR was equal to that of untreated 12-month-old SAMP8 mice. Slot blot analysis of 
levels of Aβ in brains of 4-month-old SAMP8 mice reveals that Aβ levels are equivalent 
to those of 12-month-old treated with AO, i.e., AO treatment of aged SAMP8 mice lower 
Aβ levels in brain to those of young mice (Fig. 8.2B). 
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Figure 8.1 
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Figure 8.2 
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8.3.2. Protein oxidation 
8.3.2.1 Glutamine synthetase (GS) Assay 
GS is an oxidatively-sensitive enzyme (Butterfield et al., 1997a), whose activity is 
decreased in AD brain (Hensley et al., 1995c), probably a result of specific oxidation 
(Castegna et al., 2002b; Butterfield and Pocernich, 2003). Fig 8.3 shows that the activity 
of GS in 12mR mice brains was decreased to 85.7±3.1% compared to the 4m mice brains 
(p<0.01). Antisense directed against the Aβ region of APP partially reversed this 
decrease (p < 0.05, with the activity of GS restored to 94.3±1.9% of the mean GS activity 
from 4m brains. This value was statistically identical to that between the 4m old brain 
(p>0.2).   
8.3.2.2 Protein Carbonyl level 
Protein carbonyls are an index of protein oxidation (Butterfield and Stadtman, 
1997) and are increased in AD brain (Hensley et al., 1995c; Butterfield et al., 2001b; 
Butterfield and Lauderback, 2002). Consistent with the GS assay results, Fig. 8.4 shows 
that the brain protein carbonyl levels were increased in 12mR mouse brains compared to 
those in brains from 4m mice (p < 0.05). However, by decreasing the production of Aβ 
by antisense against APP, the brain protein carbonyl levels of 12-month old SAMP8 mice 
were significantly decreased to 89.6±4.5% (p<0.01), and found to be insignificantly 
different to those in brain from 4m old mice (p>0.05).  
8.3.2.3 3-Nitrotyrosine (3NT) 
Fig. 8.5 shows that the 3-NT levels of 12mR SAMP8 brain protein were significantly 
increased compared to those in brain from 4m old mice (118±3.4%, p<0.001). However, 
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after injection of the antisense against APP, the 3-NT levels were significantly decreased 
to 99.6±2.7% (p<0.005), a level similar to that of brain from 4m mice (p>0.8).  
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 Figure 8.3 
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Figure 8.4 
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Figure 8.5 
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8.3.3 Lipid Peroxidation 
8.3.3.1 HNE  
HNE is a reactive product of lipid peroxidation (Butterfield and Stadtman, 1997) 
that is elevated in AD brain (Markesbery and Lovell, 1998; Lauderback et al., 2001; 
Butterfield et al., 2002c)}. Fig. 8.6 shows that in the 12mR SAMP8 mice brain, the 
protein-bound HNE levels were 114±0.8% of the level found in 4-month-old mice, a 
statistically significant increase (p<0.00005). However, the HNE levels for brain protein 
from 12-month-old mice was decreased significantly to 106±1.9% by the AO injection 
(p<0.005), a value only slightly elevated from that in 4m mice brain (p=0.04). 
8.3.3.2 TBARS  
Consistent with the increase in HNE levels, Fig. 8.7 shows that TBARS levels in 
12mR were increased to 108.6±3.0% of that found in 4 month old mice, a statistically 
significant increase (p<0.05). However, with the injection of AO, the TBARS levels were 
significantly decreased to 96.7±3.5% (p<0.05), a level that was not significantly different 
that in 4m mice brain (p>0.4). 
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Figure 8.6 
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Figure 8.7 
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8.4 DISCUSSION 
It was reported that AO is able to cross blood brain barrier (BBB) and led reduce 
to mRNA levels of APP in aged SAMP8 mice brains(Banks et al., 2001). We report here 
that AOs successfully cross cell membranes and enter neurons (Figures 1, 2). Others 
reported that cells in culture can take up antisense oligonucleotides against APP (Adlerz 
et al., 2003), and neuronal cells in culture appear to internalize AOs relatively efficiently 
(Larsen et al., 1999). Consistent with these other studies, we show here that small amount 
of neurons are able to internalize AOs. The low amount neuronal uptake of AOs were 
possibly due to the short incubation time (2hr). Nonetheless, AOs shown to enter the 
cells. Although no direct evidence here shows that AO binds to APP mRNA, mRNA 
level and APP level reduction were previously reported (Kumar et al., 2000b), which in 
turn reduced Aβ production. Others reported that AO against APP can reduce Aβ 
production in rats (McMahon et al., 2002). Consistent with this result, we find that AOs 
reduced Aβ level by 39% in SAMP8 mice brains. This indicates that the AO is able to 
cross the BBB (Banks et al., 2001) and enter neurons, then reduce the mRNA and protein 
levels of APP (Kumar et al., 2000b), consequently reducing the level of Aβ (Figure 2). 
Consistent with previous findings (Butterfield et al., 2001a; Farr et al., 2003), our 
current results show that the 12mR SAMP8 mice have increased brain lipid peroxidation 
and protein oxidation compared to those in brain from 4m SAMP8 mice. Therefore, the 
random AO treatments had no protective effect on lipid peroxidation or protein oxidation 
observed in aged SAMP8 mice brain. Our findings also show that brain lipid peroxidation 
and protein oxidation of 12-month-old SAMP8 mice can, indeed, be reduced by injection 
of AO and lower levels of Aβ.  
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Lipid peroxidation is an important mechanism of neurodegeneration in AD brains. 
TBARS and protein-bound HNE levels, commonly used as lipid peroxidation markers 
(Butterfield and Stadtman, 1997), are significantly elevated in AD brains (Subbarao et al., 
1990; Balazs and Leon, 1994; Palmer and Burns, 1994; Lovell et al., 1995; Sayre et al., 
1997; Marcus et al., 1998; Markesbery and Lovell, 1998; Butterfield et al., 2001b; 
Butterfield and Lauderback, 2002). HNE is able to diffuse to sites distant from that of its 
formation because of its comparatively long half-life (Butterfield and Stadtman, 1997). 
HNE elevation has been described in multiple brain regions and in ventricular 
cerebrospinal fluid (CSF) in AD (Markesbery and Lovell, 1998). Aβ leads to HNE 
formation (Mark et al., 1997); and this alkenal can alter the conformation of membrane 
proteins (Subramaniam et al., 1997). It is, therefore, a reasonable hypothesis that 
reducing the production of Aβ should decrease lipid peroxidation. Unlike other 
antioxidant studies which decrease lipid peroxidation by blocking the Aβ-associated 
radical insult (Butterfield et al., 1994; Avdulov et al., 1997; Gridley et al., 1997; Mark et 
al., 1997; Bruce-Keller et al., 1998; Daniels et al., 1998; Mark et al., 1999; Yatin et al., 
2000; Butterfield et al., 2002d), our current study shows that Aβ-mediated lipid 
peroxidation can be reduced by decreasing the production of Aβ through AO injection 
into brain.  
Protein oxidation is another important factor in aging and age-related 
neurodegenerative disorders (Stadtman, 1992; Hensley et al., 1995c; Butterfield et al., 
1997a; Butterfield and Stadtman, 1997; Butterfield and Lauderback, 2002; Butterfield et 
al., 2003; Farr et al., 2003). Protein carbonyls, 3-NT levels, and GS assay are commonly 
used as markers of brain protein oxidation(Butterfield and Stadtman, 1997). A significant 
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increase in protein carbonyls was reported in AD brains (Hensley et al., 1995c; Lyras et 
al., 1997; Aksenov et al., 2001; Castegna et al., 2002b; Castegna et al., 2002a; Butterfield 
and Pocernich, 2003). 3-NT is formed by oxidation of tyrosine by peroxynitrite. 3-NT 
levels were significantly increased in the hippocampus and cortical regions of AD as well 
as CSF (Hensley et al., 1998; Tohgi et al., 1999; Castegna et al., 2003). Other studies 
have demonstrated that oxidative processes often result in decreased activity of key 
enzymes (Floyd, 1990; Hensley et al., 1995c; Howard et al., 1996; Aksenova et al., 
1998). AD is characterized by the loss of GS activity (Hensley et al., 1995c), which can 
also be caused by Aβ (Aksenov et al., 1996; Aksenov et al., 1997; Butterfield et al., 
1997b). Antioxidants can inhibit brain protein oxidation induced by Aβ (Harris et al., 
1995; Butterfield et al., 1999a; Varadarajan et al., 1999; Yatin et al., 1999a; Yatin et al., 
1999c; Varadarajan et al., 2000; Yatin et al., 2000; Butterfield et al., 2001b; Butterfield 
and Kanski, 2001; Yatin et al., 2001), and here we show that Aβ mediated protein 
oxidation also can be inhibited by injections of AO to reduce Aβ production. 
Our laboratory has proposed a model for neurodegeneration in AD brains based 
on free radical oxidative stress associated with Aβ (1-42) (Varadarajan et al., 2000; 
Butterfield et al., 2002c; Butterfield and Lauderback, 2002). This model predicts that 
chemistry associated with the single methionine residue of Aβ(1-42) [Met-35] would 
induce lipid peroxidation and protein oxidation in neuronal membranes. The role of Met-
35 as a mediator of the toxicity of Aβ is most likely to involve an oxidative event at the 
sulfur atom (Yatin et al., 1999b; Kanski et al., 2002a; Kanski et al., 2002b). However, the 
event that initiates the oxidation of Met-35 is not yet clear. It could involve one or more 
of the several reactive oxygen species present in biological systems (Varadarajan et al., 
 174
2001) or redox metal ions (Curtain et al., 2001; Barnham et al., 2003). Since the structure 
of Aβ from position 28 to position 42 is helical (Coles et al., 1998; Shao et al., 1999), the 
backbone oxygen atom of Ile-31 is within a van der Waals distance of the sulfur atom of 
Met-35. Such an interaction could increase the susceptibility for oxidation of the sulfur 
atoms of Met-35 in Aβ, leading to sulfuramyl free radicals (Varadarajan et al., 2001; 
Kanski et al., 2002a). APP in SAMP8 mice has 89.2% homology to the human protein. 
The amino sequence of Aβ in SAMP8 mice is highly similar to that of humans with the 
exception of glycine replacing arginine at position 5, phenylalanine instead of tyrosine at 
position 10, and arginine instead of histidine at position 13 (Kumar et al., 2001). The 
critical Met-35 and Ile-31 remain present in Aβ of SAMP8 mice. Therefore, it is 
reasonable that the 12mR mouse brains suffer higher oxidative stress than the 4m mouse 
brains. In the case of 12m mouse brains, APP expression was decreased by AO 
treatments (Kumar et al., 2000b). Thus, there is less Aβ present in brain to induce 
oxidative insults. The current study suggests that decreased Aβ production contributed to 
the decreased protein oxidation and lipid peroxidation in 12m mouse brains. Reduction of 
protein oxidation and lipid peroxidation conceivably could alleviate the mitochondrial 
dysfunction, redox metal imbalance, advanced glycation end-products, and excitotoxicity 
that interact with, and are exacerbated by, Aβ (Butterfield et al., 2001b). Thus, this 
approach, which improves the learning and memory impairment observed in 12m old 
SAMP8 mice (Kumar et al., 2000b), points to the importance of Aβ in oxidative stress in 
this mouse strain, and presumably in AD patients as well. 
In previous chapters, we have shown that oxidative stress is closely related to 
learning ability and memory retention in SAMP8 mice (Farr et al., 2003). It was also 
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demonstrated that using AO against the Aβ region of APP to lower Aβ production could 
improve learning and memory in SAMP8 mice (Kumar et al., 2000b). In the current 
study, we extended the previous research and investigated the role of Aβ in oxidative 
stress associated with learning and memory impairment. Lesion studies in other animals 
have shown that spatial learning is dependent on the integrity of the septohippocampal 
pathway (O'Keefe, 1978; Farr et al., 2000). Although Aβ may not directly inhibit cellular 
function, Aβ-mediated oxidative stress in the form of lipid peroxidation may do so 
(Butterfield et al., 2001b; Butterfield et al., 2002c). It is possible that Aβ–mediated free 
radicals, possibly through the effects of the lipid peroxidation product HNE and acrolein, 
react with enzymes, receptors, and neurotransmitters (such as norepinephrine or 
dopamine), thereby disrupting the function of the septohippocampal pathway. As a result, 
the functioning of the whole septohippocampal pathway would be decreased. 
Pharmacological studies have shown that the memory defects in SAMP8 mice are 
dependent on the septohippocampal pathway (Flood et al., 1998). 
Therefore, injecting AO directed to the Aβ region of APP in 12 month old 
SAMP8 mice can alleviate the Aβ-mediated oxidative stress, improving the learning 
ability and memory retention, as reported by (Kumar et al., 2000b) and (Banks et al., 
2001). This study further indicate that the important role of oxidative stress in learning 
and memory deficit in aged SAMP8 mice. 
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CHAPTER NINE 
Proteomic Identification of Less Oxidized Brain Proteins in Aged Senescence 
Accelerated Mice Following Administration of Antisense Oligonucleotide Directed 
at the Aβ Region of Amyloid Precursor Protein 
9.1 Introduction 
 Senile plaques, neurofribillary tangles (NFTs) and synapse loss are three 
pathological features of Alzheimer’s disease (AD) (Braak and Braak, 1990; Delacourte et 
al., 2002). Senile plaques contain extracellular deposits of amyloid-β peptides (Aβ) in 
star-shaped masses of amyloid fibrils, and NFTs are composed of the microtubule-
associated protein tau (Brion et al., 1985; Grundke-Iqbal et al., 1986; Kosik et al., 1986; 
Nukina and Ihara, 1986; Wood et al., 1986). There is growing evidence that the formation 
of NFTs in AD is one of the neuronal responses to the accumulation of Aβ and Aβ-
associated stress (Selkoe, 2001). Aβ is released from cells under entirely normal cellular 
conditions (Haass et al., 1992; Seubert et al., 1992; Busciglio et al., 1993; Sherrington et 
al., 1995) during the internalization and endosomal processing of APP (Koo and 
Squazzo, 1994; Perez et al., 1999). However, accumulation of Aβ can induce 
neurotoxicity by binding to the nicotinic acetylcholine receptor (Wang et al., 2000), 
forming calcium and potassium channels in cell membranes (Arispe et al., 1993; 
Etcheberrigaray et al., 1994; Engstrom et al., 1995), decreasing glucose transport across 
brain endothelial cells (Blanc et al., 1997), and actuating the release of chemokines (Fiala 
et al., 1998) and cytokines(Akama and Van Eldik, 2000). Moreover, Aβ can induce 
oxidative damage directly to cells through its ability to produce free-radicals (Butterfield 
et al., 1994; Varadarajan et al., 2000; Butterfield et al., 2001b; Butterfield et al., 2002c; 
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Butterfield and Kanski, 2002; Butterfield and Lauderback, 2002). Aβ-mediated oxidative 
stress also includes the production of O2.-   through the stimulation of NADPH oxidase 
(Hurst and Barrette, 1989); the production of H2O2 through copper or iron reduction; and 
the production of nitric oxide (NO) production in macrophages in a microglial cell line 
(Meda et al., 1995). These Aβ mediated reactive oxygen species (ROS) can further 
oxidatively modify proteins, lipids and DNA to enact damages in cells.  
When Aβ is administrated exogenously, it causes deficits in learning and memory 
in animals (Flood et al., 1991, 1994; Cleary et al., 1995; Sisodia and Gallagher, 1998; 
Tanaka et al., 1998; Yamada et al., 1998; Chen and Fernandez, 1999). Such learning and 
memory impairments are also observed in overexpressed Aβ transgenic models (Hsiao et 
al., 1996) and the senescence accelerated mice prone 8 (SAMP8) mice (Flood and 
Morley, 1992, 1993; Flood et al., 1993; Flood et al., 1995; Nomura et al., 1996; Flood 
and Morley, 1998; Farr et al., 2003). Aged SAMP8 mice show impaired age-dependent 
defects of learning and memory (Flood and Morley, 1993), along with Aβ-like-protein 
immunoreactive granular structures in their central nervous system (CNS) (Takemura et 
al., 1993). Brains of SAMP8 mice also show spheroidal axonal dystrophy in dorsal 
column nuclei, small neurons in gracile nucleus, and some well-defined or swollen axons 
(Kawamata et al., 1998). Age-related shrinkages of the cholinergic neurons of the 
laterodorsal tegmental nucleus are observed in aged SAMP8 mice brains (Kawamata et 
al., 1998), indicating abnormal axonal transport, synaptic terminal  remodeling, and/or 
actin polymerization/depolymerization occur in SAMP8 mice brains.   
In last chapter, we showed that decreasing the production of Aβ by giving an 
intracerebroventricular injection of a 42 mer phosphorothiolated AO directed at the Aβ 
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region of the APP gene can reduce lipid peroxidation, protein oxidation (Poon et al., 
2004c) and improve cognitive deficits (Kumar et al., 2000b) in aged SAMP8 mice. In 
order to investigate how Aβ level reduction improves learning and memory performance 
of SAMP8 mice through reduction of oxidative stress in brains, we used proteomics to 
identify the proteins that are less oxidized, as well as the proteins that are expressed 
differently, in 12-month-old SAMP8 mice brains treated with AO against the Aβ region 
of APP (12mA) compared to brain from age-controlled SAMP8 mice treated with 
random AO (12mR)., an AO that show no protective effect against protein oxidation.   
9.2 Experimental Procedures 
9.2.1 Rodent Subjects  
The rodent subjects used is described in 4.2.1 
9.2.2 Antisense administration 
The antisense administration was prveously described in Section 8.2.3 
9.2.3 Sample Preparation 
 Sample preparation is the same as Section 5.2.2 
9.2.4 Two-dimensional electrophoresis  
 2D electrophoresis is similar to Section 5.2.3 with minor modification. After 2D 
electrophoresis separation, The gel was incubated in fixing solution (7% acetic acid, 40% 
methanol) for 20 min after the second dimension electrophoresis. Approximately, 60 mL 
of Sypro Ruby stain (Bio-Rad, Hercules, CA) were used to stain the gel for 2 hours. The 
gels were destained in deionized water overnight. 
9.2.5 Western Blotting 
 Western blotting is the same as Section 5.2.4 
9.2.6 Image Analysis 
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 Image analysis performed was similar to Section 5.2.5 with minor modification, 
The gels and nitrocellulose papers were scanned and saved in TIF format using Strom 
860 Scan (Molecular Dynamics, Sunnyvale, CA) and Scanjet 3300C (Hewlett Packard) 
respectively. PDQuest 2D analysis software (Bio-Rad, Hercules, CA) was used for 
matching and analysis of visualized protein spots among differential gels and oxyblots.   
Average mode of background subtraction was used to normalize intensity value, which 
represents the amount of protein (total protein on gel and oxidized protein on oxyblot per 
spot).  After completion of spot matching, the normalized intensity of each protein spot 
from individual gels (or oxyblots) was compared between the aged SAMP8 mice (n=7) 
and the aged SAMP8 mice treated with AO (n=7) using Student’s t test statistical 
analysis. 
 
9.2.7 Trypsin digestion 
 Trypsin digestion is the same as Section 5.2.6 
9.2.8 Mass Spectrometry 
 Mass spectrometry was similar to Section 5.2.7 with minor modification. 
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast 
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and 
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in 
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z 
2239.14, 2211.10, or 842.51) as lock masses.  
9.2.9 Statistics 
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 Statistical analysis is the same as Section 5.2.8 
9.3 Results 
The specific carbonyl level, obtained by dividing the carbonyl level of a protein 
spot on the nitrocellulose membrane by the protein level of its corresponding protein spot 
on the gel, indicates the carbonyl level per unit of protein. 144 proteins on 2D gels and 
2D Western blots are matched between 12mR SAMP8 and 12mA SAMP8. In 
comparison to 12mR SAMP8 mice, 12mA SAMP8 mice brains have two proteins that are 
expressed differently in terms of protein levels, and three proteins that have significantly 
lower specific carbonyl levels. The identified proteins are listed in Table 9.1. All the 
mass spectra (not shown) of the peptides were matched to the mass spectra in MSDB 
protein databases with reported probability-based Mowse score. All protein 
identifications agree with the expected MrW and pI range based on their positions on the 
gels.  
9.3.1 Protein expression levels 
Fig. 9.1 shows the representative gel of the whole brain homogenate from 12mR 
and 12mA-treated SAMP8 mice. The proteins that were expressed differently in SAMP8 
brains are summarized in Table 9.2. The expression level of α-ATP synthase (Atp5a1) 
was significantly decreased, whereas the expression of profilin 2 (Pro-2) was 
significantly increased in brain from12-month-old SAMP8 mice treated with AO.  
9.3.2 Specific Protein carbonyl level 
Fig. 9.2 shows the representative Western blots of 12mR and 12mA SAMP8 mice 
brains. The summary of the specific protein carbonyl levels is given in Table 9.3. The 
specific protein carbonyl levels of aldoase 3(Aldo3), coronin 1a (Coro1a) and 
peroxiredoxin 2 (Prdx2) were significantly decreased in the brain of 12mA SAMP8. 
 181
 
 
Table 9.1: Summary of proteins identified by mass spectrometry 
Identified Protein 
Databse 
accession 
code 
# Peptide 
matches 
Identified 
% Coverage 
matched 
peptides 
pI, MrW Mowse Score  
Profilin 2 
PRO2_MO
USE 
6 38 6.78, 14.9 68  
ATP synthase alpha 
subunit, isoform 1 
gi|6680748 14 26 9.22, 59.7 123  
Aldo3 protein gi|13435924 8 25 6.47, 39.3 87  
Peroxiredoxin 2 Q9CWJ4 7 34 5.70, 21.8 74  
Coronin, actin binding 
protein 1A 
gi|31418362 10 16 6.05, 51.0 94  
 
Mowse scores greater than 62 are considered significant (p<0.05). 
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Table 9.2: Proteins expressed differently when 12-month old SAMP8 
mice are injected with AO compared to non-treated 12-month old 
SAMP8 mice 
Identified Proteins 
Protein levels of 12-month-old 
SAMP8 injected with AOa
p-value 
alpha-ATP synthase  54.5±11.2 < 0.05 
profilin 2 139± 7.8 < 0.05 
 
a Percent of the level found in brain from 12mR-treated SAMP8 mice 
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Table 9.3: Proteins that have specific carbonyl level decreased by AO 
Identified Proteins 
Specific protein carbonyl 
levels of 12-month-old 
SAMP8 injected with AO 
p-value 
Aldo 3 9.4±0.3 <0.000001 
Coronin1A 46.4± 16.3 < 0.005 
Peroxiredoxin 2 26.8±12 < 0.005 
 
a Percent of the level found in brain from 12mR-treated SAMP8 mice 
 
 
 
 184
Figure 9.1 
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Figure 9.2 
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Figure 9.3 
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9.4 Discussion 
We showed that AO was successfully internalized by neurons and reduced the 
level of Aβ, thus reducing Aβ-mediated protein oxidation and lipid peroxidation in 12mA 
SAMP8 mice brains in the last chapeter (Poon et al., 2004c). Here we show that the 
specific carbonyl levels of Aldo3, Coro2 and Prdx2 in the 12mA SAMP8 mice brains are 
significantly decreased when compared to those in the 12mR SAMP8 mice. We also find 
that the protein levels of Pro-2 and Atp5a1 in brains of 12mA SAMP8 mice are 
significantly altered when compared to 12mR SAMP8 mice brains. In our previous study, 
we found that the specific carbonyl level of Aldo3, Coro1a and Prdx2 were increased 
(486%, 599% and 223% respectively) in 12-month-old SAMP8 mice brains when 
comparing to that in the 4-month-old SAMP8 mice brains (chapter 3). However, these 
increases of the specific carbonyl levels are not statistically significant, thus were not 
reported in the previous study (Poon et al., 2005b).  
Coro1a is an actin binding proteins (de Hostos et al., 1991) which promotes rapid 
actin polymerization by reducing the lag phase of actin polymerization. Coro1a level in 
fetal Down’s syndrome (DS) brain is reduced, indicating that it plays role in migration of 
cells and /or neuronal outgrowth (Weitzdoerfer et al., 2002). Therefore, oxidative 
inactivation of Coro1a might contribute to the neuronal shrinkage observed in SAMP8 
mice brains, thus leading to learning and memory impairment similar to DS patients. 
Here, we show that the specific carbonyl level of Coro1a was reduced with the treatment 
of AO to reduce Aβ level in SAMP8 mice brains, suggesting the oxidative inactivation of 
Coro1a was possibly recovered. Thus the normal neuronal outgrowth dynamic and 
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neuronal functions presumably were reestablished by the AO treatment in SAMP8 mice 
brains. 
Aldo3 is a brain specific glycolytic enzyme. Reduced activity of Aldo3 was 
reported in aged rats, suggesting oxidative modification may be responsible for Aldo3 
activity decline in aged animals (Leong et al., 1981). Moreover, Aldo3 interacts with 
dihydropyrimidinase-like 2 (DRP-2) in the complex of NADH-dichorophen-indophenol 
(DCIP) reductase to response to the external oxidative stress and/or antioxidants (Bulliard 
et al., 1997). Here, we show that specific carbonyl level of Aldo3 was significantly 
reduced in 12mA SAMP8 mice by i.c.v. injection of AO when compared to that in 12mR 
mice brains, which should partially restore the impaired metabolic pathway, increase 
ATP production for antioxidant defensive systems and synaptic elements in neurons of 
SAMP8 mice brains. 
Prdx2 is an antioxidant enzyme that is exclusively expressed in neurons. (Sarafian 
et al., 1999). Since Prdx2 modulates intracellular H2O2 production and H2O2 mediated 
apoptosis (Kim et al., 2000), it is possible that Prdx2 is responsible for the elimination of 
Aβ-mediated H2O2 production in neurons. The increased expression of Prdx2 in AD, 
Down’s syndrome and PD (Kim et al., 2001; Krapfenbauer et al., 2003) is likely to be in 
response to the increased oxidative stress and/or its activity loss due to oxidative 
modification. Therefore, reducing Aβ level in SAMP8 mice brain by i.c.v. injection of 
AO can reduce the H2O2 production and therefore reduce the specific carbonyl level of 
Prdx2, suggesting more active Prdx2 are available in neurons to strengthen its antioxidant 
system. This may result in improving the biological function of neurons in aged SAMP8 
mice, and contribute to the improvement in learning and memory. 
 189
Pro-2, expressed in neuronal cells, is an isoform of the profilin family. Profilin 
binds to monomeric actin to prevent the abnormal polymerization of action into 
filaments. Pro-2 also promotes actin polymerization (Pollard and Borisy, 2003). The 
expression of profilin is regulated by oxidative stress instead of protein kinase C 
(Clarkson et al., 2002), and down regulation of profilin is also observed in oxidative-
stressed  conditions, i.e. hypoxia (Vorum et al., 2004). Profilin is reported as a 
glutathionylated protein in oxidatively stressed cell lines (Fratelli et al., 2002; Fratelli et 
al., 2003), suggesting that glutathionylation might be a common mechanism for the 
global regulation of profilin functions. Our current study shows that the Pro-2 expression 
is increased in the brain of SAMP8 mice treated with AO, indicating that the neuronal 
outgrowth dynamic by actin is restored, which in turn possibly secures neuronal junction 
and improves learning and memory in SAMP8 mice. 
Atp5a1 is a member of the F1 synthase enzymatic complex that binds ADP, 
phosphate and ATP for the synthesis of ATP during oxidative phosphorylation. Atp5a1 is  
inner mitochondrial membrane protein. However, localization and accumulation of 
Atp5a1 in cytosol are demonstrated in the degenerated neurons of AD patients (Sergeant 
et al., 2003) and  level of Atp5a1 are post-transcriptionally increased as a function of age 
in the cerebral cortex of rats (Nicoletti et al., 1995; Nicoletti et al., 1998), suggesting that 
the oxidative modification of Atp5a1 causes it to accumulate in cytosol, thereby 
mediating mitochondrial dysfunction. Moreover, cytosolic Atp5a1 binds to the plasmin 
precursor, plasmininogen, which directly decreases the level of the Aβ degrading protein, 
plasmin (Tucker et al., 2000). Therefore, decreased level of Atp5a1 causes decreased 
plasmininogen and increased plasmin, thereby enhancing the Aβ reduction effect of AO. 
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Our current study shows the cytosolic Atp5a1 level is decreased by AO injections, 
suggesting less ATP synthases are released by mitochondria. This could restore the 
oxidative phosphorylation for ATP production and increase the level of plasmin for 
further reduction of Aβ level. Consistent with this notion, Aβ levels are decreased 
dramatically by 40% in brain from AO treated SAMP8 mice (Poon et al., 2004c).  
Examination of the functional interacteome by interaction explorer ™ Pathway 
Module indicating that all the protein altered by AO treatment directly or indirectly 
interacts with actin through the interaction of NFκB or the antioxidant systems. Actin 
polymerization/depolymerization plays an important role in synaptic plasticity and 
memory consolidation (Fischer et al., 1998; Matus, 2000; Lamprecht and LeDoux, 2004), 
and disruption of the actin polymerization results in growth cone collapse (Meberg and 
Bamburg, 2000). Synapse loss is one of the neuropathological features in the brains of 
patients with AD (Bertoni-Freddari et al., 1992; Brown et al., 1998), and neuronal 
shrinkage in SAMP8 brain is also observed (Kawamata et al., 1998), suggesting actin 
polymerization in AD brains as well as SAMP8 mice brain are disrupted. The disruption 
of actin polymerization is possibly due to accumulation of Aβ through activating p38 
mitogen-activated protein kinase and increasing intracellular calcium level (Furukawa 
and Mattson, 1995; Song et al., 2002). Since these processes are both associated with 
oxidative stress (reviewed in (Floyd, 1999; Annunziato et al., 2003; Torres and Forman, 
2003)). Therefore, our study showed that decreased Aβ level can reduce Aβ-mediated 
oxidative stress by improving the antioxidant. Aβ reduction potentially also decreased the 
inflammation brought about by NFκB. These changes sequentially improve the action 
polymerization, thereby cognitive improvement. Moreover, our study show that the 
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changes of antioxidant system, NFκB and action dynamics are brought about by 
alteration of specific carbonyl level or expression of Aldo3, Prdx2, Coro2, Pro2 and 
Atp5a1 in aged SAMP8 mice brains. Consistent with others (Furukawa and Mattson, 
1995; Song et al., 2002), our study suggests that agents that can improve the dynamics of 
actin polymerization may be beneficial for AD. 
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CAHPTER TEN 
Quantitative Proteomics Analysis of Specific Protein Expression and Oxidative 
Modification in Aged Mice Brain – Insight into the Mechanism of Compensation of 
Activity Lost by Oxidative Modification 
10.1 Introduction 
 Oxidative stress is one of the most important mediators in the progressive decline 
of cellular function during aging. In the brain, free radical-mediated oxidative stress plays 
a critical role in the age-related decline of cellular function as a result of the oxidation of 
nucleic acids, lipids, and proteins, which alters the structure and function of these 
macromolecules (Beckman and Ames, 1998; Poon et al., 2004b). A number of studies 
indicate a strong role for increases in protein oxidation as a primary cause of cellular 
dysfunction observed during aging as well as in age-related neurodegenerative diseases 
(Stadtman, 1992; Butterfield and Stadtman, 1997; Butterfield and Lauderback, 2002). 
 The brain is susceptible to oxidative stress because of its high content of 
peroxidizable unsaturated fatty acids, high oxygen consumption per unit weight, high 
levels of free radical-inducing iron/ascorbate, and relatively low levels of antioxidant 
defense systems (Floyd, 1999; Poon et al., 2004a, b). In most cases, the oxidation of 
proteins, including those involved in biosynthesis, energy production, cytoskeletal 
dynamics, and signal transduction, leads to their dysfunction (Butterfield and Stadtman, 
1997). Although protein oxidation contributes to this functional decline, not all proteins 
are oxidized: many enzymes preserve their activity during aging, suggesting that specific 
proteins are targets of oxidative modification during aging and in age-related 
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neurodegenerative disorders (Stadtman, 1992; Butterfield et al., 2003; Keller et al., 2004; 
Poon et al., 2004d). 
 In the previous studies, we investigated the role of oxidative stress in brain aging 
using SAMP8 mice, an accelerated aging model with cognitive decline. In order to fully 
understand the mechanism of age-related cognitive decline, we hypothesis that the 
oxidized protein profiles in the brain of normal aging mice model is different from that in 
SAMP8 mice. To investigate our hypotheis, we have used proteomics to compare protein 
expression levels and the oxidation of specific proteins, as assessed by elevated protein 
carbonyl levels, in the brains of old vs. young C C57BL/6 mice mice (a commonly used 
normal aging mice model), and to identify the differentially expressed and oxidized 
proteins. 
10.2 Experimental Procedures 
10.2.1. Rodent Subjects 
A total of ten C57BL/6 male mice were obtained from Harlan, USA; five, from 
the National Institute on Aging Aged Rodent Colonies, were 80 weeks old (the “old” 
cohort), and five were 6 weeks old (the “young” cohort). It should be noted that at 6 
weeks of age, mice are sexually mature, so “young adult” could be equally used to 
describe these mice. All 10 mice were maintained in an animal facility at the Department 
of Laboratory Animal Research on a 12 hr light:dark cycle in Bioclean units with sterile-
filtered air and provided food and water ad libitum. All protocols were implemented in 
accordance with NIH guidelines and approved by the University of Kentucky 
Institutional Animal Care and Use Committee. The body weights of the old mice ranged 
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from 32 to 35 g and of the young mice from 19 to 24 g. Following euthanasia with CO2, 
the brain was removed quickly, weighed and snap frozen in liquid N2 prior to analysis. 
10.2.2 Sample Preparation 
 Sample preparation is the same as Section 5.2.2 
10.2.4 Two-dimensional electrophoresis  
 2D electrophoresis is the same as Section 5.2.3 
10.2.5 Western Blotting 
 Western blotting is the same as Section 5.2.4 
10.2.6 Image Analysis 
 Image analysis is the same as Section 5.2.5 
10.2.7 Trypsin digestion 
 Trypsin digestion is the same as Section 5.2.6 
10.2.8 Mass Spectrometry 
 Mass spectrometry is the same as Section 5.2.7 
10.2.9 Immunochemical Detection of Lactate Dehydrogenase (LDH2), Glutamine 
Synthase (GS) and Dynamin-1 (DNM1) 
The levels of lactate dehydrogenase 2 (LDH2) and glutamine synthase (GS) were 
measured by the Slot Blot® technique described previously (Poon et al., 2004c). Briefly, 
1 μg of protein was loaded into the slots. The proteins were detected on nitrocellulose 
paper using a primary rabbit anti-LDH antibody (1:100, Chemicon, Temecula, CA) or 
mouse anti-GS antibody (1:1000, Chemicon,) followed by an alkaline phosphatase-
conjugated secondary anti-rabbit or anti-mouse IgG antibody (Sigma, St. Louis, MO), 
respectively. Antibody binding was visualized by application of 5-bromo-4-chloro-3-
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indolyl phosphate/nitro blue tetrazolium (BCIP/NBT;Sigma-Fast) followed by 
densitometric measurement using the Scion-Image software package (Scion, Frederick, 
MD). 
For quantification of dynamin-1 (DNM1) levels, 50 μg of protein from five 
individual mice in the young and old cohorts (total of ten) were resolved by SDS-PAGE 
and transferred onto nitrocellulose paper. DNM1 was detected by a mouse anti-DNM1 
primary antibody (Chemicon) and an alkaline phosphatase-conjugated anti-mouse IgG 
secondary antibody (Sigma). The bands were developed by BCIP/NBT and quantified by 
densitometric measurement as described above.  
10.2.10 Enzyme Activity Assay 
Lactate dehydrogenase activity was determined by the method previously 
described (Stambaugh and Post, 1966). Briefly, the assay was performed in 100 μL Tris 
buffer (0.2M Tris.HCl, 30mM sodium pyruvate, 6.6mM NADH, pH 7.3). The reaction 
was initiated by adding 5 µL of the brain protein samples (2mg/mL). Lactate 
dehydrogenase activity was measured as the reduction of NADH to NAD+. A decrease in 
absorbance at 340 nm was recorded as the change in A340 min-1 by using a PowerWaveX® 
microtiter plate reader spectrophotometer (Bio-Tek Instruments, Winooki, VT). GS 
activity was determined by the method of Rowe et al. (Rowe et al., 1970) as modified by 
Miller et al. [29]. The absorbance was recorded at 505 nm as described above. 
10.2.11 Immunochemical Detection of Total Protein Carbonyl Level, β-Actin 
(ACTB) CarbonylLevel and Neurofilament 66 (NF-66) Carbonyl Level. 
Slot blots and Western blots were used to detect the level of total protein 
oxidation in the brains of young and old mice as previously described (Poon et al., 
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2004c). Briefly, total protein in the homogenates from the brains of the five young and 
five old mice was derivatized by 10mM DNPH. For slot blot detection of carbonyl levels, 
250 ng of 2,4-dinitrophenyl hydrazone (DNP)-protein adducts were loaded into each slot. 
For Western blot carbonyl detection, 30 μg of DNP-protein adducts from each animal 
were resolved on SDS-PAGE gels. The technique for the immunochemical detection of 
the DNP-protein adducts was the same for both methods and was described previously 
(Poon et al., 2004c). The quantification of the DNP-protein adducts determined by slot 
blots was as described above. The quantification of the DNP-protein adducts resolved by 
Western blotting was by densitometric measurement of the immunoreactivity in the entire 
lane on the nitrocellulose paper.  
The method used for the detection of β-actin (ACTB) carbonyl levels was similar 
to that for total protein carbonyl level detection described above. The quantification of 
the DNP-actin adduct was by densitometric measurement of the bands at 40 kDa where 
actin is predominately present. 
 Neurofilament 66 (NF-66) was derivatized by DNPH for carbonyl detection as 
described above. The carbonyl levels of NF-66 were detected by Western blot after 
immunoprecipitation (IP). IP was performed as described previously (Lauderback et al., 
2001). A mouse anti-NF-66 antibody (5 µL, Chemicon) was added directly to the brain 
homogenate, and the mixture was incubated on a rotary mixer overnight at 4°C. The NF-
66/antibody complexes were precipitated with protein G-conjugated agarose beads. 
Protein G beads were added in 50 µL aliquots from a stock of 300 mg/mL in PBS and 
mixed on a rotary mixer for 1 hour at room temperature. Beads were then centrifuged and 
washed with the washing buffer (pH 8, 50mM Tris HCl, 150 mM NaCl, 0.1% Tween 20) 
 197
three times. The NF-66 proteins from each animal were resolved by SDS-PAGE and 
transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA). The method used for 
the detection and quantification of NF-66 carbonyl levels was similar to that for total 
protein carbonyl level detection described above. 
10.2.12 Statistics 
 Statistical analysis is the same as Section 5.2.8 
 
10.3 Results 
 To assess whether there were any changes in the proteomic profile in the brains of 
aging mice, we first assayed the differential expression of proteins in the brains of young 
and old mice. We found that the expression level of 7 proteins was significantly altered (4 
proteins showed increased expression and 3 protein showed decreased expression); and 
the specific carbonyl levels of 4 proteins are significantly increased in the old mice. 
Comparing the densitometric intensities of individual spots on the gels, we 
determined that 4 proteins were expressed at significantly higher levels, and 3 proteins 
were expressed at significantly lower levels in the brains of the old compared to young 
mice. Fig. 10.1 shows representative gels from the brains of a young and old mouse after 
2D-electrophoresis. To identify the differentially expressed proteins, the mass spectra of 
the peptides were matched to the mass spectra in NCBI protein databases. The four 
proteins that were up-regulated in the brains of the old mice were identified with Moswe 
scores > 62; they were dihydropyrimidinase-like 2 (DRP2), α-enolase (ENO1), dynamin-
1 (DNM1), and lactate dehydrogenase 2 (LDH2). An example of the mass spectrum for 
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LDH2, which was significantly up-regulated in the brains of old mice, is shown in Fig. 
10.2A (top), and the results of the database search are shown in Fig. 10.2A (bottom). The 
parameters for the identification of these proteins by mass spectrometry are summarized 
in Table 10.1; all protein identifications agreed with the expected MrW and pI range 
based on their positions on the gels. The quantitative details of their relative expression 
levels in old vs. young mice are summarized in Table 10.2. None of the down-regulated 
proteins were identified with a Mowse score > 62. 
 We then investigated total protein oxidation levels and the oxidation of specific 
proteins in the brains of the old vs. young mice. The total level of oxidized proteins as 
determined by slot blots and Western blots was significantly higher (by approximately 
30-40%) in the brains of the old vs. young mice (Fig. 10.3).  Comparing the 
densitometric intensities of individual spots on the oxyblots, we determined that four 
proteins had significantly higher specific carbonyl levels in the brains of old mice 
compared to young. Fig. 10.4 shows representative oxyblots from the brains of a young 
and an old mouse. The significantly oxidized proteins were identified by matching their 
mass spectra to those in the NCBI protein databases as described above. The four 
oxidized proteins were identified; they are β-actin (ACTB), glutamine synthase (GS), 
neurofilament 66 (NF-66), and an unnamed protein. An example of the mass spectrum 
for GS is shown in Fig. 10.2B (top), and the results of the database search for GS are 
shown in Fig. 10.2B (bottom). The parameters for the identification of the oxidized 
proteins by mass spectrometry are summarized in Table 10.3; these protein identifications 
agreed with the expected MrW and pI range based on their positions on the blots. The 
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quantitative details of their relative specific carbonyl levels in old vs. young mice are 
summarized in Table 10.4. 
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 Table 10.1. Mass spectrometry identification of proteins up-regulated in the brains 
of old vs. young mice 
Protein GI accession# 
 # Peptide matches 
Identified 
% Coverage 
matched 
peptides 
pI, MrW Mowse Score* 
dihydropyrimidinase-like 2 
(DRP2) 
gi|40254595 14 35 6.16, 62.16 776 
α-enolase 
(ENO1) 
gi|19353272 17 47 6.37, 47.5 166 
dynamin-1 
(  DNM1) 
gi|21961254 22 24 7.61, 98.1 155 
lactate dehydrogenase 2 
(LDH2) 
gi|28386162 13 40 5.87, 36.6 120 
* Mowse scores greater than 62 are considered significant.  
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 Table 10.2. Identified proteins up-regulated in the brains of old vs. young mice  
Protein 
Young  
(A.U. ± SEM) 
(n = 5) 
Old 
(A.U. ± SEM) 
(n = 5) 
Fold increase in 
old  
p-value 
DRP2 
 
545 ± 175 1327 ± 221 2.4 0.024 
 
ENO1 
1761 ± 202 2589 ± 259 1.5 0.036 
  DNM1 740 ± 142 1135 ± 92 1.5 0.048 
 
LDH2 
1489 ± 372 3770 ± 286 2.5 0.0012 
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 Table 10.3.  Mass spectrometry identification of oxidized proteins in the brains of old vs. young 
mice 
Protein 
GI accession
# 
 # Peptide 
matches 
Identified 
% Coverage 
matched 
peptides 
pI, MrW 
Mowse 
Score*
β-actin 
(ACTB) 
gi|49868 13 49 5.78, 39.4 121 
glutamine synthase 
(GS) 
gi|15929291 11 26 6.64, 42.8,  93 
neurofilament 66 
(NF-66) 
gi|609535 18 37 5.49, 55.5 71 
unnamed protein gi|38089221 9 12 N/A 66 
* Mowse scores greater than 62 are considered significant.  
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 Table 10.4. Identified proteins oxidized in the brains of old vs. young 
mice 
Protein 
Young  
(A.U. ± SEM) 
Old 
(A.U. ± SEM) 
Fold increase 
in old 
p-value 
ACTB 1.25 ± 0.20 3.03 ± 0.68 3.4 0.035 
 
GS 
2.4 ± 0.56 12.0 ± 2.89 5.2 0.011 
 
NF-66 
0.70 ± 0.21 3.52 ± 1.18 7.2 0.046 
unnamed protein 0.59 ± 0.196 31.7 ± 13.3 68 0.048 
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Figure 10.1  
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Figure 10.2 
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Figure 10.3 
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Figure 10.4 
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We hypothesized that oxidative modification of specific enzymes would decrease 
their activity but that the activity of enzymes whose expression level was up-regulated 
would not necessarily be changed. To test this, we measured the activities of GS, which 
was oxidized in the brains of the old mice, and lactate dehydrogenase, the LDH2 subunit 
of which was expressed at a higher level in the brains of the old mice. First, using 
immunochemical analysis (Fig. 10.5A), we validated the proteomic results that indicated 
that the level of expression of GS was unchanged and that of LDH2 was up-regulated by 
about 20%. In support of our hypothesis, Fig 10.5B shows that the activity of GS in the 
brains of old mice was significantly lower (by about 20%) than in the brains of young 
mice. In contrast, lactate dehydrogenase activity in the brains of old mice showed no 
significant difference relative to that in the brains of the young mice.  Because the 
expression level of LDH2 increased, this suggests that there is a relatively lower activity 
per unit of lactate dehydrogenase enzymatic activity in the brains of the old mice. 
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Figure 10.5 
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 We validated our proteomics results for 3 additional proteins. With 
immunochemical detection, we demonstrated that the level of expression of DNM1 in the 
brains of old mice was significantly increased by 57% (Fig 10.6), which is in close 
agreement with the results of the proteomics analysis (Table 10.2). We also measured the 
carbonyl levels of NF-66 and ACTB by IP (NF-66) and Western blotting. Consistent with 
the proteomics results, the carbonyl levels of ACTB (Fig. 10.7) and NF-66 (Fig. 10.8) 
were significantly increased by about 40% and 50%, respectively, in the brains of the old 
mice as compared to young. The increased carbonyl level of ACTB and NF-66 in the 
brains of old mice was more robust when detected by proteomics method. The 
differences in the magnitude of fold changes of carbonyl levels between the two 
techniques is likely due to the fact that proteomics measures the carbonyl level per unit of 
protein while Western blotting measures the carbonyl level of total protein. Clearly, both 
techniques show that ACTB and NF-66 are significantly oxidatively modified in the 
brains of old mice, thus validating the proteomics results.  
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Figure 10.6 
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Figure 10.7 
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Figure 10.8 
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10.4 Discussion  
Our aim in this study was to identify differentially expressed and oxidized 
proteins in the normally aging murine brain. Using the proteomics approach previously 
utilized in our laboratories (Castegna et al., 2002b; Castegna et al., 2002a; Poon et al., 
2004d; Poon et al., 2005b; Poon et al., 2005a), we determined that the expression levels 
of DRP2, ENO1, DNM1 and LDH2 were significantly increased in the brains of old mice 
when compared to the brains of young mice. Additionally, the expression levels of 3 
proteins were significantly decreased, but these proteins could not be identified because 
their mass spectra did not match any in the databases with a significant Mowse score. 
Further, we show that the total level of protein oxidation increased in the brains of old 
mice when compared to young, and that the specific carbonyl levels of ACTB, GS, NF-
66 and an unnamed protein were significantly increased in the brains of old mice. 
Selected results were validated using immunochemistry. Additionally, we demonstrated 
that for GS, which was oxidized but not expressed at significantly different levels in the 
brains of old vs. young mice, oxidation reduced enzyme activity; in contrast, for LDH, 
whose expression level was up-regulated in the brains of old mice, enzyme activity was 
unchanged. 
DRP2, one of the four proteins whose expression was up-regulated in the brains 
of old vs. young mice, is a member of the dihydropyrimidinase-related protein family. 
These proteins are involved in axonal outgrowth and path-finding through the 
transmission and modulation of extracellular signals. It was reported that DRP2 induced 
growth cone collapse by Rho-kinase phosphorylation (Arimura et al., 2000) and by 
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binding to tubulin (Fukata et al., 2002). Decreased expression of DRP2 has been 
observed in AD, Down syndrome (Lubec et al., 1999), schizophrenia, and affective 
disorders (Johnston-Wilson et al., 2000), and DRP2 is oxidized in brains from AD 
patients (Castegna et al., 2002a). The increased expression of DRP2 in brains from old 
vs. young animals may indicate that neuronal sprouting is being positively regulated as a 
compensatory response to neuronal dysfunction in the aged brain. 
Another of the up-regulated proteins, ENO1, is the α-subunit of enolase; the αγ 
isoform is a neuron-specific enolase. We recently reported that ENO1 is up-regulated in 
the olfactory bulbs (OBs) of old mice as well (Poon et al., 2005b). Enolase is a cytosolic 
enzyme involved in metabolism, cell differentiation, and normal growth; a decline of 
enolase activity results in abnormal growth and reduced metabolism in brains (Tholey et 
al., 1982). Increased ENO1 oxidation in the brains of AD patients suggests that the loss 
of activity by oxidative modification of ENO1 may lead to neurodegeneration (Castegna 
et al., 2002a; Poon et al., 2004d), emphasizing the importance of this glycolytic enzyme 
in brain metabolism. The increased levels of ENO1 in the brains of old mice may indicate 
a compensatory response to decreased activity in other metabolic and mitochondrial 
pathways in the brains of old mice and a protective response against neurodegeneration. 
Our proteomics analysis, validated with immunochemistry, demonstrated that 
DNM1 increased in abundance in the brains of old vs. young mice. Among its functions, 
DNM1 is known to inhibit phosphatidylinositol 3-kinase (PI3K), a survival signaling 
molecule that acts via its effector, Akt (Harrison-Findik et al., 2001). Thus, through its 
inhibition of PI3K, DNM1 up-regulation may cause increased cell death in the brains of 
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old mice. Alternatively, the formation of complexes between DNM1 and the actin-
binding protein profilin at sites of synaptic vesicle recycling has been well-characterized 
(Witke et al., 1998); the significant decrease in DNM1 mRNA and protein levels in AD 
brains was interpreted to reflect its role in synaptic vesicle endocytosis. (Yao et al., 
2003). We recently reported that DNM1 protein is less abundant in the OBs of old vs. 
young mice (Poon et al., 2005b); however, because the OB is a site of on-going synaptic 
remodeling, DNM1 may be constitutively expressed at high levels, and its down-
regulation may reflect this regional specialization. Thus, the increased expression of 
DNM1 in the brains of old mice may indicate increased synaptic vesicle recycling 
associated with increased synaptic plasticity as a compensatory response to age-related 
synaptic loss such as that proposed to occur in neurodegenerative diseases (Hashimoto 
and Masliah, 2003).  
LDH2, which was also up-regulated in the brains of old mice, is a subunit of the 
enzyme lactate dehydrogenase that catalyzes the reversible NAD-dependent 
interconversion of pyruvate and lactate. In astrocytes, lactate dehydrogenase favors the 
formation of lactate over that of pyruvate; the lactate is secreted by astrocytes, taken up 
by neurons, and converted to pyruvate, which enters the Kreb’s cycle for ATP production 
(Deitmer, 2001). Lactate appears to be the main energetic compound delivered by 
astrocytes and is the only oxidizable energy substrate available to support neuronal 
recovery in the CNS (Sahlas et al., 2002). The increased expression of LDH2 in the 
brains of old mice may compensate for metabolic down-regulation in other enzyme 
systems to provide sufficient lactate and ATP for cellular processes and neuronal 
survival. 
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The proteins that were identified as being up-regulated in the brains of old mice in 
this study have also been shown to be oxidized in the brains of SAMs with cognitive 
deficit and in the brains of patients with neurodegenerative diseases and in models 
thereof (Castegna et al., 2002b; Castegna et al., 2002a; Butterfield et al., 2003; Castegna 
et al., 2003; Poon et al., 2004d). Taken together, one can speculate that the up-regulation 
of these proteins may play critical roles in the cognitive stability of aged mice without 
cognitive deficit. Results from our laboratory, as well as others, have demonstrated that 
total protein oxidation in the brain increases as a function of age (Butterfield and 
Stadtman, 1997).  Our laboratory has previously used this proteomics approach to 
identify oxidized proteins in the brains of senescence-accelerated mice and humans in 
order to gain insights into the mechanism of accelerated aging and age-related 
neurodegenerative diseases (Castegna et al., 2002b; Castegna et al., 2002a; Poon et al., 
2004d). 
ACTB, which was oxidized in the brains of old vs. young mice, is a component of 
the cytoskeletal network responsible for cell structure and motility. Actin 
polymerization/depolymerization plays an important role in synaptic plasticity in 
dendritic spines (Fischer et al., 1998; Matus, 2000), and disruption of actin 
polymerization results in growth cone collapse (Meberg and Bamburg, 2000). Decreased 
levels of actin in cultured neurons as a function of increasing age indicates that the 
oxidation of actin may accelerate its degradation (Aksenova et al., 1999a). Such an effect 
is also observed in the brains of patients with Alzheimer’s disease (AD) (Aksenov et al., 
2001). The oxidative modification of ACTB in the brains of old mice may affect actin 
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filament architecture and lead to disarrangement of the cytoskeleton, thus increasing the 
susceptibility of neurons to age-related neurodegenerative diseases. 
It is well documented that GS activity declines as a function of age (Aksenova et 
al., 1998; Farr et al., 2003). The decline in enzyme activity is caused by the alteration of 
protein structure induced by oxidative modification (Butterfield and Stadtman, 1997; 
Butterfield et al., 1999b; Castegna et al., 2002b). GS catalyzes the rapid amidation of 
glutamate to form the non-neurotoxic amino acid, glutamine. This reaction maintains the 
optimal level of glutamate and ammonia in neurons and modulates excitotoxicity. The 
results presented here confirm and extend earlier studies showing that GS is specifically 
oxidized and its activity reduced in the brains of old mice, suggesting that the glutamate-
glutamine cycle in these aged brains may be impaired (reviewed in (Butterfield and 
Stadtman, 1997)). Such an impairment would contribute to the cellular functional decline 
in aging brain. Because both GS and ACTB are also oxidized in AD brains (Aksenov et 
al., 2001; Castegna et al., 2002b), the specific oxidation of these proteins may be 
involved in the increased susceptibility of aged individuals to age-related 
neurodegenerative diseases. 
NF-66 (α-internexin), which was oxidized in the brains of old vs. young mice, is 
an intermediate filament protein that contributes to cytoskeletal organization, 
neurogenesis and neuronal architecture in the brain. Oxidation or nitration of 
neurofilament (NF) proteins transform the α-helix secondary structure to β-sheet and 
random coil conformations, destabilizing the interactions between the NF proteins and 
resulting in axonal damage (Crow et al., 1997). Binding of NF-66 by viral proteins results 
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in neurological disorders, indicating that NF-66 is critical to the proper functioning of the 
CNS (Reddy et al., 1998). 
A novel unnamed protein was also oxidized in the brains of old mice. Further 
experiments will be needed to identify this protein and determine it how its oxidation 
may impact brain function. 
In this study, we have shown that there is an altered proteomic profile in the 
brains of old mice, and we identified the proteins that were differentially expressed or 
oxidized in the brains of old vs. young mice. Our results are consistent with the free 
radical theory of aging, which proposes that increased protein oxidation occurs as a 
function of age, and that the oxidation of proteins causes cellular functional decline, thus 
increasing the susceptibility of aging brains to neurodegeneration. Interestingly, several 
of the oxidized proteins in the brains of old mice are the same as those that have been 
identified in the brains of SAMP8 mice. Our results also support the possibility that the 
expression levels of certain proteins may increase as a compensatory response to 
oxidative stress. This compensation would allow for the maintenance of proper molecular 
functions in aging brains and protection against neurodegeneration. This report is our 
initial study of age-related changes in brains of mice, and as such, forms a framework for 
future studies, including the testing of potential novel therapeutic molecules that may 
modulate the effects of oxidative stress in brain aging.  
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CHAPTER ELEVEN 
Redox Proteomics Identification and Interacteome of Oxidatively Modified 
Hippocampal Proteins in Mild Cogntive Impairment: Involvement of Energy 
Metabolsim, Neuroplasticity, and Cell Cycle Events Initation in Development of 
Alzheimer’s Disease From Mild Cogitive Impairment 
11.1 Introduction 
In previous chapters, we have example the role of oxidative stress and protein 
oxidation in aged brain and brain of age-related cognitve impairment of rodent subjects. 
In this chapter, we will investigate the role of protein oxidation in age-related cognitive 
imparment of human subjects.  
Mild cognitive impairment (MCI) is generally referred to the transitional zone 
between normal cognitive function and clinically probable Alzheimer’s disease (AD) 
(Winblad et al., 2004). Most subjects with MCI eventually develop AD, suggesting MCI 
is one of the earliest phrases in the AD development (Flicker et al., 1991; Almkvist et al., 
1998; Morris et al., 2001; Luis et al., 2003). Although a variety of criteria for defining 
MCI are used, they are essentially common that, (a) MCI was referred as the measurable 
cognitive deficits of non-demented persons, and (b) MCI represent a clinical syndrome 
that does not fulfill a diagnosis of dementia, but leads to a high risk of progressing to a 
dementia disorder (Winblad et al., 2004). When persons are diagnosed with MCI, some 
of them can progress to AD and other dementia types, but some are stable or even 
recover (Winblad et al., 2004). Moreover, neuroimaging studies by magnetic resonance 
imaging (MRI) demonstrate the atrophy of the hippocampus or entorhinal cortex in MCI 
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patients, indicating the relationships with transition of normal aging to MCI, then later to 
clinical (de Leon et al., 2004).  
 Oxidative stress plays a significant role in AD (Markesbery, 1997; Markesbery 
and Carney, 1999; Giasson et al., 2002; Zhu et al., 2004). Manifested by elevated levels 
of nucleic acid oxidation, protein oxidation and lipid peroxidation, the oxidative damages 
are the most severe in AD hippocampus, a brain region that is responsible for the 
cognitive dysfunction (Butterfield and Kanski, 2001; Butterfield and Lauderback, 2002). 
Although the role of oxidative stress play in AD development is undeniable, it remains 
unclear that whether oxidative stress is a primary event or an epiphenomenon of the AD 
development. The highest level of oxidative damages are correlated to the brains region 
that exhibit the most neuronal denegation in AD (Markesbery, 1997; Markesbery and 
Carney, 1999; Butterfield and Kanski, 2001; Butterfield and Lauderback, 2002; Giasson 
et al., 2002; Zhu et al., 2004). Moreover, oxidative stress mediating entities per se induce 
neuronal death in vitro; and protein oxidation and lipid peroxidation in the superior and 
middle temoral gyri (SMTG) of MCI patients are increased (Keller et al., 2005). All of 
these studies indicate that oxidative stress is indeed a primary event to the development 
of AD.  
 In order to gain insight of the primary role of oxidative stress in the development 
of AD from MCI, we used redox proteomics to identify the proteins that are oxidatively 
modified in the hippocampus of MIC, a condition that often precedes AD. We found that 
α-enolase (ENO1), glutamine synthetase (GLUL), pyruvate kinase M2 (PKM2) and 
peptidyl-prolyl cis/trans isomerase 1 ( PIN1) are significantly oxidized in the hippocampi 
of MCI subjects when compared to that in control.    
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11.2 Experimental procedures 
11.2.1 Human Subjects 
 The normal control subjects in this study were four females and two males, and 
the average age was 82 ± 2.6 years.  The amnestic MCI patients were four females and 
two males and the average age was 88 ± 1.5 years (Table 1).  All subjects came from our 
longitudinally followed normal control group that has annual neuropsychological testing 
and neurological and physical examinations every two years.  Control subjects had:  a) no 
cognitive complaints; b) normal cognitive test scores, especially objective memory test 
scores; c) intact ADLs; and d) normal neurologic examinations.  Amnestic MCI patients 
met the criteria described by Petersen (Petersen, R.C.,(ed) Mild Cognitive Impairment, 
Aging to Alzheimer's Disease, Oxford University Press: New York 2003) which included:  
a) a memory complaint corroborated by an informant, b) objective memory test 
impairment (age and education adjusted), c) general normal global intellectual function, 
d) intact ADLs, e) Clinical Dementia Rating score of 0.0 to 0.5, f) no dementia, and g) a 
clinical evaluation that revealed no other cause for memory decline.  
11.2 2 Neuropathology 
Hippocampal specimens were taken immediately at the time of autopsy and 
immersed in liquid nitrogen.  Immediately adjacent specimens were for immersed in 
formalin for histological and immunohistochemical evaluation.  Sections also were taken 
from the middle frontal gyrus (Broadmann area 9), superior and middle temporal gyri 
(areas 21/22), inferior parietal lobule (areas 39/40), medial occipital lobe (areas 17/18), 
anterior cingulate gyrus (area 24), posterior cingulate gyrus (area 23), hippocampus, 
entorhinal cortex, amygdala, basal ganglia, thalamus, midbrain, pons, medulla, and 
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cerebellum.  Sections were stained with H & E, the modified Bielschowsky method, and 
neocortical and medial temporal lobe structures were immunostained with 10D-5 (for 
beta amyloid peptide) and alpha-synuclein using standard methods. 
 
Neurofibrillary tangles (NFT), diffuse plaques, and neuritic plaques (NP) were 
counted in the five most involved fields using Bielschowsky-stained sections of middle 
frontal gyrus, middle temporal gyrus, inferior parietal lobule, and the posterior cingulate 
gyrus.  Similar counts were performed with Gallyas stained sections of hippocampal CA1 
and subiculum, amygdala, and entorhinal cortex.  The details of the findings of 10 MCI 
cases (6 of the present series) are given in Markesbery et al. (Arch Neurol 2005, In Press) 
 
Control subjects had Braak stage scores of II or less and only modest numbers of 
diffuse and NP.  In essence, in MCI patients NP were significantly elevated in all four 
neocortical areas and the amygdala compared to controls.  There was a significant 
increase in NFT in amygdala, entorhinal cortex, and hippocampal CA1 and subiculum 
compared to controls.  None of the MCI or control subjects had Lewy bodies.  Two of the 
MCI patients had tiny microscopic infarcts – one had five microinfarcts and another had 
one.  One patient had a single lacunar infarct.  All of these were quite small and had no 
role in the patient’s symptoms. 
11.2.3 Sample Preparation 
The hippocampal samples prepared as described in Section 5.2.2 
11.2.4 Total Protein Carbonyl level 
The protein carbonyl level is measured as described in Section 4.2.5 
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11.2.5 Two-dimensional electrophoresis  
 2D electrophoresis is the same as Section 9.2.4 
11.2.6 Western Blotting 
 Western blotting is the same as Section 9.2.5 
11.2.7 Image Analysis 
 Image analysis is the same as Section 9.2.6 
11.2.8 Trypsin digestion 
 Trypsin digestion is the same as Section 5.2.6 
11.2.9 Mass Spectrometry 
 Mass spectrometry is the same as Section 9.2.8 
11.2.10 Immunopercipitation 
 The antibodies against ENO1, GLUL, PKM2 and PIN1 are commercially 
available. The anti-ENO1 antibody (Santa Cruz Biotech. Inc., Santa Cruz, CA) is raised 
against a peptide mapping near the C-termius of human ENO1. The anti-PKM2 antibody 
(Abgent, San Diego, CA) is generated from rabbits immunized with a synthetic peptide 
selected within amino acid 100-200 of human PKM2. The anti-PIN1 antibody is raised 
against amino acid 41-163 of human PIN1.  The anti-GLUL antibody is generated in 
mice with purified GLUL from sheep brain, but reactivity against human is previously 
reported (Hensley et al., 1995c). The   Immunopercipitation was performed as described 
previously (Lauderback et al., 2001). The antibodies were added directly to the 
hippocampal homogenate, and the mixture was incubated on a rotary mixer overnight at 
4°C. The antigen/antibody complexes were precipitated with protein A-conjugated 
agarose beads if the antibodies were raised in rabbit; or protein G-conjuated agarose 
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beads are used if the antibodies were raised in goat or mouse. Agarose beads were added 
in 50 µL aliquots from a stock of 300 mg/mL in PBS and mixed on a rotary mixer for 1 
hour at room temperature. Beads were then centrifuged and washed with the washing 
buffer (pH 8, 50mM Tris HCl, 150 mM NaCl, 0.1% Tween 20) three times. The ENO1, 
GLUL, PKM2 and PIN1 from each subjects (12 total) were resolved by SDS-PAGE and 
transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA).
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11.2.11 Post-Western Blot Immunochemical Detection of Protein Carbonyl Level 
The carbonyl levels of ENO1, GLUL, PKM2 and PIN1 were detected by Post-
Western blot derivatization after immunoprecipitation (Conrad et al., 2000). Following 
the electroblotting procedure, the nitrocellulose membranes were equilibrated in 20% 
methanol for 5 minutes. Membranes were then incubated in 2N HCl for 5 minutes. The 
membranes were next incubated in 0.5mM DNPH solution exactly 5 minutes. The 
membranes were washed three times in 2N HCl and five times in 50% methanol (5 
minutes each wash). After post-Western blot derivatization, the immunochemical 
detection and quantification of carbonyl levels of GLUL, PKM2 and PIN1 were similar 
to that for total protein carbonyl level detection described above. 
11.2.12 Enzyme Activities 
 Enolase activity assay was performed as described previously (Wagner et al., 
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM 
Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a 
UV-transparent microtiter plate (Corning, MA). The enzymatic activity was determined 
by the change of absorption at A240 for 5 min. 
 Glutamine synthetase was determined by the method of Rowe et al. (Rowe et al., 
1970) as modified by Miller et al. (Miller et al., 1978). The absorbance was recorded at 
505 nm as described above. 
 Pyruvate kinase activity is determined according to Mildvan et al. (Mildvan and 
Cohn, 1965). Briefly, 95 μL of assay mixture ( 1.66mM of ADP, 0.22 mM NADH, 0.1 
mM of phosphpehoalpyruvate and 5 units lactate dehydrogenase) is added to 5 μL of the 
 227
hippocampal protein (2μg/μL). The enzymatic activity was determined by the change of 
absorption at A340 for 15 min. 
 Peptidyl-prolyl cis/trans isomerase activity was measured by a protocol from 
Kullertz et. al. (Kullertz et al., 1998). Typically, the 100 μl assay mixture consisted of 97 
μl of HEPES buffer (32mM, pH 7.8), 1μL (25mg/ml) Suc-AEPF-pNA (Bachem, 
Switzerland) and 1μL (60mg/ml) of chymotrysin solution (St Louis, MO).  , The reaction 
was started by addition of 2 μl of brain homogenate (2 mg/mL) to the assay mixture, and 
the absorbance of p-nitroaniline was followed at 395nm for 10 min. 
11.2.13 Protein Interacteome 
The functional protein interacteome was obtained by using Interaction Explorer™ 
Software PathwayAssist™  software package (Stratagene, La Jolla, CA). PathwayAssist 
is a software for functional interaction analysis. It allows for the identification and 
visualization of pathways, gene regulation networks and protein interaction maps 
(Donninger et al., 2004). The proteins are first imported as the gene symbols as a set of 
data. This data set is then searched against ResNet, a database contain over 500,000 
biological interactions built by applying the MedScan text-mining algorithms to all 
PubMed abstracts. These interactions are then visualized by building interaction networks 
with shortest-path algorithms. This process can graphically identify all known interaction 
among the proteins. The information of the function of these proteins and their relevance 
to diseases are then obtained by using the BIOBASE's Proteome BioKnowledge Library form 
Incyte Corporation (Incyte, Wilmington, DE) (Hodges et al., 2002). 
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11.2.14 Statistics 
The statistical anaylsis applied was the same as Section 4.2.8 
11.3 Results 
 In order to determine if protein oxidation occurs in the hippocampi of MCI 
subjects, the total protein carbonyl level of hippocampi of MCI is compared with that of 
control subjects. The average age and post mortem interval (PMI) of the control and MCI 
subjects were not statistically different (Figure 11.1). However, the mean brain weight of 
MCI subjects were significant lower (10%) than those of the controls (Figure 11.1). 
Moreover, the Braak stage of MCI subjects range between 1 and 2 while the MCI subject 
range between 3 and 5 (Table 11.1). This is consistent with the previous findings that 
cognitive impairment is associated with lower brain weight and more severe 
neurofibrillary pathology (Riley et al., 2005). Therefore, these control subjects are age-
matched and sex-matched (4 females and 2 male) to the MCI subjects (Table 11.1). 
 When compared to control, hippocampus of MCI show increased protein carbonyl 
level (Figure 11.2). By using redox proteomics, the oxidized proteins were separated and 
identified. Figure 11.3 shows the representative 2D gels of the hippocampi of control and 
MCI subjects. The corresponding 2D Western blots of the hippocampi of control and 
MCI are shown in Figure 11.4. Comparing the densitometric intensities of individual 
spots, we determined that four proteins were oxidatively modified in the hippocampi of 
MCI subjects when compared to that of the controls, indicated by the increased carbonyl 
level of these proteins (Table 11.2).  The fold changes of the carbonyl level of these 
proteins are shown in Figure 11.5.  
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Figure 11.1 
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Figure 11.2 
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Figure 11.3 
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Figure 11.4 
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Figure 11.5 
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Table 11.1: Profile of subjects used in this study 
 Age (years) Gender 
Brain 
Weight 
(g) 
PMI (h) Braak 
Control 1 86 Female 1300 3.75 1 
Control 2 74 Male 1400 4 1 
Control 3 86 Female 1150 1.75 1 
Control 4 90 Female 1110 4 2 
Control 5 76 Female 1315 2 1 
Control 6 79 Male 1240 1.75 2 
      
MCI 1 91 Female 1155 5 3 
MCI 2 93 Female 1050 2.75 3 
MCI 3 87 Male 1200 3.5 4 
MCI 4 87 Male 1170 2.25 3 
MCI 5 88 Female 1080 2.25 5 
MCI 6 82 Female 1075 3 3 
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 The four oxidized proteins were identified by mass spectrometry; they are ENO1, 
GLUL, PKM2 and PIN1. The mass spectra of these proteins used for identification were 
shown in Figure 11.6A, and the database search for these proteins results in a single 
identification (Figure 11.6B). The parameters for the identification of the oxidized 
proteins by mass spectrometry are summarized in Table 11.3; these protein identifications 
agreed with the expected MrW and pI range based on their positions on the 2D gels. 
To validate the proteomics results, we used traditional immunochemistry to detect 
the oxidized protein in MCI subjects. Consistent with the proteomics results, the carbonyl 
levels of ENO1, GLUL, PKM2 and PIN1 were significantly increased by about 35%, 
40%, 30% and 50%, respectively, in the hippocampi of the MCI subjects as compared to 
that of controls (Figure 11.7). The increased carbonyl levels of ENO1, GLUL, PKM2 and 
PIN1 in the hippocampi of MCI subjects were more robust when detected by proteomics 
method. The differences in the magnitude of fold changes of carbonyl levels between the 
two techniques is likely due to the fact that proteomics measures the carbonyl level per 
unit of protein while Western blotting measures the carbonyl level of total protein. 
Clearly, both techniques showed that ENO1, GLUL, PKM2 and PIN1 are oxidatively 
modified in the hippocampi of MCI subjects, thus validating our current proteomics 
results.  
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Figure 11.6 
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Figure 11.7 
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 The oxidized proteins are not only oxidatively modified, but also oxidatively 
inhibited, showing by the decreased activity of ENO1 (48%), GLUL (23%), PKM2 
(26%) and PIN1 (11%) in hippocampi of MCI subjects when compared to controls 
(Figure 11.8). These results is consistent with the notion that oxidative modification of 
proteins generally leads to its inactivation (Butterfield and Stadtman, 1997; Aksenova et 
al., 1998; Babior, 1999; Sultana and Butterfield, 2004; Poon et al., 2005c). 
 Using Pathway explorer ™ to exam the functional interaction of ENO1, GLUL, 
PKM2 and PIN1 (Figure 11.9), we found that these proteins are important to energy 
metabolism, synaptic plasticity and mitogenesis/proliferation. Moreover, they 
functionally interact with SRC, hypoxia-inducible factor 1, plasminogen (PLG), MYC, 
tissue plasminogen activator (PLAT) and BCL2L1. The information of the function of 
these proteins and their relevance to diseases are stated on Figure 11.9. 
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Figure 11.8 
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Figure 11.9 
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11.4 Disscussion 
 Since early AD involved hippocampal dysfunction (Barnes, 1988) and MCI 
precede AD (Winblad et al., 2004), investigation of oxidative stress in hippocampi of 
MCI subjects can determine if oxidative stress is a primary event  or an epiphenomenon 
in the development of AD. The current study had demonstrated that the protein oxidation 
is significant increased in the hippocampi of MCI subjects when compared to that of age- 
and sex- matched controls (Figure 11.2), suggesting that protein oxidation is important to 
the development of AD. This result is consistent with the previous study suggested that 
oxidative stress is increased in the SMTG of MCI subjects (Keller et al., 2005). It was 
well established that protein oxidation is not a random event, but rather is associated with 
increased oxidative modification of particular proteins (Castegna et al., 2002b; Castegna 
et al., 2002a; Poon et al., 2004d; Perluigi et al., 2005; Poon et al., 2005b; Poon et al., 
2005c). Therefore, we further investigate the specific proteins that are oxidatively 
modified in hippocampi of the MCI subjects by using redox proteomics. The proteins that 
are significantly oxidized in the hippocampi of MCI subjects are ENO1, GLUL, PKM2 
and PIN1 (Table 11.2). Moreover, these oxidized proteins show activity decline in the 
hippomcapi of MCI subjects (Figure 11.8). 
ENO1 is a subunit of enolase, which interconvert 2-phosphoglycerate to 
phosphoenolpyruvate. It was shown that a decline of enolase activity results in abnormal 
growth and reduced metabolism in brain (Tholey et al., 1982). PKM2 is also a glycolytic 
enzyme that converts phosphoenolpyruvate to pyruvate with phosphorylation of ADP to 
ATP. Therefore, the oxidative inactivation of ENO1 and PKM2 in the hippocampi of the 
MCI subjects could conceivably result in the reduced ATP production and alter the ATP-
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dependent process, such as signal transduction, and cell potential maintenance, thereby 
leading to neuronal dysfunction. 
It is well documented that GLUL activity declines in AD (Hensley et al., 1995c; 
Aksenov et al., 1996; Howard et al., 1996; Butterfield et al., 1997b). GLUL catalyzes the 
rapid amination of glutamate to form the non-neurotoxic amino acid, glutamine. This 
reaction maintains the optimal level of glutamate and ammonia in neurons and modulates 
excitotoxicity, and glutamate receptors is important to neuroplasticity (Lamprecht and 
LeDoux, 2004). Therefore, oxidative inactivation of GLUL suggests the glutamate-
glutamine cycle in hippocampi of MCI subject was impaired, which may contribute to the 
glutamate dysregulation, and impairment neuroplasticity during the development of AD 
(Lee et al., 2002).  
PIN1 is a chaperone enzyme that reversibly alters the conformation of proteins 
from cis to trans between a given amino acid and a proline (Schutkowski et al., 1998). 
PIN1 recognizes phosphorylated Ser-Pro and phosphorylated Thr-Pro motifs in proteins, 
and thereby, binds to many cell cycle regulating proteins and tau protein. PIN1 is 
colocalized with phosphorylated tau and also shows an inverse relationship to the 
expression of tau in AD brains (Holzer et al., 2002; Kurt et al., 2003; Ramakrishnan et 
al., 2003). Moreover, PIN1 is oxidatively inhibited in AD brain (Sultana et al., 2005), and 
is able to restore the function of tau protein in AD (Lu et al., 1999). Therefore, our 
current study show that oxidative inactivation of PIN1 in the hippocampi of MCI subjects 
could be one of the initial events that trigger tangle formation, oxidative damage as well 
as cell cycle events in AD brains. 
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Examination of the interacteome of ENO1, GLUL, PKM2 and PIN1 indicates that 
they functionally interact with SRC, PLG, MYC, PLAT BCL2L1 (Figure 9). ENO1, 
PKM2 and GLUL are involved in energy metabolism since they are interacting with 
glucose during glycolysis and glutamine metabolism. Therefore, alteration of this 
proteins could eventually lead to impaired brain energy metabolism, a common feature 
that is shared by both AD and MCI subjects (Messier and Gagnon, 1996; Cao et al., 
2003). ENO1, PIN1, GLUL and BCL2L1 are involved in mitogenesis, proliferation and 
apotosis. Therefore, the alteration of these proteins in our study support the notion that 
cell cycle events initiate the apoptosis in neuronal cells (Herrup et al., 2004). Moreover, 
ENO1, PKM2, SRC, MYC, and hypoxia-inducible factor 1 are involved in RNA 
elongation and MAP kinase pathway. These processes are important to signal 
transduction and protein synthesis, two essential process of neuroplasticity and memory 
formation (Lamprecht and LeDoux, 2004). Therefore, our current study suggests that 
alteration of these proteins may contribute to the cognitive impairment in MCI subject. 
Two other proteins that interact with ENO1, GLUL, PKM2 and PIN1 are PLG and 
PLAT. PLAT converts inactive PLG to plasmin that degrade amyloid β (Aβ), the major 
component of senile plaque (Tucker et al., 2000). Since PLG and PLAT interact with the 
protein identified in this study, one can speculate that the oxidative modification of these 
proteins in the hippocampi of MCI subjects may initiate the Aβ accumulation, thereby 
leading to the development of AD. 
Compared the oxidized protein profiles of MCI subjects to that of AD, we see 
ENO1, GLUL and PIN1 overlap in two of these oxidized protein profiles (Figure 11.10). 
This suggests that oxidative inactivation of ENO1, GLUL and PIN1 alter the cellular 
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processes these proteins are involved, such as energy metabolism, 
mitogenesis/proliferation and neuroplasticity. Impaired brain energy metabolism is 
reported in both MCI and AD subjects (Messier and Gagnon, 1996; Cao et al., 2003); 
mitogenesis mediated cell cycle events in MCI subjects precede the neuronal death in AD 
(Yang et al., 2003); and decline of neuroplasiticity is suggested to correlated with the 
development of AD from MCI (Ikonomovic et al., 2003). Therefore, our current study 
not only demonstrate that protein oxidation play a significant role in the development of 
AD from MCI, but also indicates that the oxidative inactivation of ENO1, GLUL, PKM2 
and PIN1 is involved in the progression of AD from MCI, possible through impaired 
energy metabolism, triggering abnormal cell cycle events and neuroplasticity decline. 
Therefore, this study provides a framework for future studies for the development of AD 
from MCI at molecular level.  
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Figure 11.10 
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CHAPTER TWELVE 
Conclusions and Future Studies 
12.1 Conclusions 
In this desertation, we have demonstrated that increased oxidative stress in brain 
play a significant role in age-related cognitive impairment in SAMP8 mice. Moreover, 
such increased oxidative stress leads to specific protein oxidation in the brain of cognitive 
impaired subject, thereby leading to cognitive function impairment in SAMP8 mice. 
These proteins are lactate dehydrogenase 2 (LDH-2), dihydropyrimidinase-like 2(DRP-
2), α-spectrin and creatine kinase (CK). Moreover, the altered expression of 
neurofilament triplet L protein (NF-L), lactate dehydrogenase (LDH-2), heat shock 
protein 86 (HSP86), α-spectrin, and triosephosphate isomerase (TPI) may also contribute 
to the cognitive sfunctions in aged SAMP8 mice.  
Additionally, LA injection and reduce Aβ level using AO against APP reduces 
oxidative stress in aged SAMP8 mice brain, thereby improve their learning and memory. 
This desertation demonstrated that the improve learning and memory in aged SAMP8 
treated with LA are possibly due to the reduced oxidation of LDH-2, DRP-2, and α-
enolase and/or altearted expression of NF-L, α-enolase, and ubiquitous mitochondrial 
creatine kinase.  Morover, the expression level of α-ATP synthase (Atp5a1) abd profilin 
2 (Pro-2) was significantly altered in brains of aged SAMP8 mice treated with AO 
against APP. The oxidative modification of aldoase 3 (Aldo3), coronin 1a (Coro1a) and 
peroxiredoxin 2 (Prdx2) are also significantly decreased. These studies in this desertation 
indicate that the functional alterations of these proteins may leads to impaired 
metabolism, decline antioxidant system, and damaged synaptic communication. 
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Ultimately, impairment of these processes lead to neuronal damages and cognitive 
decline.  
 This desertation also show that the expression levels of dihydropyrimidinase-like 
2 (DRP2), α-enolase (ENO1), dynamin-1 (DNM1), and lactate dehydrogenase 2 (LDH2) 
were significantly increased in the normally aged brains, and the oxidation of β-actin 
(ACTB), glutamine synthase (GS), and neurofilament 66 (NF-66) were significantly 
increased. Several of the up-regulated and oxidized proteins in the brains of normal aging 
mice identified are known to be oxidized in neurodegenerative diseases as well, 
suggesting that the expression levels of certain proteins may increase as a compensatory 
response to oxidative stress. This compensation would allow for the maintenance of 
proper molecular functions in aging brains and protection against neurodegeneration. 
 In the hippomcapus of human subjects with MCI, protein oxidation is increased 
and these oxidized proteins are α-enolase (ENO1), glutamine synthetase (GLUL), 
pyruvate kinase M2 (PKM2) and peptidyl-prolyl cis/trans isomerase 1 ( PIN1) when 
compared to age-matched and sex matched controls. This is consistent of the hypothesis 
of this desertation that increased oxidative stress leads to specific protein oxidation in the 
brain of cognitive impaired subject, thereby leading to cognitive function impairment. 
Moreover, the oxidative inactivation of ENO1, GLUL, PKM2 and PIN1 is the primary 
event, not epiphonomone, of the progression of AD from MCI. 
12.2 Future Studies 
 Based on the results of this desertation, the following experiments maybe 
explored to furter understand the role of oxidative stress in aging and age-related: 
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1. Other forms of oxidative modification of proteins, such as HNE and 3-NT, should 
also be investigated in the brains of age-related cognitive decline subjects. 
2. Mass spectrometry can reveal the amino acids that are oxidatively modified. This 
information can indicate the structural changes of the oxidized proteins. 
3. Ex vivo oxidative stress in neuronal culture or synaptosome, using proteomics to 
exam the proteins with increased expression. Also, since glutatione is one of the 
system to determine the oxidative stress response, indentified the glutationated 
proteins can gain insight into the compensatory response. 
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Appendix A 
Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-
synuclein transgenic Mice - a model of familial Parkinson's disease 
A1. Introduction 
 Parkinson’s disease (PD) is the second most common neurodegenerative disorder, 
approximately 1% of the population by age 65 is affected with PD (Eriksen et al., 2003). 
Loss of dopaminergic neurons in the substantia nigra compacta results in clinical 
symptoms of PD, such as bradykinesia, resting tremor, cogwheel rigidity, and postural 
instability.  Although the majority of PD is sporadic, approximately 10% of PD are 
familial cases (Giasson and Lee, 2003). Mutations in α-synuclein, parkin, DJ-1 and 
PINK1 are all linked to early onset familial PD (Dawson and Dawson, 2003). In the case 
of α-synuclein, 4 different mutations have been identified in kindreds associated with 
familial PD:  A53T, A30P, E46A and genomic duplication (Polymeropoulos et al., 1997; 
Kruger et al., 1998).  
 Oxidative damage is a prominent pathological change in PD brains (Yoritaka et 
al., 1996; Alam et al., 1997; Floor and Wetzel, 1998).  Free radicals produced by 
autoxidation of dopamine, semiquinone formation, decreasd of antioxidant system, 
increased iron level, and polymerization of protein are all thought to contribute to the 
oxidative stress, although other stresses might also contribute to the oxidative stress 
associated with PD (Adams et al., 1972; Tse et al., 1976; Graham, 1978; Spina and 
Cohen, 1988; Youdim et al., 1989; Ostrerova-Golts et al., 2000). Toxicity associated with 
this reaction is exacerbated by over-expression of wild type or mutant α-synuclein 
(Jenner, 2003).  All of these factors might contribute to the oxidative changes observed in 
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brains of subjects with PD.  Increasing evidence suggests that oxidative stress in PD 
might also be linked to mitochondrial dysfunction, excitotoxicity, and the toxic effects of 
nitric oxide, all of which are believed to be associated with cell death in PD brains (Alam 
et al., 1997; Floor and Wetzel, 1998). Although the relationships of oxidative stress to PD 
are still unknown, basal protein oxidation is high in the substantia nigra of PD patients, 
and the levels of reactive carbonyls are increased in PD brains (Goedert, 2001).  
Together, these data suggest that oxidative stress contributes significantly to the 
pathophysiology of PD. 
 Wild-type α-synucleins can bind to lipid membranes, inhibit enzymes such as 
phospholipase D2, protein kinase C and the dopamine transporter (Reviewed in (Kohno 
et al., 2004) as well as induce brain-derived neurotrophic factor (BDNF).  The A53T and 
A30P mutant forms of α-synucleins do not induce BDNF (Ostrerova et al., 1999; Souza 
et al., 2000). α-Synuclein shares physical and functional homology with chaperone 
protein 14-3-3 and has chaperone functions (Lee et al., 2001).  Taken together,these 
studies suggest that α-synuclein is neuroprotective. However, the effects of α-synuclein 
depend on the experimental conditions.  α-Synuclein has a strong tendency to aggregate, 
and most studies suggest that the accumulation of aggregated α-synuclein is toxic. 
Expression of mutant α-synuclein cells produces increased levels of 8-hydroxyguanine, 
protein carbonyls, lipid peroxidation and 3-nitrotyrosine, and markedly accelerated cell 
death in response to oxidative insult (Li et al., 2001b, 2002). These studies suggest that 
accelerated aggregation of mutant α-synucleins stimulates oxidative stress by loss of 
protective effect of the soluble α-synuclein (Kahle et al., 2000; Neumann et al., 2002). In 
order to gain insight into the mechanism(s) by which loss of antioxidant ability caused by 
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overexpression of A30P mutant α-synuclein leads to cell death, we used proteomics to 
identify the brain proteins that are significantly oxidatively modified in symptomatic 
mice with overexpression of a A30P mutation in α-synuclein compared to the brain 
proteins from the non-transgenic mice.  
A2 Experimental procedures  
Animals 
The animals used in this study were previously described. (Sahara et al., 2002). 
The mice develop symptoms between 6-14 months.  The symptoms begin with a tremor 
and progress to an end-stage phenotype characterized by muscular rigidity, postural 
instability and ultimately paralysis. Mice that progressed to end stage symptoms were 
sacrificed by cervical dislocation and their brains hemi-sectioned.  Non-transgenic 
control mice were C57Bl/6 mice, and were also sacrificed at the same time as the 
symptomatic transgenic mice. 
Sample Preparation 
Brain tissue extraction was performed as previously described by Sahara et al. (Poon et 
al., 2004e) with minor modifications.  Left hemi-brains were weighed and homogenized 
in 3 volumes of TBS (TBS, pH 7.4, 1 mM EDTA, 5mM sodium pyrophosphate, 30 mM 
glycerol 2-phosphate, 30 mM sodium fluoride, 1 mM EDTA) containing a protease 
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO).  Protein content was determined via 
the BCA method.    
Two-dimensional gel electrophoresis  
Samples of the proteins in the whole brains were prepared as previously described 
(Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10 ReadyStrip™ 
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IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing. The focused IEF strip was 
stored at –80oC until second dimension electrophoresis was performed. 
For second dimension electrophoresis, Linear Gradient (8-16%) Precast criterion 
Tris-HCl gels (Bio-Rad) were used to separate proteins according to their molecular 
weight (MrW). Precision ProteinTM Standards (Bio-Rad) were run along with the 
samples. 
After electrophoresis, the gel was incubated in fixing solution for 20 min. Sypro 
Ruby stain was used to stain the gel for 2 hours. The gels were placed in deionized water 
overnight for destaining. 
Western Blotting 
 Western blotting for 2D gels was performed as previously described (Poon et al., 
2004e). 200μg of the brain protein were incubated with 2,4-dinitrophenyl hydrazine 
(DNPH) at room temperature (25°C) for 20 min. The gels were prepared in the same 
manner as for 2D-electrophoresis. The proteins from the second dimension 
electrophoresis gels were transferred onto nitrocellulose paper (Bio-Rad) using a 
Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hrs. The 2,4-
dinitrophenylhydrazone (DNP) adducts of the carbonyls of the brain proteins were 
detected immunochemically. 
Image Analysis 
 The gels and nitrocellulose blots were scanned and saved in TIF format using a 
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard), 
respectively. PDQuest (Bio-Rad) was used for matching and analysis of visualized 
protein spots among differential gels and oxyblots.   
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Statistics 
The data of specific carbonyl level (intensity of carbonyl level divided by the 
intensity of protein level of an individual spot) of 6 animals per groups  (6 in control 
group and 6 in A30P group) were analyzed by Student's t test. A value of p < 0.05 was 
considered statistically significant. Only the proteins that are considered significantly 
different by Student’s t-test were selected for identification. 
Trypsin digestion 
Samples were digested using the techniques previously described (Poon et al., 
2004e). Briefly, the selected protein spots were excised. The gel pieces were digested 
with 20 ng/µl modified trypsin (Promega, WI) in 25 mM NH4HCO3 with the minimal 
volume to cover the gel pieces. The gel pieces were chopped into smaller pieces and 
incubated at 37°C overnight in a shaking incubator. 
Mass Spectrometry 
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast 
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and 
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in 
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z 
2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for protein 
identification from tryptic fragments were searched against the NCBI protein databases 
using the MASCOT search engine (http://www.matrixscience.com).  Peptide mass 
fingerprinting used the assumption that peptides are monoisotopic, oxidized at 
methionine residues and carbamidomethylated at cysteine residues (Zewe and Fromm, 
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1965; Stambaugh and Post, 1966).  Up to 1 missed trypsin cleavage was allowed. Mass 
tolerance of 150 ppm was the window of error allowed for matching the peptide mass 
values. 
Enzyme Activity assay 
 Lactate dehydrogenase (LDH) enzymatic activity was determined by the method 
previously described (Poon et al., 2005). Briefly, the assay for the enzyme activity of 
LDH was performed in 100 μL Tris buffer (0.2M Tris.HCl, 30mM sodium pyruvate, 
6.6mM NADH, pH 7.3). The reaction was initiated by adding 5 µL of the samples 
(2mg/mL). LDH activity was measured as the reduction of NADH to NAD+. A decrease 
in absorbance at 340 nm was recorded as change in A340 min-1 by using a PowerWaveX® 
microtiter plated UV-VIS spectrophotometer (Bio-Tek Instruments, Winooki, VT). 
 Enolase activity assay was performed as described previously (Wagner et al., 
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM 
Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a UV-
transparent microtiter plate (Corning, MA). The enzymatic activity was determined by the 
change of absorption at A240 for 5 min. 
 Carbonic anhydrase activity is measured according to Anderson (Andersson et al., 
1972) with modification.  Briefly, a CO2 saturated Tris buffer (pH 8.3, 0.2M Tis-HCl, 
phenol red), decrease absorbance at 560nm is record upon addition of 5μL of the 
2mg/mL samples. The maximum changes of absorbance are recorded. 
A3 Results 
 We used a parallel approach to investigate the effect of an A30P α-synuclein 
mutation on specific protein oxidation. Fig. A1 shows representative 2D-electrophoresis 
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gels of brains homogenates from symptomatic A30P α-synuclein transgenic mice (A30P) 
and non-transgenic mice after Sypro Ruby staining.  Fig. A2 shows representative 2D 
western blots of the brains of symptomatic non-transgenic mouse and symptomatic 
A30P-α-synuclein transgenic mice.  The specific carbonyl levels indicate the carbonyl 
level per unit mass of protein (Table A1). 
In comparison to wild-type mice, three proteins in the brains of A30P α-synuclein 
transgenic mice were found to have significantly higher specific carbonyl levels. Only the 
specific carbonyl level of proteins that are different statistically were identified and 
reported here. These proteins were identified as carbonic anhydrase 2 (Car2), alpha-
enolase (Eno1) and lactate dehydrogenase 2 (Ldh2). Prior results suggest that the 
accuracy of protein identification by mass spectrometry is equivalent to immunochemical 
identification (Conway et al., 1998; Narhi et al., 1999; Li et al., 2001b, 2002). The 
specific carbonyl levels of these proteins are summarized in Table A1. The summary of 
the mass spectrometry results for the proteins is listed in Table A2.   
Oxidative modification of brain proteins leads to loss of their activity (Hensley et 
al., 1995a; Butterfield et al., 1997; Lauderback et al., 2001). To determine if these 
proteomic identified oxidatively modified brains proteins in the A30P α-synuclein mouse 
were dysfunctional, their enzymatic activities were analyzed. The activities of these 
enzymes in the A30P α-synuclein transgenic mice were significantly decreased when 
compared to the brain proteins from non-transgenic control (Fig A3). 
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Table A1: Specific carbonyl level of oxidized proteins in A30P-α synuclein mice 
Proteomics Identified Protein Wild-type Mice (A.U.± S.E.M.) 
(n=6) 
A30P-α synuclein 
Transgenic Mice  
(n = 6) 
p value 
Carbonic anhydrase 2 (Car2) 0.92±0.19 2.22±0.59 < 0.05 
alpha-enolase (Eno1) 0.51±0.09 0.93±0.17 < 0.05 
Lactate dehydrogenase 2 
(Ldh2) 
0.29±0.18 1.73±0.63 < 0.05 
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Table A2: Summary of proteins identified by mass spectrometry 
Identified Protein gi accession # 
# Peptides 
matched
 
% Coverage 
of  matched 
peptides 
pI, MrW 
(kD) 
Mowse 
Score 
Probability 
of a random 
identification 
Carbonic anhydrase 2 
(Car2) 
gi|33243954 9 30 6.52, 29.1 75 3.16 x 10-8
alpha-enolase (Eno1) gi|13637776 23 61 6.37, 47.4 208 1.58 x 10-21
lactate dehydrogenase 
2 (Ldh2) 
gi|6678674 11 36 5.7, 36.8 103 5.0 x 10-11
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Figure A1 
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Figure A2 
 
 263
Figure A3 
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A4 Discussion 
A30P mutation accelerates synuclein aggregation (Lee et al., 2001),. Cell in 
which mutant α-synuclein is overexpressed have increased vulnerability to oxidative 
insult (Lee et al., 2001). Taken together, these result suggest α-synuclein aggregation 
mediated oxidative stress is increased in the mutant (Neumann et al., 2002). Consistent 
with this notion, the aggregation of α-synuclein occurs in parallel with symptoms in 
A30P α-synuclein transgenic mice (Kahle et al., 2001; Giasson et al., 2002).  Also, 
transgenic mice over-expressing α-synuclein develop an age dependent-accumulation of 
α-synuclein in neurons of the brain stem (Chesler and Kaila, 1992; Deitmer and Rose, 
1996; Tong and Chesler, 1999), suggesting the α-synuclein aggregation associated 
oxidative stress is involved in the pathology in the A30P α-synuclein transgenic mice.  
 Car2 is a Zn2+ metallo-enzyme that catalyzes reversible hydration of carbon 
dioxide (CO2) to bicarbonate (HCO3-). Glia use this process to govern the pH shift 
associated with normal neuroactivity (Heck et al., 1994; Shah et al., 2000). Since the 
extracellular pH shift affects normal and pathological brain functions, dysfunction of 
Car2 usually results in neuronal abnormalities. BLAST alignments of Car2 with proteins 
from M. musculus shows high (68%) similarity in amino acid level to the mitochondrial 
counterpart carbonic anhydrase 5a (Car5a) and 5b (Car5b). One can speculate that they 
may couple or interact with each other to function in metabolic process, cellular 
transport, gluconeogenesis and mitochondrial metabolism (Bittar et al., 1996). Our study 
shows that Car2 is significantly oxidized in A30P α-synuclein mice and its activity is 
significantly decreased, suggesting its inactivation may lead to loss of the buffering 
system in brains with resulting in aggregation of synuclein and neurodegeneration.  
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Ldh2 is a subunit of lactate dehydrogenase (LDH). LDH is a glycolytic protein 
that catalyzes the reversible NAD-dependent interconversion of pyruvate to lactate. LDH 
isoform 5 (LDH-5) in astrocytes favors the formation of lactate (Brooks et al., 1999). 
Also, LDH-5 is more abundant in mitochondria than elsewhere in cells (Kasischke et al., 
2004), indicating that lactate is the predominant monocarboxylate oxidized by 
mitochondria for intracellular lactate transport (Giege et al., 2003). Here we show that 
Ldh2 is significantly modified and inactivated by oxidative insults in A30P α-synuclein 
transgenic mice brains, suggesting oxidative inactivation of LDH may contribute to 
mitochondrial dysfunction in PD patients.  
Eno1 is a subunit of enolase that interconverts 2-phosphoglycerate and 
phosphoenolpyruvate during glycolysis. The loss of the mitochondrial constituent (α-
ketoglutarate dehydrogenase complex, KGDHC)-enriched cells is proportional to the 
total loss of immunoreactivity to neuronal specific enolase (NSE),  indicating that enolase 
not only is involved in metabolism, but also in cell differentiation, normal growth and 
mitochondrial function. Moreover, enolase and other glycolytic enzymes were identified 
in an intermembrane space/outer mitochondrial membrane fraction (Schapira et al., 1998; 
Schapira, 2001; Sherer et al., 2002), suggesting glycolytic enzymes are associated with 
proper mitochondrial function. We show here that the specific carbonyl level of Eno1 is 
significantly increased and its activity is decreased in brains from A30P α-synuclein 
transgenic mice compared to that of non-transgenic mice, suggesting this oxidative 
inactivation may alter normal glycolysis and mitochondrial function in brains and 
contribute to the alteration of energy metabolism in PD. 
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The striking feature of Ldh2, Eno1 (possibly Car2) is that they are all associated 
with mitochondrial function. Oxidative inactivation of Car2 can cause the accumulation 
of CO2 and pH shift in neurons, which possibly leads to alteration of mitochondria 
potential and mitochondrial deficits. Increasing data implicate mitochondrial decrements 
and oxidation in PD (Ferrante et al., 1999; Pennathur et al., 1999; Sherer et al., 2003a; 
Sherer et al., 2003b). Also, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 
rotenone target the mitochondria with increased oxidative modification of proteins and α-
synuclein aggregation (Canet-Aviles et al., 2004; Palacino et al., 2004; Valente et al., 
2004).  Moreover, DJ-1, PINK1 and parkin all appear to modulate mitochondrial function 
(Bouyer et al., 1984; Mizuno et al., 1989; Parker et al., 1989; Shoffner et al., 1991; 
Benecke et al., 1993; Marey-Semper et al., 1993; Zeevalk et al., 1995; Zeevalk et al., 
1997).  The observation that each of the brain protein is involved in oxidative stress in 
A30P synuclein mice and each is associated with mitochondria is consistent with the 
mitochondrial hypothesis for PD and implicates mitochondrial pathology in toxicity 
associated with aggregated synuclein. 
Since impairment of energy production and mitochondrial dysfunction leads to 
neurodegeneration reminiscent of PD both in in vitro and in vivo studies, our current 
study suggests that the oxidative stress mediated impaired energy metabolism and 
mitochondrial dysfunction may be responsible, at least partially, for the 
neurodegeneration in the brains of A30P α-synuclein transgenic mice. Furthermore, this 
oxidative stress mediated impaired energy metabolism and mitochondrial dysfunction is 
brought about through the oxidative inactivation of Eno1, Ldh2 and Car2. We conclude, 
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therefore, that the mitochondria dysfunction and impaired metabolism in familial PD may 
be associated with the oxidative inactivation of Eno1, Ldh2 and Car2. 
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Appendix B 
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 
transgenic mice-a model of familial amyotrophic lateral sclerosis 
B1 Introduction: 
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron degenerative disease 
characterized by the loss of neuronal function in motor cortex, brainstem and spinal cord. 
ALS typically presents at middle age and progress rapidly. Life expectancy of victims of 
ALS usually are 3 -5 years after diagnosis (Cudkowicz et al., 1997; Orrell, 2000). 
Inherited ALS accounts for 10-15% of cases, and among all of the familial ALS (FALS) 
patients, 20-30% of them are caused by gain of-function mutations in Cu,Zn-superoxide 
dismutase (SOD1) (Deng et al., 1993; Rosen et al., 1993). SOD1 catalyzes the 
disproportionation of superoxide anion radical (O2•-) to hydrogen peroxide and oxygen. 
Over 100 different missense substitutions in the 153-amino-acid SOD1 (mSOD) have 
been described in individuals and kindreds affected by SOD1-linked FALS 
(www.alsod.org, 2000-2002). One of the most common mutations of SOD1 is the 
substitution of glycine by alanine at residue 93 (G93A) (Orrell, 2000).  
 Two principal of hypotheses have been proposed to explain the toxic gain of 
function of mutant SOD (mSOD) (Liochev and Fridovich, 2003). One is that mSOD can 
directly promote reactive oxygen species (ROS) and reactive nitrogen species (RNS) 
generation (Beckman et al., 1993; Lyons et al., 1996; Wiedau-Pazos et al., 1996; Yim et 
al., 1996; Crow et al., 1997; Yim et al., 1997). Evidence supporting this hypothesis 
showed that mSODs enhance oxidative activity by acting as peroxidases (Wiedau-Pazos 
et al., 1996; Yim et al., 1996; Valentine, 2002), superoxide reductases (Liochev and 
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Fridovich, 2000) or producing O2- to form peroxynitrite (ONOO-) (Estevez et al., 1999; 
Beckman et al., 2001). The second hypothesis is that mSODs are prone to aggregation 
due to their instability or association with other proteins (Durham et al., 1997; Cleveland 
and Liu, 2000; Julien, 2001; Okado-Matsumoto and Fridovich, 2002). These aggregates 
facilitate toxicity (Bruijn et al., 1998; Johnston et al., 2000) and deplete the mSOD-
associated proteins and thus perturb the normal functions of cells (Liochev and Fridovich, 
2003). The proteinaceous inclusion found in tissues from ALS patient (Shibata et al., 
1994; Matsumoto et al., 1996; Shibata et al., 1996) and mSOD transgenic mice (Bruijn et 
al., 1997; Bruijn et al., 1998) reportedly are rich in mSOD1, ubiquitin and neurofilament 
proteins. It is noteworthy that the hypotheses of oxidative stress and protein aggregation 
are not mutually exclusive (Butterfield and Kanski, 2002), although the roles of oxidative 
stress and aggregation in ALS are highly controversial (recently reviewed in (Cleveland 
and Liu, 2000; Cleveland and Rothstein, 2001; Bruijn et al., 2004)).  
Increased oxidative modification of macromolecules was demonstrated in 
neuronal tissues of SOD1-related FALS patients and transgenic mice (Ferrante et al., 
1997; Andrus et al., 1998; Hall et al., 1998). Enhanced susceptibility of exogenous 
oxidative stress in mSOD1 cell cultures was also observed in in-vitro studies (Mena et al., 
1997; Aguirre et al., 1998; Gabbianelli et al., 1999). Exogenous oxidative stress can even 
inhibit the rapid degradation of mSOD (Oeda et al., 2001). These studies are consistent 
with the notion that oxidative stress plays an important role in ALS development. G93A-
SOD1 transgenic mice show significant increased protein carbonyl levels in their spinal 
cord from 2 months to 4 months (Andrus et al., 1998) and eventually develop motor 
neuron disease and die within 5-6 months (Gurney et al., 1994). G93A-SOD1 catalyzes 
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the oxidation of a model substrate by H2O2 at a higher rate (Wiedau-Pazos et al., 1996) 
and has a higher capacity to generate free radicals (Yim et al., 1996) when compared to 
wild –type SOD1. Also, elevation of imflammation-related genes (i.e., induced nitric 
oxide synthase; proinflammatory cytokines, etc.) occurred at 11 weeks of age in the 
presymptomatic stage prior to motor neuron death in G93A-SOD1 transgenic mice, 
suggesting that neuroimflammation-mediated oxidative stress is also present in G93A-
SOD1 mice (Hensley et al., 2003). Therefore, the expression of G93A-SOD1 is believed 
to elevate the generation of oxygen radicals in vulnerable tissue, such as spinal cord (Gu 
and Ihara, 2000), creating oxidative stress that may be responsible for the ALS-like 
syndrome observed in the G93A-SOD1 mice. One of the oxidatively modified proteins in 
G93A-SOD1 transgenic mice is SOD1 (Andrus et al., 1998), indicating that oxidization 
of SOD1 is likely important to the development of the this model of ALS. However, 
other oxidatively modified proteins were not identified. Recent quantitative proteomic 
studies enabled the identification of oxidized protein in Alzheimer’s disease (AD) 
patients and models thereof (Butterfield et al., 2003; Butterfield and Castegna, 2003; 
Butterfield, 2004) and provided important insights of the role of protein oxidation in AD. 
In order to better understand the role of oxidative modification of proteins in ALS, we 
employed quantitative redox proteomic analysis to identify the specific oxidized proteins 
in the spinal cord of G93A-SOD1 mice. 
B2 Experimental procedures 
Animals 
Transgenic mice expressing the human SOD1 gene with a G93A mutation strain 
B6SJL/TgN (SOD1-G93A)-2Gur) (Gurney et al., 1994) were purchased from the Jackson 
 271
Laboratory (Bar Harbor, ME, USA) and maintained as hemizygotes by mating transgenic 
males with B6/SJLF1 females as previously described (Hensley et al., 2002).  
All studies of live animals were authorized and overseen by the Institutional 
Animal Care and Use Committee (IACUC) of the Oklahoma Medical Research 
Foundation, and conducted by trained and certified technical and veterinarian staff. Every 
effort was made to avoid unnecessary discomfort to the experimental animals. 
Sample Preparation 
 Whole frozen mouse spinal cords (n=6) were homogenized in 10 mM sodium 
acetate buffer pH 7.2 containing 0.1% triton X-100 and mammalian protease inhibitor 
cocktail (Sigma Chemical, St Louis, MO, USA). 
Two-dimensional (2D) gel electrophoresis  
Samples of spinal cord proteins were prepared according to the procedure 
previously described (Poon et al., 2004e). Briefly, 300μg of protein were incubated with 
4 volumes of 2N HCl at room temperature (25°C) for 20min. Proteins were then 
precipitated by addition of ice-cold 100% trichloroacetic acid (TCA) to obtain a final 
concentration of 15% TCA. The samples were then mixed with 185μL of rehydration 
buffer (8 M urea, 20mM dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea 
and bromophenol blue).  
In first-dimension electrophoresis, 200 µL of sample solution were applied to a 
ReadyStrip™ IPG strip (Bio-Rad). The strip was then actively rehydrated in protean IEF 
cell (Bio-Rad) for 16 hours at 50V. The focused IEF strip was stored at –80oC until 
second dimension electrophoresis was performed.  For second dimension electrophoresis, 
thawed IPG® Strips pH 3-10 were equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) 
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containing 6M urea, 1% (w/v) sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and 
0.5% dithiothreitol, and then re-equilibrated for 15 min in the same buffer containing 
4.5% iodacetamide in place of dithiothreitol. Linear Gradient (8-16%) Precast Criterion 
Tris-HCl gels (Bio-Rad) were used to perform second dimension electrophoresis. 
Precision ProteinTM Standards (Bio-Rad) were run along with the sample at 200V for 65 
min. The protein level on the 2D gels were detected by Bio-Safe Coomassie blue (Bi-
Rad). 
Western Blotting 
 As previously described (Poon et al., 2004e), 300μg of protein were incubated 
with 2,4-dinitrophenyl hydrazine (DNPH). The 2D gels were prepared in the same 
manner as 2D-electrophoresis. The proteins from the 2D gels were then transferred to 
nitrocellulose paper (Bio-Rad) and detected immunochemically. 
Image Analysis 
The gels and nitrocellulose blots were scanned and saved in TIF format using a 
Scanjet 3300C (Hewlett Packard). Investigator HT analyzer (Genomic Solutions Inc., 
Ann Arbor, MI) was used for matching and analysis of visualized protein spots among 
differential gels and oxyblots.  The average mode of background subtraction was used to 
normalize intensity values, which represents the amount of protein (total protein on gel 
and oxidized protein on oxyblot) per spot.  After completion of spot matching, the 
normalized intensity of each protein spot from individual gels (or oxyblots) was 
compared between groups using ANOVA.   
Trypsin digestion 
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Samples were prepared using the techniques described previously (Poon et al., 
2004e). The selected protein spots were excised with a clean blade and transferred into 
clean microcentrifuge tubes. After being washed by ammonium bicarbonate (NH4HCO3) 
and acetonitrile, the protein spots were dithiothreitol and iodoacetamide separately. Then 
the gels pieces were washed by NH4HCO3 and acetonitrile again before rehydration with 
modified trypsin (Promega, Madison, WI). The gel pieces were chopped into smaller 
pieces and incubated at 37°C overnight in shaking incubator. 
Mass Spectrometry 
Mass spectra reported in this study were acquired from both the University of 
Kentucky Mass Spectrometry Facility (UKMSF) and Department of Pharmacology in 
University of Louisville School of Medicine and VAMC. A Bruker Autoflex MALDI 
TOF (matrix assisted laser desorption ionization-time of flight) mass spectrometer 
(Bruker Daltonic, Billerica, MA) in UKMSF or a TOF Spec 2E (Micromass, UK) 
MALDI-TOF mass spectrometer in University of Louisville operated in the reflectron 
mode were used to generate peptide mass fingerprints.  Peptides resulting from in-gel 
digestion with trypsin were analyzed on a 384 position, 600 μm AnchorChipTM Target 
(Bruker Daltonics, Bremen, Germany) and prepared according to AnchorChip 
recommendations (AnchorChip Technology, Rev. 2, Bruker Daltonics, Bremen, 
Germany).  Briefly, 1 μL of digestate was mixed with 1 μL of alpha-cyano-4-
hydoxycinnamic acid (0.3 mg/mL in ethanol:acetone, 2:1 ratio) directly on the target and 
allowed to dry at room temperature. The sample spot was washed with 1 μL of a 1% TFA 
solution for approximately 60 seconds.  The TFA droplet was gently blown off the 
sample spot with compressed air.  The resulting diffuse sample spot was recrystallized 
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(refocused) using 1 μL of a solution of ethanol: acetone:0.1 % TFA (6:3:1 ratio).  
Reported spectra are a summation of 100 laser shots.  External calibration of the mass 
axis was used for acquisition and internal calibration using either trypsin autolysis ions or 
matrix clusters was applied post acquisition for accurate mass determination.  
The MALDI spectra used for protein identification from tryptic fragments were 
searched against the NCBI protein databases using the MASCOT search engine 
(http://www.matrixscience.com).  Peptide mass fingerprinting used the assumption that 
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at 
cysteine residues.  Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150 
ppm was the window of error allowed for matching the peptide mass values. 
Ubiquitin carboxyl terminal hydrolase L1 (UCH-L1) Assay  
 The activities of UCH-L1 in the spinal cord were measured by determining the 
rate of conversion of ubiquitin-C-terminal 7-amido-4-methylcoumarin (Ub-AMC) 
(Calbichem) to ubiquitin and free AMC (Dang et al., 1998). In this assay, 39 μL of buffer 
(50mM Hepes, pH 7.0, 10mM DTT, and 0.1 mg/ml ovalbumin) are mixed with 10μL of 
2mg/mL spinal cord homogenates of six individual transgenic animals and six individual 
control animals for 1 hour. Then 10 μL of 200 nM Ub-AMC was added to the enzyme 
solution, and cleavage of AMC from Ub-AMC was monitored by λex 355nm and λem 
460nm using a SpectrMAX Gemini XS fluorescence microtiter plate reader. UCH-L1 
activities of each individual were assayed by the change of λem 460nm over time. The 
average UCH-L1 activities of six transgenic animals were compared to those of six 
control animals using Student’s t test. 
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Immunoprecipitation 
 Immunoprecipitation was performed essentially as described previously 
(Lauderback et al., 2001). A rabbit anti-αB-crystallin antibody (5 µL) (Chemicon) was 
added directly to the spinal cord homogenate. Antibody/lysate solutions were incubated 
on a rotary mixer overnight at 4°C. The αB-crystallin/antibody complexes were 
precipitated with protein A-conjugated agarose beads. Protein A beads were added in 
50 µL aliquots from a stock of 300 mg/mL in PBS and mixed on a rotary mixer for1 hour 
room temperature. Beads were then centrifuged and 2D electrophoresis was performed on 
the supernatant. 
B3 Results 
 We used a parallel approach to investigate the effect of G93A-SOD1 on protein 
oxidation. The specific carbonyl levels were obtained by dividing the carbonyl level of a 
protein spot on the nitrocellulose membrane by the protein level of its corresponding 
protein spot on the gel. Such numbers give the carbonyl level per unit of protein. We 
found that in comparison to non-transgenic mice, four proteins in the spinal cords of 
G93A-SOD1 transgenic mice have significantly higher specific carbonyl levels than 
those spots for non-transgenic littermate controls. These proteins are identified as SOD1, 
translationally control tumor protein (TCTP), ubiquitin carboxyl terminal hydrolase L1 
(UCH-L1) and, αB-crystallin. The specific carbonyl levels of the proteins that are 
significantly different are summarized in Table B1.The summary of the mass 
spectrometry results for the proteins are listed in Table B2.  
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 Fig. B1 shows representative 2D-electrophoresis gels of G93A-SOD1 transgenic 
mice (A) and non-transgenic mice (B) after Coomassie blue staining. Fig.2 shows the 
representative 2D western blots of the spinal cord of a G93A-SOD1 transgenic mouse 
(A) and a non-transgenic mouse (B). We report here that the specific carbonyl levels of 
human SOD1, TCTP, UCH-L1 and, possibly αB-crystallin are significantly increased in 
the spinal cord of G93A-SOD1 transgenic mice when compared to that of non-transgenic 
mice. Spots closed to human SOD1 are modified SOD1, possibly phosphorylated SOD1. 
However, these modifications cannot be resolved by MALDI mass spectrometry. 
Although our mass spectra do not significantly match the mass spectra of αB-
crystallin, the molecular weight and pI value of αB-crystallin agree with the location of 
the gel spots on the 2D gel map. In order to assure the identification of αB-crystallin, we 
identify the protein spot immunochemically. The spot was absent in the 2D gels upon 
immunoprecipitation (Fig. B3). Therefore, the protein identification of αB-crystallin is 
assured.   
In order to confirm that oxidative modification inactived protein activity, we 
compared the activity of UCH-L1 in the G93A-SOD1 transgenic mice to that in the 
control mice. Consistent with our prior studies that demonstrate loss of activity of 
oxidatively modified proteins (Hensley et al., 1995a; Lauderback et al., 2001; Sultana and 
Butterfield, 2004), UCH-L1 activity is significantly decreased (29%) in the G93A-SOD1 
transgenic mice when compared to that of non-transgenic control (Fig B4).  
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 Table B1: Increased Specific carbonyl level of oxidized proteins in G93A-SOD1 mice (n=6) 
 
Proteomics Identified Protein 
Non-Transgenic Mice 
(A.U..± S.D.) 
(n=7) 
G93A-SOD1 Transgenic 
Mice 
(A.U.± S.D.) 
(n = 7) 
F 
Fcrit = 4.7 
p value 
Transcriptionally control 
tumor protein 1 (TCTP) 15.1±10.1 30.6±14.1 5.6 < 0.05 
Cu,Zn-Superoxide Dismutase 
(SOD1) Not Detected  2.88±1.78 18.2 < 0.005 * 
Ubiquitin carboxyl-terminal 
hydrolase isozyme L1  
(UCH-L1) 
0.74±0.23 2.31±1.27 10.3 < 0.0001 
Alpha B crystallin Not Detected  20.1±8.4 39.7 < 0.0001 *
 
* Since specific carbonyl level are not detected in non-transgenic mice, a value of 0 
was used to calculate the p value.  
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Table B2: Summary of proteins identified by mass spectrometry 
Identified Protein gi accession # 
# Peptides 
matched
% 
Coverag
e 
pI, MrW 
(kD) 
Mowse 
Score 
Probability 
of a random 
identification
Transcriptionally 
control tumor protein 
1 (TCTP) 
gi|6678437 5 28 4.76, 19.5 79 1.25 x 10-8
Cu,Zn-Superoxide 
Dismutase (SOD1) 
gi|2982081 8 42 5.73, 16.1 85 3.16 x 10-9
Ubiquitin carboxyl-
terminal hydrolase 
isozyme L1 (UCH-L1) 
gi|18203410 8 39 5.29, 24.6 86 2.5 x 10-9
Alpha B crystallin gi|6753530 5 26 7.05, 20.1 60 Not significant 
 
 279
Figure B1 
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Figure B2 
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Figure B3 
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Figure B4 
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B4 Discussion 
 The G93A-SOD1 transgenic mouse is frequently used as an animal model of 
human FALS due to the neuropatholgical similarity of this mouse model to the human 
disease (Zang and Cheema, 2002; Azari et al., 2003). Moreover, this mouse model can 
provide insight into the mechanisms of the neurotoxicity by mutant SOD in vivo. It is 
well established that mutant SOD1 enhances oxidative activity by acting as a peroxidases 
(Wiedau-Pazos et al., 1996; Yim et al., 1996; Valentine, 2002) or a superoxide reductases 
(Liochev and Fridovich, 2000). Protein carbonyl levels in the spinal cord of 3-4 month 
old G93A-SOD1 transgenic mice show a 557% increase when compared to non-
transgenic animals at same age (Andrus et al., 1998). Such protein oxidation in spinal 
cord of G93A-SOD1 transgenic mice followed an alteration of cytokine expression 
(Hensley et al., 2002). In the current study, we identified the proteins that demonstrate 
increased carbonyl levels when compared to those of the non-transgenic mice as SOD1, 
TCTP, UCH-L1 and αB-crystallin. 
 SOD1 previously was identified as one of the oxidatively modified proteins in 
G93A-SOD1 transgenic mice spinal cord immunochemically (Andrus et al., 1998). Here, 
we used a parallel proteomics approach to confirm that the specific carbonyl level of 
SOD1 is increased in the spinal cords of G93A-SOD1 transgenic mice. Although G93A-
SOD1 shows identical dismutation activity as wild-type SOD1, the activity of SOD1 in 
FALS patients with mutations decreased 50% in motor cortex, parietal cortex, and 
cerebellum (Browne et al., 1998).  Moreover, free radicals production in the G93A-SOD1 
transgenic animals is induced by SOD1 mutation (Andrus et al., 1998), alteration of 
tumor necrosis factor α (TNFα), and TNFα-modulating cytokines (Hensley et al., 2002; 
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Hensley et al., 2003). Although the issue whether oxidative stress plays an early role in 
ALS remains unknown, our current study is consistent with the notion that oxidative 
modification of SOD1 plays a role in the neurotoxicity of mutant SOD1 in the disease.  
 Another oxidatively modified protein in G93A-SOD1 transgenic mice identified 
by proteomics was TCTP. TCTP processes calcium-binding activity (reviewed in 
(Bommer et al., 2002)) and has a tubulin binding region (Kim et al., 2000). 
Overexpression of TCTP stabilizes microtubules and alters cell morphology (Gachet et 
al., 1999). Other molecular interactions of TCTP include self-interaction (Yoon et al., 
2000) and the interaction with myeloid cell leukemia 1 protein (MCL1) (Zhang et al., 
2002). TCTP levels are highly regulated in response to various stress conditions and 
extracellular signals, including growth signal (Bommer et al., 2002), cytokines (Nielsen 
et al., 1998; Teshima et al., 1998), starvation (Bonnet et al., 2000; Bommer et al., 2002), 
heat shock, heavy metals, calcium stress (Xu et al., 1999) and pro-apototic/cytotoxic 
signals (Sinha et al., 2000; Oikawa et al., 2002). Along with the structural similarity to 
chaperones (Thaw et al., 2001) and characterization as an anti-apoptotic protein (Li et al., 
2001a), these observations suggest that TCTP may exert a cytoprotective function for 
cells. The current study showed that TCTP was oxidatively modified in the spinal cord of 
G93A-SOD1 mice, suggesting that the putative cytoprotective function and the calcium 
binding affinity of TCTP are impaired in G93A-SOD1 mice since oxidative modification 
alters the structure and function of proteins (Hensley et al., 1994; Hensley et al., 1995a; 
Subramaniam et al., 1997; Lauderback et al., 2001; Sultana and Butterfield, 2004). 
Consistent with this notion, free cytosolic calcium was increased in lymphocytes from 
ALS patients (Curti et al., 1996), suggesting that oxidative modification of TCTP may 
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also play an important role in neurotoxicity of G93A-SOD1, and thus neurodegeneration 
in the spinal cords of G93A-SOD1 transgenic mice.  
 UCH-L1 belongs to a family of ubiquitin carboxyl-terminal hydrolases (UCHs) 
that play important roles in the ubiquitin-proteolytic pathway (Kon et al., 1999). The 
ubiquitin-proteasome system is a major pathway for selective protein degradation 
(Hershko and Ciechanover, 1992). Ubiquitinated proteins form polyubiquitin chains that 
are eventually degraded by the 26S proteasome (Hershko and Ciechanover, 1998). UCH-
Ls then recycle ubiquitin from ubiquitinated protein complexes or polyubiquitin chains 
by cleaving the amide linkage next to the C-terminal glycine of ubiquitin (Hershko and 
Ciechanover, 1992). Loss of UCH-L1 function causes neuroaxonal dystrophy (Yamazaki 
et al., 1988; Mukoyama et al., 1989; Saigoh et al., 1999) significant protein oxidization 
(Castegna et al., 2004), and accumulation of synuclein protein in gracile axonal 
dystrophy (GAD) mice (Wang et al., 2002). Similarly, decreased UCH-L1 activity by 
mutation also enhances protein aggregation in E. Coli (Leroy et al., 1998). Therefore, 
base on the prior literature, oxidative inactivation of UCH-L1 presented in the current 
study possibly contributes to both the protein aggregation and oxidative stress observed 
in G93A-SOD1 transgenic mice and ALS patients. Consistent with this notion and 
consistent with our finding (Fig 4), that UCH-L1 activity is decreased In G93A-SOD1 
mice spinal cord, the inclusions of human ALS and mSOD1 (including G93A) mice are 
excessively ubiquitinated (Migheli et al., 1990; Leigh et al., 1991; Mather et al., 1993; 
Watanabe et al., 2001).  
 αB-crystallin belongs to the small heat shock protein (sHSP) class of the heat 
shock protein (HSP) family. HSPs are cellular constituents synthesized by living 
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organisms under stress conditions as well as normal conditions. The major function of 
sHSP is to stabilize other proteins under stress condition, while the high molecular weight 
HSPs normally play roles in protein folding during biosynthesis (Ganea, 2001; Poon et 
al., 2004a).  Incorporation of αB-crystallin into red cell ghosts protects ATPase against 
oxidative stress (Derham et al., 2003), and overexpression of αB-crystallin protects cells 
against apoptosis and necrosis during myocardial ischemia and reperfusion (Ray et al., 
2001) by acting as a chaperone (Wang and Spector, 1995).  Therefore, one can speculate 
that αB-crystallin contributes to the neuroprotection when the cells are under oxidative 
stress. Moreover, α-crystallins were recruited to aggregates when cells were treated with 
proteasome inhibitor (Ito et al., 2003), and the degradation of αB-crystallin, along with 
ubiquitin conjugation, was decreased in bovine lens epithelial cells when αB-crystallin 
are oxidized (Huang et al., 1995). Therefore, these studies suggest that oxidized αB-
crystallin has a higher tendency toward aggregation than degradation. Therefore, 
oxidative modification of αB-crystallin observed in our current study may impair 
neuronal protection and increase aggregation of αB-crystallin in cells. Consistent with 
this notion, inclusions in ALS patients contain αB-crystallin, along with metallothionin, 
glutamine synthetase, and tubulin immunoreactivities (Kato et al., 1997).  
The remarkable feature of the oxidatively modified proteins (except for TCTP) in 
G93A-SOD1 transgenic mice is that they are involved in the formation of inclusion in 
ALS patients or ALS models. Ubiquitin protein epitopes and αB-crystallin are found in 
fibrillar neuronal inclusions in cortex of sporadic ALS patients (Migheli et al., 1990; 
Leigh et al., 1991; Mather et al., 1993; Arima et al., 1998).  Aberrant accumulation of 
mutant SOD1 is demonstrated in C. elegan expressing human mutant SOD1 (Oeda et al., 
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2001). Based on our current observations, the increased oxidatively-modification of 
SOD1, UCH-L1 and αB-crystallin plays significant roles in the protein aggregation in the 
spinal cords of G93A-SOD1 transgenic mice. Our current study provide insights into the 
mechanism of G93A-SOD1 neurotoxicity in vivo which involves oxidative modification 
of a Ca2+ regulating protein (TCTP) and proteins involved in inclusion formation (SOD1, 
UCH-L1 and αB-crystallin), suggesting a potential relationship between protein 
oxidation, protein aggregation and Ca2+ regulation in ALS.  Moreover, one can speculate 
that the oxidative modification of these proteins impairs protein stability (αB-crystallin), 
Ca2+ binding (TCTP), protein degradation (UCH-L1) and antioxidant capacity (SOD1). It 
should be noted that other oxidative modifications could also play a role in the 
pathogenesis of ALS involving other proteins (Perluigi et al., 2005). Moreover, since 
only symptomatic mice were compared to the non-transgenic mice in this study, it is 
possible that the oxidative modification of the proteins described is related to the 
consequence of the degenerative process. Therefore, future studies will address whether 
similar changes are observed in presymptomatic G93A-SOD1 mutant mice.  
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Appendix C 
Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 
transgenic mice--a model of familial amyotrophic lateral sclerosis 
C1 Introduction 
Degeneration of cortical and spinal motor neurons is the typical feature of 
amyotrophic lateral sclerosis (ALS) (Carri et al., 2003), a progressive, fatal disease 
occurring both sporadically (sALS) and as a familial disorder (fALS) accounting for 
about 10% of patient. fALS is caused by dominantly inherited mutations in the SOD1 
gene encoding Cu/Zn superoxide dismutase (Rosen et al., 1993). fALS cases are 
indistinguishable from sALS on the basis of clinical and pathological criteria (Hand and 
Rouleau, 2002), suggesting that the SOD1-mutant animal model provide insight into 
similar and converging pathogenic mechanisms shared by both sporadic and familial 
forms.  
Over 100 SOD1 mutations (Andersen, 2000) have been identified in fALS 
patients. Most of the individual mutations result from substitution of one single amino 
acid, such as SOD1G85R, SOD1G37R and SOD1G93A, which were intensely characterized in 
transgenic mouse models of ALS (Gurney et al., 1994; Ripps et al., 1995; Wong et al., 
1995; Bruijn and Cleveland, 1996). It is well established that SOD1-mediated toxicity in 
ALS is due to a “gain” of toxic properties that are independent of the levels of SOD1 
activity (Gurney, 1997).  
However, the mechanism of fALS caused by mutant SOD1 (mSOD1) is currently 
unknown. Two hypotheses have been proposed to explain the toxicity of ALS mutant 
SOD1 proteins. The oligomerization hypothesis states that mSOD1 proteins are or 
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become misfolded and consequently oligomerize to form intracellular aggregates 
(Cleveland and Rothstein, 2001; Valentine, 2002) which diminish the availability of 
essential proteins for normal cellular function. The oxidative damage hypothesis proposes 
that toxicity is caused by aberrant chemistry of the active Cu/Zn sites of the misfolded 
enzyme (Beckman et al., 1994). The mSODs exhibit enhanced oxidative stress by acting 
as a peroxidase (Valentine, 2002), superoxide reductase (Liochev and Fridovich, 2000) or 
by producing O2¯ (Estevez et al., 1999). Indeed, autooxidation of mutant SOD1 proteins 
increases the frequency of protein misfolding (Rakhit et al., 2002). Elevated levels of 
reactive free radicals and the formation of insoluble protein complexes of mutant SOD1 
protein have been detected in spinal cords of the G93A transgenic mice prior to motor 
neuron degeneration (Liu et al., 1998; Liu et al., 1999). It is tempting to assume that these 
two phenomena are linked, since oxidative damage to the SOD1 was demonstrated in the 
G93A-SOD1 transgenic mice (Andrus et al., 1998; Hensley et al., 2002; Poon et al., 
2004c). Moreover, the oxidative damage hypothesis is further supported by considerable 
evidences of increased ROS-mediated oxidative stress, such as malondialdehyde, 4-
hydroxyl-2-nonenal (HNE), oxidized proteins, DNA and membrane phospholipids, in 
sporadic and fALS (Valentine, 2002).  
Lipid peroxidation is a result of oxidative stress in living cells. Since the central 
nervous system is enriched with polyunsaturated fatty acids, it is particularly vulnerable 
lipid peroxidation. Lipid peroxidation end product, HNE, is an unsaturated aldehyde that 
can modify proteins by Michael addition to form covalent adducts with cysteine, lysine, 
or histidine (Esterbauer et al., 1991). HNE-modification initiates conformational and 
structural changes of proteins and results in neuronal death (Subramaniam et al., 1998; 
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Malecki et al., 2000). HNE level and HNE-modified proteins are increased in the spinal 
cord and ventral horn motor neurons of ALS patients indicating that HNE play a critical 
role motor neuron degeneration in ALS (Simpson et al., 2004). In order to gain insight of 
roles of HNE-modified protein in the neurodegenerative in fALS, we used a proteomic 
approach to identify the significantly HNE-modified proteins in the spinal cord of G93A-
SOD1 transgenic mice when compared to non-transgenic mice.  
C2 Experimental Procedures 
 These experiments are conducted by collaboration with Dr. Marzia Perluigi 
Animals 
Transgenic mice expressing human SOD1 gene with a G93A mutation (strain 
B6SJL/TgN (SOD1-G93A)-2Gur) (Gurney et al., 1994) were purchased from the Jackson 
Laboratory (Bar Harbor, ME, USA) and maintained as hemizygotes by mating transgenic 
males with B6/SJL F1 hybrid females. Non-transgenic littermates were used as the 
primary control group. From four months of age G93A transgenic mice showed signs of 
hindlimb weakness and rapidly developed a paralysis resembling fALS both clinically 
and pathologically (Gurney et al., 1994); they eventually died meanly 11 days after 
paralysis. Behavioral tests were carried out between postnatal days 100 and 110 to 
evaluate advanced motor dysfunction. All the studies on isolated cord were performed on 
tissue isolated from 120 days-old animals and were performed according to the guidelines 
on the ethical use of animals overseen by the Institutional Animal Care and Use 
Committee (IACUC) of the Oklahoma Medical Research Foundation. 
Sample Preparation 
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The spinal cords were rapidly removed from the mice (n=5), dissected on a bed of 
ice, immediately frozen in liquid nitrogen, and stored at –80 °C until time of analysis. 
Spinal cords were suspended in 10 mM HEPES containing 137 mM NaCl, 4.6 mM KCl, 
1.1 mM KH2PO4 and proteinase inhibitors: leupeptin (0.5 mg/mL), pepstatin (0.7 μg/mL), 
type IIS soybean trypsin inhibitor (0.5 μg/mL) and PMSF ( 40 μg/mL). Homogenates 
were sonicated 20sec three times and then centrifuged at 14,000 g for 15 min to remove 
debris. Protein concentration in the supernatant was assayed by BCA method (Pierce, 
Rockford, IL, USA). 
Two-dimensional gel electrophoresis  
 
Samples of spinal cord proteins were prepared according to the procedure of 
Levine et al. (Levine et al., 1994). 200μg of protein were precipitated by addition of ice-
cold 100% trichloroacetic acid (TCA) to obtain a final concentration of 15% TCA. 
Samples were placed on ice for 10 min to allow precipitation of proteins. Precipitates 
were centrifuged at 15,800 g for 2 min. The pellets were washed with 0.5mL of 1:1 (v/v) 
ethanol/ethyl acetate solution. After centrifugation and washing with ethanol/ethyl acetate 
solution three times, the samples were dissolved in 25 μL of 8 M urea (Bio-Rad). The 
samples were then mixed with 185μL of rehydration buffer (8M urea, 20mM 
dithiothreitol, 2.0% (w/v) CHAPS, 0.2% Biolytes, 2 M thiourea and bromophenol blue).  
For the first-dimension electrophoresis, 200 µL of sample solution were applied 
to a ReadyStrip™ IPG strip (Bio-Rad). The strips were soaked in the sample solution for 
1 hour to allow uptake of the proteins. The strip was then actively rehydrated in protean 
IEF cell (Bio-Rad) for 16 hours at 50V. The isoelectric focusing was performed at 300V 
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for 2 hours linearly; 500V for 2 hr linearly; 1000V for 2 hr linearly, 8000V for 8 hr 
linearly and 8000V for 10 hr rapidly. All the processes above were carried out at 22oC. 
The focused IEF strip was stored at –80oC until second dimension electrophoresis was 
performed. 
For second dimension electrophoresis, thawed IPG® Strips pH 3-10 were 
equilibrated for 10 min in 50 mM Tris-HCl (pH 6.8) containing 6M urea, 1% (w/v) 
sodium dodecyl sulfate (SDS), 30% (v/v) glycerol, and 0.5% dithiothreitol, and then re-
equilibrated for 15 min in the same buffer containing 4.5% iodacetamide in place of 
dithiothreitol. Linear Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were 
used to perform second dimension electrophoresis. Precision ProteinTM Standards (Bio-
Rad) were run along with the sample at 200V for 65 min. 
After electrophoresis, the gels were incubated in fixing solution (7% acetic acid, 
10% methanol) for 20 min. Approximately 40 mL of SYPRO Ruby Gel Stain (Bio-Rad) 
were used to stain the gels for 2 hours, on a gently continuous rocker. The gels were 
placed in deionized water overnight for destaining. 
Western Blotting 
 The same amount of protein samples (200μg) was used for 2D-immunoblotting 
analysis and the electrophoresis was carried out in the same way as described above. The 
proteins from the second dimension electrophoresis gels were transferred to nitrocellulose 
(Bio-Rad) using a Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 
hrs. HNE-protein adducts were detected on the nitrocellulose paper using a primary 
rabbit antibody (Intergen) specific for HNE-bound protein (1:100), followed by a 
secondary goat anti-rabbit IgG (Sigma, St Louis, MO, USA) antibody. The resultant stain 
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was developed using 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium 
(BCIP/NBT) solution (SigmaFast tablets; Sigma). 
Image Analysis 
 The gels (5 for each group, G93A-SOD1 transgenic mice and non transgenic 
mice) and nitrocellulose blots (n=10) were scanned and saved in TIF format using a 
Scanjet 3300C (Hewlett Packard). PDQuest 2-D Analysis Software (Bio-Rad, Inc.) was 
used for matching and analysis of visualized protein spots among differential gels and 
membranes to compare protein and HNE immunoreactivity content between G93A-
SOD1 transgenic and non-transgenic mice. This sophisticated software offers powerful 
comparative analysis and is specifically designed to analyze many gels or blots at once. 
Powerful automatching algorithms quickly and accurately match gels or blots and 
sophisticated statistical analysis tools allow to identify experimentally significant spots. 
The principles of measuring intensity values by 2-D analysis software were similar to 
those of densitometric measurement.  The average mode of background subtraction was 
used to normalize intensity values, which represents the amount of protein (total protein 
on gel and HNE-bound protein on the membrane) per spot. After completion of spot 
matching, the normalized intensity of each protein spot from individual gels (or 
membranes) was compared between groups using statistical analysis. Statistical 
significance was assessed by a two-tailed Student`s t-test. P values < 0.05 were 
considered significant for comparison between control (non transgenic mice) and 
experimental data (G93A-SOD1 transgenic mice). 
Trypsin digestion 
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In-gel digestion on selected gel spots was performed according to 
(Thongboonkerd et al., 2002). The selected protein spots were excised with a clean blade 
and transferred into clean microcentrifuge tubes. The protein spots were then washed 
with 0.1M ammonium bicarbonate (NH4HCO3) at room temperature for 15 min. 
Acetonitrile was added to the gel pieces and incubated at room temperature for 15 min. 
The solvent was removed, and the gel pieces were dried in a flow hood. The protein spots 
were incubated with 20 µl of 20 mM DTT in 0.1M NH4HCO3 at 56°C for 45min. The 
DTT solution was then removed and replaced with 20µL of 55mM iodoacetamide in 
0.1M NH4HCO3. The solution was incubated at room temperature in the dark for 30min. 
The iodoacetamide was removed and replaced with 0.2mL of 50mM NH4HCO3 and 
incubated at room temperature for 15 min. 200μL of acetonitrile was added. After a 15-
min incubation, the solvent was removed, and the gel spots were dried in a flow hood for 
30 min. The gel pieces were rehydrated with 20 ng/µl methylated trypsin (Promega, 
Madison, WI) in 50 mM NH4HCO3 with the minimal volume to cover the gel pieces. The 
gel pieces were chopped into smaller pieces and incubated at 37°C overnight in shaking 
incubator. 
Mass Spectrometry 
All mass spectra reported in this study were acquired at the Department of 
Pharmacology in the University of Louisville School of Medicine and VAMC. A Spec 2E 
MALDI TOF (matrix assisted laser desorption ionization-time of flight) mass 
spectrometer operated in the reflectron mode was used to generate peptide mass 
fingerprints.  Peptides resulting from in-gel digestion with trypsin were analyzed on a 384 
position, 600 μm AnchorChipTM Target (Bruker Daltonics, Bremen, Germany) and 
 295
prepared according to AnchorChip recommendations (AnchorChip Technology, Rev. 2, 
Bruker Daltonics, Bremen, Germany).  Briefly, 1 μL of digest was mixed with 1 μL of 
alpha-cyano-4-hydoxycinnamic acid (0.3 mg/mL in ethanol:acetone, 2:1 ratio) directly on 
the target and allowed to dry at room temperature. The sample spot was washed with 1 
μL of a 1% TFA solution for approximately 60 seconds.  The TFA droplet was gently 
blown off the sample spot with compressed air.  The resulting diffuse sample spot was 
recrystallized (refocused) using 1 μL of a solution of ethanol: acetone:0.1 % TFA (6:3:1 
ratio).  Reported spectra are a summation of 100 laser shots.  External calibration of the 
mass axis was used for acquisition and internal calibration using either trypsin autolysis 
ions or matrix clusters was applied post acquisition for accurate mass determination.  
The MALDI spectra used for protein identification from tryptic fragments were 
searched against the NCBI protein databases using the MASCOT search engine 
(http://www.matrixscience.com).  Peptide mass fingerprinting used the assumption that 
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at 
cysteine residues.  Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150 
ppm was the window of error allowed for matching the peptide mass values. Probability 
based MOWSE scores were estimated by comparison of search results against estimated 
random match population and were reported as –10 *LOG10(p), where p is the absolute 
probability. MOWSE score greater than 61 were considered significant (p<0.05). All the 
protein identifications were in the expected size range based on position in the gel. 
Enzyme Activity assay 
Enolase activity assay was performed as described previously (Wagner et al., 
2000) with modification. Enolase was added to 100 μL of assay mixture (20 mM 
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Na2HPO4, pH 7.4, 400 mM KCl, 0.01 mM EDTA, 2 mM 2-phospho-D-glycerate) in a 
UV-transparent microtiter plate (Corning, MA). The enzymatic activity was determined 
by the change of absorption at A240 for 5 min. 
C3 Results 
Two-dimensional (2D) electrophoresis offers an efficient tool to screen for 
abundant protein changes in different disease states as well as differences in metabolic 
pathways. Western blot and subsequent immunochemical detection of HNE allowed 
identification of HNE-modified proteins in the spinal cord tissue of transgenic G93A-
SOD1 mice in comparison to non-transgenic mice. We used a parallel approach to 
quantify the protein levels by SYPRO Ruby staining and the extent of HNE-binding by 
immunoistochemistry (Figs C1, C2). SYPRO Ruby fluorescent stain achieves a linear 
and sensitive staining of gel slabs and immunoblotting with HNE antibody allows 
specific detection of HNE-adducts in the spinal cord tissue of G93A-SOD1 transgenic 
mice. We measured the specific HNE-bound levels by dividing HNE level of a protein 
spot on blotted membrane by the protein level of its corresponding protein spot on the 
gel. Fig. C1 shows the representative 2D-electrophoresis gels of G93A-SOD1 transgenic 
mice (bottom) and non-transgenic mice (top) after SYPRO Ruby staining. Fig. C2 shows 
the representative 2D western blots of the spinal cord of a G93A-SOD1 transgenic mouse 
(bottom) and a non-transgenic mouse (top). The HNE-modified proteins identified in this 
study were dihydropyrimidinase related protein 2 (DRP-2), heat shock protein 70 
(Hsp70) and possibly α-enolase. HNE-bound protein levels of the three identified 
proteins in G93A-SOD1 mice compared to non-transgenic mice are summarized in Table 
C1. The increase of HNE immunoreactivity in G93A-SOD1 vs non-transgenic mice was 
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not significant for α-enolase but the molecular weight and the pI value of the identified 
protein match the location of the spot on the 2D gel map (Table C2). Others previously 
reported that HNE-modified proteins are increased in the spinal fluid, in the spinal cord 
and ventral horn motor neurons of ALS patients compared with control patients (Simpson 
et al., 2004), but there are few evidences indicating which individual proteins are 
specifically affected by HNE modification. In the present study, we show the 
identification of three proteins (DRP-2, Hsp70 and α-enolase) significantly modified by 
HNE in the spinal cord tissue of G93A-SOD1 mice. One example of mass spectra 
corresponding to tryptic digest of one of the identified protein is shown in Fig. C3. Also, 
we found that activity of the HNE-modified enzyme, enolase, is significantly decreased 
(39%) in the spinal cords of the G93A-SOD1 transgenic mice when compared to that in 
non-transgenic mice.  
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Table C1: HNE-bound protein levels in G93A-SOD1 mice 
 Identified Protein 
Non-Transgenic Mice
(A.U. ± S.E.M) 
(n = 5) 
G93A-SOD1 Transgenic Mice 
(A.U. ± S.E.M) 
p value 
Dihydropyrimidinase related 
protein (DRP-2) 1.16 ± 0.55 
283.48 ± 98.5 < 0.02 
Hsp70 3.46 ± 1.52 30.6 ± 7.02 < 0.005 
α-enolase 1.15 ± 0.25 10.7 ± 4.12 < 0.049 
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Table C2: Summary of proteins identified by mass spectrometry 
Identified Protein 
gi accession 
# 
# 
Peptides 
matched
% 
Coverage 
matched 
pI, MrW (kD) 
Mowse 
Score * 
Dihydropyrimidinase 
related protein 2 
(DRP-2) 
gi|13242237 18 36 5.95,  62.6 152 
Hsp70 gi|40254595 26 51 5.37,  71.1 192 
α-enolase gi|12963491 6 13 6.37,  47.7 41 
 
• MOWSE score greater than 61 are considered significant statistically. 
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Figure C1 
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Figure C2 
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Figure C3 
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Figure C4 
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C4 Discussion 
The role of ROS-mediated oxidative stress in ALS has been proposed by many 
laboratories and supported by the evidence that typical oxidation products such as 
malondialdehyde, HNE, oxidized proteins, oxidized DNA and membrane phospholipid 
peroxidation are elevated both in sporadic and fALS spinal cord (review by (Valentine, 
2002)). HNE is a reactive and cytotoxic by-product of ω-polyinsaturated fatty acids 
peroxidation. HNE can rapidly diffuse from the lipid bilayers to modify extracellular or 
intracellular membrane proteins which are necessary for normal cellular function. HNE is 
implicated in several neurodegenerative disease, including ALS (Simpson et al., 2004).  
In the present study, we have identified the proteins that were significantly modified by 
HNE in the spinal cord tissue of a model of fALS, G93A-SOD1 transgenic mice, in 
comparison to that of the non-transgenic mice. We found that increased amounts of HNE 
are significantly covalently bound to dihydropyrimidinase related protein 2 (DRP-2), to 
the heat shock protein 70 (Hsp70) and possibly to α-enolase. 
DRP-2 is a member of the DRP gene family involved in axonal outgrowth and 
pathfinding through the transmission and modulation of extracellular signals(Goshima et 
al., 1995; Minturn et al., 1995). Immunoreactivity of human DRP-2 was shown in the 
neurofibrillary tangles of Alzheimer`s Disease (AD) human brain, suggesting that DRP-2 
is involved in the neuritic degeneration in AD (Yoshida et al., 1998). Proteomic data 
obtained in our laboratory showed significantly increased specific protein carbonyls level 
of DRP-2 in AD brain (Castegna et al., 2002a), suggesting that DRP-2 is also essential in 
repairing and maintaining the plasticity of neuronal connection in aged brains. 
Dysfunction of the DRP-2 repairing activity in brain indicate that depletion of DRP-2 
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may result in neuronal abnormalities, thus accelerating the neuritic degeneration in many 
neurodegenerative disorders. Our finding, that the increased oxidative modification of 
DRP-2 in G93A-SOD1 transgenic mice when compared to non-transgenic mice, 
establishes a potential link between oxidation-mediated loss in protein function and 
neuritic regeneration and plasticity.  
It has been reported that mSOD1 is aggregated with heat shock proteins 70 and 40 
(Hsp70 and Hsp40) and alpha-crystallin in transfected cells (Shinder et al., 2001). The 
Hsp 70 is a chaperone that helps newly synthesized proteins to be folded and transported 
across the membrane (Calabrese et al., 2003). Besides the constitutive expression of 
Hsp70 in the mammalian cells, the protein is induced by a variety of stimuli including 
heat, cytotoxic drugs, imbalance in the cellular redox state, ionizing radiation, heavy 
metals, disease states and injuries (Rossner et al., 2003). Pathologically, human SOD1 
immunoreactive inclusions in spinal cord of patient and of transgenic mice are frequently 
stained with antibody against heat-shock cognate Hsc70 (Watanabe et al., 2001). 
Moreover, overexpression of Hsp70 leads to reduction of protein aggregates and 
enhanced viability of G93A-SOD1 overexpressed motor neurons (Bruening et al., 1999). 
A recent study reported a potential anti-ALS drug candidate acting as a coinducer of Hsp 
family (Kieran et al., 2004), suggesting Hsp70 plays a role in the folding of SOD1 and 
prevents aggregate formation. Here, we propose that diminished degradation of mSOD1 
is possibly due to inactivation of Hsp70, which once cross-linked to HNE is not able to 
facilitate mSOD1 degradation by the proteasome. Our data suggest that mechanisms 
regulating Hsp70 chaperone activity could play a crucial role in the pathophysiology of 
motor neurons disease, in particular in the context of mutations of SOD1.  
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In this study, we observed a trend toward increased levels of HNE-bound α-
enolase. Enolase is a glycolytic enzyme that catalyzes the dehydration of 2-phospho-D-
glycerate to form phosphoenolpyruvate. α-enolase was identified as a specifically 
oxidized protein in AD brains (Castegna et al., 2002b). Inactivation of this glycolytic 
enzyme, as a result of oxidative modification, might contribute to an impairment of 
glycolysis and leads to decrease in  production of ATP for normal cellular function. 
Levels of glucose in cerebral cortex synaptic terminals were markedly decreased in 
mSOD1 mice when compared to non-transgenic mice (Guo et al., 2000b). Consistent 
with the notion that HNE-modification of glucose transport protein (GLUT-3) impairs 
activity of glucose transport and metabolism (Derave et al., 1999), our findings indicate 
that the HNE binds  and inactivate α-enolase, thus contributes to energy metabolism 
disruption in motor neuron.  
There is evidence for increased membrane lipid peroxidation in association with 
degenerating neurons in AD, Parkinson’s disease, traumatic CNS injury and stroke, and 
in animal and cell culture model of such disorders (Butterfield, 2002; Butterfield et al., 
2002; Pocernich and Butterfield, 2003; Zarkovic, 2003; Mattson, 2004). HNE levels and 
HNE-modified proteins are consistently elevated in the spinal cord motor neurons of ALS 
patients. In the current study, we identified the proteins that are significantly modified by 
HNE in the spinal cord of G93A-SOD1 transgenic mice when compared to that of non-
transgenic mice. The evidences of protein and DNA oxidation, and membrane lipid 
peroxidation, together with elevated levels of ROS (Liu et al., 1999) in mSOD1 mice, 
support the hypothesis that free radical-triggered oxidation of major cell components is a 
pathway for motor neuron damage in fALS. Protein oxidation is one of the most 
 307
important causes of brain protein damage and dysfunction (Berlett and Stadtman, 1997; 
Butterfield and Lauderback, 2002) and decreased activity of oxidized enzymes might 
contribute to the impairment of the metabolic pathway and cell abnormalities. The results 
presented in this report show the oxidative modification of three key enzymes in cellular 
metabolism: DRP-2 (neuronal development and repair), Hsp70 (stress response) and 
possibly α-enolase (energy metabolism). With potential relevance to ALS, our data 
demonstrate that oxidative stress in the form of lipid peroxidation is implicated as a 
pivotal event in the motor neuron degeneration processes.  
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Appendix D 
Proteomics Analyses of Specific Protein Oxidation and Protein Expression in Aged 
Rat Brain and Its Modulation by L-Acetylcarnitine:  Insights into the Mechanisms 
of Action of This Proposed Therapeutic Agent for CNS Disorders Associated with 
Oxidative Stress 
D1 Introduction 
Impaired function of the central nervous system (CNS) in aged animals is 
associated with increased susceptibility to the development of many neurodegenerative 
diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic 
lateral sclerosis (ALS). Age-related brain functional deterioration is consistent with the 
free radical theory of aging, postulating that free radical reactions with biomolecules, 
such as proteins and lipids leads to cognitive decline and neurodegeneration (Harman, 
1969). This theory was later refined to include the concept that mitochondria play a key 
role in aging, acting as the major source and target of oxidants (Miquel et al., 1980). 
Mitochondrial dysfunction plays a significant role in this increased oxidative damage, 
since damaged mitochondrial enzymes in aged brains lead to increased generation of free 
radicals (Ventura et al., 2002). However, mitochondria are also a target of increased 
oxidative stress in aged brains (Sastre et al., 2003), causing mitochondrial decay in a 
reinforcing cycle that contributes to accelerated aging (Atamna et al., 2002; Ames, 2003). 
Such increased oxidative stress and mitochondrial dysfunction cause oxidation of 
proteins, thereby leading to their dysfunction in most cases (Agarwal and Sohal, 1994; 
Agrawal et al., 1996; Butterfield et al., 1997; Aksenova et al., 1998; Sohal et al., 2002; 
Butterfield, 2004). However, oxidation of proteins during aging and age-related 
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neurodegenerative disorders is specific (Stadtman, 1992; Agarwal and Sohal, 1994; 
Agrawal et al., 1996; Butterfield and Stadtman, 1997; Stadtman, 2001; Castegna et al., 
2002b; Castegna et al., 2002a; Castegna et al., 2003; Keller et al., 2004; Poon et al., 
2004e).  
L-Acetylcarnitine (LAC; γ-trimethyl-β-acetylbutrobetaine) is the acetyl ester of 
carnitine, which facilitates the transport of fatty acids and other moieties across the 
membranes of mitochondria, thereby participating in the production of energy and 
mitochondrial function within the brain (Thal et al., 2000). LAC levels are reduced in 
aged brains, and chronic administration of LAC to aged rats improves age-related 
cognitive impairment (Castorina and Ferraris, 1994). LAC-mediated modulation of 
cognitive impairment in aged animals is reported to be due to its similar structure as 
acetylcholine, thereby promote synthesis and release of acetylcholine (Castorina and 
Ferraris, 1994). However, other mechanisms also likely play a role.  For example, LAC 
elevates levels of neurotrophins, which are key factors in the mediation of neural 
plasticity and are required for memory consolidation (McDaniel et al., 2003). LAC can 
also reduce brain oxidative stress by decreasing mitochondria decay (Liu et al., 2002). 
Although it is well established that administration of LAC can decrease protein oxidation 
in aged brains (Liu et al., 2002; Sharman et al., 2002; Yasui et al., 2002; Liu et al., 2004), 
it is not clear which specific proteins are reduced in oxidative damage in the brains of  
aged rats treated with LAC. In order to gain insight into the protective mechanism of 
LAC in aged brains relevant to protein oxidation, we used a parallel proteomics approach 
to identify the proteins that are oxidized in aged brains and those proteins that are have 
reduced oxidative damage in aged brains in aged rats treated with LAC.  
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D2 Experimental Procedures 
Animals 
All animal protocols were approved by the University of Catania Laboratory 
Animal Care Advisory Committee. Wistar rats purchased from Harlan (Udine, Italy) were 
maintained in a temperature and humidity-controlled room with a 12-h light:dark cycle. 
Rats were fed ad libitum a certified diet prepared according to the recommendations of 
the AIN. Young animals are between 6-12 months old and Old animals are 28 months 
old. The old animlas was divided into two sub groups: one receiving the control diet and 
the other supplemented, from the 24th month up to 28th month (4 months), with 
acetylcarnitine (LAC), given orally dissolved in drinking water. The calculated intake of 
LAC to this sub group of rats was 150 mg/kg/day. This group of animals was then 
sacrificed at 28 months of age. After sacrifice, brains were quickly removed and 
dissected into the cerebral cortex, hippocampus, septal area and striatum according to a 
standardized procedure, in a cold anatomical chamber and following a protocol that 
allows a maximum of 50 sec time-variability for each sample across animals. Substantia 
nigra was dissected from the deepest part of the interpeduncolar fossa. 
 
Sample Preparation and Methods Employed 
Brain samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM NaCl, 
4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) containing protease inhibitors leupeptin 
(0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and  PMSF (40 
µg/mL). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The 
supernatant was extracted to determine the protein concentration by the BCA method 
(Pierce, IL).  
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Immunochemistry  
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls 
were determined immunochemically as previously described (Poon et al., 2004d). Protein 
carbonyl levels were determined as adducts of 2,4-dinitrophenylhydrazine (DNPH) 
(Stadtman, 1992; Aksenov et al., 1997). The 2,4-dinitrophenyl hydrazone (DNP) adduct 
of the carbonyls is detected on nitrocellulose membranes using a primary rabbit antibody 
(Intergen)(1:1000) specific for DNP-protein adducts. HNE and 3-NT levels were 
determined in the same manner. The HNE levels were detected using a primary rabbit 
antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000) and the 3-NT 
levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT (1:100). 
The same secondary goat anti-rabbit IgG (Sigma) antibody was used in all applications. 
The resultant stain was developed by application of Sigma-Fast [5-Bromo-4-chloro-3-
indolyl phosphate dipotassium/nitrotetrazolium 
blue chloride (BCIP/NBT)] tablets; and the line densities were quantified using Scion-
Image software. 
Two-dimensional gel electrophoresis  
Samples of the proteins in the hypocampus or cortex were prepared as previously 
described (Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10 
ReadyStrip™ IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing, and Linear 
Gradient (8-16%) Precast criterion Tris-HCl gels (Bio-Rad) were used to separate 
proteins according to their molecular weight (MrW). Sypro Ruby stain was used to stain 
the gel for 2 hours, following which the gels were placed in deionized water overnight for 
destaining. 
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Western Blotting 
 Western blotting for 2D gels was performed as previously described (Poon et al., 
2004e). 200μg of the brain protein were incubated with 10mM DNPH solution (2N HCl) 
at room temperature (25°C) for 20 min. The gels were prepared in the same manner as for 
2D-electrophoresis. The proteins from the second dimension electrophoresis gels were 
transferred onto nitrocellulose paper (Bio-Rad) using a Transblot-Blot® SD semi-Dry 
Transfer Cell (Bio-Rad) at 15V for 2 h. The adducts of the carbonyls of the brain proteins 
were detected immunochemically. 
Image Analysis 
 The gels and nitrocellulose blots were scanned and saved in TIF format using a 
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard), 
respectively. PDQuest (Bio-Rad) was the software used for matching and analysis of 
visualized protein spots among differential gels and oxyblots.  After completion of spot 
matching, the normalized intensity of each protein spot from individual gels (or oxyblots) 
was compared between groups using statistical analysis.   
Trypsin digestion 
Samples were digested using the techniques previously described (Poon et al., 
2004e). Briefly, the selected protein spots were excised and washed with ammonium 
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The gel pieces were 
digested with 20 ng/µl modified trypsin (Promega, Madison, WI) and incubated at 37°C 
overnight in a shaking incubator. 
Mass Spectrometry 
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Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast 
evaporation nitrocellulose matrix surface and analyzed with a TofSpec 2E (Micromass, 
UK) matrix-assisted laser desorption ionization-time of flight (MALDI-TOF)mass 
spectrometer in reflectron mode. The mass axis was adjusted with trypsin autohydrolysis 
peaks (m/z 2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for 
protein identification from tryptic fragments were searched against the NCBI protein 
databases using the MASCOT search engine (http://www.matrixscience.com).   
Statistics 
The data were analyzed by two-tailed Student's t tests. A value of p < 0.05 was 
considered statistically significant. Only the proteins in hippocampus and cortex of old 
rats that were significantly different from those of young brains or from old rats treated 
with LAC assessed by the Student’s t-test were selected for identification. 
 
D3 Results 
 In order to identify the brain regions that show age-associated protein oxidation 
and the reversal of such protein oxidation by LAC treatment, we measured the bulk 
protein 3-NT, HNE and carbonyl levels of cortex (CX), substantia nigra (SN), septum 
pellucidum (SP), striatum (ST), hippocampus (HP) and cerebellum (CB).  We observed 
that protein oxidation increased generally in most brain regions of aged rats. However, 
only certain brain regions of the aged rats show statistically significant increased 
oxidative modification of proteins, and administration of LAC reduced such age-
associated protein oxidation. Old rats show significant increases in protein carbonyl 
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levels in CX, SN, SP, ST, and HP compared to that of young rats (Fig. D1). 
Administration of LAC reduced the carbonyl level of all of these regions except ST (Fig. 
D1). Similar to the findings in Alzheimer’s disease (AD) (Hensley et al., 1995b), no 
change in protein oxidation was brain aging was found in CB.  
With regard to protein-bound HNE levels, significantly increased values are 
observed in CX, SP and HP of old rats, while administration of LAC reduced the HNE 
levels in all of these regions (Fig. D2). We also demonstrated a significant increase of 
protein 3-NT levels in SN and HP of aged rats, which is reduced by administration of 
LAC (Fig. D3). 
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Figure D1 
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Figure D2 
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Figure D3 
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To begin to gain insight into which oxidatively modified proteins are implicated 
in brain aging relevant to age-related learning and memory deficits, we performed a 
redox proteomics analysis (Butterfield, 2004) on the HP and CX, brain regions in which 
all indices of oxidative modification are elevated in brain aging (Fig D1-D3) and brain 
regions that are involved in learning and memory. The specific carbonyl levels of three 
proteins, hemoglobin (HMG), cofilin 1 (COF 1) and β-actin (ACT), are significantly 
increased in HP of aged rats (Table D1). All of the specific carbonyl levels of these 
proteins are reduced by LAC administration in old rats brains although the reduction of 
HMG and ACT are not statistically significant (Table D1). Figure D4 shows these 
proteins on the representative 2D western blots of the hippocampus for young rats, old 
rats and old rats treated with LAC. Moreover, expression levels of five proteins were 
significantly altered in the HP of old rats. Protein levels of mitochondrial aconitase (ACO 
2), inositol monophosphatase (IMP), and α-enolase (ENO1) are significantly increased in 
HP of old rats, while the expression level of creatine kinase B chain (CK-B), and tubulin 
alpha-1 chain (TUB 1) were decreased (Table D2). Although LAC administration 
reversed all these alterations to a level that is similar to that of young rats’ HP, only the 
reduction of IMP level is statistically significant. Figure D5 shows these proteins on the 
representative 2D electrophoresis gels of the hippocampus of young rats, old rats and old 
rats treated with LAC.  
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Table D1: Altered Protein Specific Carbonyl Level in Aged Rat Hippocampus a
SSP #b Protein 6m c 28m c 28m +LACc
p value: 
young 
vs old 
p value:  
Old vs old + 
LAC 
2004 Hemoglobin  (HMG) 100±48 8569±4334 2959±2492 P=0.06 P =0.15 
2206 Cofilin 1  (COF 1) 100±48 8053±4250 76±27 P < 0.05 P < 0.05 
7505 Actin  (ACT) 100±93 1173±380 320±184 P< 0.05 P = 0.7 
a n =4; b SSP # is assigned by the PDQuest imaging software ; c result expressed as 
mean ± S.E.M.
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Table D2: Altered Protein Levels in Aged Rat Hippocampus a
SSP #b Protein 6m c 28m c 28m +LAC c
p value: 
young vs 
old 
p value: 
Old vs old 
+ LAC 
3802 
Mitochondrial 
aconitase 
(ACO 2) 
100±14 162±21 134±14 p < 0.05 P =0.4 
4201 
Inositol 
monophosphatase 
(IMP) 
100±19 149±12 240±19 p < 0.05 P < 0.05 
5603 α-enolase (ENO1) 100±12 175±15 159±12 P < 0.01 P= 0.6 
6602 
Creatine kinase, B 
chain 
(CK-B) 
100±15 32±12 89±27 P < 0.05 P= 0.8 
7703 tubulin alpha-1 chain (TUB 1) 100±18 34±19 45±33 P < 0.05 P =0.9 
 
a n =4; b SSP # is assigned by the PDQuest imaging software; c result expressed as 
mean ± S.E.M.  
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Figure D4 
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Figure D5 
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In the CX of old rats, the specific carbonyl levels of eight proteins were increased. 
These proteins are heat shock cognate protein 70 (HSC 70), glyoxylase 1 ( GOL 1), β-
actin (ACT), 3-mercaptopyruvate sulfurtransferase (MPST), peroxiredoxin 1 (PDX), 
phosphoribosyl pyrophosphate synthetase 1 (PPRPS1), and fumarase (FUM) (Table D3). 
LAC administration reduced the specific carbonyl levels of all these protein in the CX of 
old rats though such changes did not reach statistical significance. Fig. D6 indicates these 
proteins on  representative 2D western blots of the CX of young rats, old rats and old rats 
treated with LAC. Expression levels of F-actin capping protein beta subunit (CAPZ) and 
Rab GDP dissociation inhibitor β (GDI 2) were decreased in the CX of old rats, although 
these changes were not statistically significant. In contrast, ubiquitin  (UBQ) is increased 
in CX of old rats when compared to that of young rats.  Administration of LAC alters the 
levels of each of these CX proteins in aged rats to the levels that are close to those in 
young (Table D4). Fig D7 indicates these proteins on representative 2D electrophoresis 
gels of the CX of young rats and old rats and old rats treated with LAC.  
 In order to determine if any of the changes observed in CX and HP, which do 
slow increased oxidative damage in brain aging, might be artifactual, similar proteomics 
analysis was performed in aged CB, which did not show any elevated oxidative stress 
indices in brain aging.  Consistent with the idea that our proteomics results reflect reality, 
all of the alterations mentioned in HP and CX were not observed in the cerebellum. 
  
 324
 Table D3: Protein Specific Carbonyl Level in Aged Rat Cortex a
SSP 
 # b Protein 6m 
c 28m c 28m +LAC c
p value: 
young 
vs old 
p value: 
Old vs 
old + 
LAC 
1712 Heat shock cognate protein 70(HSC 70) 100±98 547±52 223±132 p<0.05 p=0.08
2212 glyoxylase 1 ( GOL 1) 100±73 457±38 288±113 p<0.05 p=0.23
2502 beta-actin (ACT) 100±72 454±38 176±127 p<0.05 p=0.10
4407 
3-mercaptopyruvate 
sulfurtransferase 
(MPST) 
100±13 151±13 185±127 p<0.05 p=0.80
6203 peroxiredoxin 1 (PDX) 100±71 450±37 401±15 p<0.05 p=0.29
6401 
phosphoribosyl pyrophosphate
synthetase 1 
(PPRPS1) 
100±72 454±38 402±15 p<0.05 p=0.26
6606 Fumarase (FUM) 100±73 457±38 285±116 p<0.05 p=0.20
 
a n =3; b SSP # is assigned by the PDQuest imaging software; c result expressed as 
mean ± S.E.M. 
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 Table D4: Altered Protein Level in Aged Rat Cortex a
SSP  
# b Protein 6m 
c 28m c 28m +LAC c
p value: 
young 
vs old 
p value: 
Old vs 
old + 
LAC 
4303 
F-actin capping protein  
beta subunit 
(CapZ) 
100±21 42±9 75±7 p=0.06 p<0.05
5211 
Rab GTP dissociation  
inhibitor β 
(GDI-2) 
100±34 72±5 29±8 p=0.47 p<0.05
7002 Ubiquitin (UBQ) 100±12 141±19 41±25 p=0.15 p<0.05
 
a n =3; b SSP # is assigned by the PDQuest imaging software; c result expressed as 
mean ± S.E.M. 
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Figure D6 
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Figure D7 
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The identification of the proteins was performed by matching the obtained mass 
spectrum to the spectrum in the NCBI database. The Mowse score indicates the 
probability of the match being a random event (i.e., high Mowse score indicates the 
match is unlikely to be a random event). Prior results suggest that the accuracy of protein 
identification by mass spectrometry is equivalent to immunochemical identification 
(Castegna et al., 2002b). The data base characteristics and protein properties of proteins 
identified by mass spectrometry in hippocampus (Table D5) and cortex (Table D6) are 
summarized.  
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Table D5: Summary of Hippocampal Proteins in Aged Brain Identified by Mass Spectrometry 
DB accession Protein ID MW pI %  coverage
no. of  
peptide 
Matched 
Mowse 
Score a Probability 
b
gi|37748075 Hemoglobin (HMG) 154.9 8.45 48 10 113 5.01 X 10
-12
gi|34865596 Cofilin (COF) 22.2 9.37 35 6 69 1.26 X 10
-07
gi|6671509 Actin beta (ACT) 42.1 5.29 26 9 86 2.51 X 10
-09
gi|38541404 Mitochondrial aconitase (ACO 2) 86.1 7.87 27 19 205 3.16 X 10
-21
gi|44888968 Inositol monophosphatase  (IMP) 30.8 5.17 40 7 72 6.31 X 10
-08
gi|22096350 α-enolase  (ENO1) 47.5 5.84 41 12 93 5.01 X 10
-10
gi|125296 Creatine kinase, B chain (CK-B) 43.0 5.33 40 12 136 2.51 X 10
-14
A24903 tubulin alpha-1 chain (TUB) 50.8 4.94 41 12 85 3.16 X 10
-09
 
a Mowse score greater than 57 indicating the probability of the false identification of 
the protein is less than 0.05, p<0.05 ; b Probability that the reported identification of 
the proteins is a random event. 
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Table D6: Summary of Cortical Proteins in Aged Brain Identified by Mass Spectrometry 
DB accession Protein ID MW pI % coverage
no. of 
peptide
matched
Mowse 
Score a Probability 
b
gi|13242237 
Heat shock cognate 
protein 70 
(HSC 70) 
71 5.37 20 12 64 3.98 X 10 -07
gi|46485429  glyoxylase 1 (GOL 1) 21 5.12 37 9 83 5.01 X 10 
-09
gi|71620 β-actin (ACT) 42.1 5.29 24 7 92 6.31 X 10 
-10
gi|4826659 
F-actin capping 
protein beta subunit 
(Cap Z) 
31 5.69 22 6 68 1.58 X 10 -07
gi|20304123 
3-mercaptopyruvate 
sulfurtransferase 
(MPST) 
33.2 5.88 24 8 90 1.00 X 10 -09
gi|1707891  
Rab GDP dissociation 
inhibitor beta 
(GDI) 
51.2 5.66 15 6 69 1.26 X 10 -07
gi|16923958 peroxiredoxin 1 (PDX) 22.3 8.27 23 6 92 6.31 X 10 
-10
gi|10946854  
phosphoribosyl 
pyrophosphate 
synthetase 1 
35.3 6.51 26 7 68 1.58 X 10 -07
gi|227665 Fumarase FUM 54.7 9.13 26 10 87 2.00 X 10 
-09
gi|38373984 Ubiquitin (UBQ) 11.4 5.43 65 9 118 1.58 X 10 
-12
 
a Mowse score greater than 57 indicating the probability of the false identification of 
the protein is less than 0.05, p<0.05 ; b Probability that the reported identification of 
the proteins is a random event. 
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D4 Discussion 
 It this study, we demonstrated that oxidative modification of proteins (indicated 
by elevated protein carbonyl, 3-NT, and HNE-binding levels) is generally increased in all 
brain regions of old rats when compared to those of young control rats, except 
cerebellum.  Moreover, most of these age-related oxidative stress indices can be reduced 
by in vivo administration of LAC. Others reported that LAC improves memory and 
learning deficits, reduces oxidative stress and enhances impaired plasticity of the central 
nervous system (CNS) in aged animals (Laschi et al., 1990; Hagen et al., 1998b; Yasui et 
al., 2002; McDaniel et al., 2003; Liu et al., 2004; Lombardo et al., 2004). Among the 
brain regions, HP shows dramatic increases in protein carbonyl, HNE and 3-NT levels in 
old rats, and such oxidative parameters were reduced by administration of LAC. Similar 
results are observed in the CX except for 3-NT levels. Since HP and CX are involved in 
learning and memory and showed significant alterations in oxidative parameters in our 
current study, we used a parallel proteomic analysis to identify the proteins that were 
increased in specific carbonyl levels as well as those with altered expression in these 
brain regions in old rats when compared to those in young rats. Moreover, we used the 
same technique to identify the proteins that have decreased specific carbonyl levels or 
altered expression levels in HP and CX of old rats treated with LAC when compared to 
those in old rats without LAC treatment. We found that the proteins that are oxidized or 
altered in expression as a function of age can be classified into three principal categories 
by their function: antioxidant, mitochondria function, and plasticity (Fig. D8A). The 
alteration in specific carbonyl level and expression level of certain proteins by the 
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administration of LAC in the HP and CX of old rats are summarized in Fig D8B referring 
to these three categories. 
Hippocampal proteins altered in oxidation level and expression level 
 Besides being involved in oxygen transport between the lung and tissues, HMG 
also participates in other cellular functions, such as: modulation of erythrocyte 
metabolism; an onset of erythrocyte senescence by HMG oxidation; enzymatic activities 
and interactions with drugs; and sources of physiologically active catabolites (Giardina et 
al., 1995). Moreover, HMG can chelate nitric oxide to reduce oxidative stress (Mason et 
al., 1999). Upon oxidation, neuroglobin, a heme protein similar to HMG, acts as a 
guanine nucleotide dissociation inhibitor (GDI) by inhibiting the rate of exchange of 
GDP for GTP (Wakasugi et al., 2003), thus leading to protection against apoptosis 
(Schwindinger and Robishaw, 2001).  Therefore, the increased specific carbonyl level of 
HMG observed in brain-aging possibly leads to functional alteration of HMG  and, thus, 
potentially to apoptosis in aged brains. However, such increased carbonyl level of HMG 
was decreased by treatment by LAC, consistent with the concept that LAC can reduce 
oxidative stress by diminution of the carbonyl level of HMG in brain aging, thus likely 
restoring HMG function and protecting neurons from apoptosis. 
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Figure D8 
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COF1 is a putative actin binding protein involved in the regulation of actin 
polymerization and depolymerization. COF1 is accumulated in the nucleus of senescent 
fibroblast cells (Kwak et al., 2004), suggesting that COF1 is altered as a function of age. 
Since actin polymerization and depolymerization are significant processes that are 
involved in neuronal plasticity and memory consolidation (Lamprecht and LeDoux, 
2004), increased oxidative modification of brain COF1 in old rats observed in our study 
may explain the increased susceptibility of age-related decline of cognition in aged 
animals. Our study shows that LAC treatment can decrease the oxidative modification of 
COF1;, therefore, one can speculate that LAC enhances the neuroprotective effect of 
COF1and promotes COF1-mediated ability to maintain neuronal plasticity.   
 ACT is a part of the cytoskeletal network responsible for cell structure and 
motility as well as synaptic plasticity in dendritic spines (Fischer et al., 1998; Matus, 
2000). Oxidative modification of ACT in the muscles of aged rats (Goto et al., 1999) and 
decreased levels of actin in aged cultured neurons indicate that the oxidation of ACT may 
accelerate its degradation as a function of age (Aksenova et al., 1999a). Consistent with 
this notion, we showed that ACT is oxidatively modified in the HP of old rats. The 
oxidative modification of ACT may lead to its structural alteration, thereby affecting 
actin filament architecture and leading to severe disarrangement of the cytoskeleton in 
aged brain. Moreover, structural alteration of ACT can impair neuronal plasticity, thus 
increasing the susceptibility of aged brains to age-related cognitive decline. However, in 
vivo LAC treatment decreases the oxidative modification of ACT, suggesting LAC 
protects aged HP by maintaining neuronal plasticity. 
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 ACO2 is a mitochondrial matrix enzyme involved in the Kreb’s cycle. Selective 
oxidation during aging (Yan et al., 1997; Das et al., 2001) and oxidative inactivation of 
ACO2 by peroxynitrite leads to mitochondrial dysfunction (Radi et al., 2002). Also, 
stress-mediated induction of ACO2 (Rzymkiewicz et al., 2000) suggests that increased 
expression of ACO2 is a compensatory response to its oxidative inactivation . Consistent 
with this notion, our current study show that protein level of ACO2 is increased in HP of 
old rats. However, LAC treatment reduces the increased expression level of ACO2 in 
aged brains, suggesting LAC modulates oxidative stress and may restore the normal 
mitochondrial functions. 
 IMP plays a significant role in the intracellular inositol level control by 
dephosphorylating inositol monophosphate to produce inositol (Atack, 1996), which can 
then be used to produce phosphatidyl inositol (PI) to activate the PI signal transduction 
pathway (Atack and Schapiro, 2002).  IMP activity is decreased in aged mice brains 
when compared to adult mice brains (Patishi et al., 1996). Decreased IMP activity could 
be brought about by the modification of the oxidation-sensitive thiol residues in IMP 
(Knowles et al., 1992).  Moreover, increased activity of IMP in the cerebral spinal fluid 
as a function of age suggests that active IMP is lost from the brains (Atack and Schapiro, 
2002). Taken together, the increased protein level of IMP in aged HP in the current study 
is possibly a compensatory response to its loss of activity, consistent with a possible 
altered function in brain aging.  LAC increased IMP expression even further in brain 
aging, consistent with a potential restoration of the PI signal transduction pathway in 
aged rat brain. 
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 ENO1 is the α subunit of enolase, the other subunits being β- and γ-enolase. αγ 
and γγ isoforms are called neuron-specific enolases (NSE) (Keller et al., 1994). 
Decreased enolase activity results in reduced metabolism in brains (Tholey et al., 1982). 
Also, the loss of the mitochondrial resident (α-ketoglutarate dehydrogenase complex, 
KGDHC)-enriched cells is proportional to the total loss of immunoreactivity to NSE, 
suggesting that enolase is not only involved in metabolism, but also in mitochondrial 
function (Ko et al., 2001). Additionally, the increased ENO1 specific carbonyl level in 
aged senescent-accelerated mice brains (Poon et al., 2004e) suggests oxidative 
inactivation of ENO1 as a function of age. Here, we show that the protein level of ENO1 
is significantly increased in HP of aged rats, suggesting the possibility that the increased  
level is a compensatory response to the loss of activity of enolase in brain aging.  
CK, which is highly sensitive to oxidation, is found in cytoplasm and 
mitochondria of cells to catalyze the reversible transfer of high energy phosphoryl 
between the ATP and creatine phosphate (Schlegel et al., 1990; Wallimann et al., 1992; 
Wyss et al., 1992; Kaldis et al., 1994). Three protein subunits of CK are designated M 
(muscle), B (brain), and Mi (mitochondrial), which form three dimeric cytosolic (MM, 
BB and MB) and distinct mitochondrial isoenzymes (Mi-CKs). It is also well established 
that oxidative inactivation of CK-B occurs in aging, AD and other neurodegenerative 
diseases (Hensley et al., 1995b; Aksenova et al., 1998; Aksenova et al., 1999b; Yatin et 
al., 1999; Aksenov et al., 2001; Castegna et al., 2002b). Moreover, the decreased 
expression of CK-B indicates that oxidative modification of this protein accelerates its 
degradation (David et al., 1998). Consistent with this notion, our study shows that levels 
of CK in aged rat brain is reduced significantly, and therefore likely affects its activity to 
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produce ATP. However, such reduction in CK expression was reversed by LAC 
treatment, suggesting LAC treatment can improve mitochondrial function, and therefore, 
ATP production in the HP of aged rats. 
TUB 1 is a structural protein that polymerizes to form microtubules of the 
cytoskeleton. TUB1 also interacts with metabotropic glutamate receptor 7, which 
mediates a variety of responses to glutamate in brains (Saugstad et al., 2002). Therefore, 
alterations of TUB 1 not only change the cytoskeleton and intercellular trafficking, but 
also changes the intercellular glutamate level control, thereby affecting interneuronal 
signaling and potentially promotes excitotoxicity. Consistent with the notion that level of 
TUB 1 is significantly decreased as a function of age (Nishibayashi et al., 1994), our 
current study shows that the level of TUB 1 was decreased in aged rat HP, suggesting 
that the alteration of tubulin contributes to alteration of the cytoskeleton and glutamate 
dysregulation in aged brains. 
 
Cortical proteins altered in oxidation level and expression level 
 CapZ is a subunit of an actin-binding protein that binds to the barbed end of actin 
filaments. CapZ regulates actin polymerization dynamics by attaching the actin filaments 
to the Z-line of myofibrils. CapZ also interacts with 5-hydroxytryptamine type 2C (5-
HT2C) receptors, which modulate a large variety of behavioral and physiological 
processes (Becamel et al., 2002). Since actin polymerization dynamics contribute to 
memory consolidation (Lamprecht and LeDoux, 2004), one can speculate that CapZ 
contributes to the receptor-mediated molecular learning and memory consolidation 
process. Here, we show that the CapZ expression is decreased as a function of age, 
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suggesting an impaired actin polymerization process, with possibly impaired learning and 
memory in aged subjects. Moreover, we showed that the decreased level of Cap Z in CX 
of old rats can be elevated by treatment of LAC, suggesting that LAC can improve the 
actin polymerization process, thus improving learning and memory in aged brains. 
 Guanosine diphosphate (GDP) dissociation inhibitor 2 (GDI 2) regulates the 
GDP/GTP exchange reaction of Rab proteins involved in vesicle transport. This process 
is critical to the release of synaptic vesicles in synapses. Therefore, GDI 2 may play a 
regulatory role in plasticity of neurotransmission (Ishizaki et al., 2000). Moreover, GDI 2 
is oxidatively modified in aged muscle (Kanski et al., 2003). Although no significant 
alteration was found in the aged brains in our current study, we found that LAC treatment 
can significantly reduce the level of GDI 2, suggesting that LAC regulates the plasticity 
of neurotransmission by altering the level of GDI 2. 
 UBQ is a polyubiquitin protein precursor that marks cellular proteins for 
degradation. UBQ is up-regulated by stress and proteasome inhibition (Noga and 
Hayashi, 1996). Increased UBQ deposits are observed in dystrophic neurites of both 
normal aging and AD brains (Migheli et al., 1992). Moreover, increased expression of 
UBQ in aged monkey brains suggest that UBQ up-regulation is a response to age-related 
oxidative stress (Schultz et al., 2001). Consistent with this notion, we found that mean 
protein expression of UBQ is increased by 41 % in cortex of aged rats, although 
statistical significance was not reached. However, following LAC treatment, a 
statistically significant diminution of UBQ levels were found, suggesting both that the 
level of UBQ had been raised in brain aging and that LAC treatment modulates the 
oxidative stress in the CX of old rats. 
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 Age-related oxidative stress induces heat shock proteins (HSP) in aged brains. 
HSP are molecular chaperones that mediate folding and assembly of other proteins (Poon 
et al., 2004a). HSP-70 protects neurons against apoptosis by inhibiting the activation of 
the caspase cascade (Mosser et al., 1997). HSC 70, the constitutive isoforms of HSP 70, 
is recruited by the cell as a primary defense against stress conditions. HSC 70 is involved 
in the degradation of misfolded proteins by binding to a particular peptide region and 
labeling it for proteolysis (Kouchi et al., 1999). Therefore, it was suggested that HSC 70 
may be involved in the structural maintenance of proteins by coupling with the 
proteasome (Kouchi et al., 1999).  Alteration of HSC 70 and HSP 70 in aged brains is 
well established (reviewed in (Calabrese et al., 2003)). Moreover, the diminished activity 
of HSC 70 in aging was suggested to be compensated by increased expression (Cuervo 
and Dice, 2000). The decreased activity is believed to be brought about by oxidative 
modification of HSC 70 (Castegna et al., 2002a). Consistent with this idea, the current 
study suggests that HSC 70 was oxidatively modified in the CX of old rats when 
compared to that in young rats (p<0.05). This result is consistent with the notion that 
oxidative inactivation of HSC 70 in aged brains may cause impaired protein degradation 
and lead to accumulation of aggregated proteins, thereby increasing susceptibility to age-
related cognitive decline. LAC treatment reduces the mean specific carbonyl level of 
HSC 70, albeit not at a statistically significant level, potentially protecting brains from 
age-related cognitive decline. 
 GOL 1 exhibits lactoylglutathione lyase activity that detoxifies toxic compounds. 
Some of these toxic compounds are produced by the action of reactive oxygen species 
(ROS) on biological molecules (Amicarelli et al., 1999). Hypoxia-induced oxidative 
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stress impairs the activity of GOL 1 (Amicarelli et al., 1999), while antioxidant treatment 
can enhance the activity of GOL 1 as well as reducing oxidative stress parameters 
(Nagaraj et al., 2002), indicating oxidative modification could inactivate GOL 1. 
Together, one can speculate that oxidative inactivation of GOL 1 is due to the age-related 
oxidative stress. Consistent with this notion, the current study demonstrated increased 
oxidative modification of GOL 1 in brain aging, suggesting the detoxification of toxic 
species in aged CX is impaired. This would lead to accumulation of toxic species and 
potentially neuronal death. Although not statistically significant, LAC treatment reduced 
the oxidative modification of GOL 1, putatively improving its activity and reducing the 
level of toxic species in aged brains. 
 MPST catalyzes the transfer of a sulfur ion from mercaptopyruvate to 
mercaptoethanol. This reaction is especially important in regulation of the glutathione 
level (Wrobel et al., 2000). The involvement of MPST in antioxidant metabolism is 
manifested by its increased expression response to oxidative stress (Williams et al., 
2003). Our study shows that MPST is oxidatively modified and possibly inactivated in 
aged CX, suggesting decreased antioxidant metabolism in aged CX. Consistent with this 
notion, the glutathione level is also decreased in aged brains (Liu and Mori, 1993). Lower 
levels of glutathione, possibly due in part to oxidative inactivation of MPST, not only 
leads to loss of a reducing cellular component, but also could affecting expression and 
activity of protective enzymes. 
 PDX is an oxidative stress-inducible antioxidant protein with peroxidase and 
heme-binding activities. PDX is also involved in heme metabolism (Iwahara et al., 1995). 
This enzyme is essential to cellular antioxidant defense (Neumann et al., 2003) and 
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serves as a redox-regulating molecule against oxidative stress in aging (Yoshida et al., 
2003). Our proteomics analysis demonstrated increased oxidative modification of PDX in 
CX of old mice, suggesting that redox regulation and antioxidant defense in aged rat CX 
is possibly impaired by PDX oxidative inactivation, thus protecting aged brains from 
oxidative damage and subsequent cognitive decline. 
 PRPPS1 produces phosphoribosyl pyrophosphate that is required for de novo 
purine and pyrimdine biosynthesis. Mutations in PRPPS1 cause neurological impairment 
(Roessler et al., 1993), indicating the activity of PRPPS1 is important to the proper 
function of the CNS. Here, we show that oxidative modification of PRPPS1 in brain 
aging could possibly inactive this enzyme and decrease the availability of phosphoribosyl 
pyrophosphate, which is both a substrate and activator of the de novo and salvage 
pathways of purine and pyrimidine synthesis (Kunjara et al., 1993). Therefore, oxidative 
modification of PRPPS1 may be related to impaired RNA and protein synthesis necessary 
for neuroplasticity observed in aged rats (Finch and Morgan, 1990; Rattan, 1996). 
 FUM catalyzes the hydration of fumarate to L-malate in the Kerb’s cycle. Severe 
neurological impairment caused by FUM deficiency suggests that FUM is essential for 
the integrity of the CNS (Coughlin et al., 1998). FUM contains an iron-sulfur cluster 
active site that is sensitive to oxidative modification (Pan and Imlay, 2001). Therefore, 
the oxidative modification of FUM shown in our proteomics study may inactivate the 
enzyme and cause decreased ATP production, thus impairing the CNS functions in aged 
brains. The addition of exogenous thioredoxin to FUM in mitochondria displays a 
protective effect against oxidative stress (Ejima et al., 1999). Similarly, using LAC 
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treatment can reduce oxidative stress and the oxidative modification of FUM, though not 
statistically significant, thereby potentially improving cortical functions. 
Summary of findings 
The proteins identified in our study are involved in three impaired processes in 
aged brains: antioxidant, mitochondria function and plasticity (Fig E8). Impaired 
antioxidant capacity increases oxidative stress and cellular dysfunction (reviewed (Poon 
et al., 2004a, b)).  Mitochondrial dysfunction mediates increased oxidative stress and 
apoptosis cascades as well as impaired energy metabolism (Cottrell and Turnbull, 2000). 
Impaired plasticity leads to age-related learning and memory deficits (Castorina and 
Ferraris, 1994). All of these processes contribute to the functional decline of the CNS in 
aged subjects (Rattan, 1996; Cottrell and Turnbull, 2000; Foster and Kumar, 2002). 
Treatment by LAC can improve the decline of these functions. Evidence shows that 
oxidative stress is reduced and antioxidant levels are increased in aged brains treated with 
LAC (Paradies et al., 1999; Sharman et al., 2002). Furthermore, improvement of 
mitochondrial dysfunction by LAC is well established and recently reviewed (Hagen et 
al., 1998b; Hagen et al., 1998a). Moreover, LAC improves neuronal plasticity, thus 
ameliorating learning and memory deficits in aged brains (Castorina and Ferraris, 1994; 
Liu et al., 2002; Yasui et al., 2002). Therefore, our results support the point of view that 
treatment of LAC reduces oxidative stress by improving antioxidant defense and 
mitochondrial function in the CNS, thereby improving the neuroplasticity and learning 
and memory deficits in aged subjects.  Moreover, we pinpoint that the improved 
antioxidant, mitochondrial function and plasticity by LAC treatment in aged brain is, at 
least partially, due to the alteration of the oxidation or the expression of ACT, COF, 
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CapZ, GDI, PRPP1, TUB, HMG, UBQ, HSC70, GOL 1, MPST, PRDX, MPST, ACO2, 
IMP, ENO 1,CK, FUM. To our knowledge, this is the first study to identify specific 
protein targets in HP and CX in brain aging and those proteins that are positively affected 
by LAC in brain aging.  Our results provide a valuable insight into the mechanism of age-
related protein oxidation and the effect of LAC on oxidative stress reduction and 
functional improvements in the HP and CX of aged brains. We posit that LAC should be 
considered as a potential therapeutic contributor for the treatment of cognitive decline in 
aging and age-related neurodegenerative disorders.  
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Appendix E 
 Proteomics Analysis provides Insight into Caloric Restriction Mediated Oxidation 
and Expression of Brain Proteins Associated with Age-Related Impaired Cellular 
Processes: Mitochondrial dysfunction, Glutamate Dysregulation and Impaired 
Protein Synthesis 
E1 Introduction 
Age-related impairment of functionality of the central nervous system (CNS) is 
associated with increased susceptibility to the development of many neurodegenerative 
diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic 
lateral sclerosis (ALS). The free radical theory of aging postulates that free radical 
reactions with biomolecules, such as proteins and lipid membranes, are responsible for 
the functional deterioration related to aging (Harman, 1969). This theory was later refined 
to include the concept that mitochondria play a key role in aging acting as the major 
source and target of oxidants (Miquel et al., 1980).  It was proposed that there is a 
correlation between mitochondrial oxidant production and longevity in mammalian 
species (Miquel et al., 1980). Interestingly, caloric restriction (CR) can increase life span 
and resistance to various age-related disorder in rodents (Review in (Koubova and 
Guarente, 2003)).  
In the CNS, evidence shows increased oxidative stress in aged animals when 
compared to that in young animals (Floyd, 1999; Poon et al., 2004a, b).  Mitochondrial 
dysfunction plays a significant role in this increased oxidative damage. Injured 
mitochondrial enzymes in aged animal lead to increased oxidative stress (Ventura et al., 
2002). Mitochondria in aged animals are enlarged with vacuolization, cristae rupture and 
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the accumulation of paracrystalline inclusions (Floyd, 1999), consistent with the notion 
that mitochondria are targets of increased oxidative stress in aged brains (Sastre et al., 
2003).  Also, mitochondrial decay is a main contributor of accelerated aging (Atamna et 
al., 2002; Ames, 2003). Age-related increase in mtDNA deletion (common deletion) was 
found in elderly brains (Ozawa et al., 1990), causing diminished mitochondrial 
bioenergetics diminishment in aged brains (Barja, 1999). Such increased oxidative stress 
and mitochondrial dysfunction cause oxidation of proteins, thereby leading to their 
dysfunction in most cases (Agarwal and Sohal, 1994; Agrawal et al., 1996; Butterfield et 
al., 1997; Aksenova et al., 1998; Sohal et al., 2002; Butterfield, 2004). However, 
oxidation of proteins during aging and age-related neurodegenerative disorders is rather 
specific (Stadtman, 1992; Agarwal and Sohal, 1994; Agrawal et al., 1996; Butterfield and 
Stadtman, 1997; Stadtman, 2001; Castegna et al., 2002b; Castegna et al., 2002a; Castegna 
et al., 2003; Keller et al., 2004; Poon et al., 2004e). It is well established that CR can 
reduce age-related oxidative stress (Sohal and Weindruch, 1996; Lass et al., 1998; 
Parsons, 2000; Pamplona et al., 2002; Koubova and Guarente, 2003) and protein 
oxidation in brains (Dubey et al., 1996; Guo et al., 2000a; de Oliveira et al., 2003). Along 
with reduced protein oxidation,  CR is also believed to contribute to the improvement of 
age-related learning and memory deficit (Ingram et al., 1987; Moroi-Fetters et al., 1989), 
as well as the improvement of the plasticity and recovery of the CNS (Mattson, 2000a).  
Although the beneficial effects of CR on brains are well established, the 
mechanism(s) of its action remains unclear. Two general mechanisms were proposed: (1)  
CR reduces mitochondrial metabolism, thus decreases the level of mitochondrial radical 
production, or (2) CR induces mild metabolic stress response by an increased production 
 346
of neurotrophic proteins, therefore priming neurons against apoptosis (Mattson, 2000b; 
Koubova and Guarente, 2003). In order to gain insight into the beneficial effects of CR 
on oxidative stress, we located the brain regions that are benefited the most from reduced 
oxidation. Then we used the non-biased based parallel proteomics approaches to identify 
the proteins that are altered in oxidation and expression in these brain regions of CR aged 
rats when compared to those in age control rats.     
E2 Experimental procedures 
Subjects 
 All animal protocols were approved by the University of Catania Laboratory 
Animal Care Advisory Committee (Prot. Number 8488). Male Wistar rats purchased from 
Harlan (Udine, Italy) were maintained in a temperature and humidity-controlled room 
with a 12-h light:dark cycle and divided in two experimental groups. Control rats were 
fed ad libitum up to 28 months of age a certified diet prepared according to the 
recommendations of the AIN (In 100g of ad linitum, 53g Dextrin-Maltose, 25g oil 
mixture, 22g casein, with additional 0.5g methionine, 3.5g salt mixture and 1.2g vitamin 
mixture). The CR group, received at 12 months of age up to 28 months the same diet 
except for a lower caloric intake. CR regimen was accomplished starting at month 12 and 
continued until sacrifice, according to the “alternate day feeding” method, which is 
equivalent to a reduction of caloric intake to about 60% compared to the `ad libitum´ fed 
controls of the same age (Goodrick et al., 1983). In brief: the food was available all the 
time for the ad libitum fed controls, while it was given every two days and remained 
available for 24 h. Both groups were fasted for one day before scarified. Caloric restricted 
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old rats weighed significantly less (-57%) compared to old rats fed normal caloric diet (p 
<0.001). 
Sample Preparation and Methods Employed 
The brain samples were homogenized in a lysis buffer (10 mM HEPES, 137 mM 
NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4) and containing protease inhibitor 
leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 µg/mL), and  PMSF 
(40 µg/mL). Homogenates were centrifuged at 15,800 g for 10 min to remove debris. The 
supernatant was extracted to determine the concentration by the BCA method (Pierce, 
IL).  
Immunochemistry  
Levels of 3-nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) and protein carbonyls 
were determined immunochemically as previously described (Poon et al., 2004d). Protein 
carbonyl levels were determined as adducts of 2,4-dinitrophenylhydrazine (DNPH) 
(Stadtman, 1992; Aksenov et al., 1997). The 2,4-dinitrophenyl hydrazone (DNP) adduct 
of the carbonyls is detected on nitrocellulose paper using a primary rabbit antibody 
(Intergen) specific for DNP-protein adducts (1:100). HNE and 3-NT levels were 
determined in the same manner. The HNE levels were detected using a primary rabbit 
antibody (Alpha Diagnostics) specific for HNE-modified protein (1:8000) and the 3-NT 
levels were detected by primary rabbit antibody (Chemicon) specific for 3-NT (1:100). 
The same secondary goat anti-rabbit IgG (Sigma) antibody was used in all applications. 
The resultant stain was developed by application of Sigma-Fast (BCIP/NBT) tablets; and 
the line densities were quantified by Scion-Image software package. 
Two-dimensional gel electrophoresis  
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Samples of the proteins in the whole brains were prepared as previously described 
(Poon et al., 2004e). Briefly, 200μg of protein were applied to a pH 3-10 ReadyStrip™ 
IPG strip (Bio-Rad, Hercules, CA) for isoelectric focusing and Linear Gradient (8-16%) 
Precast criterion Tris-HCl gels (Bio-Rad) were used to separate proteins according to 
their molecular weight (MrW). Sypro Ruby stain was used to stain the gel for 2 hours, 
following which the gels were placed in deionized water overnight for destaining. 
Western Blotting 
 Western blotting for 2D gels was performed as previously described (Poon et al., 
2004e). 200μg of the brain protein were incubated with 10mM 2,4-dinitrophenyl 
hydrazine (DNPH) solution (2N HCl) at room temperature (25°C) for 20 min. No 
derivitization step is preformed for the measurement of the protein 3-NT levels. The gels 
were prepared in the same manner as for 2D-electrophoresis. The proteins from the 
second dimension electrophoresis gels were transferred onto nitrocellulose paper (Bio-
Rad) using a Transblot-Blot® SD semi-Dry Transfer Cell (Bio-Rad) at 15V for 2 hrs. The 
2,4-dinitrophenyl hydrazone (DNP) adducts of the carbonyls and the 3-NT of the brain 
proteins were detected immunochemically. 
Image Analysis 
 The gels and nitrocellulose blots were scanned and saved in TIF format using a 
Storm 860 Scanner (Molecular Dynamics) and Scanjet 3300C (Hewlett Packard), 
respectively. PDQuest (Bio-Rad) was the software used for matching and analysis of 
visualized protein spots among differential gels and oxyblots.  After completion of spot 
matching, the normalized intensity of each protein spot from individual gels (or oxyblots) 
was compared between groups using statistical analysis.   
 349
Trypsin digestion 
Samples were digested using the techniques previously described (Poon et al., 
2004e). Briefly, the selected protein spots were excised and washed with ammonium 
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The gel pieces were 
digested with 20 ng/µl modified trypsin (Promega, Madison, WI) and incubated at 37°C 
overnight in a shaking incubator. 
Mass Spectrometry 
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast 
evaporation nitrocellulose matrix surface and analyzed with a TofSpec 2E (Micromass, 
UK) MALDI-TOF mass spectrometer in reflectron mode. The mass axis was adjusted 
with trypsin autohydrolysis peaks (m/z 2239.14, 2211.10, or 842.51) as lock masses. The 
MALDI spectra used for protein identification from tryptic fragments were searched 
against the NCBI protein databases using the MASCOT search engine 
(http://www.matrixscience.com). Peptide mass fingerprinting used the assumption that 
peptides are monoisotopic, oxidized at methionine residues and carbamidomethylated at 
cysteine residues.  Up to 1 missed trypsin cleavage was allowed. Mass tolerance of 150 
ppm was the window of error allowed for matching the peptide mass values. Such search 
results in a probability-based Mowse score for each spectrum to indicate the probability 
that the match between the database and the spectra is a random event. Such a probability 
is 10 (-Mowse score/10). 
  
Statistics 
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The averages of specific carbonyl level, specific 3-NT level and protein level 
obtained from individual CR rats were compared with the averages of age-matched 
control by Student's t tests. A value of p < 0.05 was considered statistically significant. 
Only the proteins in CR aged brains that were significantly different from age matched 
control brains assessed by the Student’s t-test were selected for identification. Similar 
statistical analysis are usually used for proteomics data analysis (Castegna et al., 2002b; 
Korolainen et al., 2002; Maurer et al., 2005). Sophisticated statistical analysises for 
microarray data are not compatible for proteomics data (Boguski and McIntosh, 2003; 
Maurer et al., 2005). 
 
E3 Results 
 In order to locate the brain regions that are mostly affected by protein oxidation 
by CR, we measured the bulk protein 3-NT, HNE and carbonyl levels of cortex (CX), 
substantia nigra (SN), septum pellucidum (SP), striatum (ST), hippocampus (HP) and 
cerebellum (CB).  We found that CR generally reduces protein oxidation in all aged rat 
brain regions. However, only certain brain regions of the aged rats show statistically 
significant decrease in oxidative modification by CR. Aged rats with CR show significant 
decreases in protein carbonyl levels in SN (32%) and ST (19%) compared to those of age 
matched controls (Fig. E1). With regard to protein-bound HNE levels, significant 
decreased values are observed in CX (13%) and HP (12%) of aged rats with CR (Fig. 
E2). We also show a significant reduction of protein 3-NT levels in SN (26%) and HP 
(38%) of aged rats with CR (Fig. E3). 
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Figure E1 
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Figure E2 
 
 353
Figure E3 
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 In the HP of CR rats, the specific 3-NT levels of three proteins, malate 
dehydrogenase (MDH), phosphoglycerate kinase 1 (PKG1) and 14-3-3 zeta protein (14-
3-3Z), are significantly decreased (Table E1). Figure E4 shows these proteins on the 
representative 2D western blots of the HP for CR rat and age matched control. Moreover, 
expression levels of four proteins were significantly decreased in the HP of CR aged rats. 
These proteins are DLP1 splice variant 1 (DLP1), mitochondrial aconitase (ACO2), 
dihydrolipoamide dehydrogenase (DLDH), neuroprotective peptide H3 (NPH3), and 
eukaryotic translation initiation factor 5A (eIF-5A). Also, the expression level of an 
unnamed protein product (UNP1) was decreased (Table E2). This protein is indicated in 
the rat genome and shows a similar sequence to elongation factor 2 (EF-2). However, the 
function and additional information are yet to be discovered. Figure E5 shows these 
proteins on the representative 2D electrophoresis gels of the HP of CR rat and aged 
match control.  
   In the ST of CR rats, the specific carbonyl levels of six proteins were decreased. 
These proteins are pyruvate kinase M2 (PKM2), α-enolase (ENO1), inositol 
monophosphatase (INSP1), and F1-Atpase Chain B (ATP-F1B) (Table E3). Fig E6 
indicates these proteins on the representative 2D western blots of the ST of CR rat and 
aged match control. Moreover, expression levels of phosphoglycerate kinase 1 (PKG1), 
inosine monophosphate cyclohydrolase (IMPCH) and F1-Atpase Chain A (ATP-F1A) 
were significantly increased in the ST of CR rats (Table E4). Fig E7 indicates these 
proteins on the representative 2D electrophoresis gels of the ST of CR rat and aged match 
control.  
 355
 Table E1: Proteins with decreased 3-NT levels in HP of CR aged rats. 
Protein 
Control 
(n=5) 
A.U. ± S.E.M.* 
CR 
(n=5) 
A.U. ± S.E.M.* 
Fold 
Change p value 
malate 
dehydrogenase 
(MDH) 
0.418 ± 0.127 0.099 ± 0.046 4.2 ↓ p < 0.05 
phosphoglycerate 
kinase 1 (PKG1) 0.392 ± 0.056 0.081 ± 0.013 4.8 ↓ P < 0.001 
14-3-3 Zeta protein  0.028 ± 0.010 0.010 ± 0.002 2.8 ↓ p < 0.0005 
* A.U., arbitrary unit obtained from the ratio of specific 3-NT level and protein level. 
S.E.M., standard error of mean  
 
 356
Figure E4 
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Table E2: Altered protein levels in HP of CR aged rats. 
 
Protein 
Control 
(n =6) 
A.U. ± S.E.M.*
CR 
(n=6) 
A.U. ± S.E.M.* 
Fold 
Change p value 
DLP1 splice variant 1 
(DLP1) 466 ± 53 257 ± 48 1.8 ↓ p < 0.05 
mitochondrial aconitase 
(ACO2) 1839 ± 277 720 ± 247 2.6 ↓ p < 0.05 
Dihydrolipoamide 
dehydrogenase (DLDH) 2395 ± 195 1240 ± 168 1.9 ↓ p < 0.005 
Neuroprotective peptide 
H3 (NPH3) 2143 ± 221 994 ± 207 2.2 ↓ p < 0.01 
similar to Eukaryotic 
translation initiation 
factor 5A (eIF-5A) 
5251 ± 615 2477 ± 648 2.1 ↓ p < 0.05 
unnamed protein 
product 1 (UNP 1) 638 ± 103 951 ± 37 1.5 ↑ p < 0.05 
* A.U., arbitrary unit obtained from indicating protein level. S.E.M., standard error of 
mean  
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Figure E5 
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 Table E3: Proteins with decreased specific carbonyl levels in ST of CR aged rats. 
Protein 
Control 
(n=6) 
A.U. ± S.E.M.* 
CR 
(n=5) 
A.U. ± S.E.M.* 
Fold 
change p value 
pyruvate kinase M2 
(PKM2) 0.454 ± 0.217 0.016 ± 0.010 28 ↓ p = 0.05 
α-enolase (ENO1) 0.489 ± 0.242 0.003 ± 0.001 163 ↓ p = 0.05 
Inositol 
monophosphatase 
(INSP1) 
1.560 ± 0.413 0.415 ± 0.133 4 ↓ p < 0.05 
F1-ATPase Chain B 
(ATP-F1B) 2.10 ± 0.98 0.016 ± 0.007 131 ↓ p < 0.05 
 
* A.U., arbitrary unit obtained from the ratio of specific carbonyl level and protein level. 
S.E.M., standard error of mean  
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Figure E6 
 
 
 361
 Table E4: Altered proteins levels in ST of CR aged rats. 
Protein 
Control 
(n=6) 
A.U. ± S.E.M.* 
CR 
(n=5) 
A.U. ± S.E.M.* 
Fold 
Change p value 
phosphoglycerate 
kinase 1 (PGK1) 1433 ± 303 421 ± 33 3.4 ↓ p < 0.05 
F1-ATPase Chain A 
(ATP-F1A) 1243 ± 141 556 ± 68 2.2 ↓ p < 0.005 
Inosine 
monophosphate 
cyclohydrolase 
(IMPCH) 
549 ± 191 10 ± 1 54.9 ↓ p < 0.05 
 
 
* A.U., arbitrary unit obtained from indicating protein level. S.E.M., standard error of 
mean  
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Figure E7 
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  The identifications of the proteins were performed by matching the obtained mass 
spectrum to the spectrum in the NCBI database. The Mowse score indicates the 
probability that the match is a random event; high Mowse score indicates the match is 
unlikely to be a random event. Prior results suggest that the accuracy of protein 
identification by mass spectrometry is equivalent to immunochemical identification and 
immunochemical identification confirmed the identification (Castegna et al., 2002b). The 
identification of the proteins is summarized in Table E5.  
  
E4 Discussion 
 Consistent with other laboratories (Dubey et al., 1996; Radak et al., 1998; Forster 
et al., 2000), we show that oxidative modification of proteins (indicated by the protein 
carbonyl, 3-NT, and HNE levels) is generally decreased in all brain regions of CR aged 
rats when compared to those of the age matched control. It is possible that reduction of 
oxidative stress parameters could be in part due to effects of metal ions, particularly iron 
ion, since elevated non-heme iron in the aged brain is attenuated by CR (Cook and Yu, 
1998).  
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Table E5: Summary of proteins identified by mass spectrometry 
Identified Protein gi accession # 
# Peptides 
matched 
 
% Coverage 
of matched 
peptides 
pI, MrW 
(kD) 
Mowse 
Score 
Probability 
of a random 
identification hit
malate dehydrogenase 
(MDH) 
gi|42476181 8 36 8.93, 36.1 94 3.98 X 10 -10
phosphoglycerate 
kinase 1 (PGK1) (HP) 
gi|40254752 19 58 8.02, 44.9 160 1.00 X 10-16
14-3-3 zeta protein gi|13487931 16 64 4.73, 28.0 123 5.01 X 10-13
DLP1 splice variant 1 
(DLP1) 
gi|2435480 4 42 5.64, 13.3 64 3.98 X 10-07
mitochondrial 
aconitase (ACO2) 
gi|40538860 19 27 7.87, 86.1 224 3.98 X 10-23
Dihydrolipoamide 
dehydrogenase 
(DLDH) 
gi|40786469 13 32 7.96, 54.6 75 3.16 X 10-08
Neuroprotective 
peptide H3 (NPH3) 
gi|8393910 10 74 5.48, 20.9 97 2.00 X 10-10
similar to Eukaryotic 
translation initiation 
factor 5A (eIF-5A) 
gi|27672956 4 47 5.08, 17.0 62 6.31 X 10-07
unnamed protein 
product 1 (UNP1) 
gi|56082 6 8 N/A 62 6.31 X 10-07
 Table 5 continued on the next page.
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 Table E5: Summary of proteins identified by mass spectrometry (Contiuned) 
Identified Protein gi accession # 
# Peptides 
matched 
 
% Coverage 
of matched 
peptides 
pI, MrW 
(kD) 
Mowse 
Score 
Probability 
of a random 
identification hit
pyruvate kinase M2 
(PKM2) 
gi|206205 12 28 7.15, 58.3 72 6.31 X 10-08
α-enolase (ENO1) gi|22096350 20 59 5.84, 47.5 195 3.16 X 10-20
Inositol 
monophosphatase 
(INSP1) 
gi|14091736 9 36 5.17, 30.8 87 2.00 X 10-09
F1-ATPase Chain B 
(ATP-F1B) 
gi|6729935 17 57 4.95, 51.3 196 2.51 X 10-20
phosphoglycerate 
kinase 1 (PGK1) (ST) 
gi|40254752 16 48 8.02, 44.9 169 1.26 X10 -17
F1-ATPase Chain A 
(ATP-F1A) 
gi|6729934 16 43 8.28, 55.4 196 2.51 X10 -20
Inosine 
monophosphate 
cyclohydrolase 
(IMPCH) 
gi|2541906 10 24 6.72, 64.7 76 2.51 X10 -08
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 Among the brain regions, HP shows a dramatic decrease in protein carbonyl, 
HNE and 3-NT levels in CR aged rats brains even though the decrease of the protein 
carbonyl level is not statistically significant. The vulnerability to age-related protein 
oxidation and structural changes of HP in brain are well established (Dubey et al., 1996; 
Aksenova et al., 1998; Miller and O'Callaghan, 2003). Also, CR imposes a significant 
reduction of protein oxidation in HP of rats (Dubey et al., 1996; Aksenova et al., 1998). 
Since HP in the CR aged rats shows the most significant decrease (38%) of the protein 3-
NT level and is relevant to Alzheimer’s disease (AD) pathology (Kantarci and Jack, 
2003), we used parallel proteomic analysis to specifically identify the proteins that were 
decreased in specific 3-NT levels as well as those with the altered expression. Although 
tyrosine nitrosylation is a formal oxidation of the protein, it should be noted that 
nitrosylation of proteins is not only determined by ROS levels but is also affected by 
NOS activity. Thus, 3-NT is not simply reflective of ROS, but also reflects RNS.  
Moreover, we used the same technique to identify the proteins with reduced specific 
carbonyl levels or altered expression levels in ST of CR aged brains, because ST is 
another brain region that is vulnerable to protein oxidation and lipid peroxidation (Zhang 
et al., 1994; Driver et al., 2000), and relevant to age-related neurodegenerative disorders 
such as PD and Huntington’s disease (HD)(Golembiowska et al., 2002; Levesque et al., 
2003). 
 Although SN of CR rats show significant decrease of specific carbonyl and 3-NT 
levels when compared to the aged match controls, limited amount of proteins are 
harvested from SN due to the small size of SN. Therefore, parallel proteomic analysis of 
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SN is not possible. Also, proteomic analysis of HNE-modified protein is not performed 
because the majority of the HNE-modified proteins are membrane proteins that cannot be 
easily dissolved in solution for 2D-electrophoresis.    
HP 
 HP plays an important role in both memory and learning. Age-related increased 
oxidative stress in HP of aged animals causes structural alteration (Dubey et al., 1996; 
Aksenova et al., 1998; Miller and O'Callaghan, 2003).  Moreover, synaptic loss and 
increased protein oxidation in HP is the major pathology of AD (Scheff and Price, 2003). 
Consistent with the notion that CR can reduce protein oxidation in HP of aged rats 
(Dubey et al., 1996; Aksenova et al., 1998), we show that the 3-NT levels of HP is 
significantly decreased in HP of CR aged rats when compared to age matched control. 
Furthermore, we identified that the specific proteins that are reduced in 3-NT levels are 
MDH, PKG1 and 14-3-3 zeta protein. Along with the reduced 3-NT level, the expression 
of DLP1, ACO2, DLDH, NPH3, eIF-5A and UNP1 are also significantly altered in HP of 
CR rats.  
 PGK1 catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate 
in glycolysis, and MDH is located within the mitochondrial matrix to connect glycolysis 
to mitochondrial respiration. Both of these reactions convert ADP to ATP to ensure 
maximum glutamate accumulation into presynaptic vesicles. Moreover, activity of these 
enzymes are decreased during aging (Oliver et al., 1987; Hrachovina and Mourek, 1990), 
possibly due to oxidative modification (Oliver et al., 1987). Consistent with this notion, 
increased protein levels of PGK1 as a function of age (Boraldi et al., 2003) maybe a 
compensatory response to oxidative stress. Our study shows that reduced nitration of 
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MDH in HP of aged rats by CR indicates that the CR-induced activity increase is 
possibly due to reduced nitration of MDH and the  reduced  3-NT level in HP of aged 
rats, indicating that CR can possibly increase PGK1 activity in HP of this important 
region in aged rats. Both of these changes result in increasing ATP availability, synaptic 
plasticity, learning and memory, antioxidant defense and neuronal recovery as well as 
preventing neuronal cells from glutamate toxicity.    
 ACO2 and DLDH (E3 component of pyruvate dehydrogenase complex, and α-
ketoglutarate dehydrogenase) are mitochondrial matrix enzymes involved in the Kreb’s 
cycle. Age-related activity alteration (Leong et al., 1981; Ksiezak-Reding et al., 1984; 
Rajeswari and Radha, 1984; Curti and Benzi, 1989, 1990; Yan et al., 1997; Das et al., 
2001) and oxidative inhibition (Radi et al., 2002; Kumar et al., 2003; Samikkannu et al., 
2003) of these enzymes are observed. Also stress-mediated increased expression of 
ACO2 is observed, suggesting that increased expression of ACO2 is a compensatory 
response to its oxidative inactivation. In our current study, we show that CR decreased 
the level of ACO2 and DLDH in HP of aged rats, indicating the loss of the compensatory 
response to oxidative stress is likely due to the improvement of normal mitochondrial 
functions that are brought about by CR-mediated oxidative stress release. 
 Increased protein levels of PGK1 as a function of age (Boraldi et al., 2003) maybe 
a compensatory response to oxidative stress. Here we show that CR can reduce the 3-NT 
level in HP of aged rats, indicating that CR can possibly increase PGK1 activity in HP of 
this important region in aged rats, thus increasing ATP availability as well as preventing 
neuronal cells from glutamate toxicity.  
 369
 14-3-3Z  protein is involved in a number of cellular functions including signal 
transduction, protein trafficking and metabolism and mitochondrial import (Alam et al., 
1994; Dougherty and Morrison, 2004).  Oxidative insults cause dissociation of 14-3-3 
complex and activate JNK and p38 pathways, thus initiating apoptosis (Goldman et al., 
2004). Here we show that CR can reduce the oxidative modification of 14-3-3Z, thus 
maintaining normal cell functions and preventing apoptosis in aged brains.  
 DLP1 is a novel dynamin-like protein expressed in rat tissues. Dynamin is 
involved in receptor-mediated endocytosis and intercellular trafficking. Since dynamin 
interacts with phosphatidylinositol 3-kinase (PI3K) (Harrison-Findik et al., 2001),  it is 
likely in signaling and in addition may possibly promote apoptosis. Moreover, altered 
endocytic function in dendrites in older neurons is associated with the increased level of 
dynamin (Blanpied et al., 2003). Taken together, increased level of dynamin or DLP1 
alters intercellular trafficking and initiates apoptosis in neuronal cells. Our current study 
shows that CR can possibly prevent these alterations by decreasing the protein level of 
DLP1, thus protecting cells from apoptosis.   
 NPH3 is involved in various functions in the CNS, such as binding to 
phosphatidylethanolamine, enhancing acetylcholine synthesis and inhibiting Raf-kinase. 
This protein also acts as a lipid carrier and binding protein that plays a significant role in 
membrane organization (Frayne et al., 1998), a process that is critical to mitochondrial 
integrity. The mRNA and protein levels of NPH3 are significantly increased in aged 
human HP and senescence-accelerated mice (Matsukawa et al., 1999; Yuasa et al., 2001). 
Therefore, up-regulation of NPH3 as a function of age is a likely response to oxidative 
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stress. In our current study, CR reduces oxidative stress; thus, a decreased level of NPH3 
in aged CR mice when compared to their age controls are observed.  
 eIF-5A is a translation initiation factor that is involved in the initiation of protein 
synthesis. Since eIF-5A plays a pivotal role in regulation of protein synthesis, it is an 
important determinant of cell proliferation and senescence (Thompson et al., 2004). 
Inhibition of eIF-5A induces apoptosis (Tome et al., 1997), indicating that the eIF-5A 
activity is critical to normal cell functions. However, inactivation of eIF-5A by chemical 
modification inhibits cell growth and diminishes 30% of protein synthesis (Kang and 
Hershey, 1994). This study reflects that eIF-5A is required for translation of specific 
mRNAs selectively. Our current study shows that the impaired protein synthesis in aged 
brains (Finch and Morgan, 1990; Sastre et al., 2003) was possibly improved by increased 
eIF-5A protein levels in the HP of the CR rats.  This change thereby provides sufficient 
protein in neuronal cells for normal cell function in CR aged rats to compensate the 
impaired protein synthesis in aged brains. 
 UNP1 is identified as a protein that shares high similarity to the primary structure 
of elongation factor 2(EF-2), an enzyme that catalyzes the translocation step of peptide 
elongation in protein biosynthesis. UNP1 (pI = 8, Mw = 96kD) shows a slightly higher 
molecular weight (Mw) and dramatic shift of isoelectric point (pI) when compared to EF-
2 (pI = 6.65, Mw = 95kD). Interestingly, these Mw and pI alterations are also observed in 
oxidatively modified protein (Weber et al., 2004). Therefore, UNP1 is possibly the 
oxidized form of EF-2 and a decreased level of UNP1 could implicate less inactive forms 
of EF-2. Since oxidative modification of EF-2 contributes to the impaired protein 
synthesis in aged rat brains (Finch and Morgan, 1990; Parrado et al., 1999; Sastre et al., 
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2003), we speculate that our study may imply that EF-2 modification is possibly reduced 
by CR, thus restoring the normal protein syntheses protein process in aged brains. 
ST 
 The ST is best known for its role in movement, but it is also involved in a variety 
of other cognitive processes involving executive function. ST show increased protein 
oxidation and lipid peroxidation as a function of age(Zhang et al., 1994; Driver et al., 
2000). Moreover, increased oxidative stress is observed in the ST of PD and HD patients 
(Review in (Babior, 1999; Browne et al., 1999; Jenner, 2003)). These studies indicate that 
age-related protein oxidation plays critical roles in the impaired function of ST. However, 
CR can modulate these oxidative stresses in ST (Dubey et al., 1996; Bruce-Keller et al., 
1999) and improve dopamine function in ST of aged animals (Diao et al., 1997; Carr et 
al., 2003). Consistent with these studies, we show here that the protein carbonyl level of 
ST is reduced. Also we found that the specific carbonyl levels of INSP1, PKM2, ENO1, 
ATP-F1B and are decreased and the expression levels of PKG1, IMPCH, and ATP-F1A 
were significantly increased. 
 INSP1 plays a significant role in controlling the intracellular inositol level by 
dephosphorylating inositol monophosphate(s) to produce inositol (Atack, 1996), which 
can then be used to produce phosphatidyl inositol (PI) to activate the PI signal 
transduction pathway (Atack and Schapiro, 2002).  INSP1 activity is decreased in aged 
mice brains when compared to the adult mice brains (Patishi et al., 1996). Decreased 
INSP1 activity can be brought about by modifications of the oxidation-sensitive thiol 
residues in INSP1 (Knowles et al., 1992). In the current study, we found that oxidation of 
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INSP1 in aged rat ST is reduced by CR, thus possibly improving its function for the PI 
signal transduction pathway in aged rats brains.  
 PKM2 ENO1, and PGK1 are all glycolytic enzymes that are involved in ATP 
production. Activity alteration and oxidation of these enzymes were demonstrated. 
(Sharma et al., 1980; Vitorica et al., 1981; Sharma and Rothstein, 1984; Oliver et al., 
1987; Pastoris et al., 2000; Castegna et al., 2002a; Poon et al., 2004e). Here, we showed 
that decreased carbonyl level of PKM2 and ENO1 in the CR old rats could lead to 
improved  activity, and thus to improved ATP production in CR old rat brain. Moreover,  
the abnormally increased level of PKG1 in aged brains (Boraldi et al., 2003) is also 
decreased in the ST of CR, suggesting CR can improve  cellular metabolism, thereby 
conserving energy and materials in neurons in brain aging.    
 Inosine monophorsphate cyclohydrolase (IMPCH) is a bifunctional protein that 
catalyzes the last two steps of de novo purine biosynthesis , which is further used for 
mRNA and DNA synthesis. The de novo synthesis of inosine monophorsphate plays a 
role in the regulation of glutamate levels since glutamine is a substrate of the first step of 
this process. Alteration of inosine monophorsphate concentration in aged cardio muscle 
imply that IMPCH is altered as a function of age (Wegelin et al., 1996). Moreover, 
inhibition of IMPCH can retard cell growth (Szabados et al., 1998), suggesting IMPCH 
play an important role in normal cell functions. In the current study, we show that the 
level of IMPCH in ST of CR rats is significantly lower than that of age matched control. 
Since CR reduces oxidative stress, most of mRNA will not be oxidatively modified and 
therefore will be successfully translated. This results in less demand of mRNA for protein 
synthesis. Therefore, down-regulation of IMPCH might be a result of decreased demand 
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for mRNA nucleotide and improved glutamate control caused by CR mediated oxidative 
stress release.   
ATP-F1A and ATP-F1B are members of the F1 synthase (ATP F1) enzymatic 
complex that binds ADP, phosphate and ATP for the synthesis of ATP during oxidative 
phosphorylation. Post-transcriptionally increased levels of ATP-F1A are observed as a 
function of age in the cerebral cortex of rats (Nicoletti et al., 1995; Nicoletti et al., 1998), 
suggesting abnormal ATP F1 regulation in aged brains. Such abnormality can cause 
deregulation of ATP concentration equilibrium.  The current proteomics study shows the 
ATP-FA specific carbonyl level is decreased and the ATP-FB level is decreased by CR, 
suggesting that the altered ATP production in aged brains can be improved, at least 
partially, by CR. This improved ATP production is necessary for neuronal recovery.    
E5 Conclusion 
The striking feature of these proteins is that they are all involved in three impaired 
processes in aged brains: glutamate regulation, mitochondria associated metabolism and 
protein synthesis (Fig E8). Dysregulation of glutamate levels cause receptor-mediated 
toxicity and abnormal calcium levels (Foster and Kumar, 2002).  Mitochondrial 
dysfunction mediates increased oxidative stress and apoptosis cascades as well as 
impaired energy metabolism (Cottrell and Turnbull, 2000). Impaired protein synthesis 
alters of the homeostatic state of enzymes necessary for normal cell function, thus 
impairing the maintenance, repair and normal metabolic functioning of the cell (Rattan, 
1996). All of these processes contribute to the decline of function in the CNS of aged 
animals (Rattan, 1996; Cottrell and Turnbull, 2000; Foster and Kumar, 2002). CR can 
improve these functional declines. Evidence shows that regulation of glutamate levels is 
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improved in CR aged brains (Magnusson, 1997a, b; Guo et al., 2000a). Furthermore, 
improvement of mitochondrial dysfunction by CR is well established and recently 
reviewed (Sohal et al., 1994; Lambert et al., 2004). Moreover, CR increases the serum 
level of growth hormone, thus stimulating protein synthesis (Norrelund et al., 2002). 
Therefore, our results support the hypothesis that CR induces a mild metabolic stress 
response by increasing the production of neurotrophic proteins, therefore priming 
neurons against apoptosis.  Moreover, we pinpoint that the improved glutamate 
regulation, mitochondrial function and protein synthesis in aged brain by CR is, at least 
partially, due to the CR-mediated alteration of the oxidation or the expression of PKM2, 
ENO1, INSP1, ATP-F1B, PKG1, IMPCH, ATP-F1A MDH, PKG1 and 14-3-3 zeta 
protein, DLP1, ACO2, DLDH, NPH3, eIF-5A and UNP1. Our results provide a valuable 
insight into the mechanism of CR on oxidative stress reduction and functional 
improvements in the aged CNS. CR has been suggested as a potential strategy to reduce 
risk of age-related neurodegenerative disorder (Mattson, 2003), which the present study 
imply maybe due reduction  in oxidative damage and changed expression of specific 
hippocampal and striatal proteins 
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Figure E8 
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Appendix F: 
Proteomic Identification of Differentially Expressed Proteins in the Aging Murine 
Olfactory System and Transcriptional Analysis of the Associated Genes 
F1 Introduction 
Olfactory impairment and anosmia (loss of sense of smell) have been associated 
with aging in humans (Murphy et al., 2002) as well as with several age-associated 
neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases (Mesholam 
et al., 1998). Many neuroanatomical and immunohistochemical changes have been 
documented in the olfactory epithelium (OE) and olfactory bulbs (OB) of aging humans. 
These include a reduction surface area and an increase in susceptibility to apoptosis of the 
OE and a reduction of OB size and cell number (Kovacs, 2004). In the human OE, 
reduced adrenergic innervation of blood vessels and glands (Chen et al., 1993) and 
decreased levels of xenobiotic metabolizing enzymes with age (Krishna et al., 1995) 
suggest impaired secretory and vasomotor responses to environmental stressors. The age-
related reduction in HSP70 expression by human olfactory receptor neurons (Getchell et 
al., 1995) suggests a specific neuronal impairment in stress responses that may contribute 
to the loss of olfactory sensibility with age. In the human OB of elderly subjects, high 
levels of lipofuscin as well as the presence of numerous microglia, occasional β-amyloid 
fibrils and rare neurofibrillary tangles have also been observed (Getchell et al., 2002). 
Molecular alterations in the aging murine olfactory epithelium have been reported 
at the transcriptional level in OE of senescence accelerated mouse models (Getchell et al., 
1995; Getchell et al., 2003), where there was a down regulation of PI3-kinase and ERK 
signaling, up-regulated oxidative stress indicators, possible disruption of the extracellular 
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matrix and a marked immunosenescence were observed. However, the precise cellular 
changes occurring in the normally aging murine olfactory system, both at the protein and 
genomic level, have not been reported previously. In this study, we utilized an unbiased 
fundamental proteomic analysis as a discovery-based method to identify significantly 
regulated proteins in the aging OE and OB. We report significant changes in the 
molecular architecture of the aging murine olfactory epithelium and bulb at the protein 
and transcriptional levels. Our study provides the basis on which to formulate hypothesis-
driven experiments to determine how the significantly regulated proteins are modulated 
in aging. 
F2 Experimental procedures 
 The following experiments are performed with collaboration with Radhika A. 
Vaishnav. 
Animals and tissue harvesting from old and young mice  
A total of 16 C57BL/6 male mice were obtained from Harlan, US and were of two 
ages:  the first group consisted of eight 80-week old mice that were maintained as part of 
the National Institute on Aging Aged Rodent Colonies, and the second group consisted of 
eight 6-week old mice.  Throughout the text the first group is called “old” mice and the 
second group called “young” mice to identify and characterize protein and genomic age-
related changes.  Six week old mice were chosen for this study as they are sexually 
mature, young adults with a functionally developed olfactory system. The mice were 
maintained in an animal facility at the Department of Laboratory Animal Research on a 
12 h light:dark cycle in Bioclean units with sterile-filtered air and provided food and 
water ad libitum.  All protocols were implemented in accordance with NIH guidelines 
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and approved by the University of Kentucky Institutional Animal Care and Use 
Committee.  The body weights for the old mice ranged from 32 to 35 g and for the young 
mice from 19 to 24 g.  Following euthanasia with CO2, microdissection was performed to 
isolate the OE and the OB following a procedure previously reported (Getchell et al., 
2002; Getchell et al., 2004).  Immediately following tissue harvesting, the tissues were 
weighed and snap frozen in liquid N2.  For the old mice, the average OE weight and SD 
was 24.5 +/- 8.3 mg and for the OB was 32.6 +/- 3.3 mg; for the young mice, the average 
OE weight was 13.8 +/- 2.3 mg and for the OB was 25.4 +/- 5.3 mg.  The OEs and OBs 
from five old and five young mice were used for proteomic analysis; the OEs and OBs 
from three old mice and three young mice were used for RNA extraction.   
Proteomics sample preparation 
The OE and OB samples were homogenized in a lysis buffer (10 mM HEPES, 
137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6 mM MgSO4 and containing the 
protease inhibitors leupeptin (0.5 mg/mL), pepstatin (0.7µg/mL), trypsin inhibitor (0.5 
µg/mL), and PMSF (40 µg/mL)). Homogenates were centrifuged at 15,800 g for 10 min 
to remove debris. The supernatant was extracted to determine the concentration by the 
BCA method (Pierce, Rockford, IL, USA). 
Two-dimensional gel electrophoresis  
Samples of the proteins in the OE and OB were prepared as previously described 
(Poon et al., 2004e). Five individual gels for OE of old mice and five individual gels for 
OE of young mice (a total of ten) were run. Similarly, a total of ten gels were run for OB. 
Briefly, 200 μg of protein were applied to a pH 3-10 ReadyStrip™ IPG strip (Bio-Rad, 
Hercules, CA) for isoelectric focusing (IEF), based on the pI or Isoelectric pH of the 
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protein. The focused IEF strip was stored at –80oC until second dimension 
electrophoresis was performed. For second dimension electrophoresis, Linear Gradient 
(8-16%) Precast criterion Tris-HCl gels (Bio-Rad, Hercules, CA) were used to separate 
proteins according to their molecular weight (MrW). Precision ProteinTM Standards (Bio-
Rad, Hercules, CA) were run along with the samples. After electrophoresis, the gels were 
incubated in fixing solution for 20 min. Sypro Ruby stain were used to stain the gels for 2 
hours. The gels were placed in deionized water overnight for destaining. 
Image analysis 
 The gels were scanned and saved in TIF format using a Storm 860 Scanner 
(Molecular Dynamics). PDQuest (Bio-Rad, Hercules, CA) was used for matching and 
analysis of visualized protein spots among differential gels.  The principles of measuring 
intensity values by 2-D analysis software were similar to those of densitometric 
measurement.  The average mode of background subtraction was used to normalize 
intensity values, which represents the amount of protein per spot.  After completion of 
spot matching, the normalized intensity of each protein spot from individual gels was 
compared between groups using statistical analysis.   
Trypsin digestion 
Samples were digested using the techniques previously described (Poon et al., 
2004e) Briefly, the selected protein spots were excised and washed with ammonium 
bicarbonate (NH4HCO3), then acetonitrile at room temperature. The protein spots were 
incubated with dithiothreitol, then iodoacetamide solutions. The gel pieces were digested 
with 20 ng/µl modified trypsin (Promega, Madison, WI) in 25 mM NH4HCO3 with the 
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minimal volume to cover the gel pieces. The gel pieces were chopped into smaller pieces 
and incubated at 37°C overnight in a shaking incubator. 
Mass spectrometry 
Digests (1 μL) were mixed with 1 μL α-cyano-4-hydroxy-trans-cinnamic acid (10 
mg/mL in 0.1% TFA:ACN, 1:1, v/v).  The mixture (1 μL) was deposited onto a fast 
evaporation nitrocellulose matrix surface, washed twice with 2 μL 5% formic acid, and 
analyzed with a TofSpec 2E (Micromass, UK) MALDI-TOF mass spectrometer in 
reflectron mode. The mass axis was adjusted with trypsin autohydrolysis peaks (m/z 
2239.14, 2211.10, or 842.51) as lock masses. The MALDI spectra used for protein 
identification from tryptic fragments were searched against the NCBI protein databases 
using the MASCOT search engine (http://www.matrixscience.com).  Peptide mass 
fingerprinting used the assumption that peptides are monoisotopic, oxidized at 
methionine residues and carbamidomethylated at cysteine residues. Up to one missed 
trypsin cleavage was allowed. Mass tolerance of 150 ppm was the window of error 
allowed for matching the peptide mass values. 
Immunochemical analysis 
The linearity of the anti-cyclophilin A (PPIA) and anti-ferritin heavy chain 
(FTH1) antibody was measured by loading different amounts of brain protein from 
mouse tissue (OE for PPIA and OB for FTH1) into the slots. Briefly, 2 μL of the samples 
(2 μg/μL) were treated with an equal volume of Laemmli buffer (0.125M Trizma base, 
4%SDS, 20% glycerol) for 20 minutes. Levels of PPIA and FTH1 were measured by slot-
blot with 1μg of protein from OE or OB per slot, respectively. The slot blots were 
detected on the nitrocellulose paper using a primary rabbit anti-cyclophilin A antibody 
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(1:500, UpState, Lake Placid, NY) and anti-FTH1 antibody (1:500, Alpha-Diagnostic, 
San Antonio, TX) and then a secondary anti-mouse IgG (Sigma, St. Louis, MO) 
antibody. The resultant stain was developed by application of Sigma-Fast 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT) tablets followed by 
density measurement by Scion-Image software package (Scion, MD). 
RNA extraction from mouse OE and OB tissue and reverse transcription (RT) 
 RNA was extracted from the tissue (OE and OB) harvested from  three old and 
three young mice. Frozen tissue was homogenized in 1 ml of Tri-reagent using a sterile, 
RNase-free dounce. The tissue was further disrupted using a Qiashredder column 
(Qiagen, Inc., Valencia, CA) as per the manufacturer’s protocol. RNA was extracted 
according to the TRI-reagent method (Molecular Research Center, Inc., Cincinnati, OH) 
and was further purified as per the Qiagen RNeasy mini kit RNA Cleanup Protocol 
(Qiagen, Inc., Valencia, CA). The concentration and quality of the RNA were assessed by 
spectrophotometry (Beckman Coulter, Inc., Fullerton, CA) and with Bioanalyzer (Agilent 
Technologies, Palo Alto, CA). Reverse transcription was performed as per the protocol in 
the GeneAmp RNA PCR kit (Applied Biosystems, Inc., Foster City, CA).  
Primer design 
For real-time PCR validation studies, we used the following primer sequences 
(forward primer; reverse primer; annealing temperature; reference): 
OE: Aco2 [tgggtggtgattggagatga; atctgggtctcgttgaaggt; 53 C; (Tabuchi et al., 2003)];  
Aldh2 [acctggataaagccaatt; tacccagtttatcaggagc; 50 C; (Rout and Armant, 2002)]; Ppia 
(ccagggtggtgactttacac; cggaaatggtgatcttcttg; 53 C; MGI:3026778). 
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OB: Mdh1 (tggaccacaaccgagcaaa; tccccagataatgacattctttacatc; 55 C; Primer Express); 
Eno1 (tattgcgcctgctcggtta; tccatctcgatcagcttgt; 55 C; Primer Express); Dnm1 
(atgccctcaagatcgctaagg; cgtcccgcgcatctgt; 55 C; Primer Express); Fth1 
[(gatcaacctggagttgtatgcc; gatattctgccatgccagcttc; 55 C; (Carper et al., 2001)]; Atp5a1 
(tggtggaattctcttcaggtta; ccaaacacgacaactccaacatt; 55 C; Primer Express); Omp 
[gacattcttctagctgctcc; cagctttggccagcaggg, 55 C, (Buiakova et al., 1994)]. All primer pairs 
spanned at least one intron to allow for distinction of mRNA from possible genomic 
DNA amplification. 
Real-time polymerase chain reaction 
 A cDNA amount equivalent to 10 ng total RNA per well was used for real-time 
RT-PCR analysis. Experimental samples, standards and no-template controls were all run 
in triplicate. Standard curves were plotted for standards with concentrations of cDNA 
equivalent to 10 ng, 5 ng, 3.75 ng and 2.5 ng of RNA.  Each reaction mix (one well) 
consisted of 1× QuantiTect SYBR Green PCR Master Mix, cDNA, DEPC water, and 300 
nM each of forward and reverse primers.  The real-time PCR reaction was carried out on 
a ABI Prism 7000 (Applied Biosystems, Inc.) using the following parameters: 50 °C for 2 
min; 95 °C for 15 min; 40 cycles of 94 °C for 15 s, specific primer annealing temperature 
(see Primer design) for 30 s, and 72 °C for 1 min.  Finally, a dissociation protocol was 
also run at the end of each run to verify the presence of a single product with the 
appropriate melting point temperature for each amplicon. To further ascertain the 
specificity and size of the PCR products, the products were run alongside molecular 
weight markers on a 2% agarose gel in 1xTAE at 100V for 50 min. The gel was stained 
with ethidium bromide (Sigma) and visualized using UV light.  
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 The data were analyzed by setting a specific threshold for each gene at the 
approximate midpoint of the exponential phase of amplification.  The resultant threshold 
cycle (CT) values for each replicate were averaged.  Control and experimental conditions 
were evaluated statistically using an unpaired t-test.  Standard curves were generated for 
each gene of interest and R2 values were calculated.  Using the standard curves, CT -
values were converted to relative amounts of cDNA (the change in CT value inversely 
correlates with the direction of change of gene expression).  Fold-changes and technical 
p-values (using a t-test) were computed between OE/OB of three young and three old 
mice. 
F3 Results 
Proteomic analysis of the agng olfactory epithelium 
In comparison to OE of young mice, the OE of old mice had 9 proteins that were 
differentially expressed (7 up- and 2 down-regulated) (Fig. F1, left). Seven of the 9 
proteins were matched to the protein database with statistical confidence of which 6 had 
protein names assigned to their accession numbers. Fig. F2 shows representative gels for 
the OE from old and young mice. The proteins that were expressed differentially in the 
OE of old vs young mice are summarized in Table F1. Fig. F3 shows the relative 
expression levels of these nine proteins in the OE of old mice as compared to that of 
young mice. All the mass spectra (not shown) of the peptides were matched to the mass 
spectra in MSDB protein databases. A probability-based Mowse score was assigned for 
each protein identified to indicate the probability that the match between the database and 
the experimental protein is a random event. Scores greater than 62 were considered 
significant. Thus, if a match has a score higher than 62, the match as a random event has 
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the probability lower than 0.05. All protein identifications agreed with the expected MrW 
and pI range based on their positions on the gel. Aldolase 1 (ALDO1), cyclophilin A 
(peptidyl prolyl isomerase A or PPIA), mitochondrial aconitase 2 (ACO2), an unnamed 
protein product (spot number 8007) and two unidentified proteins (spot numbers 405 and 
6401) were up-regulated; and mitochondrial aldehyde dehydrogenase 2 (ALDH2) and 
albumin 1 (ALB1) were both down-regulated in the OE of the old mice as compared to 
that of the young mice. The identified proteins are listed in Table F2.   
Immunochemical validation of PPLA 
To confirm the proteomic data for PPIA, we carried out immunochemical analysis 
using slot-blot technology. We showed that our antibody-antigen reaction was linear (Fig. 
F4, top) and that the level of PPIA  was significantly greater (1.3 fold) in the OE of old 
mice when compared to that of the young mice (Fig. F4, bottom). 
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Transcriptional analysis of selected proteins in the aging olfactory epithelium 
Based on their relevance to aging and the proteomics findings, the genes selected 
for transcriptional analysis of the OE were Aco2, Ppia and Aldh2. Of these, Aco2 and 
Aldh2, for example, are both mitochondrial enzymes involved in metabolism and in the 
maintenance of intracellular homeostasis. Aco2 is a TCA cycle enzyme that is a specific 
target of mitochondrial oxidative stress during aging while Aldh2 is proposed to protect 
cells against oxidative stress. The third gene chosen for transcriptional analysis by real 
time RT-PCR was Ppia, which has been shown to be a protector against oxidative stress. 
The gene Aldo1, which is associated with aging and oxidative stress as well, was not 
chosen for transcriptional analysis as it exists in multiple isoforms in mouse tissues. 
Although ALB1 protein was also identified and found to be down-regulated in the old 
OE, the lower levels of ALB1 may reflect a reduced blood flow or constricted blood 
vessels in the OE with aging, or, alternatively, its identification could also be a sampling 
artifact of obtaining highly vascularized tissue and hence was not selected for 
transcriptional analysis. 
Real-time RT-PCR was carried out using RNA extracted from OE of 3 young and 
3 old mice for the genes Aco2, Ppia and Aldh2 as well as Omp (olfactory marker protein). 
The resultant amplification curves were plotted and CT (the cycle number for which 
amplification is at half of maximal value) was determined (Fig. F5). Using standard curve 
analysis, relative quantities were calculated for OE genes from old and young mice, 
based on their relative mean CT values. The specificity of the PCR reaction was 
confirmed by (a) matching the amplicon melting temperature obtained by dissociation 
curve analysis to the calculated melting temperature (Fig. F5, insets 1-3) and (b) the 
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presence of a single band of correct size on an ethidium bromide-stained 2% agarose gel 
(Fig F5., inset 4). A two-tailed unpaired t-test was carried out to determine the statistical 
significance of any regulation of the genes assayed (Table F3).  
Based upon the real-time RT-PCR analysis, the transcripts for Aco2 was 
determined to be present and significantly (p<0.05) up-regulated 1.4-fold in the OE of old 
mice as compared to young (Table F3). This up-regulation was in concordance with the 
increase in the protein level of ACO2 the aged OE. The transcripts for Ppia and Aldh2 
were expressed in the OE but showed no significant difference between old and young 
mice. Aldh2 transcripts were also relatively less abundant (higher CT ). We used the 
expression of Omp mRNA, which is expressed in mature olfactory receptor neurons 
(Buiakova et al., 1994), as an internal standard to evaluate degenerative effects at the 
transcriptional level. We showed that Omp transcripts were highly abundant in the OE of 
both old and young mice, and were significantly down-regulated 1.2-fold in the old 
compared to young mouse OE (Fig. F5).  
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Figure F5 
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Proteomic analysis of the aging olfactory bulb 
In comparison to OB of young mice, the OB of old mice had 20 proteins that were 
differentially expressed (Fig. F1) of which 6 matched to the database with statistical 
confidence. Figure F6 shows the representative gels from OB of old and young mice. The 
proteins that were expressed differentially in the OB of old vs young mice are 
summarized in Table F4. In Figure. F7, we have shown the relative expression of these 
20 proteins in OB of old mice as compared young mice. ATP synthase isoform 1 
(ATP5A1), enolase 1 (ENO1), ferritin heavy chain (FTH1), malate dehydrogenase 1 
(MDH1), tropomyosin alpha 3 chain (TPM3) and 10 non-identified proteins (spot 
numbers 109, 110, 1102, 1501, 1605, 1702, 4204, 4901, 5302, 5506, 6106) were up-
regulated; and dynamin-1 (DNM1) and four other proteins (spot numbers 504, 2704, 
4201 and 6204) which were not identified were down-regulated in OB of the old mice as 
compared to the young mice. Table F5 lists the proteins identified.  
Immunochemical validation of FTH1 
To confirm our data for FTH1, we carried out slot-blot analysis. We demonstrated 
that the antibody showed linearity against FTH1 (Fig. F8, top) and that the level of FTH1 
was significantly higher (2.7 fold) in the OB of old mice than of young mice (Fig. F8, 
bottom).  
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Transcriptional analysis of selected proteins in the afing olfactory bulb 
The proteomic analysis served as a basis for the selection of genes to study at the 
transcriptional level. Of the proteins that were significantly regulated and identified in the 
OB and based on their known functions and relevance to our study, we chose to further 
analyze Atp5a1, Eno1, Fth1, Mdh1 and Dnm1 as well as Omp using real-time RT-PCR 
analysis (Fig. F9). The specificity of the PCR reaction was confirmed by (a) matching the 
amplicon melting temperature obtained by dissociation curve analysis to the calculated 
melting temperature (Fig. F9, insets 1-5) and (b) the presence of a single band of correct 
size on an ethidium bromide-stained 2% agarose gel (Fig F9, inset 6). We determined that 
the transcripts for Dnm1 and Fth1 were present and significantly (p<0.05) down-
regulated 1.2- and up-regulated 1.1-fold, respectively, in the OB of old mice compared to 
the young (Table F6). These results are in concordance with the proteomic data. In 
contrast, the transcripts for Mdh1, Atp5a1 and Eno1, while present, were not significantly 
different between the old and young mouse OBs. As anticipated, Omp mRNA was 
expressed at a much lower level overall in the OB than in OE, and was not differentially 
expressed between old and young mouse OBs (Fig. F9). 
` 
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F4 Discussion 
We have shown that proteomic changes occur in the aging murine OE and OB 
and have defined whether the proteins identified are regulated at the transcriptional or 
post-transcriptional levels. Upon examination of the proteomic and transcriptional data, 
we observed that the proteins and/or transcripts that were regulated in the aging olfactory 
epithelium and bulb fell into three broadly-defined functional groups, with some in more 
than one of these groups: namely, metabolism (primarily mitochondrial metabolism); 
transport/motility; and stress response (Fig. E10).  
Metabolism: 
Of the proteins involved in metabolism, ACO2, ALDH2, ATP5A1 and MDH1 are 
mitochondrial enzymes, while ALDO1 and ENO1 are cytosolic. ACO2, a mitochondrial 
matrix enzyme involved in the Kreb’s cycle, was found to be up-regulated in the OE of 
old mice as compared to the young mice. ACO2 is a known selective target of oxidation 
during aging/oxidative stress (Sastre et al., 2003) and is also known to be specifically 
inhibited by peroxynitrite, leading to mitochondrial dysfunction (Radi et al., 2002). The 
up-regulation of ACO2 seen here in the aged OE may be a result of an accumulation of 
inactive enzyme that may be either oxidized, nitrated or both, resulting in the impairment 
of mitochondrial respiration. Transcriptional up-regulation of Aco2 with aging may be a 
cellular response to oxidative stress for compensation for this lack of active enzyme.  
ALDH2, also a mitochondrial enzyme, was down-regulated in the OE of old 
mice. This enzyme is a known target for oxidation under conditions of oxidative stress 
(Reverter-Branchat et al., 2004) and is thought to be protective against oxidative stress 
(Ohsawa et al., 2003). Also, this enzyme has been associated with age-associated 
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neurodegenerative diseases such as AD. The levels of ALDH2 were found to be higher in 
the cerebral cortex of AD patients (Picklo et al., 2001) and its deficiency has been 
associated with an increased risk of AD and elevated oxidative stress(Kim et al., 2004; 
Ohta et al., 2004). We found the protein levels of this enzyme to be down-regulated in the 
OE of old mice as compared to the young mice. This may result in an increased 
susceptibility to oxidative stress in the OE of old mice.  
ATP5A1, another mitochondrial protein and a key metabolic/bioenergetic 
component of the cell, was observed to be higher in the OB of old mice as compared to 
young. ATP5A1 is responsible for proton transport and oxidative phosphorylation as part 
of the mitochondrial electron transport chain. In a microarray study, Atp5a1 was shown 
to be down-regulated in aging human brains (Lu et al., 2004). The protein product is seen 
to accumulate as a fluorophore in lipofuscin granules in the aging brain (Szweda et al., 
2003). The protein has been shown to accumulate in the cerebral cortex of aging rats 
(Nicoletti et al., 1998) and also in the cytosol of degenerating neurons in AD brains 
(Sergeant et al., 2003). It is possible that in the mouse OB, accumulation of ATP5A1 
(possibly cytosolic) with aging could lead to a decrease in available active mitochondrial 
ATP5A1, and, consequentially, a decline in mitochondrial ATP production. 
Another mitochondrial metabolic enzyme which was seen to be up-regulated in 
the OB of old mice was MDH1. This protein was shown to be expressed in the olfactory 
cortex (Sandberg et al., 1984). This enzyme is located within the mitochondrial matrix 
and is involved in the malate-aspartate shuttle, which is the connecting link between 
glycolysis and mitochondrial respiration. This protein transfers NADH across the 
mitochondrial membrane to respiratory complex I. The up-regulation of MDH1 in the 
 406
aging OB may be compensatory for the reduced activity of ATP synthase downstream in 
the electron transport chain.  
ALDO1 is a brain-specific glycolytic enzyme that we have shown to be up-
regulated in the OE of old mice. The gene Aldo1 is highly expressed in the olfactory 
mucosa (Genter et al., 2003; Tietjen et al., 2003) as determined by microarray analysis. 
Evidence suggests that protein levels of glycolytic enzymes, including ALDO1, may be 
up-regulated during aging in order to compensate for the metabolic decline of 
mitochondrial respiration (Kopsidas et al., 2000). ALDO1 is also a target of oxidation 
under oxidative stress conditions (Reverter-Branchat et al., 2004) and has been shown to 
have reduced activity with aging in the rat lens (Bours et al., 1988). 
ENO1, a key glycolytic enzyme and also known as α-enolase (a subunit of brain-
specific enolase) (Keller et al., 1994), was up-regulated in the OB of old mice. We found 
that ENO1 was post-transcriptionally regulated, which may indicate reduced proteasomal 
degradation of this protein as a result of ENO1 possibly being oxidized/nitrated or due to 
decreased activity of the proteasome during aging (Keller et al., 2004). ENO1 is a 
specific target of oxidation under oxidative stress and is also found to be both oxidized 
and nitrated in brains of AD patients (Castegna et al., 2002a; Castegna et al., 2003; 
Reverter-Branchat et al., 2004). Also, in AD brains, ENO1 is known to be up-regulated at 
the protein level (Schonberger et al., 2001). Interestingly, similar to ALDO1, an up-
regulation of this enzyme may be part of a glycolytic compensation for mitochondrial 
metabolic decline in the OB.  
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Transport/Motility and Stress response: 
While recognizing the overlapping transport and/or stress-associated roles of 
some of the metabolic enzymes described above, we have grouped the remaining proteins 
into these two categories based on what appears to be their primary function. 
FTH1, which we showed to be highly up-regulated in the OB of old mice, is a 
transport protein primarily involved in iron homeostasis. We also confirmed this result 
immunochemically and proceeded to demonstrate that Fth1 is up-regulated at the 
transcriptional level as well in the OB of old mice. The gene for Fth1 was reported to be 
expressed in the olfactory sensory nerves (Tietjen et al., 2003) and the protein has been 
localized in oligodendrocytes and astrocytes of various human brain regions (Connor et 
al., 1990). Brains of Fth-/- mice show characteristics of increased oxidative stress 
(Thompson et al., 2003). Interestingly, both Fth1 and Aco2 mRNAs contain iron 
responsive elements (IREs), and their translation to protein is regulated by iron levels 
though the mediation of iron binding proteins (Schalinske et al., 1998). Iron (II) promotes 
lipid and protein oxidation in oxidative stress conditions, and the levels of this metal ion 
have been shown to increase in aging and neurodegenerative diseases, with high 
accumulation in lipofuscin granules (Killilea et al., 2004; Terman and Brunk, 2004). 
Thus, FTH1 may be up-regulated in response to elevated oxidative stress and may be 
exerting a protective effect in the aging olfactory system by sequestering the increased 
levels of iron ions.  
PPIA, also known as cyclophilin A, is an abundant protein belonging to the 
immunophilin family that is the primary target for the immunosuppressant cyclosporin A 
in humans (Jin et al., 2004). Cyclosporin A is a neuroprotector under conditions of 
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ischemic injury and acts via modulation of the mitochondrial permeability transition pore 
dynamics and maintenance of mitochondrial homeostasis (Sullivan et al., 1999; 
Crompton, 2004). PPIA is a pro-inflammatory cytokine that is secreted by macrophages 
(Jin et al., 2004), among other cells, in response to oxidative stress. The known functions 
of this protein include the activation of NF-κB-mediated inflammatory response in 
endothelial cells (Jin et al., 2004) and chaperone activity under stress in vitro (Ou et al., 
2001). The Ppia gene is expressed in olfactory sensory neurons as shown by single-cell 
microarray studies (Tietjen et al., 2003). In the OE of old mice, we showed an up-
regulation of PPIA protein levels that we confirmed by immunochemical analysis. An up-
regulation of PPIA  suggests a response to increased oxidative stress in the aging OE 
which would aid in protection via its chaperone activity and/or may be functioning in an 
anti-apoptotic manner. ENO1, which was described above under metabolism, also has 
chaperone activity. 
TPM3, another protein that was up-regulated in old OB, is an actin-binding 
protein. TPM3 undergoes iron (II)-mediated oxidation under oxidative stress, that targets 
this protein for proteasomal degradation (Drake et al., 2002). Altered levels of TPM3 
may affect anterograde/retrograde transport in the olfactory neurons and/or mitochondrial 
movement leading to nerve ending loss in aging mice.  
DNM1, a protein involved in cellular motor activity and receptor-mediated 
endocytosis, has been localized in the olfactory system. The protein is co-localized with 
clathrin in cell bodies, dendrites and dendritic knobs of olfactory receptor neurons 
(Rankin et al., 1999).  DNM1 has been shown to be expressed in rat OB where it forms a 
stable complex with endophilin3 (ENDO3), an inhibitor of clathrin-mediated endocytosis 
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and synaptojanin-1 and co-localizes with dopamine D2R receptors at the synaptic termini 
of olfactory sensory neurons (Faire et al., 1992; Sugiura et al., 2004). At the 
transcriptional level, dynamin-1-like gene was observed to be down-regulated in the 
aging human brain (Lu et al., 2004). Here, we have shown that  DNM1 protein is down-
regulated in the OB of old mice. Interestingly, the this protein was also down-regulated at 
the transcriptional level. Our results are indicative of altered neurotransmitter reuptake by 
olfactory neuronal synapses with aging. 
Our results are the first demonstration of proteomic changes occurring in the 
normally aging olfactory system. These alterations in the protein profile of the aging 
olfactory epithelium and olfactory bulb are specific to the pathways involving 
mitochondrial and cytosolic metabolism, intracellular transport and altered response to 
stress. Ongoing studies of the olfactory system in age-related neurodegenerative disorders 
will benefit from the studies of aged OE and OB reported here. 
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Appendix G 
Exercise Mediated Protein Oxidative Modification in Plasma is Induced by Lipid 
peroxidation End Product, 4-Hydroxynonenal, but Not 3-Nitrotyrosine 
G1 Introduction 
 Free radicals and reactive oxygen species (ROS) are produced continuously in 
cells as part of the metabolic process. When oxygen is partially reduced, free radicals are 
formed to attack cell components. The free radicals then form longer-live toxic species 
that can migrate to sites distant from where they were produced. These toxic species and 
free radicals are collectively called reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) (Halliwell and Gutteridge, 1992). ROS and RNS cause lipid peroxidation 
and protein oxidation to modify the function of proteins and lipids in biological system 
(Butterfield and Stadtman, 1997). Several antioxidant defense mechanisms have evolved 
to protect cell components from the attack of ROS and RNS. Oxidative stress is described 
as the state of imbalance resulting from the production of ROS and RNS that exceed the 
capacity of these antioxidant defense systems. The central nervous system (CNS) is more 
susceptible to oxidative stress than other tissues because it has a high content of 
unsaturated fatty acids, high oxygen consumption per unit weight, high content of lipid 
peroxidation key ingredients such as iron and ascorbate, and a relative scarcity of 
antioxidant defenses systems (Floyd, 1999).  
Oxidative stress mediated by peroxidation of arachidonic acid (AA) or linoeic 
acid forms 4-hydroxynonenal (HNE) (Esterbauer et al., 1991). Since HNE is more stable 
than free radicals, it is able to diffuse to sites that are distant from its formation and cause 
broader damage (Butterfield and Stadtman, 1997). HNE can form covalent adducts with 
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histidine, lysine and cysteine residues in proteins (Butterfield and Stadtman, 1997), thus  
consequent HNE-modified protein levels serve as a good marker for lipid peroxidation.  
One of the most commonly used methods to quantify protein oxidation is by 
measuring the protein carbonyl level (Esterbauer et al., 1991; Butterfield and Stadtman, 
1997). Carbonyl groups are introduced to proteins by either direct free radical reactions, 
or covalent reaction with lipid peroxidation end products (Esterbauer et al., 1991; 
Butterfield and Stadtman, 1997). Protein carbonyl levels are generally detected by their 
2,4-dinitrophenylhydrazone (DNP-) adducts.  However, it should be noted that the 
quantity of the protein carbonyl levels depends not only on its formation, but also on the 
degradation rate of the oxidized protein.  
The protein 3-nitrotyrosine (3-NT) content is another way to assess oxidative 
modification of proteins by oxidative stress. 3-NT forms when peroxynitrite radicals 
(ONOO.-) reacts with the ortho position of the aromatic ring on tyrosine residues of 
proteins (Beckman and Koppenol, 1996; Butterfield and Stadtman, 1997). 
Physical exercise increases the metabolic rate and production of ROS as oxidative 
phosphorylation increases to meet the higher ATP demand for physical activity. 
Mitochondria are a significant oxidant source in cells because 1-2 % of the electron flow 
in the electron transport chain in mitochondria results in generation of free radicals 
(Calabrese et al., 2000). Physical activity also increases the generation of free radicals in 
several other ways. Some examples include production by catecholamines release, 
prostanoid metabolism, xanthine oxidase, NAD(P)H oxidase and tissue repairing 
macrophages during exercise (Jackson, 2000). However, the specific reactive species that 
modify proteins during exercise is poorly understood. In an effort to understand the 
 413
oxidative modification of proteins during exercise, we measured protein carbonyl, HNE 
and 3-NT levels in two different systems. The plasma of trained and untrained runners 
was examed after a long distance run to test the hypothesis that trained runners would 
have less oxidative stress. Brain regions of young rats that exercised on treadmill for one 
week were compared to these from non-exercised rates to test the hypothesis that young 
rats would not slow any elevated oxidative modification of protein following excercise. 
G2 Experimental Procedures 
Subjects 
Human subject are trained. Details regarding the training protocol are summarized 
in Table 1. The non-trained subjects are served as control. 
Sixteen male albino Sprague-Dawley rats aged 2 months were maintained in 
individual cages and fed a standard diet without limitations; room temperature was kept 
at 21 ± 2°C; 12 hours of light was automatically alternated to 12 hours of dark.  
After one week of acclimatization, eight animals were randomly chosen for 
exercise. The exercise was produced on a specific treadmill for rats, with four lanes. The 
aim of the training protocol was to provide a gradually increasing effort and to reach in 
11 weeks 60% VO2max; such workload was sustained for further 3 weeks. Control 
animals were placed on not running treadmills during the training sessions. Animals were 
sacrificed within 48 hours from the last training session. 
Animal handling, the training protocol, and mode of sacrifice were approved by 
the Ethical Committee on the Use of Laboratory Animals of the Health Authority of 
Milan (Italy). 
Sacrifice and brain regions conservation 
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Rats were anesthetized (100 mg/kg ip heparinized sodium thiopental); blood was 
drawn by cardiac puncture, then the brains of the animals were removed and dissected 
into cortex, striatum, hippocampus, and cerebellum.  Brains regions were immediately 
placed in liquid nitrogen and, once frozen, stored at -80°C.  
Protein carbonyl, 3-Nitrotyrosine (3-NT), 4-hydroxynonenal (HNE) detection 
Detection of protein carbonyl, 3-NT and HNE levels were performed as described 
previously using Slot Blot® (Farr et al., 2003; Poon et al., 2004d).  Levels of 3-NT, HNE 
and protein carbonyls were determined immunochemically. Protein carbonyl levels were 
determined as adducts of 2,4-dinitrophenylhydrazine (DNPH) (Stadtman, 1992; 
Butterfield and Stadtman, 1997). Samples (5μL) were treated with an equal volume of 
12% SDS. Samples were then derivatized with 10 μL of 20 mM 2,4-DNPH (Chemicon, 
CA) for 20 minutes. The reaction was stopped by addition of neutralizing reagent (7.5 μL 
of  2M Tris 30% glycerol buffer, pH = 8.0). Levels of protein carbonyls were measured 
by using the slot-blot technique with 250 ng of protein loaded per slot. The (DNP-adduct 
of the carbonyls is detected on nitrocellulose paper using a primary rabbit antibody 
(Chemicon, CA) specific for DNP-protein adducts (1:100) followed by a secondary goat 
anti-rabbit IgG (Sigma) antibody. The resultant stain was developed by application of 
SigmaFast (BCIP/NBT) tablets; and the line densities were quantified by Scion Image 
software package. HNE and 3-NT levels were determined in the same manner. Samples 
(5μL) were treated with an equal volume of 12% SDS. Samples were then further 
denatured with 10 μL of Laemmli buffer (0.125M Trizma base, 4%SDS, 20% glycerol) 
for 20 minutes. Levels of 3-NT and HNE were measured by using the Slot Blot ® 
technique: 500 ng of protein per slot for protein 3-NT levels and 250 ng of protein per 
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slot for HNE levels. The HNE levels were detected on the nitrocellulose paper using a 
primary rabbit antibody (Alpha Diagnostics, TX) specific for HNE-modified protein 
(1:8000). The 3-NT levels were detected by primary rabbit antibody (Chemicon, CA) 
specific for 3-NT (1:100). The same secondary goat anti-rabbit IgG (Sigma) antibody 
was then used. The resultant stain was developed by application of SigmaFast 
(BCIP/NBT) tablets and the line densities were also quantified by Scion Image software 
package. 
G3 Results 
The details of the runners tested in this study are listed in Table F1. We observed 
a general increase of protein oxidation in the plasma of trained runners after distance 
running. However, no significant difference is observed in the untrained runners. Fig. F1 
shows the protein carbonyl, HNE and 3-NT levels of post-event runners as the percentage 
control of the respective pre-event runner. That is, each runner served as her/his own 
control. The protein carbonyl level is significantly increased 92% in post-event trained 
runner. Lipid peroxidation index, protein-HNE levels were significantly increased 30% in 
the plasma of the post-event trained runners. However, the protein 3-NT level is not 
significantly different in the plasma between the trained runners. No significant different 
in terms of carbonyl, HNE and 3-NT levels is observed in untrained runners after the long 
distance run. 
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Table G1: Details of trained and untrained runners 
 Age (years) Weight (Kg) Height (cm) Vo2max (ml·min-1·kg-1) 
Trained 
(n=6) 25.5±6.0 66.3±8.4 175.3±5.0 59.8±5.2* 
Untrained 
(n=4) 26.8±3.7 68.0±13.9 169.0±8.6 49.8±5.1 
 
* Vo2max is significantly higher in trained runners than the untrained runners, 
p<0.05 
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Figure G1 
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Figure G2 
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We observed a general decrease in different brain regions in the rats exercised for 
1 week when compared to those of non-exercised rat (Fig F2). However, the oxidative 
parameters decrement is not statistically significant.  
G4 Discussion 
It is well established that exercise induces free radical formation and oxidative 
stress in cells (reviewed in (Urso and Clarkson, 2003)). However, the specific reactive 
species that modified with the proteins are not known. Consistent with other studies, our 
study shows that following physical activity, such as running, increased oxidative 
carbonyl modification in proteins is depend on the preconditioning. Our results also 
indicate that lipid peroxidation end product, HNE, contributes to protein modification as 
the protein HNE level is significantly increased in the plasma of post-event trained 
runners. Our data suggest that lipid peroxidation is, at least partially, associated with 
protein oxidative modification during physical activity with pre-conditioned runners. 
Since regular exercise increases the number and activity of mitochondria in muscles 
(Takekura and Yoshioka, 1989), pre-conditioned runners may have more mitochondria to 
produce free radicals to modify proteins. The protein 3-NT level was not significantly 
altered in the plasma of the runners the distance running, indicating ONOO.- likely is not 
involved in the protein modification during physical activity. Since nitric oxide (NO) 
from nitric oxide synthase (NOS) is necessary to react with superoxide (O2.-) for ONOO.-  
formation, NO acts as the limiting reagent during the formation of ONOO.-. Therefore, no 
significant alteration of protein 3-NT level in the plasma of the runner during physical 
activity is most likely due to limited amount of ONOO.- produced. Although free 3-NT 
levels in serum increased after the first day of running and remained elevated during a 4-
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day race (Radak et al., 2003), the elevated free 3-NT level most likely result from NO 
production by tissue-repairing macrophages (Woods et al., 1993; Vivekananda et al., 
1994; Lu et al., 1999; Sugiura et al., 2000; Cho et al., 2001; Sugiura et al., 2002; Summan 
et al., 2003). Since only chronic exercise increases NOS gene expression in endothelial 
cells of rats (Liu et al., 2000; Yang et al., 2002), it is likely that there was not sufficient 
time for tissue repair to begin when the plasma was obtained after the distance run of the 
current study; thus, no alteration of protein 3-NT level was observed in this study.  
Unlike a one-time exercise event, regular exercise can reduce oxidative stress by 
up-regulation of antioxidant defense (reviewed in (Fitts et al., 1991; Sen, 1995; Dekkers 
et al., 1996; Moller et al., 1996; Fielding and Meydani, 1997; Niess et al., 1999; Powers 
et al., 1999; Sen, 1999; Coudert and Van Praagh, 2000; Leeuwenburgh and Heinecke, 
2001; Radak et al., 2001a; Yeo and Davidge, 2001)). However, exercise mediated 
oxidative stress in the CNS is highly dependent on the physical activity conditions 
(Somani et al., 1995; Somani and Husain, 1996; Somani et al., 1996; Somani and Husain, 
1997; Itoh et al., 1998; Radak et al., 2001c; Radak et al., 2001b; Devi and Kiran, 2004). 
Regular exercise can improve cognitive function and decrease oxidative damage in brains 
from aged rat; (Radak et al., 2001c), suggesting up-regulation of the antioxidant defense 
play significant role in the cognitive improvement (Somani et al., 1995). Consistent with 
this notion, our study shows slight reduction of protein carbonyl and 3-NT levels in the 
cortex, striatum, hippocampus, and cerebellum of the exercised young rats when 
comparing to those of non-exercise rats, although these reductions are not statistically 
significant. It is surprising that HNE levels are not altered in different brain regions with 
the exception of hippocampus. Since the hippocampus plays a significant role in 
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cognitive function and regular exercise improve cognitive function in aged rats (Radak et 
al., 2001c), one could speculate that regular exercise can improves cognitive function in 
aged rats by decreased protein oxidation in hippocampus. This is consistent with the 
previous findings that hypoxia-induced free radicals damage in brain was minimal in 
young rodent compared to aged rodents. However, only young rats were used in this 
study, which could lead to speculation that whether significant alterations would be 
observed in aged rats (Howard et al., 1996). Nevertheless, our study shows that the 
oxidative stress induced by regular physical activity does not contribute significant 
changes in protein carbonyl, 3-NT, and HNE levels in the cortex, striatum, hippocampus 
and cerebellum of young rats, suggesting the protein oxidation and up-regulation of 
antioxidant is not significantly altered in different brain regions by physical activity. 
Consistent with this notion, lipid peroxidation is observed in the liver and heart but not 
the brains of young rats (Turgut et al., 2003). 
In our current study, we found that protein oxidation occurred during the event in 
trained runners. The exercise mediated protein modification was contributed to, at least 
partially, by a lipid peroxidation end product, HNE while nitration of tyrosine residues 
was not significant during the marathon. Also, our study shows non-significant changes 
in protein oxidation in cortex, striatum, hippocampus, and cerebellum, likely consistent 
with the notion that regular exercise contributes little to the cognitive function in young 
animals. 
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Appendix H 
Data Supporting Figures and Tables 
 
Figure 4.2   
4m  4m + LA
512.6667  471.3333
272  562 
395.3333  658.3333
482  476.3333
575.3333  422.3333
414.6667  457 
415.3333  446 
504.6667   
  
12m  12m+ LA
590  617 
701.3333  590 
530.3333  588.6667
533.6667  494 
638.3333  643.6667
611.3333  598 
514.6667  582.6667
 
 
Figure 4.3    
4m 12m 4m LA 12m LA
5.067 4.9 5.066 5.88 
4.78 6.08 5.24 5.1 
5.217 3.86 5.1 6.375 
5.2 4.78 4.5 6.19 
5.38 3.86 4.44 4 
5.4 3.86 4.48 4.167 
 4.28   
 4.1   
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Figure 4.4  
4m 4mLA 
121.062 143.301 
81.784 123.493 
97.66233 140.1367 
90.19433 198.902 
143.7967 155.5957 
115.9037 152.9763 
138.6333 190.7983 
  
12m 12mLA 
174.9807 96.35267 
130.231 102.6487 
112.3627 157.0183 
154.9603 188.7003 
165.3887 106.249 
234.8503 178.121 
162.1289 138.1817 
 
Figure 6.1   
4m 12m 4m OX 
87.70764 51.82724 53.8206 
130.2326 99.66777 73.75415
71.7608 45.18272 55.81395
128.9037 26.57807 27.90698
79.73422 35.8804 53.8206 
110.299 33.22259 73.75415
82.39203 55.81395 17.9402 
108.9701 54.48505 93.68771
 
Figure 6.2   
12 m 4 m 4 m ox. 
71.94287 104.8497 97.35198
95.09075 101.5769 93.6626
98.78012 109.7292 92.53198
94.13865 99.79173 78.66706
47.26702 92.53198 94.79322
99.01815 91.34186 85.09372
94.85272 94.07914 81.64237
86.75989 106.0994 97.76852
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Figure 6.3   
12 m 4 m 4 m ox. 
99.85422 92.80272 101.6687
98.6368 92.936 84.43914
97.99833 99.81291 92.17193
101.9121 98.93544 89.05432
98.07641 98.7654 96.55432
103.327 96.77182 94.68619
106.2532 99.93216 102.765 
100.8654 97.13663 94.47708
3.113715 3.093735 6.585941
 
Figure 8.3   
4m 12mR 12mA 
2.2495 2.0905 2.359 
2.3645 2.2905 2.496 
2.697 2.2685 2.3185 
2.926 2.4825 2.553 
2.863 2.011 2.439 
2.849 2.505 2.6695 
  2.5715 
 
Figure 
8.4   
4m 12mR 12mA 
671.6667 666 464 
692 497.3333 478 
820.3333 579 433.3333
744 580.7778 369.6667
477.3333 464 282.6667
450 444.6667 347.3333
387.3333 372.3333  
456   
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Figure 
8.5   
4m 12mR 12mA 
294.3333 355.3333 302 
274.3333 327.3333 317.6667
281.6667 353 336 
283.4444 326.6667 295 
367.6667 120.1588 352.3333
393.3333 482.3333 351 
395 402.6667 387 
 375.6667 399.6667
 357.3333  
 
Figure 
8.6   
4m 12mR 12mA 
213.6667 350 189 
457.6667 291.6667 254.3333
377 569.6667 253.6667
310.6667 589 182.6667
595.3333 488 453 
596.3333 503 429.3333
 
Figure 8.7   
4m 12mR 12mA 
290.012 259.227 207.5885
244.379 250.961 233.242 
113.962 277.472 208.863 
162.4545 241.14 141.054 
183.0235 257.2 140.198 
162.7415 192.084 146.4505
155.5454 165.692  
 178.888  
 
Figure 
10.3A  
Young Old 
332.3333 444.3333
302 557.3333
373.6667 548.3333
393 449.6667
325 510 
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Figure 
10.3B  
Young Old 
7686 13101 
11812 13994 
10933 15165 
12444 14487 
12912 14471 
 
Figure 
10.5A    
GS level  
GS 
activity  
Young Old young Old 
91.9259 71.65327 317.6667 358.5 
99.26599 65.71129 328.5 262.6667
97.51835 103.2856 350 278 
89.12967 77.24572 292.6667 282.5 
122.1601 72.35232 296.3333 262 
    
    
Young Old Young Old 
60.05136 94.7411 311.6667 437.3333
80.06798 123.4944 433.3333 393 
135.3688 127.0997 408.6667 501.3333
98.72795 115.2668 408.3333 562.3333
125.7839 46.31038 421.6667 486.3333
    
 
Fig 10.5B    
LDH level  LDH activity  
Young Old Young Old 
60.05136 94.7411 311.6667 437.3333
80.06798 123.4944 433.3333 393 
135.3688 127.0997 408.6667 501.3333
98.72795 115.2668 408.3333 562.3333
125.7839 46.31038 421.6667 486.3333
 
Fig 10.6  
Young Old 
187 308 
130 184 
177 268 
213 202 
61 247 
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Fig 10.7  
Young Old 
289 426 
379 443 
262 309 
244 374 
253 421 
285.4 394.6 
 
Figure 
10.8   
Young  Old 
98  105 
70  156 
71  91 
93  120 
96  161 
 
Figure 
11.1     
 
Age 
(years) Gender 
Brain 
Weight 
(g) PMI 
Control 1 86 Female 1300 3.75 
Control 2 74 Male 1400 4 
Control 3 86 Female 1150 1.75 
Control 4 90 Female 1110 4 
Control 5 76 Female 1315 2 
Control 6 79 Male 1240 1.75 
     
MCI 1 91 Female 1155 5 
MCI 2 93 Female 1050 2.75 
MCI 3 87 Male 1200 3.5 
MCI 4 87 Male 1170 2.25 
MCI 5 88 Female 1080 2.25 
MCI 6 82 Female 1075 3 
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Figure 
11.2  
Control MCI 
486 560 
752.5 905 
506 979 
666 762 
828 1108 
602 831 
 
Figure 
11.7        
Pin 1  GS  ENO  PK3  
Control MCI Control MCI Control MCI Control MCI 
1100 2287 244 347 187 234 261 353 
3247 4775 281 359 169 214 304 362 
2171 5128 210 444 147 216 290 450 
1963 2465 322 509 178 207 394 441 
2942 5026 313 458 192 226 346 461 
3736 6036 430 425 190 322 294 413 
 
Figure 
11.8        
Pin 1  GS  ENO  PK3  
Control MCI Control MCI Control MCI Control MCI 
 13.969 0.6615 0.5015 5.75 2.071 -2.303 -1.93133
17.1 16.353 0.743667 0.65 4.607 2.161 -2.08467 -1.87467
18.5125 14.235 0.780667 0.613667 5.381 3.25 -2.34333 -1.996 
14.975 16.97 0.947667 0.658333 10.6075 6.289 -2.8 -2.093 
17.052 15.928 0.887333 0.709 4.375 3.536 -3.83 -1.9 
17.069 15.3 0.6615 0.5015 5.143 1.393 -2.61 -2.08467
 
Figure B4  
Control ALS 
102.0759 100.8769
95.03014 69.19992
134.4713 64.46098
92.17774 58.45801
76.24488 60.99797
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  Cortex    Sub. Nigra 
 Young Old Old + CAN Young Old Old + CAN 
 75.32374 140.9353 117.4101  141.3428 122.6148 103.5336 
 115.9116 133.7701 96.81767  76.58537 137.8049 93.41463 
 117.1942 116.1151 63.88489  69.25795 126.2195 120.8481 
 84.46275 122.9876 84.23811  111.2195 120.6098 120.2439 
 107.482 107.2662 103.5971  89.39929 128.6219 113.0742 
 99.62561 138.0382 104.2306  112.1951 124.0283 101.7073 
  103.3813      
Ave 100 123.2134 95.02975  100 126.6499 108.8036 
SEM 6.964833 6.108613 7.634555  10.93849 2.5043 4.171804 
        
  Septum    Septum  
 Young Old Old + CAN Young Old Old + CAN 
 105.4859 109.4044 89.92524  104.5136 113.1902 101.227 
 106.3724 125.3918 107.21  101.4899 101.7528 119.3258 
 94.51411 122.4138 83.73087  93.99649 106.6854 100.3067 
 101.4596 113.8483 110.9718  103.8202 100.7011 125.3933 
 92.16803 106.2656 103.5956  92.19101 108.8764 104.2507 
     103.9888 121.3409 118.8431 
        
 100 115.4648 99.0867  100 108.7578 111.5578 
 2.422125 3.109904 4.421166  2.236955 3.142553 4.111115 
        
  Hippocampus   Cerebellum 
 Young Old Old + CAN Young Old Old + CAN 
 80.96291 108.4746 85.08966  93.02514 99.79869 85.80697 
 110.0196 123.1147 104.3478  129.2782 121.993 101.7032 
 115.7455 98.64898 95.01351  92.86294 65.07297 110.6245 
 89.98035 132.0236 97.56817  84.83374 89.61882 73.0738 
 101.4001 128.2908 121.8075  85.45546 95.62044 101.0065 
 101.8914    110.3674 87.18573 121.389 
     104.1772 117.4371 93.91042 
 100 118.1105 100.7653  100 96.67525 98.21635 
 5.21746 5.751288 5.57015  6.504889 7.272681 6.007058 
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Figure 
D2       
  Cortex    Sub. Nigra 
 Young Old Old + CAN Young Old Old + CAN 
 101.0695 109.0909 96.25668  104.0248 103.096 105.8824 
 101.1348 111.749 89.91989  87.84466 96.69903 77.59223 
 94.65241 116.0547 97.86096  100.3096 110.5263 104.9536 
 94.32577 107.3431 89.31909  116.0388 88.7767 86.67961 
 104.5394 113.9037 97.86096  95.66563 103.096 117.0279 
 104.2781 104.2781 101.0695  96.1165 93.6699 113.7087 
       120.743 
Ave 100 110.4033 95.38119  100 99.31065 103.7982 
SEM 1.845114 1.77584 1.932157  3.895122 3.183558 6.066786 
        
  Septum    Septum  
 Young Old Old + CAN Young Old Old + CAN 
 103.1674 119.457 95.9276  98.68766 106.0367 117.5853 
 86.21473 108.2063 101.6867  91.45667 99.75415 93.76152 
 94.11765 134.8416 86.87783  97.6378 107.0866 115.4856 
 104.8978 107.6224 101.9786  103.8107 104.0873 106.7609 
 86.87783 117.6471 81.44796  101.8373 115.4856 102.8871 
 108.8874 105.2871 105.3844  104.7326 96.61955 109.158 
 115.8371 95.9276 87.78281  101.8373 94.48819 111.2861 
 100 112.7127 94.44083  100 103.3654 108.1321 
 4.255666 4.737443 3.455962  1.85563 2.914311 3.048574 
  Hippocampus   Septum  
 Young Old Old + CAN Young Old Old + CAN 
 100.1764 111.4638 104.4092  105.8824 90.65744 92.04152 
 84.63826 115.56 102.3786  80.7377 81.86475 111.0656 
 101.5873 108.642 94.53263  81.6609 98.2699 100.5123 
 115.3617 104.2616 91.97225  119.2623 123.668 119.3648 
 96.64903 107.231 101.5873  103.8062 87.19723 90.65744 
 101.5873 111.4638 90.38652  108.6505 169.5697 77.50865 
   98.76543   86.50519 99.65398 
 100 109.7704 97.71884  100 105.3903 98.68632 
 4.034293 1.605434 2.232788  6.330654 11.91429 5.21496 
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Figure 
D3       
  Cortex    Sub. Nigra 
 Young Old Old + CAN Young Old Old + CAN 
 91.49041 103.6891 93.35957  102.3589 113.6479 91.65965 
 110.9944 97.65287 123.2242  107.6813 142.1393 83.3453 
 102.9021 100.7378 93.75307  96.12468 110.615 122.4937 
 89.12909 90.98209 104.8796  102.9433 130.9404 99.71285 
 104.4761 88.1456 97.49139  101.5164 110.1938 100 
 99.87647 113.9592 57.99876  89.37545 113.2807 119.3108 
 101.1313 85.98131 111.5593     
Ave 100 97.30687 97.46655  100 120.1362 102.7537 
SEM 2.850317 3.722921 7.723462  2.604021 5.414389 5.807383 
        
  Septum    Septum  
 Young Old Old + CAN Young Old Old + CAN 
 106.5205 97.53425 84.60274  101.1757 104.5348 93.78569 
 90.97545 139.3497 119.4426  86.79879 96.74169 87.47061 
 110.0274 90.9589 89.42466  90.29224 99.56332 93.3826 
 113.0723 160.8494 135.5674  121.7333 108.8344 110.5811 
 93.15068 108.1644 92.49315  87.51592 87.51592 117.707 
 95.95222 136.7618 141.1413  106.242 93.24841 123.8217 
 90.30137 96.54795 78.46575  106.242 76.05096 97.07006 
 100 118.5952 105.8768  100 95.21278 103.4027 
 3.627788 10.17513 9.71363  4.820613 4.151846 5.255156 
        
  Hippocampus   Septum  
 Young Old Old + CAN Young Old Old + CAN 
 93.03268 116.1388 84.11452  104.1871 107.776 132.3545 
 107.6813 113.2807 83.3453  80.98988 77.27784 56.86164 
 107.626 112.8959 87.45883  93.20283 132.137 107.3116 
 102.9433 130.9404 99.71285  120.9786 104.7807 89.25759 
 87.66152 101.3428 88.97897  107.1234 108.4285 131.1582 
 89.37545 142.1393 119.3108  98.0315 92.12598 116.4763 
 111.6798 97.28908 101.5455  95.48668 124.0892 98.09679 
 100 116.2896 94.92383  100 106.6593 104.5024 
 3.702962 5.951935 4.887979  4.731377 6.961303 9.976902 
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Figure F4  
young old 
104.5188557 128.9895
102.9746424 140.9488
104.6814044 132.0404
92.00260078 134.8471
95.82249675 125.9387
 
Figure F5  
young old 
216 224 
187.3333 249.5 
159.3333 185.3333
172 153.5 
237.6667 180.5 
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